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ABSTRACT 
 
 The bivalve clams are traditional seafoods occupying a leading share to the edible 
bivalve mollusks in the estuarine and marine ecosystems of India. Corbiculid clam Villorita 
cyprinoides (black clam) and venerid clam Paphia malabarica (yellow-foot clam) are 
recognized to be the common bivalve clam resources in the coastal areas of the southwest coast 
of India. The bivalve clams, though regarded as low-value by-catch, believed to possess 
valuable nutritional qualities and pharmacological properties.  
The bivalve clams, V. cyprinoides and P. malabarica collected from the estuarine 
system of the southwest coastal waters of India, and evaluated for their nutritional composition. 
A balanced essential to non-essential amino acid ratio (> 1.0) with a greater quantity of sulfur 
containing amino acids in these species demonstrated that they could provide well-balanced 
protein depositions. P. malabarica displayed lesser atherogenicity (0.7) and thrombogenicity 
(0.3) indices and greater hypocholesterolemic to hypercholesterolemic ratio (1.7) when 
compared with those in V. cyprinoides, thereby indicating the nutritional superiority of former. 
A greater content of vitamin D3 (> 150 IU), along with significant quantities of calcium and 
phosphorus (> 500 mg/100 g) in clams signified their importance in preventing osteoporosis.  
The ethyl acetate:methanol (EtOAc:MeOH) solvent extract  of V. cyprinoides and P. 
malabarica assessed for their bioactive potentials, namely antioxidant, anti-diabetic, anti-
inflammatory and anti-hypertension using various in vitro analyses. No significant difference 
was apparent for antioxidant potentials evaluated by 1,1-diphenyl-2-picryl-hydrazil (IC50 DPPH 
0.76 mg/mL) among P. malabarica and V. cyprinoides (p > 0.05). However, EtOAc:MeOH 
extract of P. malabarica demonstrated greater 2,2’-azino-bis-3-ethylbenzothiozoline-6-sulfonic 
acid (IC50 ABTS+ 1.27 mg/mL) radical scavenging activities along with lipid peroxidation 
inhibitory potentials (2.39 mM MDAEQ/kg) than those recorded with V. cyprinoides (p < 0.05). 
Likewise, anti-inflammatory effects of EtOAc:MeOH solvent extract of P. malabarica against 
pro-inflammatory cyclooxygenase-2 (IC50 COX-2 0.92 mg/mL) and 5-lipoxygenase (IC50 5-
LOX 1.51 mg/mL) enzymes registered significant potencies than V. cyprinoides (IC50 1.03 and 
1.64 mg/mL, respectively). A greater anti-hypertensive property against angiotensin converting 
enzyme-1 (IC50 ACE-1 1.11 mg/mL) and anti-diabetic potentials against dipeptidyl peptidase-4 
(IC50 DPP-4 1.00 mg/mL) were recorded for EtOAc:MeOH extract of P. malabarica than those 
recorded with V. cyprinoides. A significant co-linearity has observed among various 
bioactivities and deshielded electronegative functionalities present in proton NMR spectra of 
EtOAc:MeOH extracts of the studied bivalve clams.  
The bioassay guided chemical investigations of EtOAc:MeOH extract of V. 
cyprinoides led to the isolation of bioactive metabolites classified under various classes of 
chemistries, like spirocyclic ether derivatives (1-2), meroterpenoids (3-5), hexahydro 
isochromenyl analogues (6-7) and cholestenol derivatives (8-10). The chemical investigations of 
EtOAc:MeOH extract of P. malabarica led to the isolation of different metabolites classified 
under aryl polyketide derivatives (1-3), tetrahydro chromenyl analogues (4-5), isopimarane 
norditerpenoid (6), meroterpeno 2H-pyranoids (7-8) and cholestenol derivatives (9-10). The 
structures of isolated compounds were unambiguously assigned by 1D (1H, 13C, 135DEPT), 2D 
(1H-1H COY, HSQC, HMBC, NOESY) nuclear magnetic resonances (NMR) spectroscopy, 
Fourier transform infrared (FTIR) and mass spectrometric experiments. The spirocyclic ether 
derivatives, 1 and 2 isolated from V. cyprinoides were displayed significantly greater (p < 0.05) 
antioxidant activities against DPPH radical (IC50 < 0.60 mg/mL) as equated with other 
compounds and standard, α-tocopherol (IC50 > 0.60 mg/mL). Likewise, the compounds 1 and 2 
(IC50 0.62-0.67 mg/mL), which along with furano meroterpenoid derivative, 5 (IC50 0.64 
mg/mL) displayed significantly greater ABTS+ scavenging effects (p < 0.05) as compared to 
those exhibited by other compounds and commercial antioxidative agent, α-tocopherol (IC50 > 
0.70 mg/mL). The spirocyclic ether derivative, 2 recorded significantly greater inhibitory 
activity against COX-1 and COX-2 (IC50 0.86 and 0.65 mg/mL, respectively) as related to other 
compounds with higher IC50 values of > 0.90 and > 0.70 mg/mL, respectively (p < 0.05). In 
addition, the compounds from V. cyprinoides (1-10) displayed potential bioactivities against 
pro-inflammatory inducible enzyme, COX-2 than the constitutive isoform COX-1, and 
consequently recorded greater selectivity indices (SI, IC50 anti-COX-1/IC50 anti-COX-2 > 1.00) 
than the anti-inflammatory drug, ibuprofen (SI 0.63). Similarly, spirocyclic ether derivatives, 1-
2 (IC50 0.75-0.77 mg/mL), hexahydrobenzo furanone, 3 (IC50 0.76 mg/mL) and furano 
meroterpenoid derivative, 5 (IC50 0.80 mg/mL) exhibited significantly greater inhibitory 
potentials against pro-inflammatory 5-LOX when compared to other compounds and ibuprofen 
(IC50 > 0.90 mg/mL; p < 0.05).  
The hydroxy oxo-pyran enclosed benzoate derivative, 3 (IC50 0.59 mg/mL) and 
furanyl-2H-tetrahydro-chromenyl, 4 (IC50 0.56 mg/mL) isolated from P. malabarica were found 
to exhibit significantly greater DPPH inhibitory activity related to other compounds in the series 
and α-tocopherol (IC50 > 0.65 mg/mL; p < 0.05). Likewise, the compounds, 3 (IC50 0.69 mg/mL) 
and 4 (IC50 0.67 mg/mL) did not display noteworthy difference in ABTS+ scavenging (p > 0.05) 
potentials. These compounds were found to display significantly greater (p < 0.05) ABTS+ 
scavenging effects when equated to other compounds and α-tocopherol (IC50 > 0.74 mg/mL). 
The hydroxy benzoate derivative, 3 (IC50 0.68 mg/mL) registered greater inhibitory properties 
against COX-2 followed by that of hydroxy benzoate, 1 (IC50 0.74 mg/mL) and furanyl-2H-
tetrahydro-chromenyl, 4 (IC50 0.72 mg/mL), in descending order. The compounds, 1-10 isolated 
from P. malabarica registered greater selectivity indices (SI > 1.05) than that recorded with 
ibuprofen (SI 0.63), which appropriately demonstrated the greater anti-inflammatory activity of 
former against pro-inflammatory COX-2 than COX-1. Moreover, these compounds (3, 6 and 4) 
exhibited significantly greater 5-LOX inhibitory properties when compared to other compounds 
and ibuprofen (IC50 > 0.77 mg/mL; p < 0.05).  
The target bioactivities of the studied compounds from V. cyprinoides and P. 
malabarica correlated with their structural parameters using different physicochemical 
descriptor variables, wherein the bioactivities of the studied compounds were directly 
proportional to their electronic parameters. An optimum hydrophobic-hydrophilic balance along 
with lesser steric bulk of the studied compounds manifested towards their greater bioactivities. 
Putative antioxidative mechanisms proposed for the studied bioactive secondary metabolites 
from V. cyprinoides and P. malabarica in the DPPH radical scavenging model. The modes of 
inhibition of COX-2 and 5-LOX pro-inflammatory enzymes by the candidate compounds from 
these bivalve clams determined by in silico molecular docking simulations. The present study 
envisaged the significance of nutritional and bio-potential functionalities of commonly available 
seafoods, V. cyprinoides and P. malabarica.  
Among various mollusks, bivalve clams, particularly V. cyprinoides and P. 
malabarica have considered as traditional health food and natural dietary source, even though, 
the scientific investigations to acknowledge the health benefits of these species were relatively 
confined. Considering the underutilization of these species, exploring bioactive compounds has 
duel benefits as health products and their commercial farming in coastal habitats of southwest 
coast of India. The current findings of bioassay guided isolation and characterization of 
secondary metabolites from V. cyprinoides and P. malabarica appropriately recommended their 
utilities as potential bioactive leads in the functional food formulations and templates for 
therapeutic applications. 
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1.1. Background 
During the previous decades, the marine organisms have significantly 
contributed towards the development of bioactive metabolites as potential therapeutic 
agents in functional foods and pharmaceuticals. An increase in the number of patents 
filed and granted in the subject area of marine bio-prospecting and pharmacophores 
from the organisms dwelling in the marine and coastal habitats is a ready testimony to 
this statement. Among various marine organisms, those belonging to the class Molluska 
are of particular interest, and have been extensively distributed in the marine and 
estuarine habitats. Estuarine and coastal mollusks, especially bivalves contribute 
significantly towards the total fish catch in the coastal and estuarine waters of India 
(Figure 1.1.). The bivalve mollusk fishery is constituted predominantly by clams, 
mussels and oysters. Over the past decades, the importance of the bivalve clams has 
been increased as unconventional resources to conventional finfish fishery in different 
regions of the world. Due to their potential market values and nutritional qualities, clam 
aquaculture recorded an increasing trend in the recent years. The greater interest in this 
field could be corroborated by the increased number of research publications with 
regard to the isolation and characterization of hitherto undescribed chemistries from 
mollusks and bivalve clams (Blunt et al., 2012; Blunt et al., 2014), which appropriately 
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signified the wider scope of the bivalves in medicinal chemistry research and 
applications. The recently published reports on bivalve mollusks of marine and 
estuarine origin, as natural bioactive products and their applications as health foods, 
nutraceuticals, cosmetics and medications (Watanabe et al., 2012) additionally 
explained the increased interest to explore these groups of invertebrates to develop 
functional food supplements and high value compounds for human health.   
Mollusks are the predominant marine phylum that appeared 545 million years 
back comprising around 1,20,000 described and 2,00,000 undescribed species 
(Chapman 2009; FAO 2012). These species are abundantly available in the coastal, 
estuarine and brackish water environments. These groups of organisms are sessile (L. 
mollis, soft) preferably with a hard shell for the purpose of defense. The percentage 
distribution of prominent group of marine organisms vis-à-vis marine and estuarine 
mollusks were presented in the Figure 1.2. The largest class among the mollusks is 
Gastropoda, followed by Bivalvia. The later broadly includes clams, oysters and 
mussels. Among the mollusks, clams formed 27.2%, cockles 21.9%, scallops 15.7% and 
the remaining 4.2% has been constituted by other mollusks (Chapman 2009). The 
estimated annual landings of mussels, oysters and clams in India during 2015 were 
92513 tonnes (CMFRI Annual Report 2015-2016), and are therefore, found as a 
valuable fishery resources in various parts of coastal regions of the southwest India. The 
southwest coastal waters of Arabian Sea are the main productive marine fishery sectors 
in India, signifying around 90% of the collective bivalve clam production (Gosling 
2002).  
Bivalve mollusks are important seafood resources in estuarine and coastal 
regions of the world constituting a predominant share in the international trade markets 
(Xie et al., 2012). Among various classes of molluskan bivalves, clams occupied a 
major share of edible mollusks in the world (Murray and Burt 2001). In general, these 
species are repeatedly undervalued and regarded as by-catch or discard fishery 
resources (Gosling 2002), and have been widely exploited for their meat and shell for 
industrial purposes. However, they were not comprehensively investigated for their 
nutritional, biochemical and pharmacological properties. The importance of low value 
bivalve clams as potential health food has been recognized very recently and the 
medicinal properties of these species began to receive considerable attention. Due to 
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their ecological significance, nutritional and market values over different parts of the 
world, bivalve clams have acknowledged for substantial interest in recent years.  
 
 
Figure 1.1.: The coastal and estuarine waters of India gifted with bivalve mollusks 
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Figure 1.2.: The percentage share of marine and coastal mollusks among various 
classes of marine organisms 
 
1.2.  Biological potentials of secondary metabolites from marine and estuarine 
habitats 
Over the previous decades, the investigations on the natural products from 
coastal, marine and estuarine environments have showed an increasing trend in the 
medicinal, nutritional and organic chemistry fields. The marine or estuarine creatures 
are inexhaustible producers of chemically or structurally distinctive and diverse bio-
potent secondary metabolites, which have been originated through the varied 
biosynthetic mechanisms (Costa-Lotufo et al., 2009). Benthic species (bivalves, 
gastropods, bryozoans, tunicates etc.) were capable of biosynthesizing specialized 
metabolites that were found to aid these organisms to survive in the adverse saline 
habitats. Marine and estuarine environments are an extremely complex ecosystem with 
broad pressure limits (1-1000 atm), thermal range (from less than freezing point in 
Antarctic areas to 350°C in deep hydrothermal vents), nutrient limits (oligotrophic to 
eutrophic) along with their broad photic and non-photic regions. These extensive eco-
chemical variations in the marine habitats have facilitated speciation at all phylogenetic 
ranks with various collections of life forms. In the view of enormous taxonomic 
varieties of the marine organisms, explorations related to the investigations of newer 
bioactive complexes from marine or estuarine habitats can be seen as an unlimited field. 
Of note is that the chemical compounds with pluralities of bioactive properties are 
present in the marine organisms as an adaptive mechanism to survive against the 
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extreme stress factors in the oceanic ecosystems, which cannot be found in terrestrial 
organisms. “Poison kills the poison”, a popular proverb is the base of researchers in the 
discovery of biomedical components or metabolites from aquatic organisms. Therefore, 
the marine living organisms were found to be an important source to develop high value 
compounds and pharmaceutically active leads (McClintock and Baker 2001). The rich 
variety of mollusk species belonging to marine and estuarine origin represents 
unexploited resources of bioactive compounds with valuable biomedical and 
pharmaceutical potencies, and there is a substantial exploitation of these compounds as 
pharmaceuticals and functional food supplements (Lordan et al., 2011).  
 
1.2.1. Importance of small molecular weight secondary metabolites  
 The low molecular weight metabolites (LMWM) are organic compounds 
from biological sources with molecular weight below 900 Dalton (Macielag 2011). 
Different terminologies are used to represent LMWMs. The pharmaceutical researchers 
categorized them as natural products (eg. antibiotics) and the biologists denoted them as 
primary and secondary metabolites. The primary metabolites are crucial for the growth 
and development of an organism and the secondary metabolites are required to survive 
in their unfavourable habitats. The LMWMs constitute a major share of bioactives in 
marine organisms, and were found to possess potential health benefits (Blunt et al., 
2015; Hadacek and Bachmann 2015).  
 The molecular size of LMWMs depended on the presence and absence of 
polar functional groups and it can be either volatile or non-volatile. These have been 
characterized by diverse combinations of functional groups, such as unsaturated bonds, 
oxygenated and/or other heteroatoms that define their chemical, structural and potential 
peculiarities (Hadacek and Bachmann 2015). The various classes of compounds, such as 
lipids, flavonoids, polyketides, terpenoids, steroids, tetrapyrroles and pyranoids are 
some common examples of small molecular weight secondary metabolites. 
Predominantly, these LMWMs were prominent in the sessile organisms, such as 
sponges, mollusks, corals, plants and in all types of microorganisms. The antioxidant 
LMWMs can scavenge free radicals, and depending on their chemical environment, it 
can act as pro-oxidant agents by reducing molecular oxygen. These molecules can also 
permeate through the lipid trans-membrane barrier with relative ease. The natural 
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components with small molecular weights can perform with more effectiveness and 
specificity in the protein receptor sites and have excellent platforms for natural product-
based drug design and development (Clardy and Walsh 2004). Moreover, due to their 
greater diversity and specificity, the investigations of newer small molecular bioactive 
components from marine and estuarine organisms were found to be an unlimited field of 
research.   
 
1.3.  Pharmacological significance of antioxidant and anti-inflammatory 
properties 
1.3.1. Free radicals and its relation to various life threatening disorders  
The knowledge of reactive oxygen species (ROS) or free radicals are an 
important area of pharmaceutical research (Aruoma 2003). Notably, the free radicals are 
formed due to the normal metabolic processes in the body or due to external exposures, 
such as ozone rays, UV radiations, X-rays, pollutants, chemicals/metals from industrial 
wastes and by enzymatic/non-enzymatic reactions (Aruoma 1994). The incidence of 
unpaired electrons makes the free radicals extremely unstable and potentially reactive 
reductants or oxidants, which can donate or accept electron(s) from other molecules 
(Cheeseman and Slater 1993). The major oxygen bearing free radicals were hydrogen 
peroxide (H2O2), hypochlorite (ClO-), hydroxyl (.OH), superoxide anion (O2-) and 
singlet oxygen. These extremely reactive species were potentially capable to destruct 
the biologically significant molecules like lipids, DNA, proteins and carbohydrates in 
the nucleus along with cell membranes which leads to cell damage and cellular 
disorders (Young and Woodside 2001). The ROS reaction mechanisms and oxidative 
cellular damages were depicted in the Figure 1.3.-1.4. 
Non-radical products (H2O2/HOCl) were also found to be powerful oxidizing 
agents in free radical induced reactions. The radical and non-radical species were 
generally accounted as “reactive oxygen species” (ROS) and the term “oxidative stress” 
was used to account for the damages in cellular membranes by mitochondrial 
respiratory chains (Poyton et al., 2009). The redox active components in the 
intracellular environment (reducing medium) were present in reduced state (RH2) by the 
autoxidation mechanisms that forwarding to the development of superoxide (O2-) 
radicals. The thiol-bound amino acid (cysteine), nucleotides, reducing sugars, 
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catecholamines etc. were easily subjected to autoxidation reactions (Carrell et al., 1975) 
catalyzed by different metal ions along with enzymes (especially lipoxygenase, 
cyclooxygenase and myeloperoxidase) and these autoxidized products were the 
potential sources of free radicals (ROS) in the tissues (Bartosz 2003). The formation of 
hydrogen peroxide/peroxide radicals were catalyzed by superoxide dismutases (SOD) 
leading to the propagation of hypochlorite radicals by the oxidation reactions of Cl- with 
hydrogen peroxide catalyzed by myeloperoxidases (MPO) (Halliwell and Gutteridge 
2006; Kanofsky 1986). The hydroxyl radicals are formed in the biological systems by 
Fenton reaction between iron/copper ions (Cu+/Fe2+ and H2O2) (Kanofsky 1989). 
Overall, the formation of primary ROS, such as superoxides resulted in the propagation 
of other reactive oxygen species.  
 
 
Figure 1.3.: Formation of reactive oxygen species and their reaction mechanisms. O2-
molecular oxygen, H2O2-hydrogen peroxide, NO-nitric oxide, H2O-water, .NO2-
nitrogen dioxide, ONOO--peroxynitrite, .O2--superoxide anion, HOCl-hypochlorous 
acid, ONOOH-peroxynitrous acid, .OH-hydroxyl radical, SCN-thiocyanate, HOSCN-
hypothiocyanous acid, NOX- NADPH oxidase, SOD-superoxide dismutase 
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Figure 1.4.: The mechanisms of oxidative cellular damage. The formation of hydroxyl 
free radicals from hydroperoxide induces oxidative cellular damage, impairment of 
DNA, protein carboxylation, peroxidation of lipids and damages in mitochondria. These 
mechanisms lead to oxidative injury and finally to cell death 
 
The unrestrained free radical generation is closely related to peroxidation of 
lipids and proteins. An imbalance in the production of free radicals and the antioxidant 
resistance mechanisms appeared to cause oxidative stress in the cell organelles. The 
ROS are also demonstrated as the mediators of inflammation, atherosclerosis, cancer, 
diabetes, gastric ulcers, hypertension and other age related problems (Stefanis et al., 
1997). The free radical associated diseases in humans were described (Figure 1.5.).  
 
 
Figure 1.5.: The free radical associated diseases in human 
8 
 
Introduction               Chapter 1 
The development and propagation of inflammations were manifested by the 
neutrophils, which is the major causes of free radicals at the pro-inflammation site 
(Mathy-Hartert et al., 2002). The generation of ROS led to the signaling cascades that 
activate the formation of pro-inflammatory mediators, such as tumour necrosis factor, 
cyclooxygenases (COX-1 and COX-2 isoforms), lipoxygenases (5-LOX isoforms), 
cytokines, interleukins, inducible nitric oxide synthases (iNOS) and chemokines. These, 
in turn, found to produce more ROS and inflammatory prostaglandins in the damaged 
sites leading to oxidative stress induced inflammations (Ryan et al., 2004). The 
sustained inflammatory responses can potentially lead to cell damages and ROS 
overproduction in the inflammatory cells. The chronic inflammation cause damages to 
DNA leading to cellular malignancy and cancer. The oxidative stress was too found to 
have major role in the development of diabetes, predominantly, type-2 diabetes. The 
diabetic complications were due to the variations in the catalases, SOD and glutathione 
peroxidase, which disposed the cells to oxidative stress (Lipinski 2001). The glucose or 
insulin levels along with dyslipidemia in diabetic patients form macroangiopathies were 
reported to cause oxidative stress and atherosclerosis (Giugliano et al., 1995). Increase 
in the levels of ROS linked to non-enzymatic glycation of proteins, lipid peroxidation 
and glucose oxidation were contributed to diabetes and related complications. The ROS 
generated within the vascular wall, vascular/endothelial smooth muscles and in the 
fibroblasts, also appeared to have significant role in causing vascular inflammation. In 
normal circumstances, the controlled or low level ROS productions can act as a 
signaling agent for vascular contractions and relaxations. The ROS production from 
NADPH oxidase was reported to activate angiotensin-2 (Ang-2) in vascular tissues 
which resulted in hypertension. Ang-2 exerted harmful functional or structural damages 
through the NADPH oxidase which resulted in the ROS generation (Virdis et al., 2011). 
 
1.3.2.  The biological defense against free radicals 
The uncontrolled generation and propagation of radicals led to oxidative 
strain in the tissues. The antioxidant molecules are termed as “free radical scavengers” 
that can neutralize the free radical(s) by the transfer of electron(s) (Antolovic et al., 
2002) (Figure 1.6.). The word antioxidant has been defined as “any matter that removes 
or prevents oxidative damages in the targeted molecules” by Halliwell (2007), whereas 
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Khlebnikov et al., (2007) defined as ‘‘any matter that directly prevents ROS or 
indirectly plays to up-regulate the antioxidant defenses or hinder ROS productions’’.  
The human body neutralizes the free radicals by using antioxidants, which 
were either supplied by external foods/supplements (exogenous) or naturally produced 
in the tissue organelles (endogenous). The antioxidant molecules also quench oxidative 
reactions related to ROS, thus counterbalancing the adverse effects of free radicals and 
free radical induced ailments (Sevanian and Ursini 2000). The antioxidant mechanisms 
against free radical induced damages were illustrated (Figure 1.7.).  
 
 
Figure 1.6.: Mechanism of neutralization of free radicals by antioxidant agents 
 
 
Figure 1.7.: Antioxidant mechanisms against free radical induced damages. The 
antioxidants inhibit the oxidative stress and constrain the nuclear factor kappa-enhancer 
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of activated B cell (NF-kB), redox reactions, inflammations and interferes metal 
chelation. The antioxidants activate superoxide dismutase (SOD), thioredoxin reductase 
(TR) and catalase (CAT). ROS-reactive oxygen species, H2O2-hydrogen peroxide, O2--
superoxide anion, .HO-hydroxyl radical  
 
Antioxidant molecules mechanized in different ways, such as (i) preventing 
and maintaining the generation of ROS to least level, (ii) quenching of ROS by catalytic 
or non-catalytic molecules and (iii) repairing the impaired targets (Zhivotovsky and 
Orrenius 2011). The two categories of antioxidant systems were found to be enzymatic 
and non-enzymatic, which can synergistically alleviate or deactivate the free radicals 
before attacking the target cells. The most effective enzymatic antioxidants are 
superoxide dismutase, glutathione peroxidase, catalase etc. (Mates et al., 1999), whereas 
non-enzymatic classes include ascorbic acid, tocopherol, thiols, carotenoids and 
flavonoids (McCall and Frei 1999). Endogenous antioxidants were potential free radical 
quenchers, even though, in certain circumstances, such as extreme oxidative stress, 
these endogenous molecules may not exhibit their efficacies. Therefore, the exogenous 
dietary antioxidant supplements (vitamins, minerals etc.) required for normal metabolic 
functions. Some antioxidants regenerate each other and develop an antioxidant network, 
which can effectively inhibit the production of ROS, thus the oxidative stress related 
diseases can be controlled (Kohen and Nyska 2002). 
 
1.3.3. The importance of natural alternatives  
Efficient antioxidant defense systems are necessary to scavenge, minimize or 
cease the formation and propagation of ROS. The free radicals are mostly connected 
with lipid peroxidation in foods resulting in the decreased nutritional qualities. 
Therefore, antioxidants were used in food/food ingredients to minimize their oxidative 
damages. Synthetic antioxidants, such as butylated hydroxyanisole (BHA), tert-
butyhydro-quinone (TBHQ) and butylated hydroxytoluene (BHT) were used to prevent 
lipid peroxidation in foodstuffs and pharmaceutical principles to increase their shelf-
life. However, these synthetic antioxidants were reported to be carcinogenic and their 
continuous uptake can potentially lead to organ damages (Schnitzer et al., 1999). 
Therefore, the natural antioxidants have acknowledged for substantial consideration in 
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the recent days to overcome the adverse effects of synthetic agents. The commonly used 
natural antioxidants were ascorbic acid, vitamin K, tocopherol etc. Flavonoids are 
another group of antioxidants, which include flavanols, flavonols, isoflavonoids, 
anthocyanins, flavanones etc., and have been typically found in the fruits and plants 
(Rice-Evans et al., 1996). Antioxidant phenolics, such as phenolic acids (rosmarinic, 
caffeic, gallic, protochatechuic), flavonoids (catechin, quercetin) and volatile oils 
(thymol, carvacrol, eugenol) have reported in literatures (Shan et al., 2007). The natural 
pigments and carotenoids were comparatively unreactive, but it can form non-radical 
compounds that can terminate radical induced damages by forming non-radical adducts 
with toxic radical intermediates (Paiva and Russell 1999). The selenium composites (or 
sulfur containing seleno-amino acids particularly in marine organisms) do not directly 
act on free radicals, but reported to exhibit their activities by inhibiting antioxidant 
enzymes (glutathione peroxidase, metalloenzymes, etc.) (Tabassum et al., 2010).  
The inflammatory ailments were mostly cured by NSAIDs (non-steroidal 
anti-inflammatory drugs). These were linked with various side effects, such as 
gastrointestinal disorders leading to mild to severe damages of gastric and intestinal 
mucosa (Weil et al., 1995). The NSAIDs deter inflammatory responses by interfering 
with cyclooxygenase (COX) pathways. In particular, the nonselective NSAIDs exert 
their effects through the quenching of constitutive COX-1 isoforms, and therefore, 
cause various side effects (Parente and Perretti 2003).  
Synthetic agents were associated with adverse effects on various clinical 
parameters, and the researchers have been interested in finding natural anti-
inflammatory agents and antioxidative formulations as substitutes of synthetics. 
Therefore, the target specified inhibitory agents from natural resources have gained 
importance in these years. Recently, antioxidant components from marine or estuarine 
organisms become a broad and widespread subject due to the safety concerns and 
increasing demand for nutraceuticals and functional food components. 
 
1.4.  Importance of mollusks and bivalves as potential resources of bioactive 
compounds  
 Antioxidant defense mechanism is an extremely well-maintained biochemical 
process that guards the organisms from destructive effects of ROS. The organisms have 
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been endowed with complex defensive mechanisms for biosynthesizing specialized 
bioactive metabolites to challenge the unfavourable oxidative stress conditions (Chainy 
et al., 2016). The marine-derived nutrients and other bioactive components were found 
to possess potential functional foods and high value compounds with health benefits. 
Previous studies established that the bioactive components from mollusks have vital 
role in the development of functional health foods and pharmaceutical leads (Datta et 
al., 2015; Hamed et al., 2015).  
The mollusks are important class of organisms representing about 23% of the 
total marine flora and fauna. Mollusks (phylum: Molluska) have been stratified into 
various classes, named as Scaphopoda, Monoplacophora, Aplacophora, Bivalvia, 
Polyplacophora, Cephalopoda and Gastropoda. Previous research findings characterized 
various groups of specialized metabolites in mollusks with antioxidant, anti-
inflammatory, anti-diabetic, anti-hypertensive, anti-cholesterol, anti-microbial, anti-
cancer and anti-HIV properties (Benkendorff 2010; Chakraborty and Joy 2017; 
Chellaram and Edward  2009; Nagash et al., 2010; Schwartsmann et al., 2001; Wei et 
al., 2007). Small (low) molecular weight compounds (LMWC), such as alkaloids, 
carotenoids, steroids, phenolics and terpenoides were found to be the predominant 
groups of bioactive compounds in mollusks (Andersen et al., 1985; Baunbaek et al., 
2008; Chattopadhyay and Pattenden 2000; Pettit et al., 2005). The gastropod mollusk, 
Dolabella auricularia (Sea hare) (Yamada et al., 2000) was reported for dolastatin 
analogues and Elysia rufescens was reported for anti-cancer agent, Kahalalide F (Lopez-
Macia et al., 2001). 
Bivalves in the coastal or estuarine areas were reported as potential sources of 
n-3 PUFAs comprising docosahexaenoic acid and eicosapentaenoic acid. Moreover, the 
utilization of bivalve mollusks afforded as an inexpensive resources of vitamins, 
minerals and protein (Astorga-Espana et al., 2007; Taylor and Savage 2006). Previous 
literatures have been established the antioxidative and anti-inflammatory functionalities 
of bivalve mussel (Chakraborty et al., 2014a; Chakraborty et al., 2016a). Recently, an 
anti-inflammatory nutraceutical, CadalminTM Green Mussel Extract (CadalminTM GMe) 
from Perna viridis (mussel) was developed to combat arthritis (Chakraborty et al., 
2014a; Chakraborty et al., 2014b). Whitehouse et al., (1997) have formulated the anti-
inflammatory potency of the oil fractionated from Green Lipped Mussel (Lyprinol™) 
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against polyarthritis. The anti-tumour and immune-stimulating effects of Crassostrea 
gigas (Oyster) hydrolysates were studied previously (Wang et al., 2010c).  
 
1.5. Bioactive potentials of bivalve mollusks and with reference to marine and 
estuarine clams 
Bivalve clams occupy a major share of the total edible mollusks in the world, 
yet they were not been explored for their biomedical and pharmaceutical properties 
(Murray and Burt 2001). The soft tissued bivalves have been adapted to adverse 
environments and believed that the cells of these sessile organisms were prolific 
producers of diverse classes of bioactive compounds and functional foods with 
biomedical significance. The antagonistic living habitats, ecological strain and filter 
feeding practices of bivalve clams were attributed towards their capacities to 
biosynthesize high value compounds (Goldberg 1975) with potential activities against 
various diseases (Lushchak 2011). The bivalve clams were exposed to extreme salinity, 
temperature and free radicals inducing noxious chemicals, even if, it’s cellular damage 
was not reported and therefore, regarded as potential natural antioxidant candidates 
(Gonzalez et al., 2015). The soft shell clam, Mya arenaria was reported to deter the 
oxidative stress conditions in response to adverse environmental circumstances (Abele 
et al., 2002), although they were not extensively explored in greater details for their 
pharmaceutical, nutraceutical and biomedical applications (Mohite et al., 2009). Earlier 
reports on bivalve clams were recognized their nutritional values as well as bioactive 
potentials (Pawar et al., 2013; Tsai et al., 2008; Wei et al., 2007). Higher α-tocopherol 
(antioxidant) and α-carotene contents were reported in the digestive gland of Antarctic 
bivalve clam, Laternula elliptica and M. arenaria (Estevez et al., 2002). Another 
carotenoid, fucoxanthin and its fatty acid ester derivatives were found in Mactra 
chinensis (Maoka et al., 2007).  
An anti-proliferative compound, Spisulosine ES-285 from Spisula polynyma 
(surf clam) and antioxidant chitosan from Donax scortum (clam) were characterized by 
extensive spectroscopic experiments (Hamann et al., 1993; Sanmugam et al., 2012). 
Meretrix lusoria (hard clam, Taiwan) was used as a remedy for hepatitis and liver 
ailments, and its metabolites were recognized to combat apoptosis in the HL-60 cell 
lines (Gauvin et al., 2000; Pan et al., 2007). An anticoagulant heparin-like compound 
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was isolated and characterized from the Italian clam, Callista chione (Luppi et al., 
2005) and from marine clam, Anomalocardia brasiliana (Cesaretti et al., 2004). The 
iron chelating Ferritin-H unit from Manila clam, Ruditapes philippinarum was found to 
display potential anti-bacterial properties (Kim et al., 2012). A novel antioxidant 
peptide was isolated and characterized from R. philippinarum with potential hydroxyl 
radical scavenging ability (Kim et al., 2013). The peptides from hard clam, M. lusoria 
were recorded ACE-inhibitory activity (Tsai et al., 2008) and polysaccharide from 
Meretrix petechialis was recorded anti-HIV activity (Amornrut et al., 1999). These 
results explained that, the bivalve clams were potential natural sources of small 
molecular weight secondary metabolites with bioactive potentials, and therefore, it is 
imperative to discover potential bioactive molecules from the bivalve clams. The 
coastline of Kerala is bestowed with large assemblage of different bivalve mollusks 
which illustrated in the Figure 1.8. 
 
 
Figure 1.8.: The coastline of Kerala bestowed with large assemblage of bivalve 
mollusks 
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1.6. Objectives 
The rich diversity of edible bivalve clams in the coastal and marine waters of 
India represents an untapped reservoir of bioactive compounds with valuable 
pharmaceutical and biomedical use. Among various bivalve clams, the Corbiculid black 
clam, Villorita cyprinoides (family, Corbiculidae) and yellow-foot Venerid clam, 
Paphia malabarica (family, Veneridae) are the common seafood resources in the 
coastal waters of India (Suja and Mohamed 2010) (Figure 1.9.-1.10.). These low-valued 
bivalve clams are traditional health food items among the coastal populace of India and 
various regions of the World. However, there were limited research findings to 
characterize the bioactive principles in these organisms, and the significant attention to 
develop potential pharmaceutical/nutraceutical leads and health-foods received 
considerable attentions in the recent years.  
 
 
Figure 1.9.: A collection site of bivalve mollusk, V. cyprinoides  
 
Figure 1.10.: A collection site of bivalve mollusk, P. malabarica 
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The samples of V. cyprinoides and P. malabarica were collected from the 
estuarine waters of Vembanad Lake (9°35’ N and 76°25’ E) and Ashtamudi Lake 
(8°59’ N and 76°36’ E), respectively, situated on the southwest coast of India, bordering 
the Arabian Sea (Figure 1.11.).  
 
 
Figure 1.11.: Sample collection sites of the bivalve clams from the southwest coast of 
India bordering the Arabian Sea in Kerala State (A); P. malabarica from Ashtamudi 
Lake at 8°59’ N and 76°36’ E (B) and V. cyprinoides from Vembanad Lake (9°35’ N 
and 76°25’ E) (C) along with shell-on samples of V. cyprinoides and P. malabarica 
 
The aim of current research points to the evaluation of nutritional qualities 
and bioactive potentials of bivalve clams V. cyprinoides and P. malabarica. The ethyl 
acetate-methanol (EtOAc:MeOH) solvent extract of these species were subjected for 
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repeated chromatographic fractionation and bioactive analyses. Furthermore, we aimed 
at the isolation of bioactive lead molecules with special reference to small molecular 
weight compounds from these bivalve clam species and their structural characterization 
using extensive spectroscopic analyses including mass, Fourier transform infrared 
(FTIR) and one/two dimensional nuclear magnetic resonance spectroscopic experiments 
(1D and 2D NMR). The bioactive potentials of newly described compounds from the 
candidate species were carried out by various in vitro analyses. The work also aimed to 
utilize different molecular descriptor variables to corroborate the structure-activity 
correlations of the titled compounds. Molecular docking simulations were carried out 
with special reference to inflammation (COX-2 and 5-LOX isoforms) and the binding 
energies obtained for the compounds were determined to understand their potential 
enzyme-ligand interactions. The hitherto undescribed bioactive compounds were 
reported in this study can be used as therapeutic leads and pharmacophore templates. 
 
 
Based on this background, the objectives of the thesis are as follows: 
 
 
 To develop an optimized procedure at laboratory for the extraction of anti-
inflammatory and antioxidant metabolites from Villorita cyprinoides (Family, 
Corbiculidae) and Paphia malabarica (family, Veneridae) available in 
southwestern coast of India.  
 To document the in vitro anti-inflammatory and antioxidant potentials of the 
crude extracts from these marine invertebrates. 
 To purify the active principles with special reference to small molecular weight 
bioactives by bioassay-guided chromatography, and to elucidate the structures of 
purified molecules by spectroscopic techniques like infrared (IR), mass and 
extensive NMR techniques, in conjunction with 2D NMR experiments.  
 To identify the molecular parameters of the lead molecules responsible for the 
bioactivities by quantitative structure-activity relationship analyses (QSAR).  
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1.7. Thesis outline 
Based upon the above mentioned objectives, the present Thesis has been 
summarized into seven chapters. The importance of this study on the nutritional and 
bioactive potentials of mollusks and bivalves, with objectives were discussed in the 
introductory chapter (Chapter 1). The detailed review of the studies based on the 
significance of mollusks and bivalves as antioxidative and anti-inflammatory bioactive 
agents along with the characterized bioactive secondary metabolites were envisaged in the 
Chapter 2. Chapter 3 described the nutritional parameters and biochemical compositions 
of bivalve clams V. cyprinoides and P. malabarica to understand their nutritional 
qualities. Chapter 4 explained the bioactive potentials, specifically antioxidant and anti-
inflammatory effects of the titled organisms and additionally reported their anti-diabetic 
and anti-hypertensive properties using different in vitro models. The isolation and 
characterization of small molecular weight secondary metabolites responsible for 
antioxidant and anti-inflammatory activities from V. cyprinoides and P. malabarica were 
described in the Chapter 5 and Chapter 6, respectively. Chapter 7 summarized the 
important research findings of the present study.  
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2.1.  Background  
Bio-prospecting of previously undescribed natural products mainly from the 
marine or estuarine environment has been improved considerably over the previous few 
decades, resulting into an investigation of newer secondary metabolites (Blunt et al., 
2015; Blunt et al., 2016; Faulkner 2000a; Faulkner 2000b). It has been stated that the 
marine/estuarine invertebrates particularly mollusks were the most prominent sources of 
natural products, and therefore, have been favourite choices of natural product chemists 
(Blunt et al., 2013; Blunt et al., 2014; Faulkner 1999). Newer natural compounds of 
marine origin have delivered promising bioactive compounds with previously 
undescribed structures/skeletons, and these could be used as promising nutraceuticals 
and therapeutic agents against various ailments (Lordan et al., 2011). Large numbers of 
newer natural compounds have been reported for their bioactivities, and as candidate 
molecules for potential drugs, even though, only a few of them qualified as drug 
candidates. Nonetheless, the worldwide and widespread bio-prospecting attempts have 
not been stopped, and continuous search for chemically and structurally different 
secondary metabolites were increased. Several novel compounds of marine origin were 
added to the natural products library, and among which, mollusks have significantly 
contributed towards the discovery of compounds with potential pharmacological 
properties (Blunt et al., 2015; Blunt et al., 2016). During the past few years, various 
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bio-potential components have been isolated, identified and characterized from different 
marine or estuarine organisms, such as mollusks, bryozoans, sponges, tunicates, corals 
etc. The key objective of this review is to emphasize the bioactive components from 
marine/estuarine mollusks, particularly from bivalves.  
 
2.2. Oxidative stress and related health problems 
The normal metabolic processes in the body or external exposures leads to the 
formation of free radicals and the studies on free radicals were found to be useful in the 
proper management of disease and health (Aruoma 2003). Free radicals were highly 
reactive species and reported to damage cellular components leading to cellular 
disorders (Young and Woodside 2001) (Figure 2.1.). The uncontrolled free radical 
generation followed by lipid and protein peroxidations resulted in various health 
disorders. The imbalance between the free radical production and the mechanism of 
antioxidant defenses pointed out to oxidative stresses. The reactive oxygen species 
(ROS) were the mediators of various ailments, such as inflammation, atherosclerosis, 
cancer, diabetes, hypertension etc. (Stefanis et al., 1997).  
The free radical accumulation in the body was found to be the primary cause 
for inﬂammatory responses as described in various literatures (Lushchak 2011; Wilcox 
2002). Therefore, it is anticipated that the antioxidant components can control the 
formation and propagation of free radicals. The lipid peroxidation caused by the free 
radicals transmutes fatty acids, lipoproteins and lipids to their corresponding 
hydroperoxides resulting in inflammatory responses (Camacho-Ruiz and Mendex 
2010). The cell membrane phospholipid generates arachidonic acid (AA), a substrate for 
prostaglandin H2 (PGH2), by the action of phospholipase enzymes. The 
cyclooxygenases and lipoxygenases catalyzes the synthesis of prostaglandins (PGs) to 
thromboxane A2 (TXA2), prostaglandin F2α (PGF2α), prostaglandin E2 (PGE2), 5-
hydroperoxyicosatetraenoic acid, 5-hydroxyeicosatetraenoic acid and leukotriene B4 
(Figure 2.2.). These were reported as mediators to develop inflammatory pathogenesis, 
and play a critical role to cause inflammatory disorders, such as arthritis (Morteau 
2000). The antioxidants were reported to effectually hinder the pro-inflammatory 
enzymes, such as cyclooxygenases and lipoxygenases (Fernandes et al., 2004) (Figure 
2.3.). Therefore, it has been anticipated that free radical inhibiting agents are better anti-
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inflammatory candidate molecules. The human metabolic system neutralizes oxidative 
stress by using antioxidants, which were either supplied by external foods/supplements 
(exogenous) or naturally produced in the tissue organelles (endogenous). The natural 
antioxidants like vitamin K, vitamin C (ascorbic acid), vitamin E (tocopherol) etc. were 
found to be effective radical scavengers. Flavonoids were found to be another group of 
antioxidants composed of flavanols, isoflavonoids, anthocyanins, flavanones etc. found 
in fruits and plants (Rice-Evans et al., 1996).  
 
 
Figure 2.1.: A schematic representation of mitochondrial ROS production. The ROS 
produced by mitochondria can leads to oxidative damages in the protein, lipid and 
DNA. The damaged mitochondrial cells increase the release of inter-membrane proteins 
like cytochrome c (cyt c) by mitochondrial outer membrane permeabilization and 
likewise, cell death. Also, mitochondrial ROS leads to the initiation of mitochondrial 
permeability transition pore (PTP) resulting in the tissue injury (Murphy 2009) 
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Figure 2.2.: Inflammatory mediators and mechanism of ROS mediated inflammatory 
responses. COX-cyclooxygenase, LOX-lipoxygenase, H2O2-hydrogen peroxide, HO.-
hydroxyl radical 
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Figure 2.3.: Relationship among reactive oxygen species induced inflammatory 
responses and the role of antioxidants to inhibit the production of inflammatory 
enzymes. ROS-reactive oxygen species, NOX-NADPH oxidase, TNF-a-tumour 
necrosis factor alpha, NF-kB-nuclear factor kappa B  
 
Synthetic antioxidants to oils/foods utilized to prevent lipid oxidations, 
although their adverse effects has been motivated the scientists to assess the natural 
compounds with bio-potential functionalities. Several synthetic antioxidants were 
reported to deter various intermediates of free radicals by reacting as oxygen scavengers 
and reduce free radical associated diseases. However, these synthetics were reported for 
serious side effects on multiple clinical parameters (Schnitzer et al., 1999). The non-
steroidal anti-inflammatory (NSAIDs) medications are common suppositories against 
inflammations. However, usage of these drugs was not safe due to the increased risk of 
gastrointestinal (GI) and cardiovascular (CVD) complications. The NSAIDs has 
reported to injure the mucosal layers of gut by reducing COX-1 derived prostaglandins 
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causing ulcers (Sostres et al., 2010). Therefore, there is an increasing trend to search for 
natural alternatives to overcome the side effects of synthetic agents and to develop 
bioactive lead molecules with greater selectivity profiles. Safety of natural agent is not 
assured, even though, there is some ease to know that these were extracted or purified 
from natural resources. Recently, bioactive agents from nature become a widespread 
and broad subject of research due to the increasing demand for functional food and 
nutraceuticals as natural therapeutic agents against various life threatening diseases. 
 
2.3. Marine habitat as a productive resource of bioactive metabolites 
Marine natural product chemistry (MNP) research was started during the 
1970’s and rapidly developed during the 1980’s before being full-fledged in the recent 
decade from 2000-2015 (Blunt et al., 2016; Faulkner 2000b). There were several 
publications available and it is very difficult to select individual papers that significantly 
impacted to the MNP field. The MNP chemistry has considerably influenced other 
fields, such as pharmaceuticals, nutraceuticals, cosmetics, functional foods, drug 
developments etc. (Faulkner 2000b). The combinations of marine biomedicals, marine 
chemical ecology and marine toxins have cumulatively substantiated the marine natural 
products with unique identity (Faulkner 2000a). The increase in the number of 
identified or published compounds from the year 1965 to 2005 were compared in the 
Figure 2.4., which envisaged the increased interest in the field of MNPs (Blunt et al., 
2006). However, the investigations have not led to prominent pharmaceutical or 
medicinal candidates, although there is a probability that many marine compounds 
could be recognized in the drug level.  
Marine habitats harbour more than 2,00,000 identified invertebrates and algae 
species, although, a greater number of species were yet to be identified (Gosling 2002; 
Gosling 2015). It is significant that the marine ecosystem is an untapped reservoir of 
novel components with therapeutic potentials, and therefore, has been a key attraction of 
natural product chemists due to its comparatively unexplored biodiversity than the 
terrestrial systems. The main resources of bioactive metabolites with pharmaceutical 
potentials were algae, mollusks, bryozoans etc. Reviews on various marine organisms, 
including bio-prospecting of mollusks, sponges, bryozoans, algae etc. were common 
and the classification of marine natural products among various phyla (Figure 2.5.).  
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Most of the marine organisms are sessile or soft bodied, and therefore, they 
have to protect themselves from the unfavourable marine ecosystems, such as salinity, 
temperature and attack of predators and pathogens in their habitats. Evolutionally, the 
response to this unfavourable condition is the development of in-built defense 
mechanisms leading to the generation and accumulation of biologically active 
metabolites. The distribution of various marine organisms evaluated for chemical 
investigations and natural product isolations over the period from 1971 to 2015 among 
different phyla was plotted in the Figure 2.6. (Blunt et al., 2016). The diverse chemical 
compounds, which were biosynthesized by the organisms for defense purpose other 
than basic metabolic requirements, defined as secondary metabolites. The compounds 
include alkaloids, peptides, terpenoids or steroids which provide natural immunities to 
the organisms. Likewise, the marine ecosystem encompasses a wide array of organisms 
with unique bio-potentials and bioactive metabolites. Moreover, it is one of the greatest 
underutilized biological resources and the search for newer bioactive compounds from 
marine/estuarine ecosystem is found to be an unlimited field of investigation and delight 
for natural product chemists. It is appropriate to state that MNPs have had an important 
impact on chemistry, pharmaceutical and drug development areas over past few years, 
and found to be valuable sources for newer bioactive templates in upcoming years.  
 
 
Figure 2.4.: Number of marine natural products over the period 1965 to 2005 (Blunt et 
al., 2006) 
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Figure 2.5.: Distribution of marine natural products by phylum (Blunt et al., 2003) 
 
 
Figure 2.6.: Distribution of marine organisms among phylum collected for natural 
product isolations over the period from 1971 to 2015 (Blunt et al., 2016) 
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2.4. Mollusks 
The phylum Molluska represents as one of the main and diverse classes of 
marine animals, and which contributed significantly greater to the total available marine 
fish catches in the world. These are soft bodied organisms as described by the Latin 
word “Molluscus” which means “soft”. These soft, sessile and heterogenous classes of 
animals were protected with shells to escape from pathogens and predators. The 
mollusks were found to be the valuable sources of food, shells, medicines, dyes etc. 
from time immemorial. The compounds from mollusk species were reported a 
significant role in the production of functional foods and nutraceuticals, which 
considered as a combination of nutritional and pharmaceutical elements (Herbert et al., 
2003; Lordan et al., 2011). However, the scientific investigations were comparatively 
lesser to understand the health benefits of mollusks. It is significant to record that the 
coastal populace of different parts of the world trusted on these animals as their 
livelihood since ancient times, whereas the molluskan shells were used by them to make 
various tools, decoratives and symbols (Benkendorff 2010; Brusca and Brusca 1990).  
The unfavourable climate and habitats were developed a definite adaptation 
mechanisms in the coastal and marine mollusks to defend themselves from the adverse 
conditions, and thus, many bioactive metabolites were evolutionally developed in these 
soft bodied organisms. Various pathogenic organisms living in the marine environment 
tend to attack the molluskan species distributed in the Sea surface, although these 
species were appeared to be resistant towards the microbial invasion. It is also to be 
noted that mollusks do not have acquired immunological systems, and therefore, it 
might have developed a substitute defense pathways to defend themselves in the coastal 
or marine ecosystems (Hooper et al., 2007). Under the extreme pressure of 
competitions, a wide variety of metabolites have been evolved by the mollusks, and 
these secondary metabolites have used as a part of their communication systems, 
predation and defense (Cimino and Gavagnin 2006). These species was found to 
synthesize various primary metabolites, such as sugars, lipids, amino acids etc., and 
secondary metabolites, such as alkaloids, terpenoids, steroids, polypropionates etc. with 
bioactive potentials (Blunt et al., 2015; Blunt et al., 2016). Mollusks were regarded as 
one of the key resources to develop valuable bioactive compounds with specific anti-
tumour, anti-hypertensive, anti-microbial, anti-HIV, anti-inflammatory, anti-diabetic 
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and antioxidant potencies (Anbuselvi et al., 2009; Benkendorff et al., 2011; Chellaram 
and Edward 2009). The compounds identified from these species exhibited bioactivities 
within the nanomolar range, and therefore, can be developed as potential drug 
candidates or lead compounds (Cimino and Gavagnin 2006). Previous studies 
established that the chemical defense mechanisms/systems were differently evolved and 
modified in different types of marine organisms. This apparently resulted in the 
formation and production of different and distinct chemical structures with bio-
potentials within the various classes of mollusks under the extreme environmental 
conditions (Cimino and Ghiselin 2001). The objective of the review is to investigate and 
understand the existing studies/literatures on the nutritional, bio-potential and the 
characterized bioactive secondary metabolites from molluskan species and to enhance 
our knowledge of chemistry of mollusks. This assessment will help to improve the 
upcoming natural product investigations.  
 
 
Figure 2.7.: Schematic representation of the distribution of molluskan phylum 
 
Mollusks are one of the largest and utmost varied classes of marine and 
estuarine organisms. Indian coasts have broad ecosystems such as lagoons, mangroves, 
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rocky regions and coral reefs in which rocky and corals regions were flourished with 
molluskan fauna. The largest phylum Molluska enclosed 50,000 described mollusk 
species, and as numerous as 200,000 living species, most of which were of marine 
origin. They feed on various food items, whereas their size ranged from big squids and 
clams to small snails with millimetre long. Mollusks are classified into seven classes, 
which belonged to Aplacophora including two classes, such as Solenogastres (~250 
species) and Caudofoveata (~150 species), Polyplacophora (~100 species), 
Monoplacophora (~30 species), Scaphopoda (~600 species), Gastropoda (> 100,000 
species), Bivalvia (~9200 species) (Huber 2010) and Cephalopoda (~1000 species) 
(Gosling 2015). Among these, gastropods are the largest and diverse class of organisms 
whereas, bivalves are the second largest and cephalopods are the most organized and 
specialized groups (Gosling 2002). Herein, we have discussed these three major classes 
of organisms, particularly the importance of bivalve class (Figure 2.7.).   
 
2.5. Cephalopods 
The class Cephalopoda symbolizes the greatly evolved, organized and edible 
class of phylum Molluska, which distributed throughout the world. These were purely 
coastal and marine organisms, whereas most of them were reported as free swimming 
shallow water predators. These species lacks calcium carbonate shell as protection with 
a compartmentalized structure (Gosling 2002). Cephalopods include squids, octopods, 
cuttlefishes etc., and these were reported to be single-time spawners with short life span, 
and therefore, adapted a rapid growth (Boyle and Rodhouse 2005). These species plays 
an important role in the exploited fisheries sectors all over the world, and began to 
receive more interest due to the cumulative export demands (Kreuzer 1984). This might 
be attributed due to the enhanced alertness about their dietary potentials (Okuzumi and 
Fujii 2000). Deteriorating catches of groundfishes have tempted to practice the potential 
non-traditional cephalopod species. During the last forty years, cephalopod stockings 
increased from 1 million metric tonnes (1970) to 4 million metric tonnes (2010), 
whereas the share of squids, cuttlefishes and octopuses in world’s fish market increased 
to 4% (2010) with greater market price. The countries like Spain, Japan, Korea, Italy 
and Hawaii have been the major consumers of cephalopods (FAO 2012). As a result of 
their nutritional and market values along with the bioactive potentials, cephalopod 
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fishery demonstrated a cumulative interest in the recent years (Lee 1995). The 
photographic representation of commonly available cephalopods in the southwestern 
coastal regions of Arabian Sea, bordering India illustrated in the Figure 2.8. 
 
 
Figure 2.8.: Photographic description of cephalopods   
 
2.5.1. Nutritional importance of cephalopods 
Cephalopods were found to be rich in protein content, and 80% of their total 
fleshy material was considered to be the edible portion for human consumption 
(Chakraborty et al., 2016c; Lee 1995). The edible portions of these species were 
accounted for n-3 polyunsaturated fatty acids, minerals, vitamins along with essential 
amino acids including antioxidative selenium (Zlatanos et al., 2006). Several reports 
were available on the biological description, occurrence, proximate composition and 
nutritional qualities of the cephalopod species (Okuzumi and Fujii, 2000; Pierce et al., 
2008). The compositions of fatty acid profiles and its relation to seasonal or annual 
variations studied for cephalopods (Ozyurt et al., 2006). As compared to marine 
finfishes, cephalopods found to be lesser in lipid content (Njinkoue et al., 2002). The 
previous study of Sepia pharaonis, Amphioctopus neglectus and other species of 
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cuttlefish, octopus and squids exhibited prominent lipid contents (> 2 mg/100 g), which 
were lesser than those recorded in the edible portion of the marine fishes (Chakraborty 
et al., 2014c; Chakraborty et al., 2016c; Zlatanos et al., 2006). The edible portions of 
cephalopod species, Uroteuthis duvauceli, Sepiella inermis, S. pharaonis, Cistopus 
indicus, and A. neglectus found to possess considerable amounts of PUFAs 
(Chakraborty et al., 2016c; Ozyurt et al., 2006). The long-chain C20-C22 PUFAs were 
found to be key biochemical markers of cephalopods, whereas C20-C22 FAs like 
docosahexaenoic acid and eicosapentaenoic acid were described to be vital for various 
human metabolic and physiological functions, and were predominant in cephalopods. 
Long chain n-3 PUFAs were essential to prevent the occurrences of numerous health 
concerns, such as cardiovascular illnesses, type-2 diabetes, hypertension, inflammation, 
asthma and cancer (Simopoulos 2009). As stated by Boucaud-Camou (1990), cuttlefish 
was composed of water (81%), protein (16.1%), lower lipids (1%), and with no 
carbohydrates. Previous studies described that the cephalopods were rich source of 
protein, EPA, DHA, micro and macro minerals, vitamins, amino acids, and therefore, 
this species can be regarded as effective health foods (Chakraborty et al., 2016c).  
 
2.5.2. Bioactive potentials of cephalopods 
 The cephalopods were considered as significant resources of bioactive 
metabolites representing various bioactive potentials (Chakraborty et al., 2017a; 
Chakraborty and Joy 2017). However, these species were not explored in significant 
details with respect to their bioactivities. The knowledge of bioactive compounds from 
these organisms will develop newer perspectives to harvest potential pharmacological 
benefits. Cephalopods believed to possesses unique biological compounds or secondary 
metabolites at higher concentrations. Most of these species lacks outer protective shell 
and found to produce venom and liquid ink materials to defend themselves from the 
predators (Cooke et al., 2015). Cephalopods comprised of structurally and chemically 
diverse and distinct anti-stress metabolites, therefore, can be considered as important 
health food items and also, can be used for formulating various nutraceuticals to combat 
diabetes and inflammatory diseases (Chakraborty and Joy 2017). The C20-C22 n-3 fatty 
acids present in these species were found to be accountable for their anti-inflammatory 
activities (Russo and Tringali 1983). Cephalopods including squid and octopus have 
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broad physiological actions, such as immune and anti-inflammatory responses along 
with neural function and reproduction (Miliou et al., 2006). The antioxidant/anti-
hypertensive potencies of S. pharaonis, U. duvaucelii, C. indicus, S. inermis and A. 
marginatus based upon spectroscopic evolution were previously reported (Chakraborty 
et al., 2017a). The ink extract of Sepia officinalis displayed anti-inflammatory and 
antioxidant potentials (Soliman et al., 2015). The cephalopod species Paraoctopus 
limaculatus (octopus) studied for their anti-mutagenic and anti-proliferative effects 
(Moreno-Felix et al., 2013). A number of investigations on antioxidant potentials of 
tissues and ink extracts of cephalopods were published (Choi et al., 2015). The anti-
hypertensive (angiotensin converting enzyme-1 (ACE-1) inhibitors) components were 
reported from squids, cuttlefish and octopus (Balti et al., 2015; Chakraborty et al., 
2017a; Lin et al., 2012). Various anti-tumour metabolites were isolated from squid 
(Chen et al., 2010), octopus (Karthigayan et al., 2006) and cuttlefish (Senan et al., 
2013).  
 Remarkably, advanced efforts have been aimed at the small molecular 
bioactive compounds and their ability to inhibit different target sites. This will lead 
towards the identification of specific regions/moieties in the compounds, which were 
responsible for particular therapeutic potentials. Likewise, the preparations or 
formulations from the cephalopods will occupy a key place in the wider range of 
pharmaceutical industry (Besednova et al., 2017).  
 
2.5.3. Secondary metabolites from cephalopods 
There are limited research works and fewer publications on the biologically 
active molecules from the cephalopods. Most of the works were carried out on their 
physiology, bioluminescence, mimicry and ink productions (Kornprobst 2010). The 
pigments, adenochromines 1-3 were discovered from Octopus vulgaris (Ito et al., 1976; 
Prota et al., 1977). Arsenolipids 4-5 were reported from squid, Todarodes pacificus 
(Ninh et al., 2007). 
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 Cephalopods used in wide range of traditional medications, even though 
chemical investigations were relatively lesser (Benkendorff 2010). Sepia ink used as a 
remedy for depression in China (Cazalet 2007). The cephalopod, Spirula spirula is an 
expensive marine mollusk as traditional medication in the Durban market (Herbert et 
al., 2003). Cyclophosphamine extracted from squid ink was a well-known 
chemotherapeutic drug (Zhong 2009). Cytotoxic tyrosinase (Russo et al., 2003) and 
peptides (from ovarian jelly) were isolated from Sepia officinalis (Bernay et al., 2006). 
The novel cardioactive peptides were purified from brain of Octopus vulgaris (Kanda 
and Minakata 2006) and Japanese octopus, Octopus minor (Iwakoshi et al., 2000). 
Astaxanthin and its ester derivatives were the major carotenoids in octopus and 
cuttlefish species (Maoka et al., 1989). 
 
2.6. Gastropods  
Gastropoda is the largest class with regard to the number and diversity of 
species. Among all other classes of mollusks, gastropods have been mostly investigated 
and reported for their bioactive secondary metabolites (Kornprobst 2010). The 
photographic representation of commonly available gastropods was illustrated in the 
Figure 2.9. 
 
34 
 
Review of literature                  Chapter 2 
 
Figure 2.9.: Photographic description of Gastropods   
 
Gastropods were classified into three sub-classes, such as Prosobranchia 
(strongly wound within the shell), Opisthobranchia (weakly wound within the shell or 
shell-less) and Pulmonata (they can breathe air through the lungs), which includes Sea 
slugs, Sea snails, abalones, Sea hares, etc. Edible gastropods collected throughout the 
world for their flesh, which was found to be the essential sources of economic value to 
world’s fishery sectors. Majority of molluskan fishery promoted by cephalopods and 
bivalves whereas, gastropods shared lower than 2% of whole yield (FAO 2015). Even 
though, some of the gastropods have reported comparatively higher economic and 
commercial values (Leiva and Castilla 2002). 
 
2.6.1. Nutritional importance of gastropods 
The gastropods are gaining more significance among mollusks during the 
recent years due to their commercial potential. Subsequently, there is an increasing 
requirement for the supply of underutilized species. Previous studies were established 
that the predator gastropod whelks possessed higher protein content than the herbivore 
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gastropods. The predatory carnivore gastropods, such as Chicoreus ramosus (Ramesh 
and Ayyakkannu 1992), Hexaplex trunculus (Zarai et al., 2011), Thais haemastoma 
(Belisle and Stickle 1978), Rapana venosa (Celik et al., 2014) were reported for their 
higher protein contents. The herbivorous snails were also good candidate source of 
protein. The nutritional profiles of gastropods varied according to the type of organisms, 
body parts, seasonal changes, collection sites, spatial changes, temporal variations and 
reproductive cycles (Smoothey 2013). Lipid content was found to be lesser in the 
predatory gastropods than those in herbivorous (Belisle and Stickle 1978; Lah et al., 
2017; Ramesh and Ayyakkannu 1992). Visceral lipid content was greater when 
compared to foot tissue and it has been recommended that visceral tissues were the lipid 
storing part of gastropods. Usually visceral tissue in larger gastropods not recommended 
for consumption and foot tissues were typically consumed by the people (Saito and 
Aono 2014). Therefore, previous studies concluded that foot tissues were suitable for 
human diet due to higher protein and lower lipid contents (Lah et al., 2017). The fatty 
acid composition especially, PUFA contents along with DHA and EPA was previously 
reported in various gastropods particularly, in snails (Brazao et al., 2003; Lah et al., 
2017; Morais et al., 2003). Gastropods were found to possess various minerals, such as 
potassium, sodium, selenium, zinc, iron and sulphur (Lah et al., 2017). Also, the 
essential amino acid components reported to be considerably higher in gastropods such 
as Chicoreus virginineus, Phalium glaucum, Rapana rapiformis and Tonna dolium 
(Babu et al., 2011). These studies described the nutritional qualities of gastropods and 
suggested that these could contribute towards the people’s diets as nutritional health 
food, particularly in the developing countries.   
 
2.6.2. Bioactive potentials of gastropods 
Gastropods reported for various bioactive potentials and believed to be rich 
sources of bioactive metabolites. These bioactive molecules generated from the immune 
response tissues of gastropods as a result of host defense mechanisms (Rajaganapathi et 
al., 2002). The gastropod snail, Abalone is an important marine mollusk with potential 
therapeutic properties, and has been recommended for physically weak patients. 
Abalone extracts exhibited anti-cancer (Lee et al., 2010), antioxidant, anti-hypertensive 
and anti-coagulant (Kim et al., 2006) properties. Conopeptides from the cone snails 
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reported for various biomedical pluralities, such as anti-noceptive, analgesic, 
neuroprotectives and anti-cancer (Han et al., 2008; Twede et al., 2009). Sea hares, 
Dolabella, Bursatella and Aplysia were found to be potential sources of anti-bacterial 
and anti-HIV metabolites (Rajaganapathi et al., 2002; Yamazaki 1993). The tissues and 
eggs of gastropods were reported to possess bioactive metabolites with anti-microbial 
properties to protect the embryos in the capsule (Kaviarasan et al., 2011). The anti-
bacterial and anti-fungal potentials of Babylonia spirata, P. glaucum, T. dolium, 
Hemifusus pugilinus, C. ramosus and Babylonia zeylanica collected from the southeast 
coast of India were investigated previously (Govindarajalu et al., 2016). The extract of 
Australian muricid gastropod, Dicathais orbita was found to exhibit anti-inflammatory 
properties along with nutraceutical functionalities (Ahmad et al., 2017). The methanol 
and ethyl acetate tissue extracts of Littorina littorea exhibited antioxidant and anti-
microbial properties (Borquaye et al., 2016). However, there were only few 
investigations were conducted to understand the commercial importance and utilities of 
gastropods. 
 
2.6.3. Secondary metabolites from gastropods 
Numerous bio-potent secondary metabolites were identified and characterized 
from gastropod mollusks. A linear homosesterterpene, granuloside (6) was isolated 
from gastropod Charcotia granulosa (Cutignano et al., 2015) and diterpene metabolites 
thuridillins 7-8 were isolated from Thuridilla splendens (Somerville et al., 2012). Rare 
∆8 unsaturated 4,4-dimethyl and 4-methyl sterols were isolated from Japanese 
gastropod, Cellana grata and C. toreuma (Kawashima et al., 2013) and pyranone ester 
derivatives or analogues 9-12 were identified from Onchidium sp. (Carbone et al., 
2013). An anti-leishmaniasis compound, 5α,8α-epidioxycholest-6-en-3β-ol was 
characterized from Dolabrifera dolabrifera (Clark et al., 2013). Mycosporine-type 
amino acids 13-15 isolated from the protective ink of Aplysia californica (Sea hare) 
(Kamio et al., 2011).  
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 The polypropionate derivatives, niuhinone A-C 16-18 identified from 
carnivorous mollusk, Philinopsis speciosa and herbivore mollusk, Bulla occidentalis. 
These suggested that the origin of these metabolites in P. speciosa was due to the 
consumption of Bulla sp. (Coval et al., 1985; Cutignano et al., 2011). A guanidine-
bound terpene derivative 19 identified from Doto pinnatida (Putz et al., 2011), an 
asteriscane sesquiterpenoid 20 afforded from Phyllodesmium magnum (Mao et al., 
2011) and rare pyran-enclosed cladiellane diterpene derivatives, tritoniopsin A-D 21-24 
isolated from Tritoniopsis elegans and its feed Cladiella krempfi (coral) (Ciavatta et al., 
2011). Novel diterpenoids 25-26 and chromoculatimine A-B 27-28 were identified and 
the tissue localisation studies revealed that these diterpenes have been obtained from 
their mantle and internal organs (Suciati et al., 2011).  
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 The isopentyl-containing alkaloids, tambjamine K 29 was identified from 
Tambja ceutae (Carbone et al., 2010). The clerodane diterpenes palmadorin A-C 30-32 
were isolated from nudibranch, Austrodoris kerguelenensis (Diyabalanage et al., 2010) 
and sesterterpenoid, ansellone A 33 was isolated from Cadlina luteromarginata (Daoust 
et al., 2010). The extraction of digestive and hermaphroditic glands of Aplysia fasciata 
(Sea hare) yielded sesquiterpenoids 34-36, acetogenin 37, and diterpenoid 38 (Ioannou 
et al., 2009). The α-pyrone polyketides, aplysiopsene A-D 39-42 has isolated from 
herbivorous Aplysiopsis formosa (slug) (Ciavatta et al., 2009). Chemical investigation 
of Chromodoris willani reported for its deoxy analogues of manoalide 43 and 
secomanoalide 44 with anti-microbial activity (Uddin et al., 2009). The anti-fungal 
compound Kabiramide B was reported from Paciﬁc nudibranch Hexabranchus 
sanguineus (Matsunaga et al., 1989).  
NH
N
OMe
NH
29   
O
O
OR
OH
30 R = H
31 R = Ac
O
O
OH
OH
OH
32
            
OH
O
OAc
O
33      
OH
OAc
Br
HO
34 35 36  
O Cl
OH
OAc
Br
OH
37 38
OO
R1
R2
39 R1=  R2 = H
40 R1 = Me; R2 = H
41 R1 = H; R2 = Me
42 R1=  R2 = Me       
OHO
O
O HO
OHC
O
O
43 44   
39 
 
Review of literature                  Chapter 2 
 The prosobranch mollusk, Onchidiopsis variegate reported for number of 
ketosteroid derivatives 45 (Santalova et al., 2007) and sacoglossan mollusk, Elysia 
grandifolia reported for two new members of cyclic depsipeptides 46-47 in kahalalide 
family (Tilvi and Naik 2007). The absolute conformation of crispatenine 
(sesquiterpenoid) 48 formerly identified from Tridachia crispata (Gavagnin et al., 
1997), and further recognized by its enantioselective synthesis (Bourdron et al., 2007). 
New pyrone compound reported from Placobranchus ocellatus 49 (Manzo et al., 
2005a) and an aromatic benzene enclosed compounds, named lignarenones reported 
from Scaphander lignarius 50-54 (Sala et al., 2007). The polypropionate analogues, 
fusaripyrones A and B 55-56 were reported from Mediterranean Haminoea fusari 
(Cutignano et al., 2007). The polyether triterpenes named as aplysiols A and B 57-58 
were identified from Aplysia dactylomela (Sea hare) collected from South China Sea 
(Manzo et al., 2007a) and the chemical investigation of this same species from 
Madagascar afforded halogenated chamigrane sesquiterpenoids 59-62 (Shubina et al., 
2007). Another Sea hare, Bursatella leachii was reported to produce 7R-conﬁgured 
malyngamide 63 (Suntornchashwej et al., 2007). A sesquiterpenoid 64 and a 
diterpenoid 65 were isolated from Hexabranchus sanguineus (Spanish dancer mollusk) 
(Zhang et al., 2007). Isocopalane diester 66 was isolated from unrevealed gastropod of 
Marion Island (van Wyk et al., 2007). A 12-keto scalarane type of compound, 67 
reported from Glossodoris averni (Queensland, Australia) and G. pallida (Hainan, 
China) (Manzo et al., 2007b). The labdane class of diterpenoids 68-69 reported from 
Pleurobranchus meckelii (Ciavatta et al., 1995).  
 The pulmonate, Siphonaria lessoni was the major source of 70, a nor-
homologue of well known metabolite, siphonarienolone (Rovirosa and San-Martin 
2006). The cytotoxic alkaloid lamellarin N reported from Lamellaria sp. and further 
structure activity analyses on lamellarin D have been carried out (Pla et al., 2006). The 
sacoglossan mollusk, Elysia cf. expansa collected from Mandapam, India was afforded 
caulerpenyne typed metabolites, dihydrocaulerpenyne 71 and expansinol 72 (Ciavatta et 
al., 2006).  
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The cyclic depsipeptides, kahalalide R-S, 73-74 were reported from E. 
grandifolia (Ashour et al., 2006). Bisabolene typed sesquiterpenes 75-78 identified 
from the crude extracts of A. dactylomela (Brito et al., 2006) and anti-tumour 
compound, aplyronine A isolated from A. kurodai (Yamada et al., 1993). The chemical 
investigation of Australian mollusk, Glossodoris atromarginata led to the identification 
of 79 and 80 for the first time (Andersen et al., 2006). 
The pyrone 81 and its possible peroxy analogue 82 from Placobranchus 
ocellatus were reported previously (Manzo et al., 2005a). Cueto et al., (2005) reported 
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elysiapyrone metabolites A-B 83-84 from Elysia diomedea. Tridachiahydropyrone 85 
isolated from Tridachia crispata and trans-decalin compound, 86 were isolated from T. 
reticulatus (Gavagnin et al., 1996; Manker and Faulkner 1987). The sesquiterpene 
derivatives 87-89 were isolated from A. dactylomela (Dias et al., 2005) with in vitro 
anti-tumour activity. The C15-halogenated derivatives 90-91 were identified from A. 
dactylomela (Manzo et al., 2005b). The metabolite (3Z)-bromofucin 92 isolated from A. 
parvula extracts (McPhail and Davies-Coleman 2005) and bioactive laurinterol 93 and 
debromolaurinterol 94 were reported from A. kurodai (Tsukamoto et al., 2005). 
Bursatella leachii was the predominant source of cytotoxic metabolites such as 
hectochlorin 95, deacetyl derivatives 96-97 (Suntornchashwej et al., 2005). Degraded 
sterols, such as aplykurodinone 1-2 (98 and 99) were purified from the skin extract of 
mollusk, Syphonota geographica (Gavagnin et al., 2005). Derivatives of dolastatin 11 
from D. auricularia (Pettit et al., 1989) and nor-sesquiterpenoid, (+)-austrodoral 100 
from Austrodoris kerguelenensis (Antarctic mollusk) were reported (Gavagnin et al., 
2003b). Furanosesquiterpene alcohol derivatives, pelseneeriols-1 101 and 2 102 were 
reported from Doriopsilla pelseneeri (Gaspar et al., 2005). The hydroquinone and 
dodecadienonyl-benzoquinone derivatives were purified from Leminda millecra 
(African gastropod) (McPhail et al., 2001). The norrisolide 103 was isolated from 
Chromodoris norrisi (Hochlowski et al., 1983) and dorisenone C 104 was identified 
from C. obsolete (Miyamoto et al., 1996). 
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 The cytotoxic components, haterumaimides L 105 and M 106 along with 3β-
hydroxychlorolissoclimide 107 were obtained from Pleurobranchus albiguttatus and P. 
forskalii (Fu et al., 2004). The isolation of scalarane-framework metabolites 108 and 
109 from G. rufomarginata was reported previously (Gavagnin et al., 2004). The 
sesquiterpenes 110-112 were fractionated from Phyllidiella pustulosa found at South 
China (Manzo et al., 2004). The sesquiterpenes (−)-tochuinyl acetate 113 and (−)-
dihydrotochuinyl acetate 114 were identified from Tochuina tetraquetra (Williams and 
Andersen 1987). The pyrone polypropionate, cyercene was reported by Vardaro et al., 
(1991) from Mediterranean Cyerce cristallina and austrodoric acid 115 from Antarctic 
A. kerguelenensis was previously reported by Gavagnin et al., (2003b). 
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 Asymmetrical polypropionate derivatives, placidenes C-F 116-119 
characterized by Cutignano et al., (2003) from Placida dendritica. Chemical 
investigation of diterpenoid acylglycerol fraction from the Antarctic gastropod, A. 
kerguelenensis yielded acylglycerols 120-122 (Gavagnin et al., 2003a). The labdane 
diterpenes 123-126 were identified from T. peruvianus (pulmonate) along with 
cytotoxic polyhydroxylated steroids 127-128 (Diaz-Marrero et al., 2003a; Diaz-Marrero 
et al., 2003b). 
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 The membrenones A-C 129-131 and γ-dihydropyrone enclosed 
polypropionates were extracted from Pleurobranchus membranaceus by Ciavatta et al., 
(1993). The chemical investigation of Siphonaria grisea was reported the 
characterization of siphonarienolone 132 and siphonarienedione 133 (Calter and Liao 
2002) polypropionates and their relative and absolute stereochemistries were established 
(Norte et al., 1990). The compound, siphonarin B 134 was reported from Siphonaria 
zelandica and S. atra (Hochlowski et al., 1984). A novel malyngamide S derivative 135 
was reported from mollusk Bursatella leachii and the compound was found to exhibit 
potential anti-inflammatory activities (Appleton et al., 2002). A wide range of diterpene 
metabolites 136-139 and new sesquiterpenes 140-142 were reported by Findlay and Li 
(2002) from Sardinian Sea hare Aplysia punctata. A progesterone analogue 143 was 
isolated by Gavagnin et al., (2002) from nudibranch Aldisa smaragdina (Spain). 
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The extensive NMR assignments of the A. dactylomela metabolites, such as 
johnstonol 144, pacifenediol 145 and paciﬁdiene 146 (Kaiser et al., 2001) along with 
tryptophan based dipeptides 147 and 148 (Appleton et al., 2001) have been previously 
reported. Another Sea hare from Japanese collection Dolabella auricularia contained a 
novel cytotoxic squalene metabolite named as auriculol 149 (Kigoshi et al., 2001). A 
non-halogenated sesquiterpene 150 that was possibly a rearranged product of a known 
chamigrane found from Aplysia sp. collected from Madagascar coast (Federov et al., 
2000). A. dactylomela contained new sesquiterpenes puertitol-B acetate 151, 
caespitenone 152 and 8-acetyl-caespitol 153 along with diterpenoids, such as 
dactylopyranoid 154 and isopinnatol B 155 with bioactivity profiles (Wessels et al., 
2000). Also, the sesquiterpenes ascobullins A 156 and B 157 metabolites were reported 
from Ascobulla ulla (Gavagnin et al., 2000). The polypropionate pyrones such as 
tridachiapyrones G 158 - J 160 and tridachiahydro pyrones B 161 - C 162 were reported 
from mollusk, P. ocellatus (Fu et al., 2000). 
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2.7. Bivalves  
 In the bivalve molluskan aquaculture, the major bivalve species includes 
clams (along with cockles, arkshells etc.), mussels, oysters, scallops and other various 
bivalves of minor importance. It was found that clams, oysters, mussels and scallops 
were the four foremost groups, based upon the production census of 2012 (FAO 2012). 
The percentage of aquaculture production among various bivalves illustrated in the 
Figure 2.10., and in which bivalve clams were found to possess major share to the total 
bivalves (FAO 2014). The photographic representation of commonly available bivalves 
in the coastal regions of Arabian Sea, bordering India illustrated in the Figure 2.11. 
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Figure 2.10.: The percentage share of bivalves, particularly clams among bivalve 
mollusks (FAO 2014)  
 
Figure 2.11.: Photographic illustration of bivalves   
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2.7.1. Nutritional importance of bivalves 
 The bivalve mollusks are prominent seafoods at coastline regions and found 
to be a dominant share to the global trade markets (Chakraborty et al., 2014b; Xie et 
al., 2012). However, these were not comprehensively investigated for their dietary and 
nutritional potentials. Bivalves are potential resources of n-3 polyunsaturated fatty 
acids comprising EPA and DHA. The bivalve mollusks were found to be the 
originators of anti-inflammatory agents (E and D sequences), which described to 
combat the biosynthesis of inflammatory prostanoids (Chakraborty et al., 2014a). In 
general, these species reported to provide an inexpensive source of proteins, minerals, 
amino acids and vitamins (Astorga-Espana et al., 2007). The bivalves, Ruditapes 
decussatus and Mytilus galloprovincialis collected from the Mediterranean Sea 
exhibited greater contents of lipid and protein (Saba 2011). The Asian hard clam, 
Meretrix lusoria and M. meretrix displayed good nutritional qualities (Supatra et al., 
2013; Xie et al., 2012), and were considered as low-value health food items. Bivalves 
were regarded next to finfish and prawns in the view of nutritional qualities, and also 
reported for the presence of bioactive lipids, for example diacylglycerols, 
sphingolipids, and phytosterols that can effect human health and alleviate 
inflammatory conditions (Li and Sinclair 2002). The nutritional qualities of green 
mussels (Perna viridis) and oysters (Crassostrea madrasensis) were reported 
previously, therefore, suggested as a substitute to equilibrate the greater consumption 
of inflammatory n-6 FAs (Chakraborty et al., 2016a; Chakraborty et al., 2016b). The 
nutritional quality parameters, such as mineral composition, fatty acids, glycogen, 
cholesterol, vitamins, carotenes and the commercial quality indicators of meat of 
striped venus clam, Chamelea gallina were studied previously (Orban et al., 2006). 
The proteins, minerals, lipids, glycogen along with minor components of lipophilic and 
hydrophilic nature were found to contribute towards the nutritive importance along 
with organoleptic features of clams (Orban et al., 2006). The clam, M. meretrix was 
historical seafood and valued resources of ancient Chinese therapeutics (Xie et al., 
2012). These previous studies established the nutritional importance of marine and 
coastal bivalve mollusks for use as nutritional health foods, particularly in the coastal 
regions of the world.   
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2.7.2. Bioactive potentials of bivalves 
 The unfavourable living environments, such as salinity and oxidative stress, 
predators along with the ﬁlter-feeding nature of marine or estuarine bivalves were found 
to be accountable for their utilities as potent resources. Bivalves were equipped with 
bioactive metabolites having various functionalities specifically against free radical 
induced oxidations and related disorders (Goldberg 1975). In general, the bivalve clams 
exposed to higher salinity and radical inducing noxious agents, although these were not 
subjected to cellular damages, and therefore, appeared as potential candidates to harness 
antioxidant molecules (Gonzalez et al., 2015). Bivalves occupied a highest share in the 
hierarchy of total eatable mollusks, although they were not extensively recognized for 
their pharmaceutical and biomedical properties (Mohite et al., 2009). Earlier reports 
demonstrated that the bivalves possessed numerous bioactive effects, like antioxidant, 
anti-inflammatory and anti-tumour characteristics (Benkendorff 2010; Chakraborty et 
al., 2014a; Nagash et al., 2010). The lipid fraction of Perna canaliculus was marketed 
as Lyprinol® which demonstrated potential activity against cyclooxygenase-2 (COX-2) 
and 5-lipoxygenase (5-LOX) inflammatory enzymes (Whitehouse et al., 1997). The 
clam, M. meretrix has displayed to harbour anti-hypertensive, hypolipidemic and 
antioxidant pluralities (Wei et al., 2007). The mollusk muscle protein hydrolysates 
reported for anti-hypertensive potentials against angiotensin-1 converting enzyme (Tsai 
et al., 2008). There were reports for the occurrence of antioxidants in mollusks which 
can constrain the cell damages from the oxidative reactions (Nagash et al., 2010). The 
methanolic or ethyl acetate extracts of bivalve mussel, Perna viridis was described for 
its scavenging properties against DPPH radical (Jena et al., 2010; Sreejamole and 
Radhakrishnan 2013). The ACE inhibitor (anti-hypertensive) peptides from mussel, 
Mytilus coruscus reported in a previous literature (Wu et al., 2013). The commercial 
freeze-dried extract of New Zealand green lipped mussel P. canaliculus was found to 
down-regulate the inﬂammatory responses (Tiffany and Bui 2002). The green mussel 
extract (CadalminTM GMe) prepared from bivalve mollusk, P. viridis displayed 
potential anti-inﬂammatory effects against pro-inflammatory prostanoids (Chakraborty 
et al., 2014a). 
 It was stated that the extracts of some oysters and clams showed anti-
microbial and anti-viral potentials (Lin-rui et al., 2012). The extract of edible clam, 
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Mercenaria mercenaria was found to prevent the development of tumours in Swiss 
mice (Schmeer and Huala 1965). The polysaccharides from Mactra chinensis (Chinese 
surf clam) were reported to possess scavenging activities against hydroxyl and 
superoxide anion free radicals (Lin-rui et al., 2012), whereas the aqueous and alcoholic 
extracts of M. veneriformis showed in vitro antioxidant potentials (Luan et al., 2011). It 
was stated that the presence of hydrophilic/lipophilic antioxidant components like 
polyunsaturated fatty acids, amino acids and carotenoids were found to be accountable 
for therapeutic potentials of clam species (Luan et al., 2011). The aqueous and ethanolic 
extracts of New Zealand surf clams, Crassula aequilatera, Mactra murchisoni and 
Paphies donacina were found to possess potential antioxidant properties (Odeleye et al., 
2016). Anti-microbial activity of the gill extract from the bivalve P. viridis was reported 
(Chandran et al., 2009). A natural thrombolytic agent, C-type hemolytic lectin with 
activity against myocardial infarction, was purified from Villorita cyprinoides 
(Sudhakar and Vincent 2014). Earlier study revealed that the extract of V. cyprinoides 
has potential anti-ulcer activity (Ajithkumar et al., 2012). Anti-bacterial activity of 
crude solvent fractions of marine clam, Anadara granosa (Linn.) and M. casta 
(Chemnitz) against pathogenic bacteria were reported (Ramasamy and Balasubramanian 
2012; Ramasamy and Balasubramanian 2014). The extracts from bivalves, P. viridis, C. 
madrasensis, C. gryphoides, M. casta, V. cyprinoides and Polymesoda erosa were found 
to possess antiviral activities against influenza virus type-A and type-B (Chatterji et al., 
2002).  
The dose-dependent antioxidant responses of methanolic extracts of P. 
malabarica and its lipid peroxidation inhibition potentials against reactive oxygen 
species were reported in earlier works (Pawar et al., 2013). The anti-inflammatory, anti-
tumour and antioxidant activities of mussel, Coelatura aegyptiaca were evaluated by 
Fahmy and Soliman (2013). A new polysaccharide bearing galactan sulfate isolated 
from clam, Meretrix petechialis exhibited anti-HIV activity (Amornrut et al., 1999). 
The Asiatic hard clam, M. meretrix (Veneridae) was reported to exhibit several 
pharmacological activities, such as anti-tumour, antioxidant, immuno-modulatory, anti-
hyperglycemia, and anti-hperlipemia along with detoxification effects (Xie et al., 2012). 
The earliest Chinese pharmacopeia Compendium of material (Li Shizhen, 16th century) 
stated that the clam, M. meretrix could diminish the inflammation, and has used in the 
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treatment of typhoid fever and to relieve pain. Another Chinese medicinal book, 
Treatise on Fevers (Zhang Zhongjing, 2nd century), suggested its potentials to eliminate 
cyst and detoxification. Several bioactive components, such as peptides, proteins, and 
enzyme inhibitors identified from M. meretrix with anti-hypertensive, anti-neoplastic, 
hypolipidemic and antioxidant effects (Huang et al., 2005; Wei et al., 2007; Xu et al., 
1999; Zhao 1992). Recent studies showed that greatly polyunsaturated cardiolipids 
(particularly EPA and DHA) were the characteristic of the marine and coastal bivalves 
(Kraffe et al., 2005). An interesting correlation was observed among the cardiolipin 
fatty acid profile and bivalve’s phylogeny (Kraffe et al., 2005). 
 The methanol, ethanol and aqueous extracts acquired from P. viridis 
exhibited anti-inflammatory properties in different in vivo models (Sreejamole et al., 
2011). In addition, P. viridis has been reported for anti-microbial, radioprotective, anti-
angiogenic and anti-HIV potencies (Annamalai et al., 2007; Mirshahi et al., 2009; Mitra 
and Chatterji 2004; Sreekumar 2007), and also, attributed for various bioactive 
components (Bichurina et al., 1994; Blunt et al., 2015; Chatterji et al., 2002). Earlier 
studies of P. viridis highlighted the potential antioxidant activities related to free radical 
inhibition and lipid peroxidation, thus suggested its utility as health food and valuable 
antioxidant source (Chakraborty et al., 2016a). A nutraceutical supplement was 
formulated from P. viridis (CadalminTM Green Mussel extract) which exhibited potent 
in vitro and in vivo anti-inflammatory effects (Chakraborty et al., 2012; Chakraborty et 
al., 2014a; Chakraborty et al., 2014b). The nutritional supplement, Seatone® developed 
from P. canaliculus has been used as an anti-inflammatory supplement (Cobb and Ernst 
2006). P. canaliculus and M. galloprovincialis were reported for anti-inflammatory 
potentials. The P. canaliculus was used against osteoarthritis and rheumatoid arthritis 
(McPhee et al., 1995). Okinawan mollusk, Pinna muricata reported for Ca2+ channel 
activation and possesses anti-inflammatory properties (Murphy et al., 2002). There were 
various reports on the nutraceutical formulations and bioactive potentials of bivalve 
mollusks, even though, these were not extensively investigated for their bioactive 
components, structural characterizations and their effectiveness as functional food 
supplements.    
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2.7.3. Secondary metabolites from bivalves 
 Recently, the research efforts on marine natural products were focused 
towards the bivalves and, there have been a sharp logarithmic increase in the number of 
reported components from these organisms. In this section, the reported secondary 
metabolites were classified under the various classes of bivalves, such as clams, oysters, 
mussels and cockles.  
 
2.7.3.1.  Secondary metabolites from bivalve clams 
    A novel sequence of n-4 PUFAs 163-168 were identified from Calyptogena 
phaseoliformis (deep Sea clam) collected from the Japan Trench (Saito 2007). The hard 
clam, M. lusoria (Taiwan) which was the primary resources of the Chinese antidote for 
hepatitis and liver illness, contained two previously reported epidioxysterols 169-170 
with anti-cancer properties (Pan et al., 2007). Two new thioarsenosugars, 171 and 172 
were identiﬁed from the extracts of brackishwater clam, Venus verrucosa (Nischwitz et 
al., 2006). The isolation and characterization of N-methyl-D-glutamic acid 173 from 
Japanese blood clam or Ark clam, Scapharca broughtonii was the first report of this 
kind of amino acid derivative as natural compound (Tarui et al., 2003). The smooth 
clam, Callista chione contained 1,1’-dimethyl-[2,2’]-bipyridyldiium salt 174 which was 
acknowledged for the first time from a natural resource (Vagias et al., 2000). A 
brevetoxin B5 175 was reported from Austrovenus stutchburyi (New Zealand cockle) 
(Ishida et al., 2004).  
 The terpenoid constituent from Tridacna maxima (giant clam) was found to 
be germacrene-C 176 (Bowden et al., 1980). The T. maxima was afforded an arsenic-
enclosed sugar sulphate 177 (Edmonds et al., 1982) by X-ray crystallography. A new 
antioxidative pigment, Chlorophyllone A 178 was isolated from short-necked clam, R. 
philippinarum (Sakata et al., 1990). An arsenic containing nucleoside, 5’-deoxy-5’-
dimethylarsinyl- adenosine 179 was isolated from T. maxima (Francesconi et al., 1991). 
The antioxidant, chlorophyllonic acid A methyl ester 180 was identified from R. 
philippinarum by single crystal experiments (Yamamoto et al., 1992). 
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 Bivalve clams contained different carotenoids with structural modifications 
and these were obtained from their micro-algal diets. Most of the carotenoids were 
derivatives of fucoxanthin, diadinoxanthin, diatoxanthin etc. Many carotenoids were 
isolated from freshwater and brackishwater corbicula clams such as Corbicula japonica, 
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C. Sandai etc. The peridininol-5,8-furanoxide (181), 7,8-didehydro-β-cryptoxanthin 
(182) pyrrhoxanthinol-5,8-furanoxide (183) and pyrrhoxanthin 5,8-furanoxide (184) 
were newly reported from the mollusks. The peridinin (185) and its analogues were the 
main carotenoids in C. japonica and lutein (186) was the main carotenoid in C. sandai. 
The corbiculaxanthin 3’-acetate (187), 6-epiheteroxanthin (188) and corbiculaxanthin 
(189) isolated from these species were not reported previously from other shellfishes 
(Maoka et al., 2005a). A series of fucoxanthin 190-195 and fucoxanthinol 196-198 fatty 
acid esters were identified from edible M. chinensis (Chinese surf clam) (Maoka et al., 
2007), R. philippinarum and M. petechialis (Maoka et al., 2010). The amarouciaxanthin 
A (199) and its ester derivatives were identified from Paphia amabills and P. amabillis 
along with C37-skeletal carotenoids (200-203) (Maoka et al., 2008).  
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2.7.3.2. Secondary metabolites from bivalve mussels 
The azaspiracids were isolated from the extracts of Mytilus edulis (mussel) 
and their chemical structures characterised by NMR or mass spectroscopy (Kilcoyne et 
al., 2015). Several carotenoids 204-206 were isolated from M. galloprovincialis 
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collected from Black Sea of Ukraine (Maoka et al., 2011). Bathymodiolamides A 207 
and B 208 with anti-tumour potentials were isolated from deep Sea mussel, 
Bathymodiolus thermophilus (Andrianasolo et al., 2011). Anti-microbial peptide, 
Mytilin-A was purified from bivalve M. edulis (Charlet et al., 1996), and the peptide 
analogue was exhibited activity towards marine Vibrio, yeasts and fungi. An 
homologous series of n-3 PUFAs along with 7,11,14,17-eicosatetraenoic acid 209 were 
identified as anti-inflammatory components in New Zealand green-lipped mussel P. 
canaliculus (Treschow et al., 2007). The chemical investigation of M. galloprovincialis 
yielded oxazinin-5 210 and a linear precursor preoxazinin-7 211 (Ciminiello et al., 
2007b) along with desulfoyessotoxin 212 from the same mussel species (Ciminiello et 
al., 2007a). The pinnatoxins and its fatty acid ester metabolites were identified from 
mussels (M. edulis) (McCarron et al., 2012), whereas oxazinin compounds 213, 214 and 
215 and their analogues were identified from digestive glands of M. galloprovincialis 
(Ciminiello et al., 2001). 
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 The oxazinin alkaloid, oxazinin-4 216 was reported from mussel, M. 
galloprovincialis extract (Ciminiello et al., 2006). The compound, 20-methyl spirolide 
G 217 was identified from M. edulis (Aasen et al., 2005). The chromatographic 
fractionation of M. galloprovincialis extracts were found to yield cytotoxic 
chlorosulfolipid 218 (Ciminiello et al., 2004) and brevetoxin analogue, brevetoxin B5 
175 identified from P. canaliculus (Ishida et al., 2004). Five undescribed azaspiracid 
analogues 219-223 were characterized by tandem mass spectrometric methods from M. 
edulis (Ireland) (James et al., 2003). The structure of polychlorinated sulfolipid 224 was 
reported from M. galloprovincialis (Ciminiello et al., 2002). 
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The cytotoxic spiro-acetals, attenols A 225 and B 226 isolated from Pinna 
attenuate (Takada et al., 1999). New bioactive alkaloids, oxazinins 1-3 227-229 
identified from M. galloprovincialis (Ciminiello et al., 2001). An alkaloidal toxin, 
pinnamine 230 was identified from P. muricata (Takada et al., 2000). The yessotoxin 
analogue, adriatoxin 231 isolated from M. galloprovincialis (Ciminiello et al., 1998) 
and brevetoxin analogue, brevetoxin B2 232 isolated from P. canaliculus (Murata et al., 
1998). The macrolides, spirolides B-C 233-234 were isolated from M. edilis (Hu et al., 
1995). The mycosporine derivatives such as mytilin A (235) and B (236) were acquired 
from M. galloprovincialis (Chioccara et al., 1979). The apocarotenoid, apoalloxanthinal 
237 isolated from the Japanese mussel, M. coruscus (Maoka 1997). The cytosolic 
phospholipase A2 inhibitors, pinnaic acid 238 and tauropinnaic acid 239 isolated from 
P. muricata (Chou et al., 1996). The spirolides E 240 and F 241 metabolites from M. 
edulis helped to define pharmacophores of spirolides (Hu et al., 1996).  
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2.7.3.3.  Secondary metabolites from bivalve oysters 
    The known spiroimine toxins pinnatoxin A and D, pinnatoxin E-G 242-244 
were isolated from digestive glands of Pacific oyster Crassostrea gigas (Selwood et al., 
2010). Ostrerine A 245 acknowledged from the extracts of Ostrea rivularis, which has 
been used as foodstuff and conventional Chinese medication (Ouyang 2006). The 
carotenoids 246-248 were reported from C. gigas (Japan) (Maoka et al., 2005b), 
whereas an anti-microbial peptide, defensin (molecular weight of 4265 Da) was isolated 
from the oyster, C. virginica (Seo et al., 2005). C. gigas was used to isolate and 
characterize brevetoxin B5 175 (Ishida et al., 2004). The carotenoids 249-253 were 
reported from C. gigas (Maoka et al., 2001). The metabolites of fucoxanthin, 
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crasssostreaxanthin A (254) and crassostreaxanthin B (255) (Fujiwara et al., 1992) 
along with C37-skeletal carotenoids (200-203) were identified from mollusk C. gigas 
(Maoka et al., 2005b). The polyphenolic compound, 3,5-dihydroxy-4-methoxybenzyl 
256 alcohol was identified from the Pacific edible oyster (C. gigas) and its potential 
antioxidant activity was determined (Watanabe et al., 2012). 
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2.7.3.4.  Secondary metabolites from bivalve scallops 
    The biosynthesis of elongated PUFA found in scallop Chlamys nobilis has 
revealed the occurrence of a novel elongase that can extend 20:5n-3 and 20:4n-6 FAs to 
C22 and C24 acids along with ∆8-desaturase (Liu et al., 2014). This PUFA 
biosynthesising enzyme exhibited an advanced adaptation to its marine environment. 
Pectenotoxin 4 (257) and Pectenotoxin 7 (258) were purified from Japanese scallop, 
Patinopecten yessoensis (Sasaki et al., 1998). Comparable macrolides, spirolides B 259 
and D 260 were reported from scallop, Placopecten magellanicus (Hu et al., 1995). The 
spirolides E and F metabolites were isolated from the scallop P. magellanicus (Hu et al., 
1996). The yessotoxin analogues, 45-hydroxyyessotoxin and 45,46,47-trinoryessotoxin 
from the Japanese scallop P. yessoensis were identified (Satake et al., 1996; Takahashi 
et al., 1996). The metabolites of alloxanthin and diatoxanthin, such as pectenol (261),  
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pectenolone (262), 4-hydroxyalloxanthin (263) and 4-ketoalloxanthin (264) were 
reported from scallops (Matsuno 2001). 
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2.8. Conclusions 
 The marine natural product research focused at the purification, isolation and 
characterization of previously undescribed specialized secondary metabolites with 
bioactive pluralities. These investigations were initially biased towards the soft bodied 
shelled or shell-less mollusks due to their vulnerability, adverse living conditions and 
lack of physical protections, even though, these were not reported for cellular damages. 
The newer approaches envisaged to identify an extremely diverse range of compounds 
including various pharmacophore templates, which aimed towards the drug discovery. 
The natural products derived from mollusks, particularly of shelled origin, have been 
used as traditional medicines and functional foods. The preliminary data on nutritional 
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assessments, bioactive potentials and bioactive components from bivalves, gastropods 
and cephalopods appropriately suggested their potential pharmacological utilities. 
Among various mollusks, bivalve clams were considered as traditional health food and 
natural dietary source, even though, the scientific investigations to acknowledge the 
health benefits of these species were confined. There are scanty and scattered 
information on bioactive lead molecules from these low value species, whereas the 
investigations on the structural characterizations of bioactive molecules were limited or 
yet to be studied. There is an increasing demand for more target oriented investigations 
related to bioactive components from mollusk, specifically from the bivalve clams. The 
bioactives from bivalve clams can be used as potential pharmacophore leads to develop 
drug templates, nutraceuticals and functional food supplements for human health and 
wellness.   
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3.1.    Background   
 Bivalve mollusks are one of the most important seafoods in the coastal areas 
of the world contributing a predominant share among the marine and estuarine 
organisms (Xie et al., 2012). Among the molluskan bivalves, the clams occupy a 
predominant share to the total edible bivalve mollusks in the world (Murray and Burt 
2001) although these are frequently underestimated and regarded as by-catch fishery 
resources (Gosling 2002). The black clam Villorita cyprinoides (family, Corbiculidae) 
and short-neck yellow-foot clam, Paphia malabarica (family, Veneridae), are the most 
important and common seafood resources in the coastal regions of India. These low 
valued clam species will be recognized as preferred food items among the coastal 
populace of the underdeveloped and developing countries of Africa and Asia, provided 
if their nutritional qualities be studied extensively (Saba 2011). The mollusks were 
accounted for possessing the essential nutritional elements, which are not present in 
sufficient quantities in our staple food items, such as cereals and pulses (Chakraborty et 
al., 2016a; Chakraborty et al., 2016b; Murray and Burt 2001). For example, the 
essential nutritional elements such as lysine and sulfur containing amino acids are 
reported to be absent in cereals, and were present in adequate quantities in the bivalve 
mollusks, this showed that these species can viably supplement the limiting amino acids 
in our daily diets (Chakraborty et al., 2016a; Chakraborty et al., 2016b). It is 
additionally significant to note that the consumption of staple food items in the daily 
diets, such as cereals and pulses can’t fulfil the obliged nutritional necessities. The quest 
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for balanced nutritional components from the low value food items are of greater 
importance particularly due to the fact that lack of proper nutrition continues to be a 
major risk factor causing death in developing and underdeveloped countries (Schofield 
and Ashworth 2002). Most of the populace in these nations can’t stand to have the 
relatively expensive food items with balanced nutritional elements. 
Marine fishes are rich in minerals and vitamins (Chakraborty and Joseph 
2015; Chakraborty et al., 2016c). The clam species have a place with the group of 
bivalve mollusks, and therefore, constitute potential low valued food items of the 
coastal populace in this area. The clam fisheries in Ashtamudi Lake of Kerala have 
acquired India’s first MSC certification (Marine Stewardship Council certification), 
which will facilitate in promoting the clam fishery in this region. The development of 
clam fishery in Ashtamudi was determined by the requirements in Thailand, Japan and 
Vietnam in 1980s to 1990s. Clam fisheries have continuous landings of approximately 
10,000 tonnes per year for as long as decade in this fishing area of India (Mohamed et 
al., 2013).  
 The fat content in pulse based food items and edible oils were accounted for 
to have elevated contents of saturated fat and n-6 fatty acids. Prior reports have 
expressed those large amounts of n-6 PUFA in the human diet realizes numerous health 
disorders due to their biotransformation to the inflammatory prostaglandin leading to 
various oxidative stresses induced inflammatory diseases (Cleland et al., 2006). It was 
reported that the n-3 PUFAs accounted for to change the unfavourable effects of n-6 
PUFAs (Calder 2004). Notably, long-chain C20-C22 n-3 PUFAs are vital for healthy diet, 
which has a significant part in different structural and metabolic capacities, for example, 
inflammation, immunity and allergic responses (Calder 2012). The n-3 polyunsaturated 
fatty acid content is predominant than saturated fatty acids in bivalve mollusks as 
demonstrated in earlier studies (Chakraborty et al., 2016a; Orban et al., 2002).  
 Bivalves are good sources of C20-C22 n-3 PUFAs, such as EPA and DHA, 
which are the precursors of anti-inflammatory resolvins (E- and D-series), and reported 
to be anti-inflammatory agents (Chakraborty et al., 2014a). In this way, shellfish were 
considered as low saturated fat and high protein food, which can be included in the low 
fat and affordable healthy diets (Food and Nutrition Board 2007). The low valued clam 
species may constitute the significant raw materials for the functional food supplements 
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and may substitute the relatively expensive nutraceuticals available in the market. Over 
the previous decades, the importance of bivalve clam has significantly expanded as 
alternative resources to the traditional finfish fishery in the distinctive parts of the 
world. Because of their nutritional and market value, clam aquaculture has additionally 
demonstrated an increment amid the recent years.  
 As of late, after the significance of low valued bivalve clams as a potential 
health food had been acknowledged, the studies on its biochemical composition began 
to receive considerable attention. The coastal waters of the southwest coast of Arabian 
Sea was found to be the most productive fishery zone in India, representing around 90% 
of the aggregate bivalve clam production. Albeit, a few studies have been directed to the 
biological description and distribution of these species (Gosling 2002; Heslinga 1989), 
there has no published studies were available on its nutritional composition. Hence, the 
present study envisaged to carry out on the essential nutritional qualities with respect to 
proximate composition, meat yield, condition indices, amino acids, cholesterol, 
proteins, lipids, fatty acids, vitamins and mineral contents of the two common clam 
species, V. cyprinoides (Gary) and P. malabarica (Chemnitz), available in abundance at 
the coastal waters of the southwest coast of India.  
 
3.2.   Materials and methods 
3.2.1. Chemicals, reagents and instrumentations 
  The solvents utilized in the study were of analytical or HPLC category (E-
Merck, Frankfurter, Darmstadt, Germany; Sigma-Aldrich, Missouri, USA) and carried 
out for redistillation. MiiliQ or double distilled (DDW) or HPLC grade water was used 
during the experimentations. The reagents were of spectroscopic or analytical category 
(E-Merck, Frankfurter, Darmstadt, Germany; Sigma-Aldrich, Missouri, USA). 
Potassium hydroxide, sodium hydroxide, sodium phosphate buffer, acetic acid, 
metaphosphoric acid, tertbutylhydroquinone (TBHQ), sodium sulfate (Na2SO4), boron  
trifluoride in methanol (BF3 in MeOH), bovine serum albumin, sodium carbonate 
(Na2CO3), copper sulfate (CuSO4), potassium-sodium tartarate, Folin-Ciocalte reagent 
(F.C. reagent), trichloro acetic acid (TCA), cholesterol (standard), O-phtalaldehyde, 
glacial acetic acid, fatty acid methyl ester (FAME) standards (Catalog No. 47885-U, 
SupelcoTM 37 Component FAME Mix), vitamin (A, D3, E, K, C) standards were 
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procured from E-Merck (Frankfurter, Darmstadt, Germany) or Sigma-Aldrich 
(Missouri, USA). The amino acid standards procured from Thermo Scientific (PIERS 
amino acid standard H) and the standards for mineral analyses were purchased from 
Perkin Elmer (Shelton, USA). All glasswares procured from Borosil (India) or Magnum 
glassworks (Cochin, Kerala, India).  
 Gas liquid chromatography (GLC) data recorded on a Perkin-Elmer 
AutoSystem XL gas chromatograph (HP 5890 Series II, Perkin Elmer, Shelton, CT, 
USA). The spectrophotometric data acquired on ultraviolet-visible spectrophotometer 
(Varian Cary 50, Walnut Creek, California, USA). The amino acid analyses performed 
on a reversed phase binary gradient high performance liquid chromatography (HPLC, 
Waters Corp., Milford, MA, USA). The analyses of fat soluble vitamins such as A, 
D3, E, K performed using HPLC instrument (Shimadzu LC 20AD, Shimadzu Corp., 
Nakagyo-ku, Japan). Mineral profiles analyzed using atomic absorption spectrometer 
(AAnalyst™ 200, Perkin Elmer, Shelton, CT, USA). The solvents were evaporated by 
rotary evaporator (Heidolph Instruments GmbH and Company, Schwabach, Germany). 
The refrigerated centrifuge (Thermo Scientific, Thermo Electron LED GmbH, 
Langenselbold, Germany) used for centrifugation. Samples were dried using laboratory 
oven (Labline, India).   
3.2.2. Study area and samples 
The two bivalve clams selected for this study were, 
 Villorita cyprinoides Family - Corbiculidae 
 Paphia malabarica Family – Veneridae 
 The samples of V. cyprinoides and P. malabarica (5 kg each) were collected 
during the month of September (post-monsoon season) from the estuarine waters of 
Vembanad Lake (9°35’ N and 76°25’ E) and Ashtamudi Lake (8°59’ N and 76°36’ E), 
respectively situated at the southwest coast of India, which is predominantly influenced 
by oceanic waters from the Arabian Sea. The photographs of sample collection sites, the 
shell on samples and the inside view of edible part of V. cyprinoides and P. malabarica 
were illustrated (Figure 3.1.-3.2.).  
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 After cleaning the fouling matters and externalities, V. cyprinoides and P. 
malabarica were transported to the laboratory in an ice box. They were thoroughly 
washed to remove mucus, debris, fecal matters, and other particles. The surface water 
on the clam samples blotted with filter paper, and the edible meat (1 kg each) separated 
from the shells before being analyzed for the biometric and nutritional parameters.  
 
 
Figure 3.1.: Sample collection site of edible clam, V. cyprinoides along the southwest 
coast of India bordering the Arabian Sea. (A) Vembanad Lake at 9°35’ N and 76°25’ E; 
(B) the shell on V. cyprinoides; (C) the inside view of V. cyprinoides with edible part 
 
 
Figure 3.2.: Sample collection sites of edible clam, P. malabarica from the southwest 
coast of India bordering the Arabian Sea. (A) Ashtamudi Lake at 8°59’ N and 76°36’ E; 
(B) the shell on P. malabarica; (C) the inside view of P. malabarica with edible part 
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3.2.3. Determination of biometric parameters, condition indices and meat yield 
 The samples of V. cyprinoides and P. malabarica measured for their 
biometrical parameters, namely length, width and thickness. The length (maximum 
anterior-posterior axis), width (maximum lateral axis), and thickness (height of 
maximum longitudinal axis) of fifty randomly selected samples measured using a 
Vernier calipers. The samples were weighed, opened by cutting the adductor muscle and 
the wet meat and shell weight were noted. The tissues were oven dried for 48 h at 60°C, 
and the dry weight was determined. Condition indices (CI) used to characterize the 
apparent health and quality of the biological entity. Three condition indices (CI) were 
taken into account in this study were as follows: (1) economic CI calculated using the 
formula: thickness/[0.5 * (length + width)] (Imai and Sakai 1961); (2) Booth CI 
calculated as wet flesh weight/total weight (Booth 1983) and (3) ecophysiological CI 
expressed as dry flesh weight/dry shell weight (Walne 1976). The dry weights of shells 
were calculated by oven drying (80°C). 
 
3.2.4.  Proximate composition 
 Moisture content in the samples were analyzed by drying the known weights 
of samples at 60°C in a hot air oven until acquiring a constant weight, followed by 
drying in a hot air oven for 2 h at 100°C (AOAC 1990). The crude protein (total 
nitrogen content) was determined by micro Kjeldhal method and the results were 
multiplied by 6.25 to attain the crude protein percentage. The crude fat was calculated 
by Soxhlet apparatus method using petroleum ether (b.p. 60-80°C). Crude fibre was 
estimated by the fraction remained after the reflux with standard, H2SO4 (1.25% w/v) 
and NaOH (1.25% w/v) solution for 30 min, under controlled condition. The 
carbohydrate content was determined by following AOAC (2005) method. 
 
3.2.5. Estimation of protein and amino acid  
3.2.5.1.  Estimation of protein  
  The protein contents in the flesh of clams were determined by recognized 
procedure of Lowry et al., (1951). The standard, bovine serum albumin stock was 
prepared and from this solution, different concentrations (0-800 µg/mL) of working 
standard were prepared by serial dilutions. Each of the above working standard solution 
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(5 mL) was added with 5 mL of freshly prepared alkaline reagent (96% of Na2CO3 2% 
in 0.1 N NaOH + 2% of CuSO4 0.5% in DDW + 2% of potassium-sodium tartarate 1% 
in DDW). This solution was mixed well and kept for 10 min incubation, along with 
addition of 0.5 mL of freshly prepared Folin-Ciocalte (1:2, v/v, F.C. reagent:DDW). 
This mixture was homogenized properly and kept for 30 min in dark (a blue colour was 
formed). The absorbance of aliquot of protein was recorded at 660 nm against the 
reagent blank by UV-Visible spectrophotometer. A linear curve of standard was plotted 
between the concentration (X-axis) and the absorbance (Y-axis). The edible tissues of 
respective clam samples (0.1-0.2 g) were mixed with DDW (1 mL) and 1 mL of 5% 
trichloro acetic acid followed by centrifugation (4°C, 20 min, 10,000 rpm). To the 
supernatant solution of samples (1 mL) were added with 5 mL of freshly prepared 
alkaline reagent (96% of Na2CO3 2% in 0.1 N NaOH + 2% of CuSO4 0.5% in DDW + 
2% of potassium-sodium tartarate 1% in DDW). This solution was mixed well and kept 
for incubation (10 min), followed by addition of 0.5 mL of freshly prepared F.C. reagent 
(1:2, v/v, F.C. reagent:DDW). This mixture was homogenized properly and kept in dark 
for 30 min (a blue colour was formed) before being measured the absorbance at 660 nm. 
The protein content was calculated from standard curve of bovine serum albumin, and 
expressed as mg/g of wet weight using the equation given below. 
 
Protein in mg/g sample = (concentration in μg/mL (x) * 2 mL)/(weight of sample in g * 
1000) 
Concentration in μg/mL (x) was obtained from the linear graph of standard using the 
equation  
y = mx + c (where “y = absorbance of sample”) 
(1000 = g converted to mg; 2 = sample dissolved in 1 mL TCA and 1 mL DDW) 
 
3.2.5.2.  Estimation of amino acid  
 The percentages of amino acids were calculated by earlier methods 
(Chakraborty and Joseph, 2015). The samples (0.2 g) were hydrolyzed at 110°C using 
HCl (10 mL, 6 N) in a closed glass tube on multi-place heating mantle for 24 h. After 
cooling the glass tubes, the seal was broken and filtered the samples through Whatman 
filter paper (No. 41) to a flask followed by evaporation to dryness in vacuum rotary 
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evaporator (75-85°C) to afford a residue. This residue was washed using DDW and 
vacuum concentrated at 75-85°C. This procedure was repeated for 3-4 times to remove 
the presence of acid and finally, the concentrate or aliquot was reconstituted in 5 mL 
0.05 N HCl. The hydrolyzed amino acids in the aliquot treated with the redrying agent 
(2:2:1, v/v/v, methanol 95%:water:triethylamine) and subsequently pre-column 
derivatization of hydrolyzable amino acids were treated with phenyl isothiocyanate 
(PITC or Edman’s reagent) to yield phenylthiocarbamyl amino acids (PTC). The 
reagent was freshly processed and composition of derivatizing agent consisted of 
methanol 95%:triethylamine:phenylisothiocyanate (20 µL, 7:1:1, v/v/v; 70 µL methanol 
+ 10 µL DDW + 10 µL triethylamine + 10 µL phenyl isothiocyanate). The 20 µL of 
PTC derivative (derivatized sample) was diluted with 20 µL of diluent (5:95, v/v, 
acetonitrile:5 mM sodium phosphate buffer, pH 7.4) before injecting into reversed 
phase HPLC equipped with column, retained at 38°C in a column oven and identified 
by UV absorbance at λmax 254 nm (Waters Corporation, Milford, MA 01757, USA). 
Mobile phase has been consisted of sodium acetate trihydrate (pH 6.4, 0.14 M, 940 mL; 
A) including 0.05% triethylamine was homogenized with 60 mL acetonitrile and 60:40 
(v/v) acetonitrile:water (B). The gradient elution method with increasing eluent B 
employed for this use. The quantification of amino acids was carried out by comparing 
the peak area of sample with the peak area of standard and the amino acid content was 
expressed as mg/100 g protein. The total essential amino acids (∑EAA), total non-
essential amino acids (∑NEAA), total amino acids (∑AA), total aromatic amino acids 
(∑ArAA), total sulfur containing amino acids (∑SAA), ratio of total essential amino 
acid to total amino acid (∑EAA/∑AA), ratio of total non-essential amino acid to total 
amino acid (∑NEAA/∑AA) and ratio of total essential amino acid to total non-essential 
amino acid (∑EAA/∑NEAA) were determined. 
 
The amino acid score for essential amino acids determined by utilizing FAO/WHO 
(FAO, WHO 1990) method:  
amino acid score = amount of amino acid per protein in sample (mg/g)/amount of amino 
acid per protein in standard protein (mg/g) with regard to standard amino acid 
requirements for adults (FAO, WHO, UNU 2007). 
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3.2.6. Estimation of lipid and fatty acid  
3.2.6.1.  Estimation of lipid  
 The extractions of lipids in tissues of bivalve clams were performed by Folch 
extraction (Folch et al., 1957) method by 2:1 chloroform:methanol (v/v, 200 mL). 
Edible portion of each species (10-30 g) were mixed with 1:1 of chloroform:methanol 
(v/v) and distilled water (200 mL). This mixture was homogenized with 0.002% TBHQ 
and kept for overnight in the dark at 4°C in the nitrogen atmosphere to extract lipids. 
The solutions were filtered through separating funnel using Whatman filter paper and 
chloroform layer (bottom layer) containing lipids was collected through Na2SO4 to a 
pre-weighed flask (w2). The filtrate was evaporated at 40-45°C and final weight of the 
flask was calculated. The percentage (%) of lipid content was calculated using the 
equation, 
  
Lipid (%) = [(W1-W2)/W3] * 100  
(W1 - weight of flask + lipid; W2 - weight of flask; W3 - weight of sample)    
 
3.2.6.2.  Estimation of fatty acid            
 The fatty acid compositions of total lipids from V. cyprinoides and P. 
malabarica were estimated as mentioned earlier (Metcalf et al., 1966). The methanolic 
KOH was added to the above obtained lipid and refluxed for 30 min at 80°C under 
nitrogen atmosphere. A solution of BF3 in methanol (5 mL) was added to the above 
mixture and again refluxed under nitrogen atmosphere (5 min). This solution was 
allowed to cool and added with petroleum ether (twice the volume of solution) to a 
separating funnel to separate the layers using distilled water. The organic layer (upper) 
was washed with distilled water for 3-4 times and collected the petroleum ether layer 
(organic) through Na2SO4 and concentrated in rotary evaporator (40°C). The 
concentrates were reconstituted in minimum amount of petroleum ether and injected in 
gas liquid chromatography (GLC). GLC data recorded on a Perkin-Elmer AutoSystem 
XL gas chromatograph (HP 5890 Series II, Perkin Elmer, Bridgeport Ave, Shelton, CT, 
USA) connected with a SP 2560 (crossbond 5% diphenyl-95% dimethyl polsiloxane) 
capillary column (100 m X 0.25 mm i.d., 0.50 µm film thickness, Supelco, Bellfonte, 
PA) utilizing a flame ionization detector (FID) equipped with a split/splitless injector, 
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which was used in the split (1:15) mode. The GLC analyses were carried out using oven 
temperature ramp program: 140°C for 1 min, rising at 30°C/min to 250°C, where it was 
held for 1.0 min, followed by an increase of 25°C/min to 285°C, where it was held for 
2.0 min, until all peaks were appeared. The injector and detector were held at 285°C and 
290°C, respectively. Nitrogen (ultra high purity > 99.99%) was used as carrier gas at 25 
cm/s flow rate. Hydrogen was used as the carrier gas at a head pressure of 20 psi. The 
injection volume was 0.02 µL. The evaluation of retention times with standards 
(SupelcoTM 37 Component FAME Mix) was identified as FAMEs and results were 
calculated as total fatty acids percentage (% TFA). Total ∑PUFA (polyunsaturated fatty 
acids), ∑MUFA (total monounsaturated fatty acids) and ∑SFA (total saturated fatty 
acids) were calculated. The different ratios of fatty acid indicating nutritional values of 
the edible clams namely, n-3/n-6, n-6/n-3, DHA/EPA and ∑PUFA/∑SFA were 
calculated.  
 
The indices of atherogenicity (AI) and thrombogenicity (TI) (Ulbricht and Southgate 
1991) have been calculated as: 
AI = (4 * 14:0 + 18:0 + 16:0)/(MUFA + Σn-3PUFA + Σn-6PUFA) 
TI = (14:0 + 18:0 + 16:0)/[(0.5 * MUFA) + (0.5 * n-3PUFA) + (3 * n-3PUFA) + (n-
3PUFA/n-6PUFA)] 
 
The hypocholesterolaemic/hypercholesterolaemic (HH) ratio determined by (Santos-
Silva et al., 2002). 
HH = (18:1n-9 + 18:2n-6 + 20:4n-6 + 18:3n-3 + 20:5n-3 + 22:5n-3 + 22:6n-3)/(14:0 + 
16:0) 
           
3.2.7. Estimation of minerals 
The mineral contents were estimated by atomic absorption spectrometer 
(AAnalyst™ 200 spectrometer, Perkin Elmer, USA). The samples were kept for ashing, 
followed by acid (HCl) digestion and aspiration. The dry samples of clam (2 g) were 
kept at 525°C in muffle furnace and the ashed samples were digested in 50 mL of 6N 
HCl, and filtered through Whatman No.1 filter paper before being diluted with milliQ 
water. The sample solution was aspirated in an atomic absorption spectrometer for the 
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determination of minerals. The analyses of calcium (Ca), sodium (Na), potassium (K), 
magnesium (Mg), copper (Cu), iron (Fe), and zinc (Zn) were performed by flame 
atomic absorption spectrometer equipped with a hollow cathode lamp containing D2 
lamp background correction system. The continuous flow hydride generator fixed with 
atomic absorption spectrometer was utilized for selenium (Se) contents (Chakraborty et 
al., 2016b). The analyses of phosphorus was carried out by alkalimetric ammonium 
molybdophosphate experiment as established in AOAC (AOAC 2005) official 
procedure 964.06. Macro (Mg, Na, Ca, K and P) and micro minerals (Fe, Cu, Mn and 
Zn) were represented as mg/100 g wet weight except for Se which was represented in 
µg/100 g wet weight. 
3.2.8. Estimation of cholesterol and vitamins 
3.2.8.1.  Estimation of cholesterol 
The total cholesterol content in bivalve clams were resolved 
spectrophotometrically (Varian Cary, USA) with appropriate alterations using O-
phthalaldehyde (50 mg/dL in glacial acetic acid) (Wanasundara and Shahidi 1999). The 
stock standard solution of cholesterol in ethanol (10 mg in 10 mL, 1000 ppm) and its 
working stock solutions were prepared (0-1000 µg/mL by serial dilution). About 0.1 mL 
of stock solution from each of the different concentration was mixed with O-
phtalaldehyde (2 mL) and Con. H2SO4 (1 mL). The absorbance of solution was recorded 
after 10 min at 550 nm. Then, a linear curve of standard was plotted by the 
concentration against (X-axis) absorbance (Y-axis). The edible tissue of respective clam 
samples (0.1 g) mixed with 33% KOH (0.3 mL) and ethanol (3 mL) followed by heating 
for 15 min in water bath (60°C). This solution was allowed to cool and mixed with 
hexane (10 mL) and DDW (3 mL). The hexane supernatant was pipetted out and 
evaporated, followed by slow addition of Con. H2SO4 (1 mL). The mixture was 
homogenized thoroughly and absorbance was recorded after 10 min at 550 nm. The 
collective cholesterol content determined from standard curve of cholesterol. The values 
were reported as mg/100 g on wet weight basis using the equation given below, 
Cholesterol in mg/100 g = (concentration in µg/mL (x) * 100)/(sample weight in g * 
1000) 
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Concentration in µg/mL (x) obtained from the linear graph of standard using the 
equation  
y = mx + c (where “y = absorbance of sample”) 
(1000 = conversion of µg to mg, 100 = 100 g sample)                             
 
3.2.8.2.  Estimation of vitamins  
 The vitamins, A, D3, E and K were estimated by Salo-Vaananen et al., (2000) 
method. The vitamin standard (Sigma-Aldrich Chemical Co. Inc, St. Louis, MO) 
solutions (1/10/ 25/50/100 ppm) were maintained at -20°C except vitamin D3 (stored at 
4°C). Lipids were yielded by the method described as in 3.2.6.1. before hydrolyzation 
(KOH/MeOH, 0.5 N, 2 mL) (Chakraborty et al., 2014b). The hydrolyzed mixture (2 
mL) was extracted with petroleum ether (fraction of 40-60°C, 15 mL) before being 
washed with deionized water (2 X 10 mL) to remove alkali content. The non-
saponifiable portion was concentrated under vacuum using a rotary evaporator 
(Heidolph Instruments GmbH and Co., Schwabach, Germany) at 50°C before being 
reconstituted in MeOH. The latter was filtered through a syringe filter (0.2 mm) before 
being injected (20 mL) in the HPLC (Shimadzu LC 20AD, Shimadzu Corporation, 
Nakagyo-ku, Japan). The HPLC system was equipped with a reverse phase column 
(phenomenex, C18 250 mm length, 4.6 mm i.d., 5 μm) that was housed in a column 
oven (32°C) and connected to a photodiode array detector. The gradient programme was 
as follows: 20% MeOH (HPLC grade) up to 3 min, which was increased to 100% in the 
next 5 min and held for 37 min with a complete run time of 45 min. The flow rate was 1 
mL/min. The vitamin C was determined based upon the quantitative discolouration of 
2,6-dichlorophenol indophenol titrimetric method (AOAC 2005). In brief, ascorbic acid 
was extracted from the clam samples (M, 15-20 g) using an acetic acid and 
metaphosphoric acid solution (HPO3-CH3COOH, 10 mL X 2). The extracts were 
transferred with distilled water into a known volume (B, mL) and filtered rapidly. The 
known volume (C, mL) of the above solution was pipetted out and titrated with the 
redox dye, 2,6-dichlorophenol indophenol solution until the faint pink colour persisted 
for 15 s. The vitamins A, D3, E and C were reported in IU (International Unit) whereas, 
vitamin K in µg/100 g wet weight. 
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Ascorbic acid content was calculated as: {(A - A0) * D * B * 10}/(M * C),  
Where A = average volume of test solution for titration in mL, A0 = average volume for 
blank titration in mL and D = mg ascorbic acid equal to 1 mL of standard indophenol 
solution.  
3.2.9. Statistical analyses 
 One way analyses of variance (ANOVA) was carried out with the Statistical 
Program for Social Sciences 13.0 (SPSS, USA, ver. 13.0) to assess significant 
differences between the means. The significant differences were represented as p < 
0.05. The values were given as mean of triplicates ± standard deviation. The 
mean variance in the data set was detected using principal component analyses 
(PCA). The various nutritional parameters were selected as the variables for PCA. 
3.3. Results and discussion 
3.3.1. Morphometric characteristics 
 The biometric estimations of clams were determined by measuring their 
length, width and thickness. The meat yield of the edible clams from their habitat 
showed that this morphometric index was not significantly distinctive between V. 
cyprinoides and P. malabarica (20-21%, p > 0.05) (Table 3.1.). The present study 
exhibited no significant difference in condition indices between the edible clams by the 
methods of Imai and Sakai, Walne and Booth (p > 0.05).  
Table 3.1.: Meat yield (%) and biometric measurement (length, width, thickness) of P. 
malabarica and V. cyprinoides 
P. malabarica V. cyprinoides 
Meat yield (%) 20.33 ± 1.15a 21.67 ± 1.53a 
Length (cm) 3.67 ± 0.15a 3.37 ± 0.15a 
Width (cm) 2.67 ± 0.15a 2.70 ± 0.10a 
Thickness (cm) 1.40 ± 0.10a 1.33 ± 0.15a 
Data were reported as mean ± standard deviation of three replicates. No significant 
differences were observed between the variants (p > 0.05) 
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Table 3.2.: Condition indices of P. malabarica and V. cyprinoides 
 P. malabarica V. cyprinoides 
Imai and Sakai 0.44 ± 0.05a 0.44 ± 0.04a 
Booth 0.20 ± 0.01a 0.22 ± 0.02a 
Walne 0.05 ± 0.01a 0.07 ± 0.01a 
Data were reported as mean ± standard deviation of three replicates. No significant 
differences were observed between the variants (p > 0.05) 
 
 Percentage edibility or the condition indices (CI) have been utilized to 
comprehend the biological value of these shellfishes used in the present study. The 
commercial quality and physiological condition of mollusks were depicted by condition 
indices. CI is closely identified with the nutrient storage and meat quality. The good CIs 
which were dictated by different methods suggested that these shellfish species can be 
used as potential sources for human consumption.  
 
3.3.2. Proximate composition 
 The proximate compositions of clams were recorded in Table 3.3. No 
significant differences in the contents of crude fibre and crude ash were apparent among 
the clam species (p > 0.05). The crude protein content varied from 13-15 g/100 g wet 
weight; the maximum of 15 g/100 g wet weight recorded for P. malabarica. The crude 
fat content ranged from 2.01-3.75 g/100 g wet weight, which was found to be 
significantly greater for V. cyprinoides (p < 0.05). The moisture content was ranged 
from 74-76 g/100 g wet weight, and found to be significantly greater for P. malabarica 
as compared to that in V. cyprinoides (p < 0.05). A direct relationship between moisture 
and protein content was apparent. V. cyprinoides was demonstrated significantly greater 
(p < 0.05) carbohydrate content (8.57 g/100 g wet weight) than that observed in P. 
malabarica (4.65 g/100 g on wet weight basis). 
 Proximate compositions were depicted by the accumulation and depletion of 
food reserves and accessibility of food. The results were showed the inverse relationship 
between crude fat and moisture. The changes in crude protein in these two species were 
only due to the variation in moisture content and these variations were found to be 
within the normal range. The principle constituent of the edible part of the clam is 
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water, an index of freshness, which was around 76% and 74% for V. cyprinoides and P. 
malabarica, respectively. These results were upheld by previous works of Murray and 
Burt (2001). The water content was found to be more than 70% that demonstrated the 
freshness of the edible bivalve mollusks. V. cyprinoides and P. malabarica possessed 
greater crude protein (13-15% wet weight) and fat (2.01-3.75% wet weight) contents 
when contrasted with other bivalve mollusks, Mytilus galloprovincialis and Ruditapes 
decussatus (12-13%) from Porto Pozzo Lagoon of central-western Mediterranean Sea. 
The crude fat content of M. galloprovincialis and R. decussatus 1.3-2.0%, which were 
lesser than those reported in the present study (Saba 2011). The term crude fibre is a 
measure of the amount of indigestible lignin, cellulose, and other components of this 
type in the food items. A lesser content of crude fibre is directly proportional to the 
digestibility of the food sample and therefore, a good quality food should contain lesser 
content of crude fibre. The crude fibre contents of V. cyprinoides and P. malabarica 
considered in the present study were 0.04-0.05 g/100 g wet weight, which indicated the 
greater digestibility of their edible parts. No significant differences in proximate 
composition of V. cyprinoides and P. malabarica with that of Asian hard clam, M. 
lusoria was noted (Supatra et al., 2013). Notwithstanding, M. meretrix from China 
reported 10-15% and 1-6% fat (Xie et al., 2012), which were equivalent with V. 
cyprinoides and P. malabarica. 
 
Table 3.3.: Proximate compositions (g/100 g wet weight) of P. malabarica and V. 
cyprinoides 
 P. malabarica V. cyprinoides 
Dry matter 23.40 ± 0.02 a    26.83 ± 0.02 b 
Moisture 76.62 ± 0.03a    74.17 ± 0.02b 
Crude protein 15.47 ± 0.01a    13.42 ± 0.02b 
Crude fat 2.01 ± 0.02a    3.75 ± 0.02b 
Crude fibre 0.05 ± 0.02 a 0.04 ± 0.02a 
Crude ash 1.22 ± 0.01a 0.93 ± 0.02a 
Carbohydrate 4.65 ± 0.04a    8.57 ± 0.02b 
Data were reported as mean ± standard deviation (n = 3). Different superscripts (a-b) 
within the same row denoted the significant differences (p < 0.05)  
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3.3.3. Lipid content and fatty acid composition 
 The lipid contents of the experimental samples were denoted in Table 3.4. 
Significant difference in lipid content was noted in the edible parts of clam species (p < 
0.05), wherein V. cyprinoides recorded greater lipid content (2.27 g/100 g wet weight) 
than P. malabarica (1.77 g/100 g wet weight).  
 The fatty acid compositions of bivalve mollusk samples were given in Table 
3.4. V. cyprinoides was demonstrated significantly greater contents of (p < 0.05) total 
SFAs (48% TFA wet weight) than that in P. malabarica (34% TFA wet weight).  The 
palmitic (16:0) and stearic acids (18:0) were found to be the predominant SFAs in V. 
cyprinoides and P. malabarica. The content of 16:0 was greater in V. cyprinoides and 
contributed about 64% of the total SFA content, whereas P. malabarica contributed 
about 53% wet weight of the aggregate SFAs. The odd chain saturated fatty acid 
pentadecanoic acid (15:0) was found to be present in significantly greater quantity 
(1.55% TFA wet weight) in P. malabarica than that in V. cyprinoides (0.42% TFA wet 
weight), whilst the concentration of docosanoic acid (22:0) was significantly greater in 
V. cyprinoides (0.77% TFA wet weight) than that in P. malabarica (0.19% TFA wet 
weight) (p < 0.05). No significant differences in the 18:0 fatty acid contents among both 
the clam species (p > 0.05) were apparent. The aggregate MUFA content in V. 
cyprinoides and P. malabarica were differed from 23-26% wet weight. The palmitoleic 
(16:1n-7), erucic acid (22:1n-9) and oleic acid (18:1n-9) were found to be the 
predominant MUFAs. The content of 16:1n-7 fatty acid was significantly greater in V. 
cyprinoides (p < 0.05), whereas P. malabarica exhibited significantly greater 18:1n-9 
cis and 22:1n-9 contents when contrasted with those in V. cyprinoides (p < 0.05).  The 
fatty acid 16:1n-7 in V. cyprinoides and P. malabarica contributed 41% and 25% of the 
total fatty acids, respectively on wet weight basis.   
   
Table 3.4.: Lipid content (g/100 g wet weight) and fatty acid composition (% total fatty 
acids wet weight) in P. malabarica and V. cyprinoides 
Fatty acids P. malabarica V. cyprinoides 
Lipid 1.77 ± 0.01a 2.27 ± 0.02b 
Saturated fatty acids 
12:0 0.05 ± 0.01a 0.03 ± 0.01a 
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14:0 2.62 ± 0.01a    4.35 ± 0.02b 
15:0 1.55 ± 0.01a    0.42 ± 0.02b 
16:0 17.92 ± 0.03a     30.57 ± 0.02b 
17:0 2.43 ± 0.02a 2.66 ± 0.02a 
18:0 8.73 ± 0.02a 8.33 ± 0.02a 
20:0 0.31 ± 0.01a       0.71 ± 0.01b 
22:0 0.19 ± 0.01a     0.77 ± 0.02b 
24:0 0.04 ± 0.00a 0.03 ± 0.00a 
∑SFA*     33.84 ± 0.01a     47.77 ± 0.15b 
Monounsaturated fatty acids 
14:1n-7 0.20 ± 0.01a        0.42 ± 0.01b 
15:1n-7 1.19 ± 0.01a    0.84 ± 0.01b 
16:1n-7 cis 5.76 ± 0.02a    10.39 ± 0.02b 
18:1n-7 0.12 ± 0.01a      0.31 ± 0.02b 
18:1n-9 cis 8.87 ± 0.01a     6.77 ± 0.02b 
20:1n-9 2.10 ± 0.1a     4.37 ± 0.01b 
22:1n-9    4.33 ± 0.01a     2.32 ± 0.01b 
24:1n-9 0.71 ± 0.01a     0.11 ± 0.01b 
∑MUFA**      23.15 ± 0.01a 25.57 ± 0.01a 
Polyunsaturated fatty acids 
18:2n-6 cis 1.34 ± 0.01a    2.68 ± 0.02b 
18:3n-6 2.72 ± 0.01a    5.05 ± 0.01b 
18:3n-3 0.22 ± 0.01a 0.36 ± 0.01a 
20:2n-6 2.92 ± 0.01a      1.68 ± 0.01b   
20:3n-6 2.63 ± 0.01a     0.39 ± 0.01b 
20:4n-6 0.76 ± 0.01a 0.60 ± 0.01a 
20:5n-3 EPA 7.68 ± 0.02a     3.57 ± 0.01b 
22:5n-3 1.62 ± 0.02a    0.92 ± 0.01b 
22:6n-3 DHA 14.35 ± 0.01a    3.22 ± 0.01b 
∑PUFA***  34.33±0.15a     18.46±0.01b 
∑n-3 23.84±0.01a     8.07±0.02b 
∑n-6 10.37±0.02a 10.39±0.01a 
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∑n-3/∑n-6 2.31±0.01a      0.77±0.01b 
DHA/EPA 1.88±0.01a    0.91±0.01b 
∑PUFA/∑SFA 1.02±0.01a    0.39±0.01b 
Atherogenicity index (AI) 0.66±0.01a    1.25±0.03b 
Thrombogenicity index (TI) 0.31±0.01a    1.04±0.03b 
HH ratio 1.71±0.01a  0.52±0.03b 
*Total saturated fatty acids, **total monounsaturated fatty acids, ***total polyunsaturated 
fatty acids. Data were presented as mean values of three samples (mean ± standard 
deviaion). Different superscripts (a-b) within the same row indicate the significant 
difference (p < 0.05). HH ratio-hypocholesterolaemic/hypercholesterolaemic ratio 
 
P. malabarica has recorded significantly greater content of PUFAs (34% 
TFA wet weight) (p < 0.05) as compared to that recorded in V. cyprinoides (18% TFA 
wet weight). The total content of n-3 PUFAs was found to be significantly greater (p < 
0.05) in P. malabarica (23.84% TFA wet weight) as compared to that in V. cyprinoides 
(8.07% TFA wet weight). The EPA and DHA contents of the edible parts of P. 
malabarica (7% and 14% TFA, respectively on wet weight basis) were found to be 
greater than those in V. cyprinoides (3.5% and 3.2% TFA, respectively on wet weight 
basis). Accordingly, the n-3/n-6 fatty acid ratio recorded to be greater (2.3) in P. 
malabarica than that in V. cyprinoides (< 1.0). P. malabarica was displayed 
significantly greater (p < 0.05) DHA/EPA (1.88) and ∑PUFA/∑SFA (1.02) than edible 
parts of V. cyprinoides [DHA/EPA (0.91) and ∑PUFA/∑SFA (0.39)]. 
 The AI and TI indices were evaluated in V. cyprinoides (1.25 and 1.04, 
respectively) and P. malabarica (0.66 and 0.31, respectively). The HH ratio was found 
to be significantly greater in P. malabarica as compared to that of the edible part of V. 
cyprinoides (p < 0.05). Figure 3.3. represented the comparison of n-3/n-6, n-6/n-3, 
DHA/EPA and ∑PUFA/∑SFA between P. malabarica and V. cyprinoides. 
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Figure 3.3.: Comparison of n-3/n-6, n-6/n-3, DHA/EPA and ∑PUFA/∑SFA between P. 
malabarica and V. cyprinoides  
 
 Among different saturated fatty acids, palmitic acid was found to be 
predominant in V. cyprinoides (31% TFA on wet weight basis) when contrasted with 
that in related bivalves, for example, Donax incarnates (28%) (Periyasamy et al., 2014) 
and M. casta (15-16% TFA) (Srilatha et al., 2013). Palmitic acid has been accounted for 
as the major SFA in mussels (Alkanani et al., 2007). SFAs with their more prominent 
caloric substance are basically used as a storage form of energy. Diets that are more 
prominent in PUFAs are connected with decreased danger of cardiovascular illness and 
atherogenesis (Andrade et al., 2012). The health Department of UK has been prescribed 
a perfect percentage of n-6/n-3 as 4.0 and the qualities greater than 4.0 are viewed as 
harmful to human wellbeing, and may prompt cardiovascular maladies (HMSO 2001). 
The n-6/n-3 degree in the present study was lesser than 2 and, in this manner, the 
bivalves can be considered as a healthy diet.  
 The aggregate n-3 PUFA content in P. malabarica was found to be 
fundamentally more prominent (p < 0.05). PUFAs are essential biochemical markers of 
bivalves contributing to their nutritional qualities. The EPA and DHA contents in P. 
malabarica were found to be 7% and 14%, respectively, on wet weight basis which 
were more noteworthy when contrasted with the normally devoured finfish Epinephelus 
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diacanthus (4.7% and 11%, respectively) (Chakraborty et al., 2014c). The long-chain 
(C20-C22) n-3 PUFAs were known to have variety of health benefits against 
cardiovascular ailments including anti-inflammatory, antihypertensive, antioxidant, and 
anti-arthritis effects (Siriwardhana et al., 2012).   
 AI is a marker of risk for cardiovascular maladies, whilst TI is an indicator of 
potential for blood platelets conglomeration. Lesser estimations of AI and TI in edible 
part of P. malabarica and V. cyprinoides were practically identical with the prior studies 
identified with the bivalves, R. decussates and M. galloprovincialis (Saba 2011). 
 
3.3.4. Protein content and amino acid composition 
 No significant differences in protein contents in V. cyprinoides and P. 
malabarica were apparent (11-12 mg/g wet weight, p < 0.05) (Table 3.5.).  
 A total of seventeen amino acids were identified and quantified in V. 
cyprinoides and P. malabarica (Table 3.5.). V. cyprinoides was exhibited significantly 
greater (p < 0.05) content of total essential amino acid (300 mg/100 g wet weight) as 
compared to P. malabarica (285 mg/100 g wet weight). No significant differences in 
the total non-essential amino acids (∑NEAA) contents were recorded in these species (p 
> 0.05). The most abundant essential amino acid was found to be arginine in V. 
cyprinoides (54 mg/100 g wet edible weight), followed by leucine (48 mg/100 g) and 
lysine (42 mg/100 g). Arginine was found to be abundant in P. malabarica (53 mg/100 
g), followed by lysine and leucine. Among the non-essential amino acids, glutamine 
was constituted the major share followed by aspartic acid (Table 3.5.). However, the 
content of aspartic acid was found to be significantly greater in P. malabarica as 
compared to that in V. cyprinoides (p < 0.05). No significant difference was noted for 
glutamine content in these samples (p > 0.05). The total sulfated and aromatic amino 
acid contents were found to be significantly greater in V. cyprinoides as compared to 
those in P. malabarica (p < 0.05). The arginine-lysine proportion was found to be 
varied from 1.22-1.29. V. cyprinoides recorded significantly higher leucine/isoleucine 
ratio as compared to that in P. malabarica (p < 0.05, Table 3.5.). 
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Table 3.5.: Protein and amino acid composition (mg/100 g wet weight) in P. 
malabarica and V. cyprinoides 
 P. malabarica V. cyprinoides 
Protein 12.64 ± 0.08a 11.15 ± 0.07a 
Essential amino acids 
Histidine* 14.64 ± 0.01a 13.54 ± 0.07a 
Methionine*  16.67 ± 0.08a 18.32 ± 0.02b 
Valine* 29.47 ± 0.15a 30.57 ± 0.03a 
Threonine* 27.23 ± 0.03a 29.95 ± 0.03b 
Isoleucine* 29.62 ± 0.03a 31.12 ± 0.03a 
Leucine* 42.95 ± 0.04a 48.35 ± 0.05b 
Lysine* 43.57 ± 0.04a 41.67 ± 0.04b 
Phenylalanine* 28.20 ± 0.03a 33.11 ± 0.17b 
Arginine* 52.94 ± 0.05a 53.57 ± 0.05a 
Non-essential amino acids 
Alanine** 28.24 ± 0.14a 27.23 ± 0.03a 
Aspartic acid** 57.73 ± 0.06a 55.20 ± 0.06b 
Glutamic acid** 78.39 ± 0.08a 77.23 ± 0.08a 
Serine** 26.53 ± 0.03a 26.83 ± 0.03a 
Glycine** 32.75 ± 0.03a 30.95 ± 0.03b 
Proline** 22.66 ± 0.11a 25.72 ± 0.03b 
Tyrosine** 13.34 ± 0.07a 13.90 ± 0.07a 
Cysteine** 6.85 ± 0.03a 8.86 ± 0.04b 
∑AA 551.78 ± 1.01a 566.12 ± 0.57b 
∑EA 285.29 ± 0.41a 300.20 ± 0.25b 
∑NEA 266.49 ± 0.59a 265.92 ± 0.32a 
∑EA/∑AA 0.52 ± 0.00a 0.53 ± 0.00a 
∑NEA/∑AA 0.48 ± 0.00a 0.47 ± 0.02a 
∑EA/∑NEA 1.07 ± 0.01a 1.13 ± 0.00a 
∑ArAA 41.54 ± 0.15a 47.01 ± 0.03b 
∑SAA 23.52 ± 0.12a 27.18 ± 0.00b 
Arg:Lys 1.22 ± 0.00a 1.29 ± 0.01a 
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Leu:Ile 1.45 ± 0.03a 1.55 ± 0.00b 
Cys:∑SAA 0.29 ± 0.02a 0.33 ± 0.00a 
*Essential amino acids; **non-essential amino acids; ∑EAA-total essential amino 
acids; ∑NEAA-total non-essential amino acids; ∑AA-total amino acids; ∑ArAA-total 
aromatic amino acids; TSAA-total sulfur containing amino acids; Data were expressed 
as mean ± standard deviation; Tryptophan was not determined; Different superscripts (a, 
b) within the same row indicates the significant difference (p < 0.05)    
 
 The amino acid scores with respect to histidine, threonine, valine, methionine 
plus lysine, aromatic amino acids (phenylalanine and tyrosine), and lysine of the bivalve 
mollusks were plotted in Figure 3.4., and these scores were found to be significantly 
greater in V. cyprinoides as compared to those in P. malabarica (p < 0.05). The 
isoleucine score was found to be greatest in the edible parts of V. cyprinoides and P. 
malabarica (99% and 84%, respectively). V. cyprinoides and P. malabarica were found 
to be rich in protein content that are fundamental for human proper growth and survival. 
The proteins, lipids and minerals are considered as the significant contributors to the 
nutritional value and organoleptic properties of mollusks (Orban et al., 2006). 
The amino acids alanine, glycine and arginine were available at a generally 
greater level in marine bivalve mollusks. In the present study, V. cyprinoides and P. 
malabarica were indicated arginine, leucine and lysine as leading fundamental amino 
acids, which were similar with the prior study of mollusk, P. viridis (Chakraborty et al., 
2016a). Any proportion of ∑EAA/NEAA greater than 1.0 is considered to be useful for 
wellbeing. The ∑EA/∑NEA proportion in the edible parts of V. cyprinoides and P. 
malabarica were ranged from 1.07-1.13 which is above the threshold limit of 1.0. It is 
demonstrated that these bivalve clams are good sources of decently adjusted and high-
quality protein source. The ∑EA/∑NEA ratio for razor clam, Ensis siliqua was found to 
be lesser (0.80) (Baptista et al., 2014) as looked at to those in the present study. The 
measures of aggregate aromatic amino acids (∑ArAA) were found to be more 
prominent for these bivalve shellfishes accordingly implying their part in keeping up 
thyroxine metabolism. The protein contents in V. cyprinoides and P. malabarica were 
found to be rich in lysine, which is the limiting amino acid in cereal-based eating 
regimens utilized as essential foods in the developing nations (Kim and Lall 2000). 
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Glutamine, a donor of nitrogen for the synthesis of purines and pyrimidines that are 
fundamental for the proliferation of cells, was found to be present in V. cyprinoides and 
P. malabarica (77-78 mg/100 g) in considerable amounts. The shellfishes displayed the 
leucine-isoleucine proportion as prescribed by FAO/WHO (FAO, WHO, UNU 2007). 
Arginine-lysine proportion (1.22-1.29) in the present study was additionally found to be 
tantamount with those in vegetables and meat (Unusan 2007). V. cyprinoides and P. 
malabarica were demonstrated good amino acid scores, an index of good quality of 
protein.  
 
 
Figure 3.4.: Comparison of essential amino acid scores between P. malabarica and V. 
cyprinoides 
 
3.3.5.  Mineral composition 
 The edible part of shellfishes used in this study was found to be rich in macro 
(K, Ca, Mg and P) and micro (Mn, Fe, Cu, Zn and Se) minerals and their concentrations 
were delineated in Table 3.6. The concentrations of macro minerals were significantly 
greater for P. malabarica when compared with V. cyprinoides (p < 0.05). The 
concentration of K and P concentration were found in appreciable quantities in P. 
malabarica (94 and 584 mg/100 g wet weight, respectively). The Na/K ratio in the 
clams was ranged from 1.3-1.5 mg/100 g wet weight. The Ca+P content were 
essentially greater for P. malabarica (> 600 mg/100 g) than V. cyprinoides (p < 0.05). 
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No significant variations were observed in micro mineral compositions with the 
exception of Fe between P. malabarica and V. cyprinoides. P. malabarica showed 
significantly greater content of Fe (7.64 mg/100 g wet weight) than recorded in V. 
cyprinoides (5.65 mg/100 g wet weight; p < 0.05). The aggregate micronutrient content 
was found to be varied from 11-13 mg/100 g wet weight in the edible part of the clam 
samples. The Se concentration was significantly greater (p < 0.05) for P. malabarica 
(30 µg/100 g wet weight) compared with V. cyprinoides (27 µg/100 g wet weight). 
 
Table 3.6.: Mineral composition (mg/100 g wet weight) in P. malabarica and V. 
cyprinoides 
 P. malabarica V. cyprinoides 
Macronutrients  
Na 118.50 ± 0.57a      92.00 ± 0.90b 
K 94.23 ± 0.87a     60.21 ± 0.12b 
Na/K 1.25 ± 0.01a 1.51 ± 0.02a 
Ca 34.25 ± 0.61a    28.52 ± 0.69b 
P 583.62 ± 0.99a    534.23 ± 0.75b 
Ca/P 0.06 ± 0.00a 0.06 ± 0.00a 
Ca+P 617.87 ± 1.24a    562.75 ± 1.43b 
Mg 36.75 ± 0.38a    25.86 ± 0.45b 
Micronutrients 
Mn 2.03 ± 0.05a 1.75 ±0.09a 
Cu 0.46 ± 0.06a 0.30 ± 0.02a 
Zn 3.01 ± 0.13a 3.26 ± 0.07a 
Fe 7.64 ± 0.14a     5.65 ± 0.04b 
Se (µg/100 g wet weight) 30.15 ± 0.09a   27.27 ± 0.04b 
Data were expressed as mean ± standard deviation (n = 3). Different superscripts (a, b) 
within the same row indicate significant difference (p < 0.05) 
 
 Shellfish meat is rich in key minerals needed for vital enzymes and for 
different metabolic pools. The bivalves were demonstrated more prominent content of P 
(534-583 mg/100 g wet weight) evidently due to more noteworthy extent of 
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phospholipid and phosphoprotein contents in the bivalves. The K contents of V. 
cyprinoides and P. malabarica were found to be at 94 and 60 mg/100 g, respectively on 
wet weight basis, which is basic to keep up legitimate osmotic equalization of body 
liquid and pH of the body (Ensminger et al., 1995). It was accounted for that the mean 
K and P contents of molluskan fauna (P. globosa, B. bengalensis, M. tuberculata, L. 
marginalis, A. convexiusculus and Helix sp) were around 48 and 103 mg/100 g sample, 
respectively (Baby et al., 2010), which were lesser when contrasted with the present 
study. The Ca, Fe and Cu contents in the edible bivalves were notably lesser as 
compared to those in the edible part of the hard clam, M. meretrix, reaped from the 
shoreline of China (Xie et al., 2012). It is to note that the bivalves in current 
investigation appeared to posses higher than 20 mg/100 g of Mg as well as Ca on wet 
weight basis. Ca is responsible for bone development and maintenances, whereas, Mg is 
crucial cofactor to complete different biochemical responses in the body. The Zn 
content in V. cyprinoides and P. malabarica was found to be around 3 mg/100 g edible 
part. Zn is vital for recuperating wounds and bone advancement. D. incarnates, a wedge 
clam demonstrated Fe and Zn contents of around 1.4 and 0.3 mg/g dry weight, 
respectively, which were tantamount with those reported in the present study 
(Periyasamy et al., 2014). Selenium has been connected with security of body tissues 
against oxidative stress, upkeep of protections against contamination and balance of 
development and improvement. A more prominent bit of the selenoproteins has enzyme 
activities and selenocysteine as a key segment of the catalytic cycle (Liu et al., 2012). 
This element was found to change between 27-30 µg/100 g on wet weight basis in V. 
cyprinoides and P. malabarica, and was fundamentally more noteworthy than in grains, 
fruits, vegetables (Levander and Burk 1994), and various marine finfishes (10-20 
µg/100 g) (Chakraborty et al., 2014c). It is subsequently, important to consume these 
clam species in our day by day eating regimens to meet the base prerequisite of 
selenium. 
 
3.3.6. Cholesterol content and vitamin composition 
 The cholesterol contents of the edible part of these species were found to be 
lesser than 60 mg/100 g wet weight, and were within the threshold limits (Table 3.7.). 
The cholesterol content of P. malabarica was found to be significantly greater (59 
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mg/100 g wet weight) than that recorded in V. cyprinoides (56 mg/100 g wet weight) (p 
< 0.05). 
 Vitamin contents of V. cyprinoides and P. malabarica were shown in Table 
3.7. No significant differences in vitamin A, E, K and C contents were discernable 
between these species (p > 0.05). The vitamin D3 content was significantly greater (p < 
0.05) in V. cyprinoides (183 IU wet weight) as compared to that in P. malabarica (161 
IU wet weight). Vitamin A contents varied from 39-41 IU wet weight. The vitamins 
with antioxidative properties such as E and C contents in P. malabarica and V. 
cyprinoides were found to vary from 0.32-0.39 IU and 10-11 IU, respectively on wet 
weight basis.  
 
Table 3.7.: Cholesterol and vitamin composition in P. malabarica and V. cyprinoides 
 P. malabarica V. cyprinoides 
Cholesterol (mg/100 g) 59.02 ±0.72a 56.27 ± 0.38b 
Vitamins    
Retinol A (IU) 39.46 ±0.38a 41.11 ± 0.86a 
Cholecalciferol D3 (IU) 161.29 ±1.05a     183.28 ± 1.13b 
α-tocopherol E (IU) 0.39 ± 0.01a 0.32 ± 0.01a 
Phylloquinone K1 (μg/100 g) 0.75 ± 0.04a 0.65 ± 0.03a 
Ascorbic acid C (IU) 10.2 ± 0.11a 11.36 ± 0.16a 
Data were expressed as mean ± standard deviation (n = 3). Different superscripts (a, b) 
within the same row indicate significant difference (p < 0.05) 
 
 V. cyprinoides and P. malabarica were demonstrated cholesterol level within 
the threshold levels. Cholesterol was accounted as the significant sterol in M. edulis and 
P. canaliculus (Murphy et al., 2002). The present study has been exhibited that the 
mollusks are good sources of vitamins. The content of vitamin D3 of the shellfishes was 
found to be greater than 160 IU, which is fundamental for the support of ordinary blood 
levels of Ca and phosphate (Trivedi et al., 2003). The vitamin A and D3 contents were 
more prominent in V. cyprinoides and P. malabarica than those reported in M. casta 
(Srilatha et al., 2013). The vitamin C content reported in V. cyprinoides and P. 
malabarica were found to vary from 10-11 IU wet weight, and was greater than that in  
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M. meretrix (5.83 µg/mg) (Gopalakrishnan and Vijayavel 2008). This water soluble 
vitamin is a crucial antioxidative supplement for people, yet an extra outer dietary 
source is obliged in light of the fact that it is not biosynthesized by human digestion 
system (Jeevitha et al., 2013). It furthermore helps the body assimilate to iron and 
calcium, backs in wound recovering, and helps cerebrum capacity (Iqbal et al., 2004). 
3.3.7. Principal component analyses 
 The similarities and contrasts among the nutritional parameters of V. 
cyprinoides and P. malabarica were statistically assessed by utilizing the principle 
component analyses (PCA). The distinctive parameters, which were considered to PCA, 
were vitamins, lipid, cholesterol, ∑SFA, ∑MUFA, ∑PUFA, DHA, EPA, ∑n-3 and ∑n-6 
fatty acids (Figure 3.5.). The stacking of the first and second order principal components 
(PC1 and PC2) represented 55.28% and 44.72% of the variance, respectively. PC1 was 
fundamentally impacted by vitamins of P. malabarica, vitamin C, D and E of V. 
cyprinoides. PC2 was principally affected by lipid, SFA, DHA of P. malabarica and 
SFA of V. cyprinoides. The more prominent positive loadings were for the variables, 
vitamin D and EPA of P. malabarica and negative loadings for the variables, lipid and 
PUFA of V. cyprinoides on PC1.  
The PCA was performed to focus the similarities between protein, ∑EA, 
∑NEA, ∑AA, ∑ArAA, and ∑SAA of V. cyprinoides and P. malabarica, and were 
demonstrated in Figure 3.6. The PC1 clarified 66.17% variances, which accounted for 
the similarities between the total sulfur containing aromatic acid (TSAAVC), total 
amino acid (TAAVC) and total non-essential amino acid (TNEAVC) of V. cyprinoides. 
The PC2 axis explained 33.83% variances with greater similarities of total essential 
amino acid (TEAPM), total non-essential amino acid (TNEAPM) and total amino acid 
(TAAPM) of P. malabarica. The more noteworthy positive loadings were for the 
variables, total aromatic amino acid content of V. cyprinoides (TArAAVC) on PC1 axis 
and total essential amino acid of V. cyprinoides (TEAVC) on PC2 axis.  
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Figure 3.5.: Loading plot diagrams (PCA) showing the correlation of vitamins, lipid, 
cholesterol, SFA, MUFA, PUFA, DHA, EPA, n-3 and n-6 of V. cyprinoides (VC) and 
P. malabarica (PM)  
 
 
Figure 3.6.: Loading plot diagrams showing the correlation of protein content, AA, EA, 
NEAA, ArAA, SA of P. malabarica (PM) and V. cyprinoides (VC). 
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The principal component analyses plot (Figure 3.5.) delineated that there was 
no clear relationship between lipid content (lipidPM) and vitamins, expect vitamin A 
(VitAPM). Nonetheless, the lipid content (lipidPM) was displayed similarity with SFA 
(SFAPM), DHA (DHAPM) and n-3 fatty acids (n3PM). The lipid content of V. 
cyprinoides demonstrated similitude with ∑PUFA (PUFAVC), ∑MUFA (MUFAVC), 
DHA (DHAVC) and n-3 fatty acids (n3VC) which indicated the more noteworthy 
comparability with the PUFA contents. It may be because of the way that the lipid 
content of V. cyprinoides was contained greater share of PUFAs. The Figure 3.6. 
demonstrated that the protein content of V. cyprinoides was at negative correlation with 
the protein content of P. malabarica. The aggregate non-essential amino acid 
(TNEAAPM) and total essential amino acid (TEAPM) contents of P. malabarica was 
showed closer similarities, while aggregate sulfur containing amino acids (TSAVC) and 
total aromatic amino acids (TAAVC) of V. cyprinoides exhibited greater correlation 
than other parameters.  
3.4. Conclusions 
 The present study has been provided comprehensive biochemical profile of 
the bivalve clams, V. cyprinoides and P. malabarica collected from the estuarine waters 
of southwest shoreline of India. Clam is a source of high valued nutrients and is 
abundantly available, principally to the individuals living in the coastal areas. It is a rich 
source of minerals, vitamin, long-chain n-3 polyunsaturated fatty acid contents, and 
which can conceivably supplant the artificial food supplements available in the market. 
The present study likewise provided useful information in regards to the importance of 
these candidate species for fisheries and aquaculture.   
 The present study has been presented a better understanding into nutritional 
composition of two bivalve clams, V. cyprinoides and P. malabarica harvested from the 
estuarine waters situated at the southwest coast of Arabian Sea. Greater levels of long-
chain C20-C22 n-3 polyunsaturated fatty acids, especially, eicosapentaenoic acid, 
docosahexaenoic acid and higher n-3/n-6 fatty acid proportions were characterized for 
these species. The more prominent contents of essential/non-essential amino acid ratio, 
vitamin D3, calcium and phosphorus were showed that these bivalves are good sources 
of well-balanced diet. The present study demonstrated that V. cyprinoides and P. 
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malabarica can be utilized as nutritionally rich sources of sea food. The ideal 
atherogenic index, thrombogenicity index, hypocholesterolemic/hypercholesterolemic 
ratio along with fatty acid and amino acid based health markers were qualified these 
low-esteemed mollusk species as potential health food. These low-value bivalve clam 
species can be considered as an ideal raw material for further bio-potential analyses as 
explained in the upcoming chapters.   
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4.1. Background 
The adverse living conditions, such as environmental stress and filter feeding 
habits of bivalves are responsible for their utilities as potential sources to harness 
bioactive metabolites with different functional properties, particularly, the prevention of 
free radical induced metabolic disorders (Goldberg 1975). The reactive oxygen species 
(ROS) formed during the regular metabolic activities and their overproduction plays a 
vital role in the progression of oxidative stress induced diseases, such as inflammation, 
type-2 diabetes, hypertension, atherosclerosis, cancer, ageing and cell death (Lushchak 
2011). It is, therefore, anticipated that the antioxidants assume greater importance in 
controlling the initiation and development of these life threatening diseases. The origin 
of hypertension together with various pathophysiological manifestations including type-
2 diabetes were reported to be due to excessive production of ROS leading to oxidative 
stress and inflammatory responses (Wilcox 2002). Several synthetic drugs were capable 
of deterring free radical intermediates by acting as oxygen scavengers and decrease the 
free radical induced diseases, but they were reported to cause severe side effects 
(Schnitzer et al., 1999).  
 The bivalve clams have been exposed to high salinity and free radical 
inducing toxic chemicals, even though, they were not reported for cellular damage, and 
therefore, are considered as potential candidates as natural antioxidants (Gonzalez et al., 
2015). These species occupy a major share of the total edible clams in the world, and 
have high percentage edibility, yet they were not been explored for their biomedical and 
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pharmaceutical properties (Mohite et al., 2009). The mollusk, P. canaliculus was 
demonstrated to be active against inflammatory cyclooxygenase-2 (COX-2) and 5-
lipoxygenase enzymes (5-LOX) (Whitehouse et al., 1997). Bioactive components and 
enzyme inhibitors were identified from M. meretrix with anti-hypertensive, 
hypolipidemic and antioxidant properties (Wei et al., 2007).  
 With innumerable edible clams from the coastal ecosystem representing a 
large community of marine fauna, the Indian coasts are acknowledged for their 
particular richness. Among different clams, the black clam Villorita cyprinoides 
(family, Corbiculidae) and yellow-foot clam, Paphia malabarica (family, Veneridae) 
are the common seafood resources abundantly available in the coastal regions of India, 
and their cultivation methodologies were developed and standardized. Considering the 
promising perspective for the utilization of these groups of bivalve clams, and limited 
research reports on their utilization as potential health food, as a result their 
pharmaceutical potentials began to receive considerable attention. Therefore, the current 
study aims to evaluate the free radical scavenging guided evaluation of the anti-
inflammatory, anti-diabetic and anti-hypertensive properties of ethyl acetate:methanol 
extract (EtOAc:MeOH , 1:1, v/v) of V. cyprinoides and P. malabarica by various in 
vitro assays. Nuclear magnetic resonance spectroscopy based proton and carbon 
fingerprinting of the solvent extracts derived from these species were used to understand 
the various functional groups, which might be a useful tool for the preliminary 
prediction of biological activities associated with these extracts.  
 
4.2. Materials and methods 
4.2.1.  Chemicals, reagents and instrumentations 
  All chemicals and reagents used in this study were of analytical/spectroscopic 
grade and were obtained from E-Merck (E-Merck, Frankfurter, Darmstadt, Germany) 
and Sigma Aldrich (Missouri, USA). Double distilled or miiliQ or HPLC grade water 
was used throughout the work. Sodium carbonate (Na2CO3), malondialdehyde standard, 
thiobarbituric acid (TBA), acetic acid, 1,1-diphenyl-2-picryl-hydrazil (DPPH), 
potassium persulfate (K2S2O8), 2,2’-azino-bis-3-ethylbenzothiozoline-6-sulfonic acid 
diammonium salt (ABTS+), gallic acid, Folin-Ciocalteu (F.C.) reagent, hydrogen  
peroxide  (H2O2), potassium phosphate buffer, ferrozine, ferrous sulfate (FeSO4), leuco-
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2,7-dichlorofluoresce in diacetate, sodium hydroxide (NaOH), tris-buffer, hematin, 
phenol, arachidonic acid, linoleic acid, sodium phosphate buffer, 3,5-dinitrosalicylic 
acid reagent were acquired from E-Merck/Sigma-Aldrich/HiMedia (HiMedia 
Laboratories LLC, Pennsylvania, USA). The dipeptidyl peptidase-4 (DPP-4, from 
porcine kidney), angiotensin converting enzyme-1 (ACE-1, from rabbit lung), N-(3-[2-
furyl]acryloyl)-Phe-Gly-Gly (FAPGG), Gly-Pro-p-nitroanilide, cyclooxygenase-1 
(COX-1, from sheep), cyclooxygenase-2 (COX-2, human recombinant) were procured 
from Sigma-Aldrich and 5-lipoxygenase (5-LOX, from soybean) extra pure, α-amylase 
(obtained from porcine pancreas) and lyophilized powder of α-glucosidase (acquired 
from yeast) were purchased from Sisco Research Laboratories (SRL, Mumbai, India). 
All glasswares were procured from Borosil (India) or Magnum glassworks (Kochi, 
Kerala, India).  
  The solvents evaporated using rotary vacuum evaporators (Heidolph 
instruments GmbH and Co., Schwabach, Germany; Ika rotary evaporator, IKA® Works, 
North Chase Pkwy SE, Wilmington, USA) and rotational vacuum concentrators (RVC, 
Martin Christ, GmbH, Osterode, Germany). The refrigerated centrifuge (Thermo 
Scientific, Thermo Electron LED GmbH, Robert-Bosch-Str-1, Langenselbold, 
Germany) was used to perform centrifugation. UV-VIS absorbances were acquired on 
an ultraviolet-visible (UV-VIS) spectrophotometer (Varian Cary 50, Walnut Creek, 
California, USA) and microplate spectrophotometer (Thermo Scientific™ Multiskan™ 
GO, Waltham, MA USA). The glass cuvettes (1 cm X 1 cm X 4.5 cm) were utilized in 
the UV-VIS spectrophotometer and 96-well microplates (Nunclon™ Plates with Delta 
Surface, Thermo Fisher Scientific, Suzhou, Jiangsu, China) used in the microplate 
spectrophotometer for the absorbance measurements. A laboratory scale lyophilizers 
(Alpha 1-4 LD plus, Martin Christ, Osterode, Germany; Scanvac, CoolsafeTM, 
LaboGene, DK-3540 Lynge, Denmark) used for freeze drying. The samples were kept 
in the -80°C deep freezer (ultra-low temperature freezer, Eppendorf, Hamburg, 
Germany). The solvent extractions of samples were carried out using rotary shaker 
(Orbital shaker, Labline, India) and ultrasound sonicator (water bath sonicator, Elma, 
Hohentwiel, Germany). Perkin-Elmer Series 2000 Fourier transform infrared (FTIR) 
spectrometer recorded FTIR spectra between the scan range of 4000 and 400 cm-1 on 
KBr pellets (Perkin-Elmer FTIR, Winter Street, Waltham, Massachusetts, USA). The 
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samples (15 mg) were homogenized with KBr (150 mg) and applied a pressure of 
around 5 X 106 Pa to afford clear transparent disc (1 mm thickness X 13 mm diameter). 
The IR absorption readings were represented as percentage transmittance (%T). The 
proton (1H) and carbon (13C) (one-dimensional) nuclear magnetic resonance (NMR) 
spectra were documented on Bruker Avance DPX 500 (500 MHz) spectrometer 
utilizing deuteriated chloroform (CDCl3) with internal standard  tetramethylsilane (δ 0 
ppm), (TMS, Cortec, Paris, France) (Bruker, Karlsruhe, Germany) and connected with 5 
mm probes. The 1H and 13C NMR spectroscopic interpretations were carried out using 
the software MestReNova version 7.1.1-9649© 2012 (Mestrelab Research, S.L. 
Feliciano Barrera, Santiago de Compostela, Spain). 
 
4.2.2. Sample collection and pretreatment  
 The bivalve clams, V. cyprinoides and P. malabarica (10 kg each) used for 
this study were freshly collected from their natural habitat at the estuarine waters of 
Vembanad Lake (9°35’ N and 76°25’ E) and Ashtamudi Lake (8°59’ N and 76°36’ E), 
respectively situated along the southwest coast of the Arabian Sea, bordering India. 
After cleaning the externalities, V. cyprinoides and P. malabarica were transported to 
the laboratory in an ice box. The shell-on samples were systematically cleaned in 
running distilled water and edible meat (6 kg each) was separated from the shells by 
manually without heating. The edible flesh samples were subsequently homogenized by 
grinding machine and kept back for overnight in the deep freezer (ultra-low temperature 
freezer, Eppendorf, Hamburg, Germany) at -80°C for freezing. It was then lyophilized 
by utilizing freeze drier (Scanvac, CoolsafeTM Denmark; Martin Christ, Alpha 1-4 LD 
plus, Germany) to yield the freeze dried clam samples (1500 g each; yield 25 g/100 g). 
This was powdered and preserved in vacuum packed polythene biohazard autoclavable 
bags (Fisherbrand TM, Fischer Scientific) in the deep freezer at -80°C until further 
processing. The freeze lyophilized powder of clam samples used for solvent extraction. 
 
4.2.3. Preparation of the crude extracts of bivalve clams  
    The lyophilized powder (1500 g; yield 25 g/100 g on wet basis) of bivalve 
clam material extracted with 1:1 (v/v) ethyl acetate:methanol (EtOAc:MeOH) by 
sonication (Elma, Hohentwiel, Germany) and shaking (Orbital shaker, Labline, India ) 
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for 4 h under an inert atmosphere of nitrogen. This extraction procedure repeated for 
three times to recover maximum bioactive components in the crude extract. The extract 
contents then filtered through filter paper (Whatman No. 1) to yield the clarified filtrates 
and again filtered through Na2SO4 (30 g). The solvent filtrates concentrated (40°C) by 
rotary vacuum evaporator (Ika, USA; Heidolph, Germany) to afford concentrated 
extracts of V. cyprinoides and P. malabarica. The extracts dried in the rotational 
vacuum concentrators (RVC, Martin Christ, Germany) to yield corresponding solvent 
extracts of V. cyprinoides (50 g; yield 3.33 g/100 g on dry weight basis) and P. 
malabarica (55 g; yield 3.67 g/100 g on dry weight basis). This EtOAc:MeOH crude 
extracts of clam samples used for the evaluation of bioactive potentials against various 
targets. 
 
4.2.4.  Determination of bioactive potentials of extracts of bivalve clams 
4.2.4.1.  In vitro antioxidant assays 
4.2.4.1.1. Determination of total phenolic content 
 Total phenolic content in EtOAc:MeOH extracts of V. cyprinoides and P. 
malabarica assessed according to established method (Chew et al., 2008). Briefly, the 
known quantities of the extracts (10 mg) were added into a vial containing MeOH (1 
mL). It was mixed with 5 mL of Folin-Ciocalteu (F.C.) solution and 4 mL of 0.7 M 
sodium carbonate followed by incubation at 25°C for 120 min. The absorbances were 
recorded at 760 nm by UV-VIS spectrophotometer, relative to the blank (MeOH). A 
standard curve of various concentrations of gallic acid (0.2-0.005 mg/mL) along X-axis 
and absorbance along Y-axis were plotted. The amounts of total phenolic contents 
calculated in milligram of gallic acid equivalents (mg GAE)/g of extracts using the 
following equation:  
  
mg Gallic acid equivalent/g of sample =  
(concentration of mg/g gallic acid equivalent (x) * weight of sample in g)/volume of 
extract 
Concentration of mg/mL gallic acid equivalent (x) was obtained from the linear graph 
of standard using the equation: y = mx + c (where “y = absorbance of sample”) 
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4.2.4.1.2.  Free radical scavenging assays 
4.2.4.1.2.A. 1,1-Diphenyl-2-picryl-hydrazil (DPPH) radical scavenging assay 
 The free radical scavenging activity of the solvent extracts of V. cyprinoides 
and P. malabarica were estimated by utilizing the stable free radical, DPPH based on 
earlier methods (Chew et al., 2008). In brief, stock solutions of extracts in methanol 
were prepared followed by the preparation of the serial dilutions from the corresponding 
stock solutions to afford various concentrations (0.25 to 2.0 mg/mL) of the extracts. The 
various concentrations of extracts were added to equal volumes of 0.1 mM DPPH in 
methanol (2.0 mL). The solutions were mixed properly and kept for 30 min at room 
temperature in dark. The absorbance of various concentrations of extracts and control 
solutions (2.0 mL DPPH solution + 2.0 mL methanol) were recorded against a reagent 
blank (MeOH) after 20 min at 517 nm using UV-VIS spectrophotometer. The triplicate 
experiments were carried out. An equal volume of test samples with different 
concentrations (0.25-2.00 mg/mL) were analyzed to determine the percentage inhibition 
and the IC50 values. The percentage inhibition (%) was calculated as follows: ((AC-
AS)/AC) * 100, where AC and AS represented the absorbance of control and sample, 
respectively. 50% Inhibitory Concentration (IC50) can be calculated from the graph 
plotted with concentrations of sample (X-axis) against percentage inhibition (Y-axis). 
The results were expressed as IC50, the concentration of samples at which it 
inhibits/scavenge 50% of enzyme/radical activities and were expressed in mg/mL. 
 
4.2.4.1.2.B. 2,2’-Azino-bis-3-ethylbenzothiozoline-6-sulfonic acid diammonium salt 
   (ABTS+) radical scavenging assay 
 The radical scavenging potentials of EtOAc:MeOH extracts of V. cyprinoides 
and P. malabarica were determined by ABTS+ decolourization assay (Vijayabaskar and 
Shiyamala 2012). In brief, ABTS+ (7 mM) and potassium persulfate (2.45 mM) were 
mixed and kept for 16 h in dark at room temperature. The intensely coloured resultant 
ABTS+ stock solution was diluted with MeOH to get ~0.70 absorbance at 734 nm. The 
diluted ABTS+ (5 mL) was mixed with 0.1 mL of extracts (0.25 to 2.0 mg/mL; in 
MeOH) and their corresponding absorbance were recorded at 734 nm against blank 
solution (MeOH) using UV-VIS spectrophotometer. The triplicate analyses were 
performed. An equal volume of test samples with different concentrations (0.25-2.00 
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mg/mL) were analyzed to determine the percentage inhibition and the IC50 values. The 
percentage inhibition (%) was calculated as follows: ((AC-AS)/AC) * 100, where AC and 
AS represented the absorbance of control and sample, respectively. 50% Inhibitory 
Concentration (IC50) can be calculated from the graph plotted with concentrations of 
sample (X-axis) against percentage inhibition (Y-axis). The results were expressed as 
IC50, the concentration of samples at which it inhibits/scavenge 50% of enzyme/radical 
activities and were expressed in mg/mL. 
 
4.2.4.1.2.C. Hydrogen peroxide (H2O2) radical scavenging assay 
 The ability of EtOAc:MeOH extracts to inhibit H2O2 was measured by the 
established method (Gulcin 2007). The 40 mM H2O2 in phosphate (pH 7.4) buffer was 
prepared. The different concentrations of extracts, ranging from 0.25-2.0 mg/mL in 
methanol were prepared by serial dilutions using a stock solution of extracts (2 mg/mL). 
Equal volumes of extracts (3.0 mL) and H2O2 solution (3.0 mL) were mixed and kept 
for 10 min incubation. The absorbance of various concentrations of extracts and control 
(H2O2 solution + MeOH) recorded at 230 nm against phosphate buffer without H2O2 
(blank) using UV-VIS spectrophotometer after 10 min. This assay performed in 
triplicates. An equal volume of test samples with different concentrations (0.25-2.00 
mg/mL) analyzed to determine the percentage inhibition and the IC50 values. The 
percentage inhibition (%) was calculated as follows: ((AC-AS)/AC) * 100, where AC and 
AS represented the absorbance of control and sample, respectively. 50% Inhibitory 
Concentration (IC50) can be calculated from the graph plotted with concentrations of 
sample (X-axis) against percentage inhibition (Y-axis). The results were expressed as 
IC50, the concentration of samples at which it inhibits/scavenge 50% of enzyme/radical 
activities and expressed in mg/mL. 
 
4.2.4.1.2.D. Ferrous ion (Fe2+ ion) chelating assay 
 The ferrous ion (Fe2+ ion) chelating ability of EtOAc:MeOH extracts 
evaluated according to the established method (Gulcin 2007). The crude extracts (1 mL) 
with various concentrations (0.25 to 2.0 mg/mL) mixed to ferrozine (1.0 mL, 0.3125 
mM) and FeSO4 (1 mL, 0.125 mM). This was homogenized and equilibrated for 10 
min. The absorbance of extracts and control (consisting of FeSO4 and ferrozine 
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solution) recorded at 562 nm against blank (MeOH) using UV-VIS spectrophotometer 
after 10 min. The investigations carried out in triplicates. An equal volume of test 
samples with different concentrations (0.25-2.00 mg/mL) were analyzed to determine 
the percentage inhibition and the IC50 values (mg/mL). The percentage inhibition (%) 
was calculated as follows: ((AC-AS)/AC) * 100, where AC and AS represented the 
absorbance of control and sample, respectively. 50% Inhibitory Concentration (IC50) 
can be calculated from the graph plotted with concentrations of sample (X-axis) against 
percentage inhibition (Y-axis). The results were expressed as IC50, the concentration of 
samples at which it inhibits/scavenge 50% of enzyme/radical activities and were 
expressed in mg/mL. 
 
4.2.4.1.2.E. Lipid peroxidation inhibitory assay  
 The ability of clam extracts to arrest lipid peroxidation assessed by 
thiobarbituric acid reactive species (TBARS) assay (Kulisic et al., 2004). The extracts 
of V. cyprinoides and P. malabarica (10 mg) added to 20% ice cold acetic acid (2 mL) 
and 2 mL of thiobarbituric acid (0.78% in acetic acid). This was incubated for 45 min in 
water bath at 95°C and cooled followed by centrifugation (8000 rpm/10 min). The 
corresponding absorbances were recorded at 532 nm. The mixture of 2 mL acetic acid 
(20%) and 2 mL TBA was used for the blank reading. The different concentrations of 
malondialdehyde (0.1mL; 0.1, 0.05, 0.025, 0.0125 and 0.00625 µg/mL) was mixed with 
20% ice cold acetic acid (2 mL) and 2 mL of thiobarbituric acid (0.78% in acetic acid) 
followed by water bath incubation (95°C/45 min). The absorbance was reported at 532 
nm and a standard curve of mM MDA was plotted [concentration (µg/mL) at X-axis 
and absorbance at Y-axis]. The lipid peroxidation inhibitory potency was expressed as 
mM of malondialdehyde equivalent compounds per kg sample (MDAEQ/kg sample) 
using the following equation:  
 
mM MDA/kg sample = (mM MDA equivalent (x) * 1000000)/(4 * W1) 
where, (4 = total sample volume; W1 = sample weight in mg; 1000000 = conversion of 
mg to kg) 
The mM MDA equivalent (x) was obtained from the standard curve using the equation:  
y = mx + c (where “y = absorbance of sample”) 
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4.2.4.2.  In vitro anti-inflammatory assays 
4.2.4.2.1.  Cyclooxygenases (COX) inhibition assay  
 The cyclooxygenase (COX-1 and COX-2) inhibition assays were performed 
by 2,7-dichlorofluorescein method (Larsen et al., 2009). In brief, 5 mg of leuco-2,7-
dichlorofluorescein diacetate hydrolyzed in 1 M NaOH (50 μL) at room temperature (10 
min) followed by adding of 30 μL HCl (1 M) to counteract additional NaOH before 
resultant leuco-dichlorofluorescein was dissolved in tris-buffer (0.1 M; pH 8). The 
cyclooxygenase enzymes, COX-1 and COX-2 were dissolved in 0.1 M tris-buffer. The 
various concentrations of samples (0.25 to 2.0 mg/mL) were pre-incubated with 
enzymes in hematin (5 min). The phenol, arachidonic acid and 1-DCF were mixed with 
enzymes to get a final mixture of 1 μM hematin, 500 μM phenol, 50 μM arachidonic 
acid and 20 μM 1-DCF in 1 mL of tris-buffer. The absorbances were assessed at 502 
nm. Also, a blank (without enzyme) solution was evaluated in the same wavelength. 
The investigations were performed in triplicate. An equal volume of test samples with 
different concentrations (0.25-2.00 mg/mL) were analyzed to determine the percentage 
inhibition and the IC50 values. The percentage inhibition (%) was calculated as follows: 
((AC-AS)/AC) * 100, where AC and AS represented the absorbance of control and 
sample, respectively. 50% Inhibitory Concentration (IC50) can be calculated from the 
graph plotted with concentrations of sample (X-axis) against percentage inhibition (Y-
axis). The results were expressed as IC50, the concentration of samples at which it 
inhibits/scavenge 50% of enzyme/radical activities and were expressed in mg/mL. 
 
4.2.4.2.2.  5-Lipoxygenase (5-LOX) inhibition assay   
The 5-lipoxygenase inhibitory analyses were carried out using earlier method 
(Baylac and Racine 2003). An aliquot of the various concentrations (0.25 to 2.0 mg/mL) 
of extracts (29:1, w/w, 50 µL, in DMSO and Tween 20 mixture) were prepared and 
mixed with 2.95 mL of pre-heated potassium phosphate buffer (0.1 M, pH 6.3) and 48 
µL of linoleic acid. Then, ice-cold potassium phosphate buffers (12 µL) were added to 
5-LOX (100 U). The absorbances were obtained spectrophotometrically at 234 nm. The 
control was prepared with DMSO:Tween 20 mixture without enzyme. The triplicate 
evaluations were carried out. An equal volume of test samples with different 
concentrations (0.25-2.00 mg/mL) analyzed to determine the percentage inhibition and 
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the IC50 values. The percentage inhibition (%) was calculated as follows: ((AC-AS)/AC) 
* 100, where AC and AS represented the absorbance of control and sample, respectively. 
50% Inhibitory Concentration (IC50) can be calculated from the graph plotted with 
concentrations of sample (X-axis) against percentage inhibition (Y-axis). The results 
were expressed as IC50, the concentration of samples at which it inhibits/scavenge 50% 
of enzyme/radical activities and were expressed in mg/mL. 
  
4.2.4.3.  In vitro anti-diabetic assays 
4.2.4.3.1.  α-Amylase inhibition assay  
The in vitro anti-diabetic investigations against α-amylase were measured by 
previously described assay (Hamdan and Afifi 2004). Equal volumes of the test samples 
(0.25-2.00 mg/mL) and α-amylase (0.5 mg/mL) enzyme in phosphate buffer (0.20 
mM/pH 6.9) which were incubated for 10 min at 25°C. Thereafter, it was incubated 
with 1% solution of starch in phosphate buffer (0.02 M/pH 6.9) for 10 min at 25°C and 
the reaction was ceased using 3,5 dinitrosalicylic acid followed by keeping in boiling 
(for 5 min) water bath. The absorbances were reported at 540 nm subsequent to diluting 
with DDW. The α-amylase inhibitory potency of control was carried out in the same 
way by replacing the extracts with vehicle. The investigations were repeated. An equal 
volume of test samples with different concentrations (0.25-2.00 mg/mL) were analyzed 
to determine the percentage inhibition and the IC50 values. The percentage inhibition 
(%) was calculated as follows: ((AC-AS)/AC) * 100, where AC and AS represented the 
absorbance of control and sample, respectively. 50% Inhibitory Concentration (IC50) 
can be calculated from the graph plotted with concentrations of sample (X-axis) against 
percentage inhibition (Y-axis). The results were expressed as IC50, the concentration of 
samples at which it inhibits/scavenge 50% of enzyme/radical activities and expressed in 
mg/mL. 
 
4.2.4.3.2.  α-Glucosidase inhibition assay  
The α-glucosidase scavenging effects (Hamdan and Afifi 2004) determined 
by incubating various concentrations of clam extracts (0.25-2.00 mg/mL) in tris-buffer 
(pH 8, 0.2 M) with starch substrate (2%) at 37°C (5 min). The experiment started by 
mixing α-glucosidase (1 U/mL) enzyme followed by incubation (37°C/10 min). The 
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reaction mixture heated for 2 min, then 3,5-dinitrosalicylic acid was added to stop the 
reaction followed by incubation and dilution. The amount of glucose liberation was 
calculated by glucose oxidase peroxidase experiment. An equal volume of test samples 
with different concentrations (0.25-2.00 mg/mL) were analyzed to determine percentage 
inhibition and the IC50 values. The percentage inhibition (%) was calculated as follows: 
((AC-AS)/AC) * 100, where AC and AS represented the absorbance of control and 
sample, respectively. 50% Inhibitory Concentration (IC50) can be calculated from the 
graph plotted with concentrations of sample (X-axis) against percentage inhibition (Y-
axis). The results were expressed as IC50, the concentration of samples at which it 
inhibits/scavenge 50% of enzyme/radical activities and were expressed in mg/mL. 
 
4.2.4.3.3.  Dipeptidyl peptidase-4 (DPP-4) inhibition assay  
 The DPP-4 inhibitory potency (Kojima et al., 1980) was performed by using 
different concentration of extracts (0.25-2.00 mg/mL; 350 μL) in tris-HCl buffer (50 
mM/pH 7.5) pre-incubated with 0.05 U/mL of DPP-4 enzyme (15 µL) in 100 mM tris-
HCl buffer (pH 8). This was incubated at 37°C (30 min), followed by mixing of 50 µL 
of 1.4 mM Gly-Pro-p-nitroanilide (0.2 M in tris-HCl buffer). This mixture was kept at 
37°C (30 min) and the absorbances were measured at 405 nm. DPP-4 inhibitory activity 
of control was carried out in the same way by replacing extracts with vehicle. The 
investigations were repeated. An equal volume of test samples with different 
concentrations (0.25-2.00 mg/mL) were analyzed to determine the percentage inhibition 
and the IC50 values. The percentage inhibition (%) was calculated as follows: ((AC-
AS)/AC) * 100, where AC and AS represented the absorbance of control and sample, 
respectively. 50% Inhibitory Concentration (IC50) can be calculated from the graph 
plotted with concentrations of sample (X-axis) against percentage inhibition (Y-axis). 
The results were expressed as IC50, the concentration of samples at which it 
inhibits/scavenge 50% of enzyme/radical activities and were expressed in mg/mL. 
 
4.2.4.4.  In vitro anti-hypertensive assay 
4.2.4.4.1.  Angiotensin converting enzyme-1 (ACE-1) inhibitory activity  
 The ACE-1 scavenging ability was evaluated by earlier technique of 
Holmquist et al., (1979). Briefly, 20 μL of 20 mU ACE-1 (1 U/mL) was added to 
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EtOAc:MeOH extracts of V. cyprinoides and P. malabarica (concentrations of 0.2, 0.3, 
0.4 and 0.7 mg). Then, FAPGG (1 mL/0.5 mM) suspended in tris-buffer (50 mM/pH 
7.5) comprising sodium chloride (0.3 M) was added. The declined absorbances were 
recorded at 345 nm. An equal volume of test samples with different concentrations (0.2, 
0.3, 0.4 and 0.7 mg) were analyzed to determine the percentage inhibition and the IC50 
values. The percentage inhibition (%) was calculated as follows: ((AC-AS)/AC) * 100, 
where AC and AS represented the absorbance of control and sample, respectively. 50% 
Inhibitory Concentration (IC50) can be calculated from the graph plotted with 
concentrations of sample (X-axis) against percentage inhibition (Y-axis). The results 
were expressed as IC50, the concentration of samples at which it inhibits/scavenge 50% 
of enzyme/radical activities and were expressed in mg/mL. 
 
4.2.5. Spectroscopic analyses 
4.2.5.1.  Fourier transform infrared (FTIR) spectroscopy 
The Fourier transform infrared (FTIR) spectra of EtOAc:MeOH extracts of V. 
cyprinoides and P. malabarica were scanned between 4000 and 400 cm-1 (Perkin-Elmer 
FTIR, Winter Street, Waltham, Massachusetts, USA). 
 
4.2.5.2.  Proton (1H) and carbon (13C) nuclear magnetic resonance spectroscopy 
 The 1H and 13C spectroscopic analyses of the EtOAc:MeOH extracts of 
bivalve clams, V. cyprinoides and P. malabarica were recorded on a Bruker Avance 
DPX 500 (500 MHz) spectrometer in deuteriated chloroform (CDCl3) with standard, 
tetramethylsilane (TMS) (Bruker, Karlsruhe, Germany).  
 The 1H spectra were mainly categorized in six different regions, including 
saturated hydrocarbons (RCH3, R2CH2 and R3CH) from δ 0.1-2.0, RC(=O)-CH3 (acetyl) 
or -CH2=CH-CH3 (allylic) from δ 2.0-2.5, RCH2-X (alkyl halide) or -OCH3 (methoxy) 
or RCH2OH (alkanols) from δ 2.5-3.5, directly attached protons to oxygen of ester 
linkages or RCH2C(=O)-OCH3 (alkyl alkanoates) from δ 3.5-4.5, oleﬁnic (RCH=CHR1) 
protons from δ 4.5-6.5 and aromatic protons from δ 6.5-8.5. The protons at 
characterized zones of the 1H NMR were solved and integrated to obtain numbers of 
protons in the corresponding areas. The 13C NMR spectra partitioned into characteristic 
carbons in the specific positions which were found to be carbonyl carbon atoms from δ 
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180-210, alkanoate ester carbon atoms from δ 160-180, aryls from δ 140-160, oleﬁnic 
from δ 110-140, carbon atom bonded to hydride moiety of alkyl alkanoates from δ 70-
80, alkoxy (RCH2OR1) from δ 45-70 and saturated hydrocarbons from δ 10-40. The 
spectroscopic analyses were carried out to study the nature, characteristics of 
components present in the extract, and its relation to bioactive potentials.  
 
4.2.6. Statistical analyses 
 One way analyses of variance (ANOVA) was carried out using Statistical 
Program for Social Sciences 13.0 (SPSS, USA, ver. 13.0) to assess the significant 
differences between the means of bioactivities. The significant differences were 
represented as p < 0.05 and the values were given as the means of triplicates ± standard 
deviation. The variances in the data were evaluated by utilizing the principal component 
analyses (PCA) in which specific factors for PCA were anti-diabetic, anti-inflammatory, 
antioxidant and anti-hypertensive potentials demonstrated by EtOAc:MeOH extracts of 
V. cyprinoides and P. malabarica.  
 
4.3. Results and discussion 
4.3.1. Yield of EtOAc:MeOH crude extracts of V. cyprinoides and P. malabarica 
 The recovery of EtOAc:MeOH crude extracts derived from the bivalve clams, 
V. cyprinoides and P. malabarica were found to be 3.33% and 3.67%, respectively 
based on the dry weight of clam samples. 
 
4.3.2. Total phenolic content and antioxidant activities  
 The total phenolic content and antioxidant potentials against various targets 
along with ferrous ion chelating potentials were tabulated in the Table 4.1. The 
EtOAc:MeOH extracts of P. malabarica was showed significantly greater (p < 0.05) 
total phenolic content (88.62 mg GAE/g, 5 mg/mL) than recorded in V. cyprinoides 
(73.87 mg GAE/g, 5 mg/mL).  
 The EtOAc:MeOH extract derived from P. malabarica displayed 
significantly greater ABTS+ scavenging activity (IC50 1.27 mg/mL) than that of V. 
cyprinoides (IC50 1.41 mg/mL), whilst no characteristic differences in H2O2/DPPH 
quenching and Fe2+ ion chelating activities of V. cyprinoides and P. malabarica were 
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apparent (Table 4.1.). Both the species exhibited greater DPPH scavenging potentials 
with lower IC50 value of 0.76 mg/mL. Also, the IC50 values of Fe2+ ion chelating 
activities and H2O2 scavenging potentials were found to be ~1.86 and ~1.42 mg/mL, 
respectively for both the studied clam species. The lipid peroxidation inhibition activity 
was found to be significantly greater (p < 0.05) for P. malabarica than those from V. 
cyprinoides. This was apparent from the lower value of TBARS (malondialdehyde, 
MDA) formation by the EtOAc:MeOH extracts of P. malabarica (2.39 mM 
MDAEQ/kg) when compared to V. cyprinoides (3.18 mM MDAEQ/kg).  
The EtOAc:MeOH extract of P. malabarica showed significantly greater total 
phenolic contents (~88.6 mg GAE/g) than those in V. cyprinoides (~73.9 mg GAE/g). 
The phenolic compounds reported to possess radical scavenging properties and were 
assured to shield the delicate bodied mollusks from photoxidation. The present work 
likewise observed a significant correlation between the phenolic contents and the 
antioxidant activities which signified the role of phenolics as antioxidants like earlier 
reports of other marine living organisms (Escrig et al., 2001; Karawita et al., 2004). 
 
Table 4.1.: Phenolic content and antioxidant activities (IC50) of EtOAc:MeOH extracts 
of P. malabarica and V. cyprinoides 
  P. malabarica V. cyprinoides 
wTotal phenolic content (5 mg/mL) 88.62 ± 0.33a 73.87 ± 0.33b 
xDPPH radical scavenging activity 0.76 ± 0.02a 0.76 ± 0.03a 
xABTS+ radical scavenging activity 1.27 ± 0.02a 1.41 ± 0.00b 
xFe2+ ion chelating activity  1.86 ± 0.02a 1.87 ± 0.02a 
xH2O2 scavenging activity   1.41 ± 0.03a 1.44 ± 0.04a 
yLipid peroxidation inhibitory activity 2.39 ± 0.07a 3.18 ± 0.04b 
The samples were analyzed in triplicate (n=3) and expressed as mean ± standard 
deviation. Means followed by the different superscripts (a-b) within the same row 
indicated significant differences (p < 0.05). wTotal phenolic contents were presented as 
mg of gallic acid equivalence (mg GAE)/g. xThe IC50 values were expressed as mg/mL. 
yLipid peroxidation inhibitory (TBARS assay) was expressed as mM MDAEQ/kg 
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  It is evident that owing to their greater number of hydroxyl groups, 
polyphenols display higher redox potential and in this manner are efficient electron 
donors. By virtue of this, they can act as reducing agents, metal chelating agents or 
singlet oxygen quenchers. The EtOAc:MeOH extract of V. cyprinoides and P. 
malabarica were demonstrated greater Fe2+ ion chelating ability (IC50 ~1.86 mg/mL) 
therefore, efficient in neutralizing the H2O2 (IC50 ~1.42 mg/mL), ABTS+ radicals (IC50 
1.27-1.41 mg/mL) and DPPH (IC50 0.76 mg/mL). Significant positive correlations 
between total phenolic contents and various antioxidant activities of the solvent 
extracts, as acknowledged by correlation analyses, showed the vicinity of phenolic 
compounds responsible for free radical scavenging ability. Previous studies showed that 
the extracts containing phenolic or electronegative groups were potential antioxidants 
(Hodzic et al. 2009; Lindsay 1996). In the present study, the EtOAc:MeOH extracts 
derived from the bivalve clams were demonstrated higher TPC content, which might 
explain the greater ABTS+ and DPPH radical scavenging properties. The methanolic 
and EtOAc extract of bivalve mollusk, P. viridis reported to exhibit significant 
scavenging property against DPPH radical, which support the outcome of the present 
study (Jena et al., 2010; Sreejamole and Radhakrishnan 2013).  
 
4.3.3. Anti-inflammatory activities 
 The EtOAc:MeOH extract of P. malabarica exhibited significantly greater 
anti-inflammatory properties as determined by COX-1 and COX-2 enzyme inhibitory 
activities (IC50 2.36 and 0.92 mg/mL, respectively) (p < 0.05) than those extracted from 
V. cyprinoides (IC50 2.54 and 1.03 mg/mL, respectively) (Table 4.2.). P. malabarica 
also exhibited significantly (p < 0.05) greater 5-LOX inhibitory activity (IC50 1.51 
mg/mL) than the EtOAc:MeOH extract derived from V. cyprinoides (IC50 1.64 mg/mL). 
The selectivity indices (IC50 value of anti-cyclooxygense-1/IC50 value of anti-
cyclooxygense-2) of EtOAc:MeOH extract obtained from P. malabarica and V. 
cyprinoides were 2.57 and 2.47, respectively which was found to be greater than the 
commercially available non-steroidal anti-inflammatory drugs (NSAIDs, SI < 2.0).  
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Table 4.2.: Anti-inflammatory activities (IC50) of EtOAc:MeOH extracts of P. 
malabarica and V. cyprinoides 
  P. malabarica V. cyprinoides 
xCOX-1 inhibitory activity 2.36 ± 0.03a 2.54 ± 0.04b 
xCOX-2 inhibitory activity 0.92 ± 0.01a 1.03 ± 0.02b 
ySelectivity index 2.57 ± 0.02a 2.47 ± 0.03b 
x5-LOX inhibitory activity 1.51 ± 0.01a 1.64 ± 0.02b 
The samples were analyzed in triplicate (n=3) and expressed as mean ± standard 
deviation. Means followed by the different superscripts (a-b) within the same row 
indicated significant differences (p < 0.05). xThe IC50 values were expressed as mg/mL. 
ySelectivity index is the ratio of  IC50 value of anti-COX-1 to IC50 value of anti-COX-2 
(IC50 anti-COX-1/IC50 anti-COX-2) 
 
 The EtOAc:MeOH extract derived from P. malabarica was exhibited 
significantly greater anti-COX-2/anti-5-LOX properties (IC50 0.92 and 1.51 mg/mL, 
respectively) than those extracted from V. cyprinoides, which indicated that these 
antioxidants might have significant role in deterring pro-inflammatory enzymes in the 
system. The EtOAc:MeOH extracts of bivalve clams registered the ratio of inhibitory 
concentration for COX-1/COX-2 as greater than 2.0 compared to non-steroidal anti-
inflammatory drugs (< 1.0), which confirmed their greater selectivity against 
inflammatory reactions and greater selectivity profiles. The EtOAc:MeOH extracts 
derived from the bivalve clams considered in the present study were found to effectively 
inhibit pro-inflammatory enzymes, which leads to the declined production of 
inflammatory prostaglandins, such as prostaglandin E2 (PGE2) and prostaglandin F2a 
(PGF2a) (Fernandes et al., 2004). It is of note that the lipid peroxidation transforms 
lipids, fatty acids and lipoproteins to hydroperoxide lipids by free radicals resulting in 
inflammation (Camacho-Ruiz et al., 2010). It is therefore apparent that the free radical 
quenching species were good anti-inflammatory candidates. Earlier studies reported that 
commercially prepared freeze dried extract of New Zealand green lipped mussel P. 
canaliculus was down regulate the inflammatory sequence (Tiffany and Bui  2002). 
Green mussel (P. viridis) reported to exhibit anti-inflammatory properties against COX-
2 (50%) and 5-LOX (47%) enzymes (Chakraborty et al., 2014a). 
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4.3.4.  Anti-diabetic and anti-hypertensive activities  
 The EtOAc:MeOH extract of P. malabarica exhibited greater α-amylase and 
α-glucosidase inhibitory activities (IC50  1.39 and 1.47 mg/mL, respectively) than V. 
cyprinoides (IC50 ~1.54 mg/mL for anti-α-amylase and anti-α-glucosidase) (Table 4.3.). 
Likewise the DPP-4 inhibition activity of EtOAc:MeOH extract of P. malabarica 
appeared to be appreciably higher (IC50 1.00 mg/mL) than the same derived from V. 
cyprinoides (IC50 1.06 mg/mL).  
The EtOAc:MeOH extract derived from P. malabarica was displayed 
significantly greater anti-hypertensive properties as dictated by angiotensin-1 converting 
enzyme inhibitory activity (IC50 1.11 mg/mL) compared to V. cyprinoides (IC50 1.16 
mg/mL). 
Oxidative stress was found to be an important reason for increased blood 
sugar level and type-2 diabetes related disorders in human. More recently, inflammatory 
mediators have become increasingly implicated in the development of type-2 diabetes. 
The present studies has been demonstrated the potentials of P. malabarica to prevent 
the formation of free radicals due to the presence of greater numbers of electronegative 
functional groups, to decelerate the digestion of starch and carbohydrate by inhibiting α-
amylase along with α-glucosidase enzymes (Brayer et al., 2000). 
 
Table 4.3.: Anti-diabetic and anti-hypertensive activities (IC50) of EtOAc:MeOH 
extracts of P. malabarica and V. cyprinoides. 
  P. malabarica V. cyprinoides 
Anti-diabetic activities 
xα-amylase inhibitory activity 1.39 ± 0.04a 1.54 ± 0.05b 
xα-glucosidase inhibitory activity 1.47 ± 0.02a 1.54 ± 0.04b 
xDPP-4 inhibitory activity 1.00 ± 0.06a 1.06 ± 0.06b 
Anti-hypertensive activity 
xACE-1 inhibitory activity 1.11 ± 0.05a 1.16 ± 0.04b 
The samples were analyzed in triplicate (n=3) and expressed as mean ± standard 
deviation. Means followed by the different superscripts (a-b) within the same row 
indicated significant differences (p < 0.05). xThe IC50 values were expressed as mg/mL 
 
112 
 
Bioactive potentials of Villorita cyprinoides and Paphia malabarica            Chapter 4 
 Earlier studies were demonstrated that the mollusks, Hemifusus pugilinus and 
Natica didyma possessed anti-diabetic potential (Ravi et al., 2012). Inhibition of DPP-4 
enzyme was considered to be the potential target in the treatment of diabetics. The 
positive control, diprotein A (Ile-Pro-Ile), a reported DPP-4 inhibitor, was found to 
covalently bound to Ser630 forming a hemiacetal and trapped as a tetrahedral 
intermediate of the hydrolysis reaction. The anti-diabetic potentials assessed by DPP-4 
scavengers reported to possess electrophilic functionalities that can directly interact with 
the hydroxyl group of catalytic serine630 in active site of DPP-4 enzyme. 
 The EtOAc:MeOH extract obtained from P. malabarica showed significantly 
greater anti-hypertensive properties than that from V. cyprinoides as displayed by ACE-
1 inhibitory activity. This apparently showed that the antioxidants from the solvent 
extract of P. malabarica might have a prominent role in deterring the hypertensive 
modulators. Likewise significant co-linearity was found to exist between anti-
inflammatory and anti-diabetic properties vis-à-vis antioxidative activities of solvent 
extracts from bivalve clams. 
Many synthetic drugs developed to combat elevated blood pressure though 
they cause unfavourable side effects. To overcome the side effects of these drugs, 
targeted ACE inhibitors were developed particularly from the marine resources, for 
example, ACE inhibitor peptides from mussel, Mytilus coruscus (Wu et al., 2013). 
Numerous reports have recognized that hypertension is associated with decreased 
antioxidant capacity (Lacy et al., 2000), greater levels of lipid peroxidation (Manning et 
al., 2005) and the formation H2O2 (Russo et al., 1998), which appropriately suggested 
the relationship between free radicals and hypertension. 
 
4.3.5.  Spectroscopic labeling of the functional groups in the EtOAc:MeOH 
extracts of bivalve clams 
4.3.5.1.  NMR based proton and carbon labeling  
 The labeling of protons and carbons associated with different magnetic 
environments of the prominent functional groups in the EtOAc:MeOH extracts of 
bivalve clams were analyzed by 1H NMR spectroscopy (Figure 4.1.) conjugated with 
13C NMR approach (Figure 4.2.). A comparison of proton integrals at different regions 
were plotted for EtOAc:MeOH extracts derived from these species (Figure 4.3.).  
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Figure 4.1.: The stacked plot representing the 1H NMR spectra of EtOAc:MeOH 
extracts of P. malabarica and V. cyprinoides. (A) deconvolated 1H NMR and (B) 
acquired 1H NMR spectra of EtOAc:MeOH extract of P. malabarica. (C) Deconvolated 
1H NMR and (D) acquired 1H NMR spectra of EtOAc:MeOH extract of V. cyprinoides. 
The protons at the defined regions of the 1H NMR spectra were integrated to get the 
number of protons in specific regions. The functional groups representing the distinct 
regions of the 1H NMR spectra were illustrated as insets 
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Figure 4.2.: The stacked plot representing the (A) deconvolated and (B) acquired 13C 
NMR spectra of EtOAc:MeOH extract of P. malabarica. (C) deconvolated and (D) 
acquired 13C NMR spectra of EtOAc:MeOH extract of V. cyprinoids. Chemical shift (δ) 
values are expressed in parts per million (ppm) and were referenced to the residual 
solvent signals of CDCl3 
 
The 1H NMR spectra of EtOAc:MeOH extract from V. cyprinoides and P. 
malabarica showed that the total proton integral due to saturated hydrocarbon groups 
were more prominent in V. cyprinoides (63.36) than that in P. malabarica (57.23). The 
proton integrals at the olefinic region (δ 4.5-6.5) of the EtOAc:MeOH extract of P. 
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malabarica were more prominent (22.23) than V. cyprinoides (13.79). The number of 
protons at δ 2.5-3.5, presumably of methoxy (-OCH3)/alkyl halide (RCH2-
X)/functionalized hydride H of the substituted alkanol (RCH2OH), were found to be 
greater in P. malabarica (proton integral of 12.24), whilst, exceptionally frail proton 
signals at this locale for V. cyprinoides (total proton integral of 6.68) were obvious. The 
1H integrals at δ 3.5-4.5 corresponded towards the alkyl alkanoates (RCH2C(=O)OCH3) 
or protons directly attached to oxygen of ester linkages were greater for P. malabarica 
(proton integral of 8.29) when compared to V. cyprinoides (7.27).  
 
 
Figure 4.3.: Type and integral values of protons obtained from the 1H NMR spectra 
of EtOAc:MeOH extracts of P. malabarica and V. cyprinoides 
 
 The signal intensity and number of carbon atoms with saturated hydrocarbons 
(δ 10-40) were more noteworthy in the EtOAc:MeOH extracts derived from P. 
malabarica than in V. cyprinoides. The number of methine (-CH-) signals at δ 30-40 
was found to be greater in the EtOAc:MeOH extracts of V. cyprinoides and P. 
malabarica. The characteristic peaks due to alkanoate carbon atom of esters 
(RC(=O)OR1) were discernible at δ 160-180 present in these species. The number of sp2 
hybridized olefinic carbon atoms in the region between δ 110-140 were found to be 
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greater in the EtOAc:MeOH extracts derived from P. malabarica than in V. cyprinoides. 
The signals at δ 45-70 due to the alkoxy carbon (RCH2OR1) were present in greater 
intensity in EtOAc:MeOH extracts of P. malabarica. These signals were found to be 
absent or present in minor quantity in V. cyprinoides.  
 
4.3.5.2.  FTIR analyses  
 The FTIR spectra of the EtOAc:MeOH extracts from the bivalve clams were 
used to analyze the various functional groups (Figure 4.4.). The dominant differences of 
the characteristic FTIR signals of the EtOAc:MeOH extracts of V. cyprinoides and P. 
malabarica were due to the carbonyl bands in infrared spectra. Two intense absorption 
bands in 1736-1636 cm-1 region of the FTIR spectra of the EtOAc:MeOH extract 
derived from P. malabarica was demonstrated the presence of esters (at 1736 cm-1) and 
carbonyl groups (such as esters or ketones, at 1636 cm-1) adjacent to the electron 
withdrawing functional groups preferably of olefinic nature. Unlike P. malabarica, the 
IR spectrum of V. cyprinoides was showed only one intense signal at 1740 cm-1 and that 
the peak at 1646 cm-1 in EtOAc:MeOH extract obtained from V. cyprinoides was feeble, 
which evidently suggested the absence of electron withdrawing functional groups 
adjacent to the carbonyl functionalities. A particularly intense signal was recorded in the 
EtOAc:MeOH extract derived from P. malabarica at 1461-1405 cm-1, which is 
particular to the C-C stretching frequency of the aryl ring framework. The signals at this 
region were weak in the EtOAc:MeOH extract derived from V. cyprinoides. The broad 
absorption peaks around 3000-3500 cm-1 in the FTIR spectra of the EtOAc:MeOH 
extracts of V. cyprinoides and P. malabarica were because of more prominent 
intensities of H-bonded -OH stretching vibrations of the characteristic lead molecules 
present in the solvent extracts, although, it is hard to precisely foresee the molecular 
interactions due to their broad character. The peaks were likewise recognized at 1200-
1000 cm-1 in the EtOAc:MeOH extract obtained from P. malabarica, evidently because 
of the vicinity of C=C stretching vibration due to the olefinic groups. The peaks in this 
region were feeble in the solvent extract of V. cyprinoides. 
 
117 
 
Bioactive potentials of Villorita cyprinoides and Paphia malabarica            Chapter 4 
 
Figure 4.4.: FTIR spectra of EtOAc:MeOH extracts of (A) P. malabarica and (B) V. 
cyprinoides. The functional groups representing the distinct regions of the IR spectra 
were illustrated.  
 
 Spectroscopic analyses, for instance, 1H and 13C NMR of EtOAc:MeOH 
extracts of the bivalve clam species were provided a clear idea to comprehend and 
compare the signal pattern and component intensities of the distinctive sorts of protons 
and carbons. This gave an understanding into the distinctive functional groups 
connected with the EtOAc:MeOH extracts. Since the spectra is a mixture of different 
compounds, it is apparently difficult to break down some multiplets because of their 
complexity to interpret and peak overlaps as a result of regular line width impediment 
imposed by the T2 (spin-spin relaxation), which forestalls significant data to be 
identified in the multiplets. The large numbers of transitions in 1H spectra of 
compounds were made disentangled by the peak analyses algorithm, Global Spectral 
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Deconvolution (GSD), which applies a deconvolution of the entire range of the 
spectrum in this way making us to work out the signature peaks in an effective manner. 
 The total number of protons at the region depicting the saturated 
hydrocarbons (δ 0.1-2.0) was fundamentally lesser (an aggregate proton integral of 
about 57.23) in P. malabarica than the EtOAc:MeOH extract derived from V. 
cyprinoides (63.36). It is intriguing to note that the bioactivity of the latter was lesser 
due to the presence of more prominent saturated hydrocarbons leading to greater 
hydrophobicity. This might result in lesser electrostatic or dipole-dipole interactions 
with the enzyme active site. The 1H NMR spectrum of EtOAc:MeOH extract from P. 
malabarica acquired well resolved, deshielded signals at about δ 4.5-6.5, which 
presumably showed the vicinity of the olefinic protons or those associated with the 
parent hydride group of alkyl alkanoates (RCH2C(=O)OCH3). This explained the 
greater antioxidant capacity of P. malabarica compared to V. cyprinoides. These 
observations have been further validated with the 13C NMR data of the EtOAc:MeOH 
extract. The strong signals in the 1H NMR spectrum of the EtOAc:MeOH extract of P. 
malabarica at δ 2.5-3.5 (proton integral of 12.24) could be ascribed to the vicinity of 
protons because of the presumably of methoxy (-OCH3)/alkyl halide (RCH2-
X)/functionalized hydride H of the substituted alkanol (RCH2OH) groups capable of 
preventing lipid peroxidation. The greater radical scavenging activity (antioxidant 
activity) of the EtOAc:MeOH extracts from P. malabarica could also be explained with 
the presence of electron donating methoxy (-OMe) or hydroxyl groups (-OH) (Cai et al., 
2006).  
 The EtOAc:MeOH extracts of the bivalve clams were recorded the 
occurrence of electronegative groups, such as RC(=O)CH3 or RCH2C(=O)OR1 or 
CH2=CH-CH3 at δ 2.0-2.5 in the 1H NMR spectra that might be responsible for the 
significant inhibition towards pro-inflammatory 5-LOX, COX-1 and COX-2 along with 
diabetic (DPP-4) enzymes. The EtOAc:MeOH extracts of P. malabarica displayed very 
intense signals at δ 2.5-3.5, which ascribed to be because of the vicinity of 
electronegative auxochromes, for example, alkoxy/alkyl halide/functionalized hydride 
H of the substituted alkanols. In general, the EtOAc:MeOH extract derived from P. 
malabarica was showed greater proton integrals than V. cyprinoides when these 
potentially electronegative regions were taken into consideration. This assumption was 
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further validated by the presence of bands in the FTIR and 13C NMR spectra. It can 
therefore be inferred that the functional electronegative groups present in the downfield 
space of the 1H and 13C NMR spectra might frame strong electrostatic linkage with the 
amino acid residues in the enzyme active site leading to greater bioactivity.  
 
4.3.6. Correlation analyses 
  The similarities and differences of antioxidant, anti-inflammatory, anti-
diabetic and anti-hypertension activities of EtOAc:MeOH extracts of bivalve clams P. 
malabarica and V. cyprinoides were statistically analyzed using principle component 
analyses (PCA). The loadings of first and second principal components (PC1 and PC2) 
accounted for 78.70% and 21.30% of the variance, respectively (Figure 4.5.). The IC50 
value of DPPH activity (DPPHPM) for P. malabarica was displayed similarity with 
COX-2 (COX2PM), 5-LOX (LOXPM), α-glucosidase (GlucoPM) and α-amylase 
(AmylPM) activities on PC1. Nonetheless, the IC50 value of DPPH activity of V. 
cyprinoides (DPPHVC) demonstrated resemblance with the IC50 values of ABTS+ 
(ABTSVC), Fe2+ ion chelating (FeCh+VC), H2O2 scavenging (HyPeroVC), COX-2 
(COX2PM) and DPP-4 inhibition (DPPIVVC) on PC1. Similarly, the IC50 value of total 
phenolic content of V. cyprinoides (TPCVC) displayed positive similarity with its COX-
1 (COX1VC) and α-amylase (AmylVC) activities on PC2 component. Nevertheless, the 
lipid peroxidation inhibitory potency of V. cyprinoides (TBARSVC) demonstrated 
closer resemblance with the IC50 values of 5-LOX (LOXVC) and α-glucosidase 
(GlucoVC) on PC2 axis. The EtOAc:MeOH extract derived from P. malabarica and V. 
cyprinoides were exhibited significantly greater anti-inflammatory properties as 
determined by COX-2 inhibitory activity, which apparently indicated that these 
antioxidants might have significant role in deterring inflammatory modulators in the 
system. 
 A positive correlation as portrayed by PCA analyses was showed the co-
linearity between antioxidative properties and anti-ACE activities. A considerable co-
linearity was found to exist between the olefinic groups and the ACE-inhibitory activity. 
A positive correlation might suggest an interaction depending on the polarizability of 
the bioactive leads present in the extract. It is of note that the proton integral of the 
olefinic protons (at δ 4.5-6.5) in the EtOAc:MeOH extract derived from P. malabarica 
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was about 22.23 (as compared to 13.79 in V. cyprinoides), which possibly interact with 
the contacting polar space in the enzyme (ACE), thereby inhibiting the enzyme 
responsible for hypertensive activity. It can therefore be inferred that the electronic 
descriptors might significantly contribute towards the greater anti-ACE activity of the 
solvent extracts derived from the experimental clam species. 
 
 
Figure 4.5.: Loading plot diagram (PC-1 and PC-2 in rotated space) of antioxidant 
potentials compared with anti-inflammatory, anti-diabetic and anti-hypertensive 
potentials of solvent extracts from P. malabarica (PM) and V. cyprinoides (VC). 
  
  Antioxidant compounds play immense role against various diseases, for 
example, inflammation, type-2 diabetes, hypertension, atherosclerosis etc (Kohen and 
Nyska 2002), which explain their potential use in pharmaceutical field and functional 
food industry. Bivalve mollusks have been described as very important marine fauna, 
which were reported to be endowed with potential antioxidative and anti-inflammatory 
properties (Chakraborty et al., 2014a). The rich diversity of bivalve clams were 
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accessible throughout the southwest coast of Arabian Sea represented an untapped 
reservoir of antioxidative principles with potential health benefits. There were reports 
for the presence of antioxidants in mollusks that can prevent cell damage from oxidative 
responses (Conforti et al., 2005; Nagash et al., 2010; Nawar 1996). The present study 
has been demonstrated the potentials of EtOAc:MeOH extracts of the bivalve clams V. 
cyprinoides and P. malabarica as antioxidative, anti-diabetic, anti-inflammatory, and 
anti-ACE-1 activities. 
 
4.4. Conclusion 
 The present study has been revealed that the EtOAc:MeOH extract of bivalve 
clam P. malabarica registered greater antioxidative properties and the activities were 
showed a significant positive correlation with the anti-hypertensive, anti-inflammatory 
and anti-diabetic activities. The utilities of spectroscopic tools for analyzing the 
signature peaks and relative abundance of the vital functional groups present in the 
solvent extracts and to furnish with essential rules regarding the presence of these 
functional groups responsible for bioactivities were illustrated. A significant co-linearity 
was found to exist between the electronegative groups present in the deshielded position 
of the NMR spectra and the bioactivities of the EtOAc:MeOH extracts derived from the 
bivalve clam species. The results from the present study will be helpful to develop 
nutraceutical supplements from these bivalve clam species in combating oxidative stress 
induced disorders, for example, diabetes, inflammation, and hypertension. The present 
study demonstrated that the bivalve clams, particularly P. malabarica have been well 
equipped with potential sources of antioxidants and anti-inflammatory principles. 
Therefore, the following chapters (5 and 6) were focused towards the bioactivity-guided 
isolation and characterization of compounds with bioactive potentials, particularly with 
reference to the antioxidative and anti-inflammatory activities. 
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CHAPTER 5 
ISOLATION AND CHARACTERIZATION OF 
SECONDARY METABOLITES FROM 
VILLORITA CYPRINOIDES 
Contents 
5.1.  Background 
5.2.   Materials and methods 
5.3.   Results and discussion 
5.4.   Conclusions 
5.1. Background 
Novel secondary metabolites from the natural resources have been 
increasingly recognized in the field of natural product chemistry research for use against 
reactive oxygen species (ROS) and inflammatory mediators. The ROS has been 
considered as major end products of several metabolic reaction cascades and believed to 
be the potential initiators or intermediates for the inflammatory reactions through lipid 
peroxidation and generation of pro-inflammatory cyclooxygenases and lipoxygenases 
(Vapaatalo 1986). There were reports of synthetic derivatives being used as antioxidants 
or anti-inflammatory agents, while they were found for acute toxicities and severe 
carcinogenic origin (Schnitzer et al., 1999). With the increasing requirement for 
enhanced life expectancy and improved lifestyle, the newer term “nutraceuticals” or 
“functional foods” with natural bioactive molecules were developed (Fung et al., 2013). 
In a successive attempt to this area of interest, numerous investigations were focused on 
natural dietary components, particularly from unharnessed marine or estuarine resources 
that could prevent the oxidative damages and related ailments (Luan et al., 2011; 
Odeleye et al., 2016). Research on the extracts of various marine and estuarine bivalve 
mollusks, such as oysters, mussels, clams etc. were found to display anti-bacterial, 
antioxidant, anti-inflammatory, anti-cancer and anti-diabetic activities (Chakraborty et 
al., 2016a; Chakraborty et al., 2016b; Lin-rui et al., 2012). Exhaustive investigations 
have described the effectiveness of various edible bivalve clams, such as surf clams, 
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black clams, hard clams etc. for their bioactive and nutritional properties (Odeleye et 
al., 2016).  
 Earlier reports on secondary metabolites from mollusks and bivalves were 
suggested different classes of compounds, such as chromenyls, pyranoids, spiro 
compounds, polyketides, polypropionates, steroids, heterocyclics with bioactive 
properties (Blunt et al., 2015; Ciavatta et al., 2011). The oxygen heterocyclic ring 
systems as the principle antioxidative domain and electronegative ester groups as 
lipophilic components coupled with lesser steric bulk and lipophilic (recommended log 
Pow < 5) factors (that implies the absence of an extended side chain moiety) in the 
bioactive compounds were vital for their greater bioavailability and bioactivity. 
Extensive study of naturally occurring chromenyl, furanyl, cholestene or pyranyl 
enclosed compounds with substitutions of different electronegative functionalities, such 
as hydroxyls, esters, ethers, alkenes etc. can lead to potential high value templates for 
functional health foods and antioxidative nutraceuticals. The α-pyrone methyl 
derivatives were reported from mollusks, H. fusari and Siphonaria lesson (Cutignano et 
al., 2007; Rovirosa and San-Martin 2006). Spirocyclic ether possessing unrearranged 
monocyclofarnesane skeleton were reported from mollusk, Aplysia dactylomela 
(Schmitz et al., 1978). Steroidal compounds with unusual structures were predominant 
in the mollusks along with terpenoids and meroterpenoid analogues (Fontana et al., 
1993; Zhao et al., 2013). 
 Bivalve clam, Villoritta cyprinoides (Corbiculidae) are traditional seafoods 
among the coastal populations of the southwestern coast of the Indian Penninsula. These 
predominantly available bivalve clams were found to have commercial/export values, 
and reported for its nutritional properties and bio-potentials, even though, these 
commercially significant species have not been investigated to its entirety for the 
presence of specialized bioactive metabolites, and their application as potential 
pharmacophores. Hence, this chapter directed towards the isolation and characterization 
of bioactive secondary metabolites from the ethyl acetate:methanol extract of bivalve 
clam, V. cyprinoides by repetitive chromatographic fractionation methods. The 
characterized bioactive secondary metabolites classified under various classes of 
chemistries, named as irregular spirocyclic ether derivatives (1-2), irregular 
meroterpenoids (3-5), hexahydro isochromenyl analogues (6-7) and cholestenol 
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derivatives (8-10). These compounds characterized by various spectroscopic techniques, 
such as nuclear magnetic resonance (NMR) comprising one/two dimensional (1D/2D 
NMR), FTIR and mass experiments. The chromatographic fractions and pure 
metabolites assessed for their anti-inflammatory {anti-cyclooxygenase (anti-COX)/anti-
lipoxygenase (anti-5-LOX)} and free radical inhibitory (DPPH/ABTS+ scavenging) 
potentials. The target bioactivities of these compounds correlated with their structural 
parameters using different physicochemical descriptors, such as hydrophobic parameter 
(logarithmic octanol-water partition value, log Pow), electronic (polarizability, 
Pl/topological polar surface area, tPSA) and steric {molar refractivity (MR)/molar 
volume (MV)/parachor (Pr)} factors. This chapter also proposed the antioxidative 
mechanisms of secondary metabolites (1-10) isolated from V. cyprinoides in the DPPH 
radical model system. The modes of COX-2 and 5-LOX enzyme inhibitions by selected 
compounds were determined by molecular docking models. 
 
5.2. Materials and methods 
5.2.1. Chemicals, reagents and instrumentations 
 All chemicals and reagents used in this study were of analytical/spectroscopic 
grade and obtained from E-Merck (E-Merck, Frankfurter, Darmstadt, Germany) and 
Sigma-Aldrich (Missouri, USA). Redistilled or milliQ or HPLC grade water used 
throughout the work. 1,1-Diphenyl-2-picryl-hydrazil, potassium  persulfate, 2,2’-azino-
bis-3-ethylbenzothiozoline-6-sulfonic acid diammonium salt, leuco-2,7-dichloro 
fluorescein diacetate, sodium hydroxide, tris-buffer, hematin, phenol, arachidonic acid, 
linoleic acid, sodium phosphate buffer, 3,5-dinitrosalicylic acid reagent were purchased 
(E-Merck, Germany and Sigma-Aldrich, USA). Pro-inflammatory enzymes, such as 
cyclooxygenase-1 (sheep) and cyclooxygenase-2 (human recombinant) were procured 
from Sigma-Aldrich, whereas 5-lipoxygenase extra pure (5-LOX from soybean) 
procured from Sisco Research Laboratories (SRL, Mumbai, India). The natural 
compound, α-tocopherol (Himedia, Pennsylvania, USA) was used as a standard for 
antioxidant assays and synthetic compound, ibuprofen (Sigma Aldrich, USA) was used 
as a standard for anti-inflammatory assays. All glasswares were procured from Borosil 
(India) or Magnum glassworks (Cochin, India).  
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 The solvents were evaporated using rotary vacuum evaporators (Heidolph 
instruments GmbH and Co., Schwabach, Germany; Ika rotary evaporator, IKA® Works, 
North Chase Pkwy SE, Wilmington, USA) and rotational vacuum concentrator (RVC, 
Martin Christ, GmbH, Osterode, Germany). Laboratory scale lyophilizers (Alpha 1-4 
LD plus, Martin Christ, Osterode, Germany; Scanvac, CoolsafeTM, LaboGene, DK-3540 
Lynge, Denmark) were used for freeze drying. The samples were kept in the -80°C deep 
freezer (ultra-low temperature freezer, Eppendorf, Hamburg, Germany). The extractions 
of samples were carried out using rotary shaker (Orbital shaker, Labline, India) and 
ultrasound sonicator (water bath sonicator, Elma, Hohentwiel, Germany). The melting 
points of pure compounds were determined using melting point apparatus (VMP-DS, 
Veego, Mumbai, India) and the angle of rotation of compounds recorded on a 
polarimeter (AP-300, ATAGO, Japan). The UV lamp (short/long-wave UV lamp, 
wavelength 254/365 nm; Cole-Parmer, India) was used to identify the various spots or 
bands developed in the TLC/PTLC plates. 
 
5.2.2. Chromatographic analyses 
5.2.2.A.  Column chromatography (CC) 
 The column chromatographic purifications were carried out using various 
mesh sized dry silica (230-400, 100-200 and 60-120 mesh size; E-Merck, Darmstadt, 
Germany) pre-packed in a vertically clamped glass columns (10 mm X 300 mm, 10 mm 
X 450 mm, 18 mm X 450 mm, 18 mm X 600 mm and 40 mm X 1000 mm; Borosil, 
India; Magnum glassworks, India). The column was packed and saturated with the 
desired non-polar solvent as mobile phase (mainly n-hexane) prior to sample loading. 
The extracts were mixed with the same solvent in small volume and silica gel (60-120 
mesh, 4.5 g) to make into slurry before being filled into glass column. This slurry was 
thereafter packed onto the column using modified syringe. The mobile phase was added 
by step gradient elution with non-polar/medium polar solvent(s) (n-
hexane/dichloromethane) and polarity was regularly increased using the increasing 
amounts of polar solvents (EtOAc/MeOH). The successive column fractions were 
collected separately. The mobile phase was pumped through the column using the air 
pressure.   
 
126 
 
Isolation and characterization of secondary metabolites from Villorita cyprinoides          Chapter 5 
5.2.2.B.  Flash chromatography (FC) 
The extracts or fractions resolved by ﬂash (Biotage AB SP1-B1A, Sweden) 
chromatography on silica column (230-400 mesh silica; Biotage No. 25 + M KP Si or 
12 + M Si). The desired collection/monitor wavelengths and a step gradient elution of 
non-polar to polar solvents as mobile phase were used for chromatographic 
fractionation. The extracts were packed onto the column either as slurry (extracts mixed 
with silica gel) or as liquid (extracts dissolved in solvents) using modified syringe. The 
various fractions were separately collected based on the chromatograph.  
 
5.2.2.C.  Thin layer chromatography (TLC) 
 Thin layer chromatographic technique was used for the separation of various 
components from mixtures and for checking the purity of isolated compounds. The pre-
coated preparative TLC (PTLC) glass plates with silica gel 60 GF254 (thickness 0.2 mm 
and size 20 X 20 cm; Merck KGaA, Germany) was used for the purification of 
compounds from various column fractions using various percentages of mobile phases 
(n-hexane, dichloromethane, EtOAc, MeOH). The spots or bands separated on PTLC 
were detected under the UV lamp (short/long-wave UV lamp, wavelength 254/365 nm; 
Cole-Parmer, India) at 254 nm (short UV) and 365 nm (long UV). 
 Thin layer chromatography was carried out on a pre-packed aluminium sheets 
with silica 60F254 of size 20 X 20 cm (Kieselgel-60F254; E-Merck, Frankfurter, 
Darmstadt, Germany) to check the purity of isolated compounds and to screen the 
various components present in the mixtures by considering their retention factors (Rf: 
ratio of distance travelled by spot to distance travelled by solvent front). Various 
percentages of solvents (n-hexane, dichloromethane, EtOAc, MeOH) were used as 
mobile phases. The spots or bands on TLC were detected under the UV lamp 
(short/long-wave UV lamp, wavelength 254/365 nm; Cole-Parmer, India) at 254 nm 
(short UV) and 365 nm (long UV). The extracts dissolved in small volume of desired 
solvents and applied on the PTLC or TLC plates using capillary tubes. 
 
5.2.2.D.  High pressure liquid chromatography (HPLC) 
 The preparatory high pressure liquid chromatograph (PHPLC) system 
(Shimadzu Corporation, Nakagyo-ku, Japan) connected with a bonded reverse phase 
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C18 (RP C18) column (Shimadzu; Luna 250 mm X 14.0 mm, 5 μm) ﬁtted with binary 
gradient pump (Shimadzu LC-20AP), column oven (CTO-20AC, Shimadzu), 
photodiode array detector (SPD-M20A, Kyoto, Japan) and a controller (CBM-20A, 
Shimadzu) were used for the purification of compounds. The injection volume was 2 
mL and the column temperature retained at 40°C. The various percentages of MeOH 
and acetonitrile utilized as mobile phase with 6-8 mL/min flow rate. The absorbances 
recorded between the ranges of 200-800 nm wavelengths.  
 An analytical HPLC system (Shimadzu Corporation, Nakagyo-ku, Japan) 
bonded with reverse phase C18 (RP C18) column (Phenomenex, Torrance, California, 
USA; Luna 250 mm X 4.6 mm, 5 μm) ﬁtted to binary gradient pump (Shimadzu LC-
20AD), column oven (CTO-20A, Shimadzu), photodiode array detector (SPD-M20A, 
Kyoto, Japan) and a controller (CBM-20A, Shimadzu) were used to analyze the purity 
of isolated compounds. The injection volume was 20 μL and column temperature was 
maintained to 40°C. The mobile phase comprised of various percentages of MeOH and 
acetonitrile with 1 mL/min flow rate. The absorbances recorded between 200-800 nm.  
 The samples were passed through the solid phase extraction (SPE) cartridges 
(Strata C18-E; 55 Μm, 70 Å; Phenomenex, Torrance, California, USA) and filtered 
through the syringe filter (0.20 μm, PTFE, Minisart syringe filter, Sartorius, 
Goetteingen, Germany) before being injected into reversed phase HPLC instruments. 
 
5.2.3. Spectrophotometric analyses 
 The UV-VIS spectra of chromatographic fractions/isolated pure compounds 
along with UV-VIS absorbances acquired on ultraviolet-visible (UV-VIS) 
spectrophotometer (Varian Cary 50, Walnut Creek, California, USA) and microplate 
spectrophotometer (Thermo Scientific™ Multiskan™ GO, Waltham, MA USA), as 
appropriate. The glass cuvettes (1 cm X 1 cm X 4.5 cm) were used in the UV-VIS 
spectrophotometer and 96-well microplates (Nunclon™ Plates with Delta Surface, 
Thermo Fisher Scientific, Jiangsu, China) used in the microplate spectrophotometer. 
 
5.2.4.  Spectroscopic analyses 
5.2.4.A.  Fourier transform infrared (FTIR) spectroscopy  
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The Perkin-Elmer Series 2000 Fourier transform infrared (FTIR) 
spectrometer used to record FTIR spectra between the scan range of 4000 and 400 cm-1 
on KBr (Perkin-Elmer FTIR, Winter Street, Waltham, Massachusetts, USA). The 
samples (15 mg) prepared in KBr (150 mg) and applied 5 X 106 Pa pressure to afford 
clear transparent disc (thickness 1 mm X diameter 13 mm). The IR values have been 
expressed in percentage transmittance (% T). The FTIR spectrometer-Alpha from 
Bruker Optics (Bruker, Karlsruhe, Germany) also used for the FTIR analysis. 
 
5.2.4.B.  Mass spectrometry 
 The gas-chromatographic mass-spectrometric (GC-MS) experiments carried 
out by using the EI (electronic impact) ionization method (GC-MS Perkin-Elmer 
Clarus-680, Winter Street, Waltham, Massachusetts, USA). Helium (He) was used as 
the carrier gas and the flow rate was 1 mL/min. The injection volume was 1 μL in a split 
mode and temperature of the injector was 280°C. Electron ionization energy was set at 
70 eV. The scan rates were set as 10 spectra/s and ion source temperature maintained at 
200°C. The compounds fractionated with non-polar capillary column (Elite-5 bonded 
phase, 50 m X 0.22 mm i.d. X 0.25 µm film thicknesses). The exact molecular ion 
weights of pure compounds have been acquired by direct injection in high resolution 
mass spectrometer {HRESIMS, [M+H]+)} and compared with the MarinLit database 
(Royal Society of Chemistry, London, Burlington House, London W1J 0BA dedicated 
to marine natural products) and NIST database (NIST standard reference database 1A 
v17, National Institute of Standards and Technology, Gaithersburg, MD, USA). 
 
5.2.4.C.  Nuclear magnetic resonance (NMR) spectroscopy 
 The one dimensional NMR analyses, such as proton (1H;  500 MHz), carbon 
(13C;  125 MHz), distortionless enhancement by polarization transfer (135DEPT) and two 
dimensional NMR analyses, such as 1H-1H correlation spectroscopy (1H-1H COSY), 
heteronuclear single-quantum coherence spectroscopy (1H-13C HSQC), heteronuclear 
multiple-bond correlation spectroscopy (1H-13C HMBC) and nuclear overhauser effect 
spectroscopy (NOESY) were analyzed on Bruker AVANCE III 500MHz (AV 500) 
spectrometer (Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient 
temperature with internal standard (TMS; δ 0 ppm) fitted to 5 mm probes. The 1H NMR 
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signals corresponding to the types of hydrogen nuclei in a molecule and numbers of 
characteristic protons were obtained from the proton integral values. The 13C NMR 
signals recognized the various types of carbons in a molecule. The multiplicities of 
carbons established from 135DEPT spectra, which differentiated the number or 
possibilities of methylenes (-CH2; signals appeared in the downward direction), methyls 
(-CH3; signals appeared in the upward direction with lower chemical shift values in the 
range δ 10-40) and methines (-CH; signals appeared in the upward direction with higher 
chemical shift values in the range δ 45-160). The signal that was apparent in the 13C 
NMR spectra and absent in the 135DEPT spectra denoted the occurrence of quaternary 
carbons. The 1H-1H COSY spectra determined the signals, which were correlated with 
the neighbouring protons by J couplings through-bond and the spectra were obtained by 
diagonal peaks and cross peaks. The resonances in HSQC spectra represented 1H-13C 
correlations, which determined the unique proton directly attached to unique carbon 
heteronucleus. The HMBC spectra denoted correlations between protons and carbons, 
which were separated by two, three and four bond distances. The NOESY spectra were 
similar to 1H-1H COSY and attained with diagonal peaks and cross peaks. But, the cross 
peaks represented the resonances from nucleus, and were spatially close to each other 
than the direct bond couplings. In short, NOESY spectra determined the special 
arrangements and close proximities of adjacent spin systems. 
 The NMR spectral interpretations carried out using the software MestReNova 
ver. 7.1.1-9649 © 2012 (Mestrelab Research, S.L. Feliciano Barrera, Santiago de 
Compostela, Spain). 
 
5.2.5. Animal material and extraction 
The shelled V. cyprinoides (10 kg) samples were freshly gathered from their 
natural locality, Vembanad Lake situated at the southwestern coast of the Indian 
Penninsula (9°35’ N and 76°25’ E), bordering the Arabian Sea (Figure 5.1.). After 
cleaning the externalities, the samples were transported to the laboratory in an ice box. 
The shell-on samples thoroughly washed in distilled water and the edible meat (6 kg) 
was manually separated from the shells without applying heat. The edible flesh samples 
thereafter homogenized by a grinding machine before being kept overnight in the deep 
freezer at -80°C (ultra-low temperature freezer, Eppendorf, Hamburg, Germany) for 
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freezing. It was then lyophilized by freeze drier (Alpha 1-4 LD plus, Martin Christ, 
Germany; Scanvac, CoolsafeTM Denmark) for 48 h to yield the lyophilized black clam 
powder (1500 g; yield 25 g/100 g wet weight basis). This was stored in vacuum packed 
polyethylene biohazard autoclave bags (FisherbrandTM, Fischer Scientific) in the deep 
freezer at -80°C until further processing. The lyophilized powder was used for the 
solvent extraction. 
 
 
Figure 5.1.: The fresh shelled V. cyprinoides samples collected from the southwestern 
coast of the Indian Penninsula (9°35’ N and 76°25’ E), bordering the Arabian Sea 
 
The lyophilized powder (1500 g) of black clam material was homogenized 
with ethyl acetate:methanol (1:1, v/v, EtOAc:MeOH) by sonication (Elma, Hohentwiel, 
Germany) and shaking (Orbital shaker, Labline, India) for 4 h under an inert atmosphere 
of nitrogen. This extraction procedure repeated for three times to recover maximum 
bioactive components in the crude extract. The extract contents were then ﬁltered 
through ﬁlter paper (Whatman No. 1) using Na2SO4 (30 g) to obtain the clarified 
filtrates. The solvent filtrates concentrated (40°C) in rotary evaporator (Heidolph, 
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Germany; Ika, USA) to afford the brown viscous crude solvent extract of V. 
cyprinoides. Then, the extracts were completely dried in the rotational vacuum 
concentrators (RVC, Martin Christ, Germany) to yield the corresponding solvent 
extracts of V. cyprinoides (50 g; yield on dry weight basis 3.33%). The crude solvent 
extract was kept under an inert nitrogenous atmosphere and used for the isolation of 
bioactive compounds by repeated chromatographic fractionations. 
 
5.2.6. Chromatographic purification of pure compounds from V. cyprinoides 
The crude extract of V. cyprinoides (45.0 g) was partitioned by exhaustive 
column chromatography over silica gel as adsorbent. The schematic diagram showing 
the purification of EtOAc:MeOH extract of V. cyprinoides was illustrated in Figure 5.2. 
The extract was made into slurry with silica (5 g, 60-120 mesh) before being filled into 
column (1000 mm X 40 mm) enclosing silica gel as adsorbent (60-120 mesh, 50 g). The 
column was primarily eluted with n-hexane (100%) followed by dichloromethane 
(DCM, 100%), ethyl acetate (EtOAc, 100%) and finally methanol (MeOH, 100%) to 
obtain a total of 4 column fractions, such as VC1, VC2, VC3 and VC4, respectively. The 
column fractions were assessed for their anti-inflammatory and antioxidant activities. 
The two fractions, VC2 and VC3 were selected for further purifications as it exhibited 
reasonably better antioxidant and anti-inflammatory activities compared to other 
fractions. 
 The fraction, VC2 (8 g; 17.78%), which obtained by eluting with 100% DCM 
was fractionated by vacuum liquid chromatography on a glass column (450 mm X 30 
mm) packed with silica (230-400 mesh) using n-hexane/EtOAc/MeOH to aquire 25 
fractions of 25 mL each, which reduced to 9 fractions (VC2-1-VC2-9) after TLC (n-
hexane:EtOAc, 9:1, v/v) analysis. The VC2-4 fraction (10% EtOAc:n-hexane, v/v; 1023 
mg; 2.27%), VC2-5 (12% EtOAc:n-hexane, v/v; 1136 mg; 2.52%) and VC2-6 (15% 
EtOAc:n-hexane, v/v; 1323 mg; 2.94%) were acquired in greater yields compared to 
other fractions. Also, the sub-fractions were checked for their potentials in which VC2-4, 
VC2-5 and VC2-6 registered greater bioactive properties, and therefore, selected for 
further fractionation. The fraction, VC2-4 eluted at 10% EtOAc:n-hexane (v/v) appeared 
to be mixture and purified to homogeneity by preparative HPLC (reverse phase C18 
PHPLC) using 80% MeCN:MeOH (v/v) to yield compound 10 (195 mg; 0.43%). The 
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another fraction, VC2-5 was found to be mixture, and therefore, sub-fractionated on 
preparative HPLC (RP C18 PHPLC; 80% MeCN:MeOH, v/v) to yield pure compound 9 
(134 mg; 0.30%). The solvents allowed to evaporate from their respective fractions 
followed by TLC analysis by utilizing 95:5, v/v, n-hexane:EtOAc to support its purity.  
 The VC2-6 fraction (1323 mg; 2.94%) was flash chromatographed (Biotage 
AB SP1-B1A, 25+M, 230-400 mesh, 12 g; Biotage AB, Uppsala, Sweden) on silica 
column at collection UV wavelength of 250 nm using n-hexane/EtOAc/MeOH to afford 
total of 52 fractions (8 mL each) and pooled to six fractions (VC2-6-1-VC2-6-6). The sub-
fractions, such as VC2-6-2, VC2-6-4, VC2-6-5 and VC2-6-6 were exhibited greater bioactive 
potentials, therefore, selected for further purifications. The fraction VC2-6-2 (205 mg; 
0.46%) on repeated column chromatography followed by PTLC (4% EtOAc:n-hexane) 
purifications afforded 3 (79 mg; 0.18%) and its purity was checked with silica gel GF254 
TLC using n-hexane:EtOAc (9:1, v/v). The fraction, VC2-6-4 (214 mg; 0.48%), on 
repeated RP C18 PHPLC (80% MeCN:MeOH X 5) purification techniques yielded 4 
(59 mg; 0.13%), and the homogeneity was confirmed by TLC analysis using 15% 
EtOAc:n-hexane (v/v). The fraction, VC2-6-5 (510 mg; 1.13%) on repeated PTLC (4% 
EtOAc:n-hexane, v/v) acquired compound 8 (143 mg; 0.32%) and its purity was 
checked by TLC analyses (10% EtOAc:n-hexane, v/v). The VC2-6-6 (196 mg; 0.44%) 
fraction on repeated column chromatography was afforded sub-fractions, VC2-6-6-1-VC2-
6-6-4 and in which the sub-fraction, VC2-6-6-2 (134 mg; 0.30%) exhibited greater 
bioactivities. The sub-fraction, VC2-6-6-2 on RP C18 PHPLC (80% MeCN:MeOH, v/v) 
fractionation yielded compound 5 (69 mg; 0.15%) and its purity was checked by TLC 
analysis (15% EtOAc:n-hexane, v/v). 
 Another active fraction, VC3 (11 g; 24.44%), which eluted at 100% EtOAc, 
was further fractionated on flash chromatography (Biotage AB SP1-B1A, 230-400 
mesh, 25+M; 12 g; Biotage AB, Uppsala, Sweden) using n-hexane/EtOAc/MeOH on 
silica gel column at a collection UV wavelength of 264 nm. The solvent polarity was 
initiated from 100% n-hexane followed by EtOAc and MeOH to afford 85 (12 mL each) 
fractions and were reduced to 6 (VC3-1-VC3-6) fractions. The sub-fraction, VC3-4 (1640 
mg; 3.64%) and VC3-6 (1540 mg; 3.42%) were acquired in greater yields with greater 
bioactive potentials, and therefore, considered for further purifications. The sub-
fraction, VC3-4 fractionated by flash (Biotage AB SP1-B1A, 230-400 mesh, 12+M; 
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Biotage AB, Uppsala, Sweden) chromatography on a silica gel column at a collection 
UV wavelength of 250 nm with n-hexane/EtOAc/MeOH to yield five pooled sub-
fractions (VC3-4-1-VC3-4-5). The fraction, VC3-4-3 (398 mg; 0.88%) was found to contain 
two major compounds and further purified by RP C18 PHPLC (MeOH/MeCN, 2:8, v/v 
X 4) to yield two pure compounds, 6 (169 mg; 0.38%) and 7 (156 mg; 0.35%). These 
compounds were found to be homogenous on TLC over silica gel GF254 (15 mm) using 
n-hexane:EtOAc (98:2, v/v).  
    
 
Figure 5.2.: Schematic diagram of purification of EtOAc:MeOH extract of V. 
cyprinoides. CC-column chromatography; FC-flash chromatography; PTLC-preparative 
thin layer chromatography; TLC-thin layer chromatography; RP C18 PHPLC-reverse 
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phase C18 preparatory high pressure liquid chromatography; E-ethyl acetate; H-n-
hexane; M-methanol. The coloured boxes represented the pure compounds and were 
characterized by detailed spectroscopic experiments 
 
 Another active fraction, VC3-6 fractionated by flash chromatographic 
purification (Biotage AB SP1-B1A, 230-400 mesh, 12+M; Biotage AB, Uppsala, 
Sweden) on a silica gel column at a collection UV wavelength of 252 nm with n-
hexane/EtOAc/MeOH to furnish three sub-fractions, which were designated as VC3-6-1-
VC3-6-3. The fractions, VC3-6-1 (546 mg; 1.21%) and VC3-6-2 (489 mg; 1.09%) were 
selected for repeated purifications. The fraction, VC3-6-1 on PTLC using 2% EtOAc:n-
hexane (v/v) solvent system resulted in the isolation of compound 1 (147 mg; 0.33%) 
and its purity was determined using TLC {n-hexane:EtOAc (90:10, v/v)}. The other 
fraction, VC3-6-2 on PTLC (5% EtOAc:n-hexane, v/v) fractionation yielded compound 2 
(96 mg; 0.21%) and its purity was checked using TLC (90:10, v/v, n-hexane:EtOAc) 
and RP C18 HPLC (8:2, v/v, MeOH/MeCN).  
 
5.2.7. Physicochemical data of bioactive secondary metabolites from 
EtOAc:MeOH extract of V. cyprinoides 
5.2.7.1.  Physicochemical data of compound 1 (VC3-6-1-1) 
16-Hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-
propanoate: Yellow oily; UV (MeOH) λmax (log ε): 231.9 nm (2.55);  TLC (Si gel 
GF254 15 mm; 10:90, v/v, EtOAc/n-hexane) Rf: 0.63; Rt (RP C18 HPLC, 8:2, v/v, 
MeOH:MeCN): 5.33 min; IR (cm-1) (stretching ν, bending δ, rocking ρ): 3411 (br, O-
Hν), 2924, 2854 (C-Hν), 1731 (C=Oν), 1460 (C-Hδ), 1376 (C-Hρ), 1167 (C-Cν), 1045 
(C-Oν), 972 (=C-Hδ), 826, 657 (C-Hδ); 1H (CDCl3, 500 MHz): δ 6.50 (1Hα, d, J=8.84 
Hz), 6.25 (1Hα, d, J=8.84 Hz), 5.36 (1Hα, t, J=3.54 Hz), 5.35 (1Hα, t, J=3.93 Hz), 4.18 
(1Hα, t), 4.14 (1Hβ, t), 3.97 (1Hα, m), 2.35 (2H, t), 2.32 (1Hβ, m), 2.10 (1Hα, m), 2.02 
(2H, t), 1.92 (2H, m), 1.86 (2H, m), 1.61 (2H, m), 1.52 (2H, m), 1.30 (2H, m), 1.25 
(3Hα, s), 1.01 (3Hβ, s), 0.88 (3H, t), 0.82 (3H, t); 13C (125 MHz, CDCl3): δ 173.95, 
135.40, 132.30, 130.73, 129.94, 82.17, 79.47, 66.47, 65.04, 39.43, 36.89, 34.69, 34.11, 
31.92, 30.06, 29.70, 27.22, 24.88, 22.69, 22.54, 18.17, 14.12; COSY and HMBC data 
were given in Table 5.5. EIMS (Electron impact ionization mass spectrometry): found 
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m/z 364.2620 [M]+, cal. for C22H36O4 364.2614 (Δ 1.6 ppm). HRESI-MS (positive 
mode) m/z: for C22H37O4 365.2692 [M+H]+). 
 
5.2.7.2.  Physicochemical data of compound 2 (VC3-6-2-1) 
 (E)-18-Ethyl-17,19-dihydroxyhept-14-enyl-(2-ethyl-2,6-dimethyl-1-
oxaspiro[4.5]dec-3,8-dien)-10-acetate: Yellow oily; UV (MeOH) λmax (log ε): 236 nm 
(2.17); TLC (Si gel GF254 15 mm; 10:90, v/v, EtOAc/n-hexane) Rf: 0.51; Rt (RP C18 
HPLC, 8:2, v/v, MeOH:MeCN): 3.28 min; IR (cm-1): 3389 (br, O-Hν), 2923, 2855 (C-
Hν), 1728 (C=Oν), 1459 (C-Hδ), 1375 (C-Hρ), 1042 (C-Oν), 971 (=C-Hδ), 730, 650 (C-
Hδ); 1H (CDCl3, 500 MHz): δ 6.50 (1Hα, d, J=8.64 Hz), 6.25 (1Hα, d, J=8.64 Hz), 5.41 
(1Hα, t, J=3.74 Hz), 5.38 (1Hα, q, J=3.29 Hz), 5.21 (1Hβ, q, J=10.77 Hz), 5.17 (1Hα, q, 
J=10.14 Hz), 4.18 (1Hα, d), 4.15 (1Hβ, d), 3.97 (1Hα, m), 3.69 (1Hβ, d), 3.60 (1Hα, d), 
2.81 (1Hβ, m), 2.35 (2H, d), 2.10 (1Hα, m), 2.02 (2H, t), 1.92 (2H, t), 1.63 (2H, q), 1.58 
(1Hα, m), 1.33 (2H, m), 1.25 (3Hα, s), 1.01 (3Hβ, s), 0.88 (3H, t), 0.80 (3H, t); 13C (125 
MHz, CDCl3): δ 174.36, 135.40, 135.18, 132.30, 130.76, 130.73, 129.94, 82.17, 79.44, 
66.46, 65.15, 63.33, 39.43, 36.89, 34.69, 31.92, 29.69, 27.98, 25.54, 23.40, 22.69, 
22.53, 18.16, 14.11; COSY and HMBC data were given in Table 5.6. EIMS: found m/z 
406.2725 [M]+, cal. for C24H38O5 406.2719 (Δ 1.5 ppm). HRESI-MS (positive mode) 
m/z: for C24H39O5 407.2797 [M+H]+). 
 
5.2.7.3.  Physicochemical data of compound 3 (VC2-6-2-1-2) 
 8-(1,3,3a,4,5,7a-Hexahydro-1-(hydroxymethyl)-3-oxoisobenzofuran-4-yl)-
ethyl pentanoate: Dark brown oily; UV (MeOH) λmax (log ε): 235.3 nm (2.76); TLC (Si 
gel GF254 15 mm; 1:9, v/v, EtOAc/n-hexane) Rf: 0.81; Rt (RP C18 HPLC, 2:3, v/v, 
MeOH:MeCN): 3.03 min; IR (cm-1): 3089 (br, O-Hν), 2984 (C-Hν), 1737 (C=Oν), 1446 
(C-Hδ), 1233, 1043 (C-Oν), 847 (=C-Hδ), 786, 734 (C-Hδ); 1H (CDCl3, 500 MHz): δ 
5.37 (1Hα, q, J=3.53 Hz), 5.35 (1Hα, t, J=3.64 Hz), 4.17 (1Hβ, d), 4.15 (1Hα, d), 4.08 
(1Hβ, m), 3.73 (3H, d), 2.81 (1Hα, m), 2.35 (2H, t), 2.32 (1Hα, d), 2.08 (1Hβ, m), 2.02 
(2H, m), 1.63 (2H, m), 1.30 (2H, m), 1.29 (2H, m), 0.88 (3H, t); 13C (125 MHz, CDCl3): 
δ 178.41, 173.95, 129.99, 129.70, 68.26, 65.00, 61.42, 50.10, 34.10, 31.92, 29.69, 
27.21, 25.62, 24.88, 22.68, 14.11; COSY and HMBC data were given in Table 5.7. 
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EIMS: found m/z 296.1630 [M]+, cal. for C16H24O5 296.1624 (Δ 2.0 ppm). HRESI-MS 
(positive mode) m/z: for C16H25O5 297.1702 [M+H]+). 
 
5.2.7.4.  Physicochemical data of compound 4 (VC2-6-4-1) 
Tetrahydro-3-methoxy-5-((E)-8,12-dimethyloct-8-enyl)-pyran-2-one: Pale 
yellow oily; UV (MeOH) λmax (log ε): 218.6 nm; (3.76); TLC (Si gel GF254 15 mm; 
15:85, v/v, EtOAc/n-hexane) Rf: 0.67; Rt (RP C18 HPLC, 1:4, v/v, MeOH:MeCN): 3.41 
min; IR (cm-1): 2922, 2852 (C-Hν), 1740 (C=Oν), 1462 (C-Hδ), 1376 (C-Hρ), 1116, 
1049 (C-Oν), 910 (=C-Hδ), 732, 648 (C-Hδ); 1H (CDCl3, 500 MHz): δ 5.35 (1H, t, 
J=3.95 Hz), 4.17 (1Hα, d), 4.14 (1Hβ, d), 4.08 (1Hα, t), 3.67 (3H, s), 2.35 (2H, t), 2.01 
(2H, m), 1.86 (3Hα, s), 1.82 (2H, d), 1.63 (1Hβ, m), 1.50 (1Hα, m), 1.30 (2H, m), 1.13 
(2H, m), 0.99 (3Hβ, d), 0.87 (3H, t); 13C (125 MHz, CDCl3): δ 173.92, 135.14, 130.02, 
68.40, 65.04, 50.68, 34.11, 31.93, 30.97, 28.03, 27.22, 24.90, 23.73, 22.69, 15.26, 
14.02; COSY and HMBC data were given in Table 5.8. EIMS: found m/z 268.2044 
[M]+, cal. for C16H28O3 268.2038 (Δ 2.2 ppm). HRESI-MS (positive mode) m/z: for 
C16H29O3 269.2117 [M+H]+). 
 
5.2.7.5.  Physicochemical data of compound 5 (VC2-6-6-2-2) 
 Dihydro-5-(8-(9,12-dihydro-8-methyl-11-propyl-2H-pyran-8-yl)-ethyl)-
furan-2-(3H)-one: Pale brown oily; UV (MeOH) λmax (log ε): 234.6 nm (2.52); TLC (Si 
gel GF254 15 mm; v/v, 15:85, EtOAc/n-hexane) Rf: 0.73; Rt (RP C18 HPLC, 1:4, v/v, 
MeOH:MeCN): 4.38 min; IR (cm-1): 2919, 2851 (C-Hν), 1739, 1710 (C=Oν), 1462 (C-
Hδ), 1375 (C-Hρ), 1168, 1114 (C-Oν), 971 (=C-Hδ), 721 (C-Hδ); 1H (CDCl3, 500 
MHz): δ 5.35 (1Hβ, t, J=7.23 Hz), 4.17 (1Hβ, d), 4.14 (1Hα, d), 4.08 (1Hβ, m), 2.35 
(2H, t), 2.02 (2H, d), 1.86 (2H, t), 1.65 (2H, m), 1.60 (2H, m), 1.30 (2H, t), 1.28 (2H, 
m), 1.25 (3Hα, s), 0.89 (3H, t); 13C (125 MHz, CDCl3): δ 177.63, 135.84, 130.02, 72.12, 
68.41, 65.04, 34.11, 33.67, 31.93, 30.73, 29.69, 27.23, 24.72, 22.69, 14.11; COSY and 
HMBC data were given in Table 5.9. EIMS: found m/z 252.1730 [M]+ cal. for C15H24O3 
252.1725 (Δ 2.0 ppm). HRESI-MS (positive mode) m/z: for C15H25O3 253.1804 
[M+H]+). 
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5.2.7.6.  Physicochemical data of compound 6 (VC3-4-3-1) 
 (10E)-Butyl-9-(6-ethyl-3,4,6,7,8,8a-hexahydro-1H-isochromen-3-yl)pent-
10-enoate: Light yellow oily; UV (MeOH) λmax (log ε): 231 nm (3.13); TLC (Si gel 
GF254 15 mm; 2:98, v/v, EtOAc/n-hexane) Rf: 0.62; Rt (RP C18 HPLC, 1:4, v/v, 
MeOH:MeCN): 8.31 min; IR (cm-1): 2974, 2853 (C-Hν), 1711 (C=Oν), 1460 (C-Hδ), 
1377 (C-Hρ), 1167 (C-Cν), 1094 (C-Oν), 910 (=C-Hδ), 731 (C-Hδ); 1H (CDCl3, 500 
MHz): δ 5.43 (1Hβ, q, J=10.97 Hz), 5.40 (1Hα, q, J=10.52 Hz), 5.36 (1Hα, d, J=7.72 
Hz), 4.20 (1Hβ, t), 4.17 (1Hα, t), 3.94 (1Hβ, p), 3.70 (1Hβ, d), 3.63 (1Hα, d), 2.86 (2H, 
d), 2.44 (2H, d), 2.36 (1H, p), 2.07 (2H, t), 2.03 (1Hβ, m), 1.73 (2H, m), 1.64 (2H, m), 
1.62 (2H, m), 1.32 (2H, m), 1.29 (2H, m), 0.99 (3H, t), 0.90 (3H, t); 13C (125 MHz, 
CDCl3): δ 174.34, 132.04, 129.93, 128.29, 128.07, 70.27, 65.14, 63.36, 34.15, 34.04, 
31.91, 31.51, 29.68, 29.65, 27.21, 25.64, 24.90, 22.68, 14.10, 14.05; COSY and HMBC 
data were given in Table 5.10. EIMS: found m/z 320.2356 [M]+, cal. for C20H32O3 
320.2351 (Δ 1.6 ppm). HRESI-MS (positive mode) m/z: for C20H33O3 321.2430 
[M+H]+). 
 
5.2.7.7.  Physicochemical data of compound 7 (VC3-4-3-2) 
 (12E)-(3,4,6,7,8,8a-Hexahydro-1H-isochromen-3-yl)-methyl-hept-12-
enoate: Light yellow oily; UV (MeOH) λmax (log ε): 229 nm (2.08); TLC (Si gel GF254 
15 mm; 2:98, v/v, EtOAc/n-hexane) Rf: 0.68; Rt (RP C18 HPLC, 1:4, v/v, 
MeOH:MeCN): 6.66 min; IR (cm-1): 2923, 2853 (C-Hν), 1711 (C=Oν), 1460, 1412 (C-
Hδ), 1377 (C-Hρ), 1167 (C-Cν), 1094 (C-Oν), 974, 910 (=C-Hδ), 731, 647 (C-Hδ); 1H 
(CDCl3, 500 MHz): δ 5.30 (1Hβ, q, J=10.96 Hz), 5.29 (1Hα, q, J=10.53 Hz), 5.27 (1Hα, 
d, J=7.02 Hz), 4.07 (1Hβ, d), 4.06 (1Hα, d), 3.84 (1H, p), 3.59 (1Hβ, d), 3.52 (1Hα, d), 
2.73 (2H, d), 2.30 (2Hβ, d), 2.26 (1H, p), 1.98 (2H, m), 1.94 (2H, m), 1.54 (2H, m), 1.22 
(2H, m), 1.20 (2H, m), 0.80 (3H, t); 13C (125 MHz, CDCl3): δ 174.37, 135.46, 129.99, 
129.80, 129.68, 70.22, 65.05, 63.35, 34.14, 31.89, 31.75, 29.67, 29.63, 27.20, 24.88, 
22.66, 14.08; COSY and HMBC data were given in Table 5.11. EIMS: found m/z 
278.1886 [M]+, cal. for C17H26O3 278.1882 (Δ 1.4 ppm). HRESI-MS (positive mode) 
m/z: for C17H27O3 279.1960 [M+H]+). 
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5.2.7.8.  Physicochemical data of compound 8 (VC2-6-5-2) 
 19 (10→5) Abeo-20-methyl-pregn-1-en-3-yl-3β-methoxy-hex-25-enoate: 
White solid; melting point (m.p.) 138.2°C; [α]26D -20.5° (CHCl3, c0.011); UV (MeOH) 
λmax (log ε): 222.3 nm (3.61); TLC (Si gel GF254 15 mm; 10:90, v/v, EtOAc/n-hexane) 
Rf: 0.42; Rt (RP C18 HPLC, 3:2, v/v, MeOH:MeCN): 3.19 min; IR (cm-1): 2923, 2855 
(C-Hν), 1719 (C=Oν), 1457 (C-Hδ), 1375 (C-Hρ), 1167 (C-Cν), 1050 (C-Oν), 973 (=C-
Hδ), 722, 655 (C-Hδ); 1H (CDCl3, 500 MHz): δ 5.41 (1H, td, J=9.02, 7.03 Hz), 5.40 
(1H, td, J=9.14, 7.05 Hz), 5.39 (1Hα, t, J=6.50 Hz), 4.62 (1Hα, p), 2.87 (2H, d), 2.32 
(1Hβ, t), 2.29 (1Hα, t), 2.08 (1Hα, m), 2.05 (2H, m), 1.97 (1Hβ, m), 1.86 (2H, m), 1.72 
(1Hβ, d), 1.59 (2H, m), 1.57 (1Hα, d), 1.52 (2H, m), 1.35 (2H, m), 1.32 (2H, m), 1.15 
(2H, t), 1.10 (1Hα, m), 1.04 (3Hβ, s), 1.00 (1Hβ, m), 0.98 (1Hβ, m), 0.95 (3H, t), 0.90 
(3H, d), 0.88 (3H, d), 0.70 (3Hβ, s); 13C (125 MHz, CDCl3): δ 173.28, 139.70, 132.01, 
128.20, 122.57, 73.66, 56.70, 56.15, 50.04, 42.32, 39.53, 38.17, 37.02, 36.60, 36.20, 
35.81, 31.91, 31.88, 29.71, 28.02, 25.64, 24.29, 22.83, 22.57, 21.05, 19.33, 18.73, 
11.86; COSY and HMBC data were given in Table 5.12. EIMS: found m/z 412.3347 
[M+1]+, cal. for C28H44O2 412.3341 (Δ 1.4 ppm). HRESI-MS (positive mode) m/z: for 
C28H45O2 413.3420 [M+H]+). 
 
5.2.7.9.  Physicochemical data of compound 9 (VC2-5-1) 
 (22E)-241-Homocholesta-5,22-dien-(3β,241β)-diol: White solid; m.p. 
139.1°C; [α]26D -18.3° (CHCl3, c0.014); UV (MeOH) λmax (log ε): 221.5 nm (3.46); TLC 
(Si gel GF254 5:95, v/v, 15 mm; EtOAc/n-hexane) Rf: 0.54; Rt (RP C18 HPLC, 3:2, v/v,  
MeOH:MeCN): 6.00 min; IR (cm-1): 3366 (br, O-Hν), 2934, 2865 (C-Hν), 1653 
(C=Cν), 1459 (C-Hδ), 1327 (C-Hρ), 1242, 1191 (C-Cν), 1107 (C-Oν), 928, 881, 801 
(=C-Hδ), 737, 625 (C-Hδ); 1H (CDCl3, 500 MHz): δ 5.34 (1Hα, dd, J=6.25, 6.31 Hz), 
5.18 (1H, m, J=9.81 Hz), 5.17 (1H, td, J=10.44, 9.61 Hz), 3.64 (1Hα, m), 3.52 (1Hα, p), 
2.28 (1Hα, d), 2.23 (1Hβ, d), 2.03 (2H, t), 2.00 (1Hα, t), 1.95 (1H, t), 1.86 (1H, m), 1.85 
(1Hα, t), 1.83 (1Hα, m), 1.69 (2H, m), 1.53 (1Hα, m), 1.52 (1H, m), 1.51 (1Hβ, m), 1.49 
(1Hβ, m), 1.47 (2H, m), 1.14 (1Hβ, t), 1.10 (1Hα, m), 1.08 (1Hβ, m), 1.03 (1Hβ, t), 1.01 
(3Hβ, s), 0.95 (1Hβ, m), 0.92 (1Hα, m), 0.90 (3Hα, d), 0.86 (3H, d), 0.84 (3H, d), 0.69 
(3Hβ, s); 13C (125 MHz, CDCl3): δ 140.75, 135.83, 131.72, 121.70, 71.80, 70.44, 56.77, 
56.02, 50.14, 46.25, 42.81, 42.30, 40.16, 39.79, 37.27, 36.51, 33.10, 31.91, 31.65, 
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28.54, 28.02, 24.30, 22.69, 21.09, 19.89, 19.40, 17.62, 11.87; COSY and HMBC data 
were given in Table 5.13. EIMS: found m/z 414.3504 [M]+, cal. for C28H46O2 414.3498 
(Δ 1.4 ppm). HRESI-MS (positive mode) m/z: for C28H47O2 415.3576 [M+H]+). 
 
5.2.7.10.  Physicochemical data of compound 10 (VC2-4-1) 
(22E),(241E)-241,242-dihomocholesta-5,22,241-trien-3β-ol: White solid; 
m.p. 140.4°C; [α]26D -17.3° (CHCl3, c0.016); UV (MeOH) λmax (log ε): 220 nm (3.32); 
TLC (Si gel GF254 15 mm; 20:80, v/v, EtOAc/n-hexane) Rf: 0.58; Rt (RP C18 HPLC, 
3:2, v/v, MeOH:MeCN): 8.99 min; IR (cm-1): 3366 (br, O-Hν), 2934, 2894 (C-Hν), 
1663 (C=Cν), 1459 (C-Hδ), 1329 (C-Hρ), 1242, 1133 (C-Cν), 1044 (C-Oν), 963, 836, 
801 (=C-Hδ), 737 (C-Hδ);. 1H (CDCl3, 500 MHz): δ 5.39 (1H, q, J=10.49 Hz), 5.35 
(1Hα, dd, J=6.77, 5.03 Hz), 5.20 (1H, t, J=11.02 Hz), 5.16 (1H, td, J=9.55, 9.00 Hz), 
5.03 (1H, t, J=9.04 Hz), 3.52 (1Hα, p), 2.28 (1Hα, d), 2.25 (1Hβ, d), 2.02 (2H, t), 2.00 
(1Hα, t), 1.95 (1H, t), 1.85 (1H, m), 1.84 (1Hα, t), 1.83 (1Hα, m), 1.68 (2H, m), 1.53 
(1Hα, m), 1.51 (1H, m), 1.50 (1Hβ, m), 1.49 (1Hβ, m), 1.47 (2H, m), 1.16 (1Hβ, t), 1.12 
(1Hα, m), 1.08 (1H, m), 1.03 (1Hβ, t), 1.01 (3Hβ, s), 0.95 (1Hβ, m), 0.92 (1Hα, m), 0.90 
(3Hα, d), 0.87 (3H, d), 0.86 (3H, d), 0.68 (3Hβ, s); 13C (125 MHz, CDCl3): δ 140.75, 
138.26, 135.83, 131.72, 129.32, 121.70, 71.80, 56.85, 56.02, 50.17, 42.81, 42.30, 42.25, 
40.16, 39.69, 37.26, 36.52, 33.10, 31.91, 31.66, 28.24, 28.02, 24.30, 22.82, 21.19, 
19.86, 19.40, 17.62, 11.87; COSY and HMBC data were given in Table 5.14. EIMS: 
found m/z 410.3555 [M]+, cal. for C29H46O 410.3549 (Δ 1.5 ppm). HRESI-MS (positive 
mode) m/z: for C29H47O 411.3627 [M+H]+). 
 
5.2.8. Determination of bioactive potentials  
5.2.8.1.  In vitro antioxidant assays  
5.2.8.1.A. 1, 1-Diphenyl-2-picryl-hydrazil (DPPH) radical scavenging assay 
The antioxidant activities of chromatographic fractions and pure compounds 
isolated from the EtOAc:MeOH extracts of V. cyprinoides were measured using the 
stable free radical, DPPH as explained in the section 4.2.4.1.2.A. under Chapter 4. 
 
5.2.8.1.B.  2,2’-Azino-bis-3-ethylbenzothiozoline-6-sulfonic acid diammonium salt 
(ABTS+) radical scavenging assay 
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The free radical scavenging activity of chromatographic fractions and pure 
compounds isolated from the EtOAc:MeOH extracts of V. cyprinoides were determined 
by ABTS+ decolourization assay as explained in the sections 4.2.4.1.2.B. under Chapter 
4. 
 
5.2.8.2.  In vitro anti-inflammatory assays 
5.2.8.2.A. Cyclooxygenases (COX) inhibition assay 
 The cyclooxygenase (COX-1 and COX-2) inhibitory analyses of 
chromatographic fractions and pure compounds isolated from EtOAc:MeOH extracts of 
V. cyprinoides  were carried out as explained in the sections 4.2.4.2.1.under Chapter 4. 
 
5.2.8.2.B. 5-Lipoxygenase (5-LOX) inhibition assay   
 The 5-lipoxygenase (5-LOX) inhibitory analyses of chromatographic 
fractions and pure compounds isolated from EtOAc:MeOH extracts of V. cyprinoides  
were carried out as explained in the sections 4.2.4.2.2.under Chapter 4. 
 
5.2.9.  The structure-activity relationship analyses of bioactive secondary 
metabolites isolated from EtOAc:MeOH extract of V. cyprinoides  
All the structures in this chapter were produced with the use of ChemDraw 
drawing program by presetting in ACS style-sheet format in the ChemDraw 
(CambridgeSoft Corporation, Cambridge, MA,USA; ver. 8.0 and ver. 12.0). 
Structure-activity relationship analyses of the characterized bioactive 
secondary metabolites isolated from V. cyprinoides and the standards (α-tocopherol and 
ibuprofen) were analyzed by the molecular descriptor variables, named hydrophobic 
(logarithm of octanol-water partition co-efficient, log Pow), steric bulk {molar 
refractivity (MR), molar volume (MV), parachor (Pr)} and electronic (topological polar 
surface area tPSA, polarizability Pl) descriptors (Chakraborty et al., 2017b; Lipinski 
2000) using ChemDraw Ultra (CambridgeSoft Corporation, Cambridge, MA,USA; ver. 
8.0 and vers. 12.0) and ACD ChemSketch (Advanced Chemistry Development, Inc., 
Canada; ver. 12.0) softwares. 
 
5.2.10.  In silico molecular modeling  
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5.2.10.1.  Molecular structures of protein and energy minimization   
The X-ray crystal structures of cyclooxygenase-2 (COX-2) (PDB ID 3LN1; 
resolution 2.4 Å) bound with celecoxib (Wang et al., 2010b) and 5-lipoxygenase 
enzyme (5-LOX) (PDB ID 1N8Q; resolution 2.1 Å) bound with protocatechuic acid 
(Borbulevych et al., 2004) were recovered from the Protein Data Bank (www.pdb.org) 
as PDB file (text). The water molecules were removed and the two target enzymes 
energetically minimized by Swiss-PdbViewer (SPDBV v4.1.0) software tool. The 
minimized protein was further taken for the docking studies. 
 
5.2.10.2.  Preparation of ligands  
The titled compounds (1-10) were constructed by utilizing ACD/ChemSketch 
(Freeware) 2016.2.2. (Advanced Chemistry Development, Inc. Toronto, Canada) and 
saved as MDL Molfiles (V2000). These MDL molfiles were converted to PDB format 
using the software OpenBabelGUI 2.4.1 (O’Boyle et al., 2011). 
 
5.2.10.3.  Molecular docking  
The molecular docking of title compounds (1-10) were carried out to evaluate 
their possible binding modes between COX-2 and 5-LOX enzyme active sites other than 
calculating the binding strength, energy of the complex and binding affinity. The 
docking studies were performed using AutoDock 4 (AutoDock Tools ver. 1.5.6). In the 
Autodock software, all ligands, protein bound water and cofactors were eliminated. The 
macromolecules were assigned for polar hydrogens, atomic solvation parameters and 
Kollman charges. Thereafter, the ligands were selected and their torsion bonds were 
defined. To assign the perfect grid for each ligand, grid box was generated by Auto Grid 
algorithm and grid box values were selected by trial and error and also, based on the 
previous studies. Grid map set values for the docking of COX-2 was selected as 
x=47.975, y=-33.687, z=18.295 (54 Å X 56 Å X 106 Å) points and the grid box values 
for the docking of 5-LOX was found to be x=10.500, y=0.583, z=18.972 (48 Å X 32 Å 
X 42 Å). Each map was centered so that it can cover the entire protein particularly, all 
probable binding sites. The molecular docking studies were performed using Genetic 
Algorithm and Lamarckian genetic algorithm (LGA) docking methods. Cygwin-I 
terminal was used for running the docking algorithm. After the successful completion of 
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autodocking, the RMSD (Root-Mean-Square Deviation of atomic positions) results 
were analyzed. The docked conformations of the title compounds were ranked based on 
their binding energies and the conformation with the lowest free binding energies were 
selected for further studies. Among the ten compounds described in this chapter, the 
best five molecules with lowest binding energies were selected and carried out Cygwin-
II terminal for optimization and visualization. The visualization and interpretation of 
molecular docking analyses of the selected (five) molecules were carried out by using 
USCF Chimera 1.11.2 software to recognize the hydrogen-bond interactions between 
the selected molecules and targeted enzymes (COX-2 and 5-LOX). 
 
5.2.11. Statistical analysis 
One way analysis of variance (ANOVA) was analyzed using SPSS software 
(Statistical Program for Social Sciences, USA, ver. 13.0) to study the significant 
differences among the means of bioactivities. The significant differences were signified 
as p < 0.05 and values were represented as means of triplicates ± standard deviation.  
 
5.3. Results and discussion 
5.3.1.  Chromatographic fractionation, bioactive potentials and spectroscopic 
analysis of intermediate fractions from EtOAc:MeOH extract of V. 
cyprinoides 
5.3.1.1. Chromatographic fractionation and bioactive potentials of intermediate 
fractions from EtOAc:MeOH extract of V. cyprinoides 
 Chromatographic fractionation of EtOAc:MeOH extract of V. cyprinoides 
afforded four pooled sub-fractions, named VC1 to VC4 based upon the TLC (8:2, n-
hexane:EtOAc, v/v) and RP C18 HPLC (3:2, v/v, MeOH/acetonitrile) experiments. The 
four sub-fractions checked for their target bioactive potentials against free radicals and 
pro-inflammatory enzymes. The yields and bioactivities of these column fractions 
presented in Table 5.1.  
 The percentage yields of sub-fractions, VC1 (10.0 g), VC2 (8.0 g), VC3 (11.0 
g) and VC4 (13.0 g) were found to be 22.22%, 17.78%, 24.44% and 28.89%, 
respectively on EtOAc:MeOH crude extract weight basis. The sub-fractions, VC2 and 
VC3 exhibited significantly greater (p < 0.05) DPPH radical scavenging potentials and 
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their IC50 values were found to be 0.93 and 1.06 mg/mL, respectively compared to VC1 
(IC50 1.23 mg/mL) and VC4 (IC50 1.16 mg/mL). Similarly, the ABTS+ radical inhibitory 
effects were significantly greater (p < 0.05) for VC2 (IC50 1.03 mg/mL) and VC3 (IC50 
1.06 mg/mL) compared to VC1 (IC50 1.43 mg/mL) and VC4 (IC50 1.34 mg/mL). The 
anti-inflammatory potentials against inflammatory enzymes COX-2 and 5-LOX were 
found to be considerably higher for sub-fractions, VC2 and VC3 and their IC50 values 
were ranged from 1.06-1.10 and 0.96-1.01 mg/mL, respectively when compared to VC1 
and VC4. The sub-fractions, VC1 and VC4 registered IC50 of > 1.45 and > 1.25 mg/mL, 
respectively for anti-COX-2 and anti-5-LOX. Hence, the sub-fractions VC2 and VC3 
were regarded as appropriate for sequential fractionation to obtain bioactive 
compounds. 
 
Table 5.1.: Yield and bioactive (antioxidant and anti-inflammatory) potentials of sub-
fractions from EtOAc:MeOH extract of V. cyprinoides 
Sub-
fractions 
#Yield 
Bioactive potentials  (IC50 value) 
Antioxidant Anti-inflammatory 
g % *DPPH *ABTS+ *COX-2 *5-LOX 
VC1 10 22.22 1.23 ± 0.04a 1.43 ± 0.05a 1.52 ± 0.06a 1.39 ± 0.07a 
VC2 8 17.78 0.93 ± 0.02b 1.03 ± 0.03b 1.06 ± 0.04b 0.96 ± 0.05b 
VC3 11 24.44 1.06 ± 0.05b 1.06 ± 0.06b 1.10 ± 0.07b 1.01 ± 0.08b 
VC4 13 28.89 1.16 ± 0.03c 1.34 ± 0.04c 1.46 ± 0.05a 1.26 ± 0.06c 
#The percentage of yield was calculated on the basis of crude EtOAc:MeOH extract 
(45.0 g EtOAc:MeOH crude extract weight). The samples were analyzed in triplicate 
(n=3) and expressed as mean ± standard deviation. Means followed by the different 
superscripts (a-c) within the same column indicated the significant differences (p < 
0.05). *The IC50 values were expressed as mg/mL 
 
5.3.1.2.  Spectroscopic analysis of intermediate fractions from EtOAc:MeOH 
extract of V. cyprinoides 
 The intermediate sub-fractions (VC1-VC4) subjected to 1H NMR analysis 
(Figure 5.3.) to acquire proton integral values corresponded to characteristic functional 
group signals (Table 5.2.). The proton integrals for VC2 in the regions δ 0.1-2.0 
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(saturated hydrocarbons), 2.0-2.5 (Ar-CH and acetylinic groups), 2.5-3.5 (-CH-C=O and 
-CH-Ar), 3.5-4.5 (electronegative groups) and 4.5-6.5 (vinylic, conjugated) were found 
to be 54.00, 4.09, 1.85, 4.44 and 2.73, respectively. Likewise, the proton integrals in the 
regions δ 0.1-2.0, 2.0-2.5, 2.5-3.5, 3.5-4.5 and 4.5-6.5 were found to be 47.42, 5.85, 
4.03, 1.73 and 4.15, respectively for VC3. The sub-fractions, VC1 and VC4 were 
registered lesser proton integrals in the regions of δ 2.0-2.5 and 3.5-4.5, which were 
found to be ~2.15 and ~0.92, respectively. In general, VC2 and VC3 sub-fractions 
showed significantly greater proton integrals than the other fractions (VC1 and VC4) 
when the potentially electronegative regions δ 3.5-4.5 and 2.0-2.5 were taken into 
consideration. The signals at δ 0.1-2.0 respective to saturated hydrocarbons were more 
prominent in the fraction, VC3 (47.42) and VC2 (54.0), which could be attributed 
towards the methylene or end methyls in alkyl chains. 
 
Table 5.2.: Types and integral values of protons obtained from the 1H NMR spectra of 
sub-fractions from EtOAc:MeOH extract of V. cyprinoides 
 Proton integral (ΣH) 
Proton signal VC1 VC2 VC3 VC4 
0.1-2.0 24.14 54.00 47.42 33.13 
2.0-2.5 2.13 4.09 5.85 2.19 
2.5-3.5 0.03 1.85 4.03 2.96 
3.5-4.5 0.87 4.44 1.73 0.96 
4.5-6.5 0.21 2.73 4.15 2.81 
6.5-8.5 0.00 0.04 0.05 0.20 
 
 The greater radical scavenging property of VC3 and VC2 might be attributed 
to more electron donating methoxy/hydroxyl groups (δ 3.5-4.5) whereas, VC1 and VC4 
recorded comparatively lesser number of olefinic/oxygenated groups, and therefore, 
exhibited significantly lower activities. The sub-fraction, VC3 displayed very intense 
signals and greater number of proton integrals at δ 2.0-2.5, 2.5-3.5 and 4.5-6.5 followed 
by VC2, which was ascribed to the alkenic and electronegative auxochromes, such as 
alkoxy/alkyl halide/functionalized hydride H of substituted alkanols. In general, VC3 
and VC2 fractions derived from EtOAc:MeOH extract of V. cyprinoides showed greater 
proton integrals than other column fractions when these potentially electronegative 
regions were taken into consideration. A significant co-linearity was found between 
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bioactive properties and the deshielded electronegative groups present in intermediate 
fractions from EtOAc:MeOH extract of V. cyprinoides. The proton NMR based 
bioactivity analyses of intermediate fractions (VC1-VC4) suggested that the sub-
fractions, VC3 and VC2 could be considered as better candidate fractions for further 
chromatographic purifications to isolate the bioactive compounds. 
Figure 5.3.: 1H NMR spectra of intermediate sub-fractions, (A) VC1, (B) VC2, (C) VC3 
and (D) VC4 from the EtOAc:MeOH extract of V. cyprinoides with integration values 
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5.3.1.3.  Isolation of bioactive secondary metabolites from EtOAc:MeOH extract 
of V. cyprinoides 
The sub-fractions, VC2 and VC3 were selected for the isolation of bioactive 
principles. The yield (in mg and in %), retention factor (Rf), bioactivities 
(antioxidant/anti-inflammatory) of each column/flash/PTLC/PHPLC sub-fractions 
obtained from the candidate fractions were recorded in Table 5.3.-5.4. 
The fraction, VC2 (8.0 g; 17.78%) eluted at 100% DCM was subjected to 
vacuum liquid chromatography using the step-wise elution of n-hexane/EtOAc/MeOH 
to furnish 9 sub-groups (VC2-1-VC2-9). Among these, column fractions such as VC2-4 
(1023 mg; 2.27%), VC2-5 (1136 mg; 2.52%) and VC2-6 (1323 mg; 2.94%) exhibited 
significantly higher antioxidant activities with respect to scavenge DPPH (IC50 0.69-
0.98 mg/mL) and ABTS+ (IC50 0.71-0.99 mg/mL) radicals. The anti-inflammatory 
effects were also greater for VC2-4 (IC50 anti-COX-2 0.65 mg/mL and IC50 anti-5-LOX 
0.73 mg/mL), VC2-5 (IC50 anti-COX-2 1.03 mg/mL and IC50 anti-5-LOX 0.94 mg/mL) 
and VC2-6 (IC50 anti-COX-2 0.83 mg/mL and IC50 anti-5-LOX 0.84 mg/mL) when 
compared to other fractions (IC50 > 1.15 mg/mL).  
The bioactive fraction, VC2-4 was found to be mixture, and therefore, 
fractionated by preparative HPLC (80% MeCN:MeOH) to yield compound 10 (195 mg; 
0.43%; VC2-4-1). Likewise, VC2-5 on preparative HPLC (80% MeCN:MeOH) 
fractionation yielded compound 9 (134 mg, 0.30%; VC2-5-1). The fraction, VC2-6 (1323 
mg; 2.94%) was subjected to flash chromatography using n-hexane/EtOAc/MeOH to 
afford six fractions (VC2-6-1-VC2-6-6). The sub-fractions, such as VC2-6-2 (205 mg; 
0.46%), VC2-6-4 (214 mg; 0.48%), VC2-6-5 (510 mg; 1.13%) and VC2-6-6 (196 mg; 0.44%) 
displayed greater bioactive potentials, and therefore, selected for further purifications 
(Table 5.3.).  
The fractions, VC2-6-2, VC2-6-4, VC2-6-5 and VC2-6-6 registered greater 
antioxidant (IC50 0.72-0.86 mg/mL for DPPH scavenging; IC50 0.70-0.89 mg/mL for 
ABTS+ scavenging) and anti-inflammatory potentials (IC50 0.78-0.93 mg/mL for anti-
COX-2; IC50 0.81-0.96 mg/mL for anti-5-LOX). The fraction, VC2-6-2 on column 
chromatography using n-hexane/EtOAc/MeOH afforded three sub-fractions, VC2-6-2-1 
(138 mg; 0.31%), VC2-6-2-2 (26 mg; 0.06%) and VC2-6-2-3 (34 mg; 0.08%), wherein VC2-
6-2-1 was registered greater antioxidant (IC50 DPPH scavenging 0.79 mg/mL and IC50 
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ABTS+ scavenging 0.78 mg/mL) and anti-inflammatory (IC50 anti-COX-2 0.77 mg/mL 
and IC50 anti-5-LOX 0.83 mg/mL) potentials. The VC2-6-2-1 on PTLC purification 
afforded compound 3 (79 mg; 0.18%; VC2-6-2-1-2). The fraction, VC2-6-4 on repeated RP 
C18 PHPLC purification techniques yielded compound 4 (59 mg; 0.13%; VC2-6-4-1) with 
greater antioxidant (IC50 0.71-0.76 mg/mL) and anti-inflammatory (IC50 0.89-0.92 
mg/mL) potentials, along with a minor fraction, VC2-6-4-2. The fraction VC2-6-5 on 
repeated PTLC acquired compound 8 (143 mg; 0.32%; VC2-6-5-2) with anti-
inflammatory (IC50 ~1.04 mg/mL) and antioxidant (IC50 ~0.90 mg/mL) potentials, along 
with a minor fraction, VC2-6-5-1 (Table 5.3.). 
The VC2-6-6 on repeated column chromatography afforded four sub-fractions, 
VC2-6-6-1 (14 mg; 0.03%), VC2-6-6-2 (134 mg; 0.30%), VC2-6-6-3 (16 mg; 0.04%) and VC2-
6-6-4 (24 mg; 0.05%). Among these, VC2-6-6-2 exhibited greater DPPH (IC50 0.81 mg/mL) 
and ABTS+ scavenging (IC50 0.79 mg/mL) along with COX-2 (IC50 0.85 mg/mL) and 5-
LOX (IC50 0.91 mg/mL) inhibitory potentials. Therefore, the fraction, VC2-6-6-2 was 
opted for further fractionation. The sub-fraction, VC2-6-6-2 on RP C18 PHPLC 
purification yielded the pure compound 5 (69 mg; 0.15%; VC2-6-6-2-2) along with two 
minor fractions (VC2-6-6-2-1 and VC2-6-6-2-3) (Table 5.3.). 
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Table 5.3.: The yield (in mg and in %), retention factor (Rf), bioactivities (antioxidant/anti-inflammatory) of column/flash/PTLC/PHPLC 
fractions obtained from the sub-fraction, VC2 of EtOAc:MeOH extract of V. cyprinoides 
#Yield 
Rf 
*Bioactive Potentials  (IC50 value; mg/mL)
Antioxidant Anti-inflammatory 
mg % DPPH ABTS+ COX-2 5-LOX 
VC2 CC (n-hexane/EtOAc/MeOH) 8000 17.78 0.93 ± 0.02 1.03 ± 0.03 1.06 ± 0.04 0.96 ± 0.05 
VC2-1 (100% n-hexane) 849 1.89 1.76 ± 0.03 1.68 ± 0.10 1.76 ± 0.02 1.68 ± 0.09 
VC2-2 (2% EtOAc:n-hexane) 231 0.51 2.35 ± 0.05 2.42 ± 0.04 2.16 ± 0.04 2.12 ± 0.00 
VC2-3 (5% EtOAc:n-hexane) 126 0.28 1.26 ± 0.07 1.07 ± 0.01 1.55 ± 0.03 1.23 ± 0.05 
VC2-4 (10% EtOAc:n-hexane) 1023 2.27 0.69 ± 0.02 0.71 ± 0.02 0.65 ± 0.01 0.73 ± 0.02 
VC2-5 (12% EtOAc:n-hexane) 1136 2.52 0.98 ± 0.00 0.99 ± 0.02 1.03 ± 0.02 0.94 ± 0.01 
VC2-6 (15% EtOAc:n-hexane) 1323 2.94 0.88 ± 0.01 0.89 ± 0.03 0.83 ± 0.03 0.84 ± 0.02 
VC2-7 (25% EtOAc:n-hexane) 351 0.78 1.25 ± 0.00 1.84 ± 0.04 1.85 ± 0.04 1.36 ± 0.05 
VC2-8 (100% EtOAc) 960 2.13 1.21 ± 0.02 2.35  ± 0.05 1.42 ± 0.03 1.17 ± 0.08 
VC2-9 (100% MeOH) 1042 2.32 1.92 ± 0.04 2.16 ± 0.04 2.12 ± 0.00 2.42 ± 0.04 
VC2-4 RP C18 PHPLC (80% MeCN:MeOH) 1023 2.27 
VC2-4-1 (Compound 10) 195 0.43 0.58 0.91 ± 0.01 1.08 ± 0.01 1.12 ± 0.03 1.19 ± 0.02 
VC2-4-2  665 1.48 1.85 ± 0.04 1.82 ± 0.02 1.91 ± 0.01 1.95 ± 0.01 
VC2-5 RP C18 PHPLC (80% MeCN:MeOH) 1136 2.52 
VC2-5-1 (Compound 9) 134 0.30 0.54 0.93 ± 0.01 1.05 ± 0.01 1.15 ± 0.03 1.17 ± 0.02 
VC2-5-2  712 1.58 1.85 ± 0.04 1.52 ± 0.02 1.71 ± 0.01 1.55 ± 0.01 
149 
Isolation and characterization of secondary metabolites from Villorita cyprinoides          Chapter 5 
VC2-6 FC (n-hexane/EtOAc/MeOH) 1323 2.94 
VC2-6-1 (5% EtOAc:n-hexane) 54 0.12 1.70 ± 0.01 1.72 ± 0.01 1.61 ± 0.03 1.84 ± 0.02 
VC2-6-2 (10% EtOAc:n-hexane) 205 0.46 0.84 ± 0.04 0.88 ± 0.02 0.92 ± 0.01 0.96 ± 0.01 
VC2-6-3 (20% EtOAc:n-hexane) 82 0.18 1.76 ± 0.02 1.78 ± 0.02 1.91 ± 0.04 1.80 ± 0.03 
VC2-6-4 (25% EtOAc:n-hexane) 214 0.48 0.86 ± 0.05 0.89 ± 0.03 0.93 ± 0.02 0.94 ± 0.02 
VC2-6-5 (100% EtOAc) 510 1.13 0.72 ± 0.03 0.70 ± 0.03 0.78 ± 0.05 0.81 ± 0.04 
VC2-6-6 (100% MeOH) 196 0.44 0.84 ± 0.06 0.81 ± 0.04 0.90 ± 0.03 0.94 ± 0.03 
VC2-6-2 CC (n-hexane/EtOAc/MeOH) 205 0.46 
VC2-6-2-1 (10% EtOAc:n-hexane) 138 0.31 0.79 ± 0.01 0.78 ± 0.01 0.77 ± 0.03 0.83 ± 0.02 
VC2-6-2-2 (50% EtOAc:n-hexane//MeOH) 26 0.06 1.85 ± 0.04 1.82 ± 0.02 1.96 ± 0.01 1.89 ± 0.01 
VC2-6-2-3 (100%MeOH) 34 0.08 2.70 ± 0.02 2.65 ± 0.02 2.41 ± 0.04 2.60 ± 0.03 
VC2-6-2-1 PTLC (4% EtOAc:n-hexane) 138 0.31 
VC2-6-2-1-1 29 0.06 1.54 ± 0.01 1.49 ± 0.01 1.79 ± 0.03 1.84 ± 0.02 
VC2-6-2-1-2 (Compound 3) 79 0.18 0.81 0.63 ± 0.04 0.72 ± 0.02 0.74 ± 0.01 0.76 ± 0.01 
VC2-6-4 RP C18 PHPLC (80% MeCN:MeOH) 214 0.48 
VC2-6-4-1 (Compound 4) 59 0.13 0.67 0.71 ± 0.01 0.76 ± 0.01 0.89 ± 0.03 0.92 ± 0.02 
VC2-6-4-2 121 0.27 1.84 ± 0.04 2.02 ± 0.02 2.11 ± 0.01 2.15 ± 0.01 
VC2-6-5 PTLC (4% EtOAc:n-hexane) 510 1.13 
VC2-6-5-1 342 0.76 1.36 ± 0.01 1.94 ± 0.01 1.49 ± 0.03 1.64 ± 0.02 
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VC2-6-5-2 (Compound 8) 143 0.32 0.42 0.86 ± 0.04 0.94 ± 0.02 1.05 ± 0.01 1.03 ± 0.01 
VC2-6-6 CC (n-hexane/EtOAc/MeOH) 196 0.44 
VC2-6-6-1 CC (n-hexane/EtOAc/MeOH) 14 0.03 1.65 ± 0.01 1.67 ± 0.01 1.68 ± 0.03 1.57 ± 0.02 
VC2-6-6-2 CC (n-hexane/EtOAc/MeOH) 134 0.30 0.81 ± 0.04 0.79 ± 0.02 0.85 ± 0.01 0.91 ± 0.01 
VC2-6-6-3 CC (n-hexane/EtOAc/MeOH) 16 0.04 1.97 ± 0.02 1.87 ± 0.02 1.67 ± 0.04 1.54 ± 0.03 
VC2-6-6-4 CC (n-hexane/EtOAc/MeOH) 24 0.05 2.01 ± 0.03 2.10 ± 0.03 2.08 ± 0.05 2.09 ± 0.04 
VC2-6-6-2 RP C18 PHPLC (80% MeCN:MeOH) 134 0.30 
VC2-6-6-2-1 23 0.05 1.70 ± 0.01 1.76 ± 0.01 1.79 ± 0.03 1.76 ± 0.02 
VC2-6-6-2-2 (Compound 5) 69 0.15 0.73 0.69 ± 0.04 0.78 ± 0.02 0.76 ± 0.01 0.80 ± 0.01 
VC2-6-6-2-2 32 0.07 1.76 ± 0.01 1.87 ± 0.02 1.54 ± 0.03 1.79 ± 0.03 
#The percentage of yield was calculated on the basis of crude EtOAc:MeOH extract (45.0 g EtOAc:MeOH crude extract weight). CC-
column chromatography; FC-flash chromatography; PTLC-preparative thin layer chromatography; PHPLC-preparatory high pressure 
liquid chromatography; EtOAc-ethyl acetate; MeOH-methanol. The samples were analyzed in triplicate (n=3) and expressed as mean ± 
standard deviation. *The IC50 values were expressed as mg/mL  
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The fraction, VC3 (11.0 g; 24.44%) eluted at 100% EtOAc was subjected to 
vacuum liquid chromatography using the step-wise elution of n-hexane/EtOAc/MeOH 
to furnish 6 sub-groups (VC3-1-VC3-6). Among these, the column fractions, such as VC3-
4 (1640 mg; 3.64%) and VC3-6 (1540 mg; 3.42%) were displayed significantly higher 
antioxidant activities with respect to scavenge DPPH (IC50 0.98 and 0.69 mg/mL, 
respectively) and ABTS+ (IC50 1.03 and 0.71 mg/mL, respectively) radicals. The anti-
inflammatory effects were also greater for VC3-4 (IC50 anti-COX-2 0.93 mg/mL and IC50 
anti-5-LOX 1.01 mg/mL) and VC3-6 (IC50 anti-COX-2 0.65 mg/mL and IC50 anti-5-
LOX 0.74 mg/mL) when compared to other fractions (IC50 > 1.25 mg/mL) (Table 5.4.).  
The sub-fraction, VC3-4 fractionated by flash chromatographic purification 
using n-hexane/EtOAc/MeOH to yield five pooled sub-fractions (VC3-4-1-VC3-4-5). The 
fraction, VC3-4-3 has registered greater antioxidant (IC50 DPPH quenching 0.84 mg/mL 
and IC50 ABTS+ quenching 0.79 mg/mL) and anti-inflammatory (IC50 anti-COX-2 0.76 
mg/mL and IC50 anti-5-LOX 0.68 mg/mL) potentials when compared to other fractions 
(IC50 > 1.40 mg/mL). The RP C18 PHPLC purification of VC3-4-3 afforded two pure 
bioactive compounds, 6 (169 mg; 0.38%; VC3-4-3-1) and 7 (156 mg; 0.35%; VC3-4-3-2) 
(Table 5.4.). 
Another active fraction, VC3-6 fractionated by flash chromatographic 
purification with n-hexane/EtOAc/MeOH to acquire three sub-fractions, VC3-6-1 (546 
mg; 1.21%), VC3-6-2 (489 mg; 1.09%) and VC3-6-3 (213 mg; 0.47%). The fractions, VC3-
6-1 and VC3-6-2 were selected for further purifications due to their greater antioxidant 
(IC50 DPPH scavenging 0.71-0.81 mg/mL and IC50 ABTS+ scavenging 0.73-0.86 
mg/mL) and anti-inflammatory (IC50 anti-COX-2 0.74-0.81 mg/mL and IC50 anti-5-
LOX 0.79-0.84 mg/mL) potentials. The fraction, VC3-6-1 on further purification by 
PTLC (using 2% EtOAc:n-hexane) resulted in the isolation of compound 1 (147 mg; 
0.33%; VC3-6-1-1) along with a minor fraction, VC3-6-1-2. The other fraction, VC3-6-2 on 
PTLC (5% EtOAc:n-hexane) fractionation yielded the compound 2 (96 mg; 0.21%; 
VC3-6-2-1) along with two minor fractions (VC3-6-2-2) (Table 5.4.). 
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Table 5.4.: The yield (in mg and in %), retention factor (Rf), bioactivities (antioxidant/anti-inflammatory) of column/flash/PTLC/PHPLC 
fractions obtained from the sub-fraction, VC3 of EtOAc:MeOH extract of V. cyprinoides 
#Yield 
Rf 
*Bioactive potentials  (IC50 value; mg/mL)
Antioxidant Anti-inflammatory 
mg % DPPH ABTS+ COX-2 5-LOX 
VC3 FC (n-hexane/EtOAc/MeOH) 11000 24.44 1.06 ± 0.05 1.06 ± 0.06 1.10 ± 0.07 1.01 ± 0.08 
VC3-1 2500 5.56 2.16 ± 0.04 1.25 ± 0.00 1.21 ± 0.02 1.92 ± 0.04 
VC3-2 1113 2.47 2.35 ± 0.05 2.42 ± 0.04 2.16 ± 0.04 2.12 ± 0.00 
VC3-3  1320 2.93 2.05 ± 0.06 2.02 ± 0.05 2.06 ± 0.05 2.02 ± 0.01 
VC3-4  1640 3.64 0.98 ± 0.00 1.03 ± 0.02 0.93 ± 0.03 1.01 ± 0.04 
VC3-5  1227 2.73 2.42 ± 0.04 2.12 ± 0.00 1.42 ± 0.03 1.26 ± 0.07 
VC3-6 1540 3.42 0.69 ± 0.02 0.71 ± 0.02 0.65 ± 0.01 0.74 ± 0.01 
VC3-4 FC (n-hexane/EtOAc/MeOH) 1640 3.64 
VC3-4-1 281 0.62 1.94 ± 0.04 1.66 ± 0.05 1.56 ± 0.03 1.82 ± 0.10 
VC3-4-2 240 0.53 1.40 ± 0.03 1.63 ± 0.04 1.67 ± 0.02 1.86 ± 0.09 
VC3-4-3 398 0.88 0.84 ± 0.02 0.79 ± 0.03 0.76 ± 0.01 0.68 ± 0.08 
VC3-4-4 291 0.65 1.54 ± 0.04 1.30 ± 0.05 1.49 ± 0.03 1.85 ± 0.10 
VC3-4-5 289 0.64 1.68 ± 0.09 1.76 ± 0.02 1.84 ± 0.03 1.36 ± 0.04 
VC3-4-3 RP C18 PHPLC (80% MeCN:MeOH) 398 0.88 
VC3-4-3-1 (Compound 6) 169 0.38 0.62 0.76 ± 0.01 0.85 ± 0.01 0.90 ± 0.03 0.96 ± 0.02 
VC3-4-3-2 (Compound 7) 156 0.35 0.68 0.79 ± 0.04 0.87 ±0.02 0.89 ± 0.01 0.98 ± 0.01 
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VC3-6 FC (n-hexane/EtOAc/MeOH) 1540 3.42 
VC3-6-1 546 1.21 0.71 ± 0.01 0.73 ± 0.01 0.74 ± 0.03 0.79 ± 0.02 
VC3-6-2  489 1.09 0.81 ± 0.04 0.86 ± 0.02 0.81 ± 0.01 0.84 ± 0.01 
VC3-6-3 213 0.47 1.85 ± 0.05 1.82 ± 0.03 1.99 ± 0.02 1.89 ± 0.02 
VC3-6-1 PTLC (2% EtOAc:n-hexane) 546 1.21 
VC3-6-1-1 (Compound 1) 147 0.33 0.63 0.59 ± 0.01 0.67 ± 0.01 0.70 ± 0.03 0.77 ± 0.02 
VC3-6-1-2 213 0.47 1.82 ± 0.03 1.99 ± 0.02 1.91 ± 0.01 1.85 ± 0.05 
VC3-6-2 PTLC (5% EtOAc:n-hexane) 489 1.09 
VC3-6-2-1 (Compound 2) 96 0.21 0.51 0.54 ± 0.01 0.62 ± 0.01 0.65 ± 0.03 0.75 ± 0.02 
VC3-6-2-2 195 0.43 1.80 ± 0.04 2.35 ± 0.05 2.42 ± 0.04 1.94 ± 0.01 
#The percentage of yield was calculated on the basis of crude EtOAc:MeOH extract (45.0 g EtOAc:MeOH crude extract weight). CC-
Column chromatography; FC-Flash chromatography; PTLC-Preparative thin layer chromatography; PHPLC-Preparatory high pressure 
liquid chromatography; EtOAc-Ethyl acetate; MeOH-Methanol. The samples were analyzed in triplicate (n=3) and expressed as mean ± 
standard deviation. *The IC50 values were expressed as mg/mL  
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5.3.2. Spectroscopic analysis of bioactive secondary metabolites isolated from 
EtOAc:MeOH extract of V. cyprinoides 
Repetitive chromatographic fractionations of EtOAc:MeOH extract of V. 
cyprinoides yielded potent bioactive secondary metabolites. The structures of identified 
metabolites assigned by extensive one (1H, 13C and 135DEPT NMR) and two (1H-1H 
COSY, HSQC, HMBC and NOESY) dimensional spectroscopic experimentations 
combined with mass and FTIR experiments. The characterized bioactive secondary 
metabolites from V. cyprinoides classified under various classes, such as spirocyclic 
ether derivatives (1-2), irregular meroterpenoids (3-5), hexahydro isochromenyls (6-7) 
and cholestenol derivatives (8-10). 
5.3.2.1.  Structural characterization of spirocyclic ether derivatives (1-2) 
The compounds with O-heterocyclic-spiro functionalities were found to be 
significant bioactive agents among various classes of organic compounds and present in 
many natural products (Blunt et al., 2015; Perron and Albizati 1989; Wermuth 1996; 
Zheng et al., 2014). Spiro compounds enclosed two rings (identical or different rings) 
shared with one atom (the quaternary spiroatom). The conformation of ligands 
(compounds) has been rigidified by the introduction of ring framework and the cyclic 
derivatives apparently experience a reduced conformational stress when it binds to a 
target site (enzymes or proteins). Moreover, the conformational restraint can be 
executed by the addition of spiro ring skeletons (Wermuth 1996). A search for newer 
compounds with O-heterocyclic-spiro ring systems as principle bioactive domains along 
with lower lipophilic (log Pow < 5) factor and greater electronegative functionalities in 
the pharmacophore templates appeared to be vital for bioactive potentials and 
bioavailability. Spirocyclic ether compounds enclosed rearranged monocyclofarnesyl 
framework (Schmitz and McDonald 1974) with a dihydrofuran ring spiro fused to 
substituted cyclohexene framework coupled with an oxaspiro[4.5]deca-dienyl skeleton. 
The di-tertiary ether natures of these compounds were detailed in previous literatures of 
dactyloxene derivatives (Schmitz et al., 1981). 
The spirocyclic ether possessing unrearranged monocyclofarnesane skeleton 
were previously reported from mollusk, Aplysia dactylomela (Schmitz et al., 1978). 
Herein, we have reported the characterization of two spirocyclic ether derivatives, 
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named as 16-hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-
propanoate (1) and (E)-18-ethyl-17,19-dihydroxyhept-14-enyl-(2-ethyl-2,6-dimethyl-1-
oxaspiro[4.5]dec-3,8-dien)-10-acetate (2) with the help of comprehensive NMR and 
mass analyses. 
5.3.2.1.A. Structural characterization of compound 1 (VC3-6-1-1) 
16-Hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-
propanoate (1) 
 
Yield 147 mg; 0.33% 
Physical description Yellow oily 
Molecular formula C22H36O4
Molecular mass 364.2614 
The irregularly prenylated spirocyclic ether derivative, 16-hydroxyhexyl-(2-
ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-propanoate isolated as yellow oily 
compound. It displayed UV absorbance (in MeOH) at λmax (log ε 2.55) 231.9 nm 
assigned to a chromophore with olefinic and carbonyl systems (Figure 5.4.). The purity 
of compound supported by RP C18 HPLC {using 8:2 MeOH:MeCN, v/v (Rt 5.33)} 
experiments (Figure 5.5.). 
Figure 5.4.: UV spectrum of 16-hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-
oxaspiro[4.5]dec-3,8-dien)-10-propanoate (1) 
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Figure 5.5.: HPLC chromatogram of 16-hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-
oxaspiro[4.5]dec-3,8-dien)-10-propanoate (1) 
 
The irregularly spirocyclic ether derivative (1) with molecular formula 
C22H36O4, recorded its molecular ion peak at m/z 364 (EIMS found m/z 364.2620 [M]+, 
cal. for C22H36O4 364.2614), which exhibited double bond indices of five corresponding 
to three double bonds and two rings. The compound has a rearranged 
monocyclofarnesyl framework (Schmitz and McDonald 1974) with a dihydrofuran ring 
spiro-fused to substituted cyclohexene framework, and found to possess an 
oxaspiro[4.5]deca-dienyl skeleton. This spirocyclic ether skeleton bonded to 
hydroxyhexyl fragment through carboxylate {-(C=O)-O-} group which was attributed 
by COSY, HSQC and HMBC experiments (Figure 5.11.-5.13.). The titled compound 
exhibited chemical shifts for four each of methyls and sp2 methines, three sp3 methines, 
eight sp3 methylenes and three quaternary (one carboxylate and two oxygenated) 
carbons, which were assigned by exhaustive 1H along with 13C NMR and DEPT 
experiments (Figure 5.8.-5.10.; Table 5.5.). The 1H and 13C resonances were exhibited 
characteristic signals for one each of ester carbonyl (δC 173.95), oxygenated methylene 
(δH 4.18, 4.14/δC 65.04), hydroxylated methine (δH 3.97/δC 66.47) and carbonyl 
methylene (δH 2.35/δC 34.69), along with two isolated disubstituted alkenes (δH 
6.50/δC 130.73, δH 6.25/δC 135.40 and δH 5.35/δC 132.30, δH 5.36/δC 129.94). The 
13C spectrum enclosed highly deshielded singlet resonances for two carbon atoms 
directly bonded to oxygen, and were found at δ 82.17 (C-2) and 79.47 (C-5). These 
attributions demonstrated the di-tertiary ether nature of the title compound, as supported 
by previous literatures of dactyloxene derivatives (Schmitz et al., 1981). Greatly 
deshielded sp2 protons at δ 6.50 (H-3) and 6.25 (H-4) with doublet splitting were 
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attached to δ 130.73 and 135.40, respectively as derived from the HSQC data. Both 
protons were directly connected by one bond 1H-1H COSY conjunctions (H-3 to H-4) 
and exhibited HMBC interactions with the carbons at δ 82.17 (C-2) and 79.47 (C-5). 
Also, HMBC relations were apparent from H-3 to C-4 and H-4 to C-3, thus, the 
dihydrofuran ring with two quaternary carbon atoms at C-2 and C-5 were confirmed. 
The C-2 position was satisfied by one each of singlet methyl (δH 1.25/δC 22.54) and 
ethyl groups. The spin system was apparent between the H-21 and H-22 {δ 1.86 (H-
21)/0.88 (H-22); -CH2-CH3} (Figure 5.6.A). The attachment of ethyl and methyl groups 
to the basic dihydrofuran ring of spirocyclic ether was confirmed by HMBCs from δ 
1.86 (H-21) to δ 82.17 (C-2); δ 0.88 (H-22) to δ 22.54 (C-23), 82.17 (C-2) and δ 1.25 
(H-23) to δ 82.17 (C-2), 130.73 (C-3) (Figure 5.6.B). The two spin systems, H-6 to H-8 
{δ 2.10 (H-6)/2.02 (H-7)/5.35 (H-8)} comprising H-6 to H-20 {δ 2.10 (H-6)/1.01 (H-
20)} and H-9 to H-10 {δ 5.36 (H-9)/2.32 (H-10)} together with HMBC correlations 
from δ 2.02 (H-7) to δ 129.94 (C-9), 34.11 (C-10); δ 1.01 (H-20) to δ 36.89 (C-6), 
132.30 (C-8), 34.11 (C-10) attributed for 6-methyl cyclohexene ring system. This 6-
methyl cyclohexene directly linked to 2-ethyl-2-methyl dihydrofuran at C-5 quaternary 
carbon (δ 79.47), hence the bicyclic framework, oxaspiro[4.5]deca-diene was satisfied. 
The oxaspiro[4.5]deca-dienyl skeleton ascertained by HMBC relations, such as δ 6.25 
(H-4) to δ 36.89 (C-6); δ 2.02 (H-7) to δ 79.47 (C-5); δ 2.32 (H-10) to δ 79.47 (C-5) and 
δ 1.01 (H-20) to δ 135.40 (C-4), 79.47 (C-5). The short bond 1H-1H COSYs from H-10 
to H-12 {δ 2.32 (H-10)/1.61 (H-11)/2.35 (H-12)} proved the attachment of propanoate 
part of 16-hydroxyhexyl-propanoate at C-10. Further, long bond relations, such as δ 
2.32 (H-10) to δ 173.95 (C-13); δ 1.61 (H-11) to δ 173.95 (C-13) and δ 2.35 (H-12) to δ 
24.88 (C-11) confirmed the side chain assignments. Higher chemical shift signals at δ 
4.18, 4.14 (H-14) exhibiting HSQC cross peaks with δC 65.04 was located at the 
oxygen end of carboxylate {-C(=O)-O-CH2-} and signal at δ 3.94 (H-16, m) displayed 
HSQC correlation with δC 66.47 was directly bonded to hydroxyl {-CH(-OH)-} group 
of 16-hydroxyhexyl-10-propanoate side chain. The occurrence of side chain affirmed by 
spin systems from H-14 to H-19 {δ 4.18, 4.14 (H-14)/1.92 (H-15)/3.97 (H-16)/1.52 (H-
17)/1.30 (H-18)/0.82 (H-19)} and HMBCs from δ 4.18 (H-14) to δ 66.47 (C-16); δ 3.97 
(H-16) to δ 65.04 (C-14) and δ 1.30 (H-18) to δ 14.12 (C-19). The linkage of 16-
hydroxyhexyl part to the oxygenated end of 10-propanoate moiety established by 
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HMBC connections from δ 4.18 (H-14) to δ 173.95 (C-13) and δ 1.92 (H-15) to δ 
173.95 (C-13). Remarkably, the two di-substituted olefinic groups at δ 6.50 (H-3), 6.25 
(H-4) and δ 5.35 (H-8), 5.36 (H-9) had lower coupling constants (J) of 8.84, 8.84 and 
3.93, 3.54 Hz, respectively. Thus, the configuration of these olefinic groups in 
oxaspiro[4.5]dec-3,8-diene affirmed as cis (Z) orientation. The relative configurations at 
chiral centers, mainly at C-6, C-10 and C-16 were deduced by extensive NOESY 
experiments (Figure 5.14.). The NOE correlations from δ 3.97 (H-16)/2.10 (H-6)/6.25 
(H-4)/6.50 (H-3)/5.35 (H-2)/2.02 (H-7)/1.25 (H-23)/4.18 (H-14α) confirmed the close 
proximity of these protons with each other and their same plane of alignment, and 
therefore, were arbitrarily assigned as α-disposed. The alkenic protons exhibited NOE 
couplings with each other, and this further confirmed its cis (Z) orientation. The 
hydroxyl (-OH) group at C-16 position was placed opposite to α-disposed proton at δ 
3.97 and it was attributed as β-hydroxylated. The ethyl and singlet methyl at C-2 
disposed at β and α disposition, respectively, as deduced from NOESYs and previous 
reports (Schmitz et al., 1978). Other NOEs recorded among δ 1.01 (H-20)/2.32 (H-
10)/4.14 (Hβ-14), which implied that these were on identical molecular plane, but did 
not show couplings with α-oriented protons, and therefore, assigned as β-aligned with 
regard to molecular plane of symmetry. The β-disposed H-10 proton further confirmed 
the α-disposition of the side chain, 16-hydroxyhexyl-10-propanoate (Figure 5.7.).  
 
Table 5.5.: NMR spectroscopic data of 16-hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-
oxaspiro[4.5]dec-3,8-dien)-10-propanoate (1) in CDCl3 
C. No.  13C  1H (int.,mult.,J in Hz)a COSY  HMBC  
1  -  -  -  -  
2  82.17  -  -  -  
3  130.73  6.50 (1Hα,d,8.84)  H-4  C-4,2,5  
4  135.40  6.25 (1Hα,d,8.84)  - C-3,2,5,6  
5  79.47  -  - - 
6  36.89  2.10 (1Hα,m)  H-20,7  - 
7  27.22  2.02 (2H,t)  H-8  C-8,9,5,10  
8  132.30  5.35 (1Hα,t,3.93)  - C-7  
9  129.94  5.36 (1Hα,t,3.54)  H-10  - 
10  34.11  2.32 (1Hβ,m)  H-11  C-5,13,11  
11  24.88  1.61 (2H,m)  H-12  C-10,12,13  
12  34.69  2.35 (2H,t)  - C-11,13  
13  173.95  -  - - 
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14  65.04  4.18 (1Hα,t)  H-15  C-13,16  
  4.14 (1Hβ,t)  - - 15  39.43  1.92 (2H,m)  H-16  C-14,16,13  
16  66.47  3.97 (1Hα,m)  H-17  C-14  
17  31.92  1.52 (2H,m)  H-18  C-18  
18  29.70  1.30 (2H,m)  H-19  C-19  
19  14.12  0.82 (3H,t)  - C-18,17  
20  22.69  1.01 (3Hβ,s)  - C-4,5,6,10,8  
21  30.06  1.86 (2H,m)  H-22  C-22,2  
22  18.17  0.88 (3H,t)  - C-23,21,2  
23  22.54  1.25 (3Hα,s)  - C-2,3  
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 
500MHz, while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, 
multiplicity and coupling constants (J=Hz) were indicated in parentheses. The 
assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and NOESY 
experiments 
 
 
 
 
 
Figure 5.6.: 1H-1H COSY (A) and HMBC (B) correlations of 16-hydroxyhexyl-(2-
ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-propanoate (1). The key 1H-1H 
COSY couplings have been represented by bold face bonds. The HMBC couplings were 
indicated by double barbed arrow 
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Figure 5.7.: NOESY correlations of 16-hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-oxaspiro 
[4.5]dec-3,8-dien)-10-propanoate (1). The NOESY relations were represented by double 
barbed arrow 
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Figure 5.8.: 1H NMR spectrum of 16-hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-
oxaspiro[4.5]dec-3,8-dien)-10-propanoate (1) 
Figure 5.9.: 13C NMR spectrum of 16-hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-
oxaspiro[4.5]dec-3,8-dien)-10-propanoate (1) 
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Figure 5.10.: 135DEPT NMR spectrum of 16-hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-
oxaspiro[4.5]dec-3,8-dien)-10-propanoate (1) 
Figure 5.11.: 1H-1H COSY NMR spectrum of 16-hydroxyhexyl-(2-ethyl-2,6-dimethyl-
1-oxaspiro[4.5]dec-3,8-dien)-10-propanoate (1) 
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Figure 5.12.: HSQC NMR spectrum of 16-hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-
oxaspiro[4.5]dec-3,8-dien)-10-propanoate (1) 
Figure 5.13.: HMBC NMR spectrum of 16-hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-
oxaspiro[4.5]dec-3,8-dien)-10-propanoate (1) 
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Figure 5.14.: NOESY NMR spectrum of 16-hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-
oxaspiro[4.5]dec-3,8-dien)-10-propanoate (1) 
Figure 5.15.:  FTIR spectrum of 16-hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-oxaspiro 
[4.5]dec-3,8-dien)-10-propanoate (1) 
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The compound 1 exhibited infrared absorption stretching vibrations 
equivalent of hydroxyl at 3411 cm-l, alkoxy (-C-O) at 1045 cm-l and alkanes at 2924, 
2854 cm-l. The absorption band was appeared at 1731 cm-1 which recognized the 
occurance of an ester carbonyl group (Figure 5.15.).  
The mass fragmentation spectrum (Figure 5.16.) indicated that the molecular 
ion at m/z 364 eliminated a methyl radical to afford an ion at m/z 347 (a). The later 
underwent elimination of methyl and ethyl side chains at C-3 to acquire an ion at m/z 
304 (b) followed by C2H5+ and two successive C2H5O+ radical eliminations registered 
peaks at m/z 279 (c) and 195 (e), respectively. The fragment ion at m/z 167 (f) was 
formed from m/z 195 (e) by removal of CHO• radical. The later appeared to undergo 
ethyl elimination and rearrangements to acquire 3-cyclohexylpropan-1-ol radical (h, m/z 
140), which fragmented a methoxy and two sequential methyl radicals to yield a base 
peak of cyclohexane radical (k, C6H11+) at m/z 83. Further fragmentations of this 
cyclohexane radical by two consecutive methyl radical eliminations resulted in the 
formation of stable butane radical with m/z 57 (m) (Figure 5.17.).   
 
Figure 5.16.: EIMS spectrum of 16-hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-oxaspiro 
[4.5]dec-3,8-dien)-10-propanoate (1) 
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Figure 5.17.: Mass fragmentation pattern of 16-hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-
oxaspiro[4.5]dec-3,8-dien)-10-propanoate (1) 
 
5.3.2.1.B. Structural characterization of compound 2 (VC3-6-2-1) 
(E)-18-Ethyl-17,19-dihydroxyhept-14-enyl-(2-ethyl-2,6-dimethyl-1-
oxaspiro[4.5]dec-3,8-dien)-10-acetate (2)  
 
 
Yield 96 mg; 0.21% 
Physical description Yellow oily 
Molecular formula C24H38O5 
Molecular mass 406.2719 
 
The irregularly prenylated spirocyclic ether derivative, (E)-18-ethyl-17,19-
dihydroxyhept-14-enyl-(2-ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-acetate 
isolated as yellow oily compound. It displayed UV absorbance (in MeOH) at λmax (log ε 
2.17) 236 nm and was assigned to a chromophore with olefinic and carbonyl systems 
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(Figure 5.18.). The purity of the compound was supported by RP C18 HPLC using 8:2 
(v/v) MeOH:MeCN (Rt 3.29) experiments (Figure 5.19.). 
 
 
Figure 5.18.: UV spectrum of (E)-18-ethyl-17,19-dihydroxyhept-14-enyl-(2-ethyl-2,6-
dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-acetate (2) 
 
Figure 5.19.: HPLC chromatogram of (E)-18-ethyl-17,19-dihydroxyhept-14-enyl-(2-
ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-acetate (2) 
 
 The extensive one and two dimensional NMR experimentations (1H-1H 
COSY, HSQC and HMBC) of irregularly prenylated spirocyclic ether derivative, (2) 
ascertained that the structural attributions of this compound was found to be similar to 
those of 1 apart from the presence of distinctive 18-ethyl-17,19-dihydroxyhept-14-enyl-
10-acetate unit (in 2) at C-10 (Figure 5.22.-5.27.). Its molecular ion peak was appeared 
at m/z 406 (EIMS m/z: 406.2725 [M]+, cal. for C24H38O5, 406.2719) demonstrated the 
occurrence of six degrees of unsaturations equivalent to four double bonds and two 
rings. The irregular spirocyclic ether exhibited resonances for four methyls, ten 
methines, seven sp3 methylenes and three quaternary (one carboxylate and two 
oxygenated) carbons (Table 5.6.). The characteristic chemical shift signals 
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corresponding to ester carbonyl (δ 174.36), three sets of isolated disubstituted alkenes 
(δH 6.50/δC 130.76, δH 6.25/δC 135.40; δH 5.38/δC 132.30, δH 5.41/δC 129.94 and δH 
5.21/δC 130.73, δH 5.17/δC 135.18), one oxygenated methylene (δH 4.18, 4.15/δC 
65.15), one hydroxylated methine (δH 3.97/δC 66.46), one hydroxylated methylene (δH 
3.69, 3.60/δC 63.33) and one carbonyl methylene (δH 2.35/δC 34.69) characterized 
from 1H and 13C resonances. The occurrence of dihydrofuran ring with two oxygenated 
quaternary carbon shifts at C-2 and C-5 and its attachment to 6-methyl cyclohexene ring 
moiety at C-5 junction was similar to those as 1, and these assignments confirmed by 
extensive 1H-1H COSY and HMBC connections along with earlier reports of 
dactyloxene compounds (Schmitz et al., 1981). The 1H-1H COSY correlations from H-
10 to H-11 {δ 2.81 (H-10)/δ 2.35 (H-11)} proved the attachment of acetate part of 18-
ethyl-17,19-dihydroxyhept-14-enyl-10-acetate side chain at C-10, and this attributions 
were verified by HMBC from δ 2.35 (H-11) to δ 174.36 (C-12), 65.15 (C-13). The 
deshielded protons at δ 4.15, 4.18 (H-13) exhibiting HSQC correlation with δ 65.15 was 
placed at oxygen end of acetate {-C(=O)-O-CH2-} unit at C-10. The methine group at 
C-14 (δH 3.94 (m)/δC 66.47) and methylene group at C-19 (δH 3.69 (d), 3.60 (d)/δC 
63.33) directly bonded to hydroxyls (-OH) which were represented by -CH(-OH)- and -
CH2(-OH)- moieties, respectively in heptenyl side chain. Two 1H-1H COSY spin 
systems from H-13 to H-14 {δ 4.15, 4.18 (H-13)/δ 5.21 (H-14)} and H-15 to H-19 {δ 
5.17 (H-15)/1.92 (H-16)/3.97 (H-17)/1.58 (H-18)/3.69, 3.60 (H-19)} including δ 1.58 
(H-18)/1.33 (H-20)/0.80 (H-21) supported 18-ethyl-17,19-dihydroxyhept-14-enyl side 
chain moiety (Figure 5.20.A). This side chain moiety and its attachment to acetate at C-
10 were further clarified by long range conjunctions from  δ 4.15 (H-13) to δ 174.36 (C-
12); δ 5.17 (H-15) to δ 3.97 (C-17); δ 1.92 (H-16) to δ 29.69 (C-20); δ 3.97 (H-17) to δ 
63.33 (C-19) and δ 3.69 (H-19) to δ 23.40 (C-18) (Figure 5.20.B). Noticeably, the 
geometric alignment of two di-substituted olefnic groups in oxaspiro[4.5]dec-3,8-diene 
ring was cis (Z) oriented and this assignment confirmed by its lesser coupling constant 
values (J), such as 8.64 (δ 6.50, H-3), 8.64 (δ 6.25, H-4), 3.29 (δ 5.38, H-8) and 3.74 (δ 
5.35, H-9) Hz. However, di-substituted alkene in side chain, 18-ethyl-17,19-
dihydroxyhept-14-enyl-10-acetate has higher coupling constant of 10.77 and 10.14 Hz, 
respectively for H-14 (δ 5.21) and H-15 (δ 5.17) protons, and therefore, the trans (E) 
orientation of the respective alkene established. The relative configurations at chiral 
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positions C-18, C-17, C-6 and C-10 were established by NOESY relations (Figure 
5.21.). NOE connections among the protons at δ 3.94 (H-17)/3.60 (Hα-19)/2.10 (H-
6)/6.25 (H-4)/6.50 (H-3)/5.38 (H-2)/2.02 (H-7)/1.25 (H-25)/4.18 (H-13α)/5.41 (H-
9)/1.58 (H-18)/5.17 (H-15) attributed to their close special proximity and their 
disposition at identical plane of molecular geometry, and therefore, arbitrarily assigned 
as α-disposed. The hydroxyl (-OH) group at C-17 position was placed opposite to the α-
disposed proton at δ 3.97, likewise the β-position of hydroxyl was correlated. The ethyl 
and singlet methyl at C-2 oriented towards β and α plane of compound, respectively, as 
elucidated by NOESY conjunctions and previous reports (Schmitz et al., 1978). Further, 
NOE relations were recorded between δ 5.21 (H-14)/1.01 (H-20)/2.81 (H-10)/4.15 (Hβ-
13)/3.69 (Hβ-19) which indicated that these were disposed on identical plane, but no 
correlations with α-oriented protons, consequently assigned at β-disposition (Figure 
5.21.). The β-disposed, H-10 proton further confirmed the α-disposition of bulky side 
chain, 18-ethyl-17,19-dihydroxyhept-14-enyl-10-acetate. 
 
Table 5.6.: NMR spectroscopic data of (E)-18-ethyl-17,19-dihydroxyhept-14-enyl-(2-
ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-acetate (2) in CDCl3 
C. No.  13C  1H (int.,mult.,J in Hz)a COSY  HMBC  
1  -  -  -  -  
2  82.17  -  -  -  
3  130.76  6.50 (1Hα,d,8.64)  H-4  C-2,4,5  
4  135.40  6.25 (1Hα,d,8.64)  -  C-2,3,5,6  
5  79.44  -  -  -  
6  36.89  2.10 (1Hα,m)  H-22,7  C-5  
7  27.98  2.02 (2H,t)  H-8  C-8  
8  132.30  5.38 (1Hα,q,3.29)  -  C-6  
9  129.94  5.41 (1Hα,t,3.74)  H-10  C-7  
10  25.54  2.81 (1Hβ,m)  H-11  C-9  
11  34.69  2.35 (2H,d)  -  C-10,12,13  
12  174.36  -  -  -  
13  65.15  4.15 (1Hβ,d)  H-14  C-12  
  4.18 (1Hα,d)  -  -  14  130.73  5.21 (1Hβ,q,10.77)  -  C-13  
15  135.18  5.17 (1Hα,q,10.14)  H-16  C-17  
16  39.43  1.92 (2H,t)  H-17  C-17,20  
17  66.46  3.97 (1Hα,m)  H-18  C-19  
18  23.40  1.58 (1Hα,m)  H-20,19  -  
19  63.33  3.69 (1Hβ,d)  -  C-18  
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  3.60 (1Hα,d)  -  -  20  29.69  1.33 (2H,m)  H-21  C-21  
21  14.11  0.80 (3H,t)  -  C-20  
22  22.69  1.01 (3Hβ,s)  -  C-8,6  
23  31.92  1.63 (2H,q)  H-24  C-5  
24  18.16  0.88 (3H,t)  -  C-23,2,25  
25  22.53  1.25 (3Hα,s)  -  C-23,2,3  
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 
500MHz, while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, 
multiplicity and coupling constants (J=Hz) were indicated in parentheses. The 
assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and NOESY 
experiments 
 
 
 
 
     
 
Figure 5.20.: 1H-1H COSY (A) and HMBC (B) correlations of (E)-18-ethyl-17,19-
dihydroxyhept-14-enyl-(2-ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-acetate 
(2). The key 1H-1H COSY couplings have been represented by the bold face bonds. The 
HMBC couplings were indicated by double barbed arrow 
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Figure 5.21.: NOESY correlations of (E)-18-ethyl-17,19-dihydroxyhept-14-enyl-(2-
ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-acetate (2). The NOESY relations 
were represented by double barbed arrow 
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Figure 5.22.: 1H NMR spectrum of (E)-18-ethyl-17,19-dihydroxyhept-14-enyl-(2-ethyl-
2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-acetate (2) 
Figure 5.23.: 13C NMR spectrum of (E)-18-ethyl-17,19-dihydroxyhept-14-enyl-(2-
ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-acetate (2) 
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Figure 5.24.: 135DEPT NMR spectrum of (E)-18-ethyl-17,19-dihydroxyhept-14-enyl-
(2-ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-acetate (2) 
Figure 5.25.: 1H-1H COSY NMR spectrum of (E)-18-ethyl-17,19-dihydroxyhept-14-
enyl-(2-ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-acetate (2) 
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Figure 5.26.: HSQC NMR spectrum of (E)-18-ethyl-17,19-dihydroxyhept-14-enyl-(2-
ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-acetate (2) 
Figure 5.27.: HMBC NMR spectrum of (E)-18-ethyl-17,19-dihydroxyhept-14-enyl-(2-
ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-acetate (2) 
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Figure 5.28.: NOESY NMR spectrum of (E)-18-ethyl-17,19-dihydroxyhept-14-enyl-(2-
ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-acetate (2) 
Figure 5.29.: FTIR spectrum of (E)-18-ethyl-17,19-dihydroxyhept-14-enyl-(2-ethyl-
2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-acetate (2) 
 
The present compound exhibited IR stretching absorptions of hydroxyl at 
3389 cm-l, alkoxy group (-C-O) at 1042 cm-l and alkanes at 2923, 2855 cm-l. The ester 
carbonyl group absorption band was found at at 1728 cm-1 (Figure 5.29.). 
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Figure 5.30.: EIMS spectrum of (E)-18-ethyl-17,19-dihydroxyhept-14-enyl-(2-ethyl-
2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-acetate (2)  
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Figure 5.31.: Mass fragmentation pattern of (E)-18-ethyl-17,19-dihydroxyhept-14-enyl-
(2-ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-acetate (2) 
 
The mass fragmentation spectrum (Figure 5.30.) indicated that the molecular 
ion at m/z 406 eliminated a methyl radical to afford an ion at m/z 391 (a). The later 
appeared to undergo elimination of methyl and ethyl side chains at C-3 acquired an ion 
at m/z 353 (b) followed by C2H5•/CH3O• and methyl radical eliminations were registered 
peaks at m/z 295 (c) and 279 (d), respectively. The ionat m/z 279 (d) fragmented to m/z 
237 (e), 220 (f), 209 (g), 179 (h), 137 (i) and followed by rearrangement to 3-
cyclohexylpropan-1-ol fragment. The later on removal of methoxy and two methyl 
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radicals yielded a base peak of cyclohexane radical (l, C6H11+) at m/z 83. Further 
fragmentations of this cyclohexane radical by two consecutive methyl radical 
eliminations were resulted in the formation of stable butane radical (C4H9+) with m/z 57 
(m) (Figure 5.31.).   
Two bioactive prenylated spirocyclic ether derivatives (1-2) were 
characterized from V. cyprinoides. It envisaged the significance and the better efficacy of 
natural compounds isolated from commonly available seafood, V. cyprinoides. The 
furanyl, hydroxyl and carboxyl enclosed titled natural compounds can develop a 
constructive and cardinal bioactive pharmacophore templates.  
 
5.3.2.2.  Structural characterization of irregular meroterpenoid derivatives (3-5)  
The secondary metabolites from marine mollusks grouped into different 
classes of compounds based on their structural frameworks, particularly, pyranoids, 
furanoids, polypropionates etc. (Blunt et al., 2015; Ciavatta et al., 2011). Pyran/pyrone 
and furan/furanone derivatives were important class of heterocyclic organic compounds, 
which found in marine and estuarine organisms with greater pharmacological potentials 
(Ciavatta et al., 2011). The bioactive pyran, pyrone, furan and furanone containing 
compounds reported previously (Cutignano et al., 2007; Fischedick et al., 2013). The α-
pyrone methyl derivatives reported from mollusks, Haminoea fusari and S. lesson 
(Cutignano et al., 2007; Rovirosa and San-Martin 2006). The furanoid monoterpenes, 
furoplocamioids from Plocamium cartilagineum (Darias et al., 2001) and an anti-
bacterial compound, 6-pentyl-2H-pyran-2-one were previously reported (Parker et al., 
1997). Herein, we have detailed the characterization of hexahydro isobenzofuranone 
derivative (3), tetrahydro pyranone derivative (4) and dihydrofurano-dihydropyran 
derivative (5) isolated from V. cyprinoides. 
 
 
 
 
 
 
176 
 
Isolation and characterization of secondary metabolites from Villorita cyprinoides          Chapter 5 
5.3.2.2.A. Structural characterization of compound 3 (VC2-6-2-1-2) 
8-(1,3,3a,4,5,7a-Hexahydro-1-(hydroxymethyl)-3-oxoisobenzofuran-4-yl)-
ethyl pentanoate (3) 
 
 
Yield 79 mg; 0.18% 
Physical description Dark brown oily 
Molecular formula C16H24O5 
Molecular mass 296.1624 
 
An irregular C16 hexahydro oxoisobenzofuran-meroterpenoid, 8-(1,3,3a,4,5, 
7a-hexahydro-1-(hydroxymethyl)-3-oxoisobenzofuran-4-yl)-ethyl pentano- ate (3) 
isolated as dark brown oily compound. It displayed UV absorbance (in MeOH) at λmax 
(log ε 2.76) 235.3 nm was assigned to a chromophore with olefinic and two isolated 
carbonyl systems (Figure 5.32.). The purity of the compound supported by RP C18 
HPLC using 2:3 (v/v) MeOH:MeCN (Rt 3.04) experiments (Figure 5.33.). 
 
 
Figure 5.32.: UV spectrum of 8-(1,3,3a,4,5,7a-hexahydro-1-(hydroxymethyl)-3-
oxoisobenzofuran-4-yl)-ethyl pentanoate (3) 
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Figure 5.33.: HPLC chromatogram of 8-(1,3,3a,4,5,7a-hexahydro-1-(hydroxymethyl)-
3-oxoisobenzofuran-4-yl)-ethyl pentanoate (3) 
 
 An irregular C16 hexahydrobenzo furanone derivative, (3) recorded its 
molecular ion peak at m/z 296 (EIMS 296.1630 [M]+, cal. 296.1624 for C16H24O5) and 
its double bond equivalences were calculated as five (three double bonds and two ring 
moieties). It housed a C11 diterpene based skeleton, which attached with the pentanoate 
side chain at C-9, and these attributions were based on exhaustive 1H-1H COSY, HSQC, 
HMBC NMR experimental data (Figure 5.38-5.40.). The chemical shift resonances of 
one methyl (doublet), three sp3 methines, two sp2 methines, two sp3 methylenes (one 
oxygenated and one hydroxylated), five aliphatic methylenes and two quaternary 
carbons were recorded in the 1H, 13C and DEPT spectra (Table 5.7.; Figure 5.35.-5.37.). 
The characteristic disubstituted alkene (δH 5.37/δC 129.99; δH 5.35/δC 129.70), two 
ester carbonyls (δC 178.41 and 173.95) (Jin et al., 2016), one oxygenated methine (δH 
4.08/δC 68.26), one carbonyl methine (δH 2.32/δC 50.01), and one oxygenated 
methylene (δH 4.17, 4.15/δC 65.00) groups were identified. The title compound 
composed of a basic C11 skeleton including the hexahydro oxoisobenzofuran and 
pentanoate side chain, which linked through the ethyl linkage among C-4 and C-10. The 
1H-1H COSY spectrum of the titled compound revealed that it enclosed two spin 
systems in the 8-(hexahydro-1-(hydroxymethyl)-3-oxoisobenzofuran-4-yl)-ethyl part 
and one spin system in the pentanoate side chain. The correlations between the proton 
shifts at δ 3.73 (H-11)/4.08 (H-1)/2.81 (H-7a)/5.35 (H-7); δ 2.81 (H-7a)/2.32 (H-
3a)/2.08 (H-4)/1.30 (H-8)/4.17, 4.15 (H-9); δ 2.02 (H-5)/5.37 (H-6) along with δ 2.35 
(H-11)/1.63 (H-12)/1.29 (H-13)/0.88 (H-14) were satisfied the above mentioned spin 
systems (Figure 5.34.A). The hexahydro-3-oxoisobenzofuranyl framework was further 
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supported by long range conjunctions from δ 4.08 (H-1) to δ 178.41 (C-3), 25.62 (C-
7a); δ 2.32 (H-3a) to δ 178.41 (C-3), 27.21 (C-5); δ 2.08 (H-4) to δ 50.10 (C-3a); δ 2.02 
(H-5) to 129.70 (C-7); δ 5.37 (H-6) to δ 27.21 (C-5) and δ 2.81 (H-7a) to δ 129.99 (C-
6), 129.70 (C-7) (Figure 5.34.B). The position of hydroxymethyl (-CH2-OH) at C-1 of 
dihydro furanone was confirmed by the HMBCs from δ 3.73 (C-11) to δ 68.26 (C-1), 
25.62 (C-7a). The isolated double bonds, δ 5.37 and 5.35 at C-6 and C-7, respectively 
had lesser J (coupling constant) values (3.53 and 3.64 Hz, respectively), and this 
affirmed its cis (Z) orientation in hexahydro-oxoisobenzofuranyl ring. The pentanoate 
side chain validated by long range correlations such as, δ 2.35 (H-11) to δ 173.95 (C-
10); δ 1.63 (H-12) to δ 173.95 (C-10) and δ 0.88 (H-14) to δ 34.10 (C-11). The ethyl 
linkage between hexahydro-3-isobenzofuranone skeleton and pentanoate side chain 
further supported by HMBCs from δ 1.30 (H-8) to δ 50.10 (C-3a), δ 129.99 (C-6); δ 
4.17 (H-9) to δ 173.95 (C-10), 31.92 (C-4) along with δ 2.08 (H-4) and δ 2.02 to δ 29.69 
(C-8). Comparison of proton and carbon signals of 3 with 1-acetoxy-6α-(2-
methylbutyryl)-eriolanolide suggested that the former enclosed hexahydro-
isobenzofuran-3-one as basic skeleton and tetrahydro-3-methylene benzo furan-2-one in 
the latter (Jin et al., 2016). The relative stereochemistries of chiral protons at H-1, H-3a, 
H-7a and H-4 were confirmed by correlations in NOE spectrum (Figure 5.41.). The 
NOE correlations recorded between δ 2.32 (H-3a)/5.37 (H-6)/2.81 (H-7a)/5.35 (H-
7)/4.15 (Hα-9) that signified their equiplanar orientation and arbitrarily designated as α-
disposed. The α-disposition of ring junction protons at C-3a and C-7a was also 
confirmed from previous studies (Fischedick et al., 2013). The protons at δ 4.08 (H-
1)/4.17 (Hβ-9)/2.08 (H-4) exhibited intense NOE correlation and found to be opposite to 
α-protons, which signified that H-1, Hβ-9, H-4 protons were at their β-disposition 
(Figure 5.34.C). 
 
Table 5.7.: NMR spectroscopic data of 8-(1,3,3a,4,5,7a-hexahydro-1-(hydroxymethyl)-
3-oxoisobenzofuran-4-yl)-ethyl pentanoate (3) in CDCl3 
C. No. 13C 1H (int.,mult.,J in Hz)a  COSY HMBC 
1 68.26 4.08 (1Hβ,m) H-11,7a C-3,7a 
11 61.42 3.73 (3H,d) - C-1,7a 
2 - - - - 
3 178.41 - -  
3a 50.10 2.32 (1Hα,d) H-7a,4 C-3,5 
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4 31.92 2.08 (1Hβ,m) H-8 C-8,3a 
5 27.21 2.02 (2H,m) H-6 C-6,7,8 
6 129.99 5.37 (1Hα,q,3.53) - C-5 
7 129.70 5.35 (1Hα,t,3.64) H-7a C-5 
7a 25.62 2.81 (1Hα,m) - C-6,7 
8 29.69 1.30 (2H,m) H-9 C-3a,6 
9 65.00 4.17 (1Hβ,d) - C-10,4 
  4.15 (1Hα,d) - - 
10 173.95 - - - 
11 34.10 2.35 (2H,t) H-12 C-12,10 
12 24.88 1.63 (2H,m) H-13 C-10,11 
13 22.68 1.29 (2H,m) H-14 - 
14 14.11 0.88 (3H,t) - C-13,11 
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 
500MHz, while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, 
multiplicity and coupling constants (J=Hz) were indicated in parentheses. The 
assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and NOESY 
experiments 
 
 
 
 
 
Figure 5.34.: 1H-1H COSY (A), HMBC (B) and NOESY (C) correlations of 8-
(1,3,3a,4,5,7a-hexahydro-1-(hydroxymethyl)-3-oxoisobenzofuran-4-yl)-ethyl pentanoa-
te (3). The key 1H-1H COSY couplings have been represented by the bold face bonds. 
The HMBC couplings were indicated by double barbed arrow. The NOESY relations 
were represented by double barbed arrow 
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Figure 5.35.: 1H NMR spectrum of 8-(1,3,3a,4,5,7a-hexahydro-1-(hydroxymethyl)-3-
oxoisobenzofuran-4-yl)-ethyl pentanoate (3) 
Figure 5.36.: 13C NMR spectrum of 8-(1,3,3a,4,5,7a-hexahydro-1-(hydroxymethyl)-3-
oxoisobenzofuran-4-yl)-ethyl pentanoate (3) 
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Figure 5.37.: 135DEPT NMR spectrum of 8-(1,3,3a,4,5,7a-hexahydro-1-(hydroxy 
methyl)-3-oxoisobenzofuran-4-yl)-ethyl pentanoate (3) 
Figure 5.38.: 1H-1H COSY NMR spectrum of 8-(1,3,3a,4,5,7a-hexahydro-1-(hydroxy 
methyl)-3-oxoisobenzofuran-4-yl)-ethyl pentanoate (3) 
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Figure 5.39.: HSQC NMR spectrum of 8-(1,3,3a,4,5,7a-hexahydro-1-(hydroxymethyl)-
3-oxoisobenzofuran-4-yl)-ethyl pentanoate (3) 
 
Figure 5.40.: HMBC NMR spectrum of 8-(1,3,3a,4,5,7a-hexahydro-1-(hydroxymethyl) 
-3-oxoisobenzofuran-4-yl)-ethyl pentanoate (3) 
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Figure 5.41.: NOESY NMR spectrum of 8-(1,3,3a,4,5,7a-hexahydro-1-(hydroxy 
methyl)-3-oxoisobenzofuran-4-yl)-ethyl pentanoate (3) 
 
Figure 5.42.: FTIR spectrum of 8-(1,3,3a,4,5,7a-hexahydro-1-(hydroxymethyl)-3-oxo 
isobenzofuran-4-yl)-ethyl pentanoate (3) 
 
The IR spectrum illustrated absorption bands at 1737 cm-l, which was 
indicative of ester group. The alkane (2984 cm-l), acyl (1233 cm-l), hydroxyl (3089 cm-l) 
and alkoxy (1043 cm-l) stretching vibrations were also accounted for this compound 
(Figure 5.42.). 
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Figure 5.43.: EIMS spectrum of 8-(1,3,3a,4,5,7a-hexahydro-1-(hydroxymethyl)-3-
oxoisobenzofuran-4-yl)-ethyl pentanoate (3) 
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Figure 5.44.: Mass fragmentation pattern of 8-(1,3,3a,4,5,7a-hexahydro-1-(hydroxy 
methyl)-3-oxoisobenzofuran-4-yl)-ethyl pentanoate (3) 
 
The mass spectrum has registered a molecular ion peak for the current 
compound at m/z 296 (Figure 5.43.). It fragmented a methoxy radical to yield an ion at 
m/z 265 (a, C15H21O4+). This appeared to undergo sequential elimination of ethyl 
followed by methyl radical afforded a fragment at m/z 222 (c). The later underwent 
sequential elimination of C2H3O• and C2H5• radicals yielded ion peak of tetrahydro 
isobenzofuranone at m/z 137 (f), which on removal of hydroxy radical yielded a peak at 
C8H11O• (g) with m/z 123. This further fragmented to C7H13• with m/z 97 (h) and C6H11• 
with m/z 83 (i) after eliminating methoxy and methyl radicals, respectively. The base 
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ion peak of butene radical was obtained at m/z 55 (j, C4H7•) by the fragmentation of 
C2H4•• radical from C6H11• (i) (Figure 5.44.).  
5.3.2.2.B. Structural characterization of compound 4 (VC2-6-4-1) 
Tetrahydro-3-methoxy-5-((E)-8,12-dimethyloct-8-enyl)-pyran-2-one (4) 
 
Yield 59 mg; 0.13% 
Physical description Pale yellow oily 
Molecular formula C16H28O3
Molecular mass 268.2038 
The compound, tetrahydro-3-methoxy-5-((E)-8,12-dimethyloct-8-enyl)-pyran 
-2-one (4) isolated as yellowish oily compound. It displayed UV absorbance (in MeOH) 
at λmax (log ε 3.76) 218.6 nm assigned to chromophore with olefinic and carbonyl 
systems (Figure 5.45.). The purity of compound was supported by RP C18 HPLC using 
1:4 (v/v) MeOH:MeCN (Rt 3.41) experiments (Figure 5.46.).  
Figure 5.45.: UV spectrum of tetrahydro-3-methoxy-5-((E)-8,12-dimethyloct-8-enyl)-
pyran-2-one (4)  
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Figure 5.46.: HPLC chromatogram of tetrahydro-3-methoxy-5-((E)-8,12-dimethyloct-
8-enyl)-pyran-2-one (4)  
 
The compound, 4 was found to be α-pyrone enclosed sesquiterpene based 
C16 prenylated bisabolene type of meroterpenoid. Its molecular formula, C16H28O3 was 
assigned by molecular ion peak at m/z 268 (EIMS: found m/z 268.2044 [M]+, cal. 
268.2038) indicating the occurrence of three indices of hydrogen deficiencies. The 13C 
NMR in combination with DEPT validated the presence of four methyls (one methoxy), 
six methylenes, and four methines along with two quaternary (carboxylate and alkene) 
carbons (Table 5.8.; Figure 5.50-5.51.), which was comparable with basic skeleton of α-
pyrone analogues from Dysidea cinerea (sponge) and fungus Nectria sp (Kiem et al., 
2013; Li et al., 2015a). It is interesting to note that the basic skeletons of tetrahydro 
pyran-2-one and the side chain 5-(E)-8,12-dimethyloct-8-enyl were formed as C15 
terpenoid by irregular array of three isoprene units yielding a sesquiterpene-type 
prenylated bisabolene meroterpenoid. Notably, the title compound was found to house 
the pyrone ring skeleton. Highly deshielded 13C resonances at δ 173.92 (C-2), 135.14 
(C-8) and 130.02 (C-9) were accounted for carboxyl {-C=O(O)-}, 4° alkene (>C=CH; 
C-8) and secondary alkene (C-9), respectively. Investigations of 1H, 13C NMR and 
HSQC data of 4 revealed the occurrence of oleﬁnic bond (δC 130.02 (C-9)/δH 5.35), 
methoxy (17-OMe; δC 50.68 (C-17)/δH 3.67), methines with higher {-(O=C)-CH-O-; 
δC 68.40 (C-3)/δH 4.08} and lower (δC 24.90 (C-5)/δH 1.63; δC 30.97 (C-12)/δH 1.50) 
chemical shifts and four deshielded methylenes {(δC 65.04 (C-6)/δH 4.17/4.14 for CH2-
O-(C=O)-; δC 34.11 (C-4)/δH 2.35; δC 27.22 (C-10)/δH 2.01; δC 31.93 (C-7)/δH 
1.82)} (Figure 5.49.-5.50., 5.53.). The shielded methyl protons at δ 0.87 {δC 14.02 (C-
14)} and δ 0.99 {δC 15.26 (C-15)} along with deshielded singlet proton at δ 1.86 {δC 
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28.03 (C-16)} were recorded. The α-pyrone ring part was deduced by 1H-1H COSY 
cross peaks from H-3 to H-6, which were δ 4.08 (H-3)/2.35 (H-4)/1.63 (H-5)/4.17, 4.14 
(H-6) (Figure 5.47.A, 5.52.). The pyrone ring further validated with HMBC peaks from 
δ 4.08 (H-3) to δ 65.04 (C-6); δ 2.35 (H-4) to δ 173.92 (C-2), 24.90 (C-5); δ 1.63 (H-5) 
to δ 173.92 (C-2); δ 4.17 (H-6) to δ 173.92 (C-2), 68.40 (C-3) (Figure 5.47.B, 5.54.). 
The distinctive cross peaks from 17-OMe δ 3.67 (H-17) to δ 173.92 (C-2) and 68.40 (C-
3) in the HMBC spectrum assigned the methoxyl group at C-4, which was comparable 
with the chemical shifts values in previous reports (Ding et al., 2012). The title 
compound exhibited similarity with skeletons of α-pyrone based polypropionate 
derivatives (Cutignano et al., 2007). The fusaripyrone polypropionates isolated from 
mollusk H. fusari and necpyrone from fungus Nectria sp. were found to enclose a 
methoxy group bonded at the sp2 alkenic quaternary carbon, C-4 (Cutignano et al., 
2007), whereas the methoxy (17-OMe) in title compound was at sp3 methine carbon 
located at C-3. The attachment of side chain 8,12-dimethyloct-8-enyl at C-5 was 
assigned by 1H-1H COSY correlation from δ 1.63 (H-5) to 1.82 (H-7). The acyclic chain 
assignments were made by 1H-1H COSY connectivities from H-9 to H-15, which were δ 
5.35 (H-9)/2.01 (H-10)/1.30 (H-11)/1.50 (H-12)/1.13 (H-13)/0.87 (H-14) including δ 
1.50 (H-12)/0.99 (H-15). This was further established from the HMBC correlations, 
such as δ 1.63 (H-5) to δ 135.14 (C-8), 31.93 (C-7); δ 1.82 (H-7) to δ 135.14 (C-8), 
130.02 (C-9); δ 2.01 (H-10) to δ 30.97 (C-12); δ 1.50 (H-12) to δ 130.02 (C-9); δ 0.87 
(H-14) to δ 30.97 (C-12), 22.69 (C-11); δ 0.99 (H-15) to δ 30.97 (C-12), 22.69 (C-11). 
The 13C NMR signal at δ 135.14 was lesser in intensity than alkenic shift at δ 130.02, 
which was attributed to slow relaxation due to sp2 quaternary carbon. The relaxation 
delay has been too small (RD = 1.7 s) for the carbons, which were not attached to any 
protons, that determined the closeness of protons. The presence of tri-substituted alkene, 
>C(8)-CH(9)- was assigned by HMBCs from δ 5.35 (H-9) to sp2 quaternary carbon at δ 
135.14 (C-8) in side chain moiety (Rovirosa and San-Martin 2006). The low-field 
singlet methyl (C-16) was bonded to alkenic quaternary carbon at C-8, which was 
proposed by HMBC relations from δ 1.86 (H-16) to δ 130.02 (C-9), 135.14 (C-8) and 
based on earlier literatures (Bromley et al., 2012). The cis (Z) geometrical configuration 
of alkenic proton at C-9 (δ 5.35) in dimethyloct-8-ene confirmed from its lesser J value 
(3.95 Hz). The greater chemical resonance of C-16 alkenic methyl (δC 28.03) than 
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typical alkenic shift values (δC 13-19) further specified the cis-configuration (Z) of C-8 
alkene (Bromley et al., 2012; Rovirosa and San-Martin 2006). The relative 
configurations at chiral centre, mainly that of C-3 with methoxy proton and C-5 with 
(E)-8,12-dimethyloct-8-enyl chain deduced from NOESY experiments (Figure 5.55.). 
NOE cross relations among the protons, δ 4.08 (H-3)/4.17 (Hα-6)/5.35 (H-9)/1.86 (H-
16)/1.50 (H-12)/0.87 (H-14) affirmed their close proximity and equiplaner alignment, 
and arbitrarily assigned as α-disposed. Other NOEs recorded between δ 1.63 (H-5)/4.14 
(Hβ-6)/0.99 (H-15) designated that these moieties were on same side of molecular 
plane, and thus, orientated at β-plane of reference (Figure 5.48.A). The α-disposed H-3 
proton confirmed the β-orientation of 17-OMe group, likewise the β-oriented H-5 
proton established the α-geometry of (E)-8,12-dimethyloct-8-enyl side chain.  
 
Table 5.8.: NMR spectroscopic data of tetrahydro-3-methoxy-5-((E)-8,12-dimethyloct-
8-enyl)-pyran-2-one (4) in CDCl3 
C. No.  13C  1H (int.,mult.,J in Hz)a COSY  HMBC  
1  -  -  -  -  
2  173.92  -  -  -  
3  68.40  4.08 (1Hα,t)  H-4  C-6  
4  34.11  2.35 (2H,t)  H-5  C-2,7,5  
5  24.90  1.63 (1Hβ,m)  H-6,7  C-4,2,8,7  
6  65.04  4.17 (1Hα,d)  -  C-2,3  
  4.14 (1Hβ,d)  -  -  7  31.93  1.82 (2H,d)  -  C-8,9  
8  135.14  -  -  -  
9  130.02  5.35 (1H,t,3.95)  H-10  C-10,8  
10  27.22  2.01 (2H,m)  H-11  C-9,12  
11  22.69  1.30 (2H,m)  H-12  C-12  
12  30.97  1.50 (1Hα,m)  H-13,15  C-9  
13  23.73  1.13 (2H,m)  H-14  C-12  
14  14.02  0.87 (3H,t)  -  C-12,11  
15  15.26  0.99 (3Hβ,d)  -  C-12,11  
16  28.03  1.86 (3Hα,s)  -  C-8,9  
17  50.68  3.67 (3H,s)  -  C-3,2  
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 
500MHz, while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, 
multiplicity and coupling constants (J=Hz) were indicated in parentheses. The 
189 
 
Isolation and characterization of secondary metabolites from Villorita cyprinoides          Chapter 5 
assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and NOESY 
experiments 
 
 
 
 
 
Figure 5.47.: 1H-1H COSY (A) and HMBC (B) correlations of  tetrahydro-3-methoxy-
5-((E)-8,12-dimethyloct-8-enyl)-pyran-2-one (4). The key 1H-1H COSY couplings have 
been represented by bold face bonds. The HMBC couplings were indicated by double 
barbed arrow 
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Figure 5.48.: NOESY correlations of tetrahydro-3-methoxy-5-((E)-8,12-dimethyloct-8-
enyl)-pyran-2-one (4). The NOESY relations were represented by double barbed arrow  
 
Figure 5.49.: 1H NMR spectrum of tetrahydro-3-methoxy-5-((E)-8,12-dimethyloct-8-
enyl)-pyran-2-one (4)  
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Figure 5.50.: 13C NMR spectrum of tetrahydro-3-methoxy-5-((E)-8,12-dimethyloct-8-
enyl)-pyran-2-one (4)  
Figure 5.51.: 135DEPT NMR spectrum of tetrahydro-3-methoxy-5-((E)-8,12-dimethyl 
oct-8-enyl)-pyran-2-one (4)  
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Figure 5.52.: 1H-1H COSY NMR spectrum of tetrahydro-3-methoxy-5-((E)-8,12-di 
methyl-oct-8-enyl)-pyran-2-one (4)  
 
Figure 5.53.: HSQC NMR spectrum of tetrahydro-3-methoxy-5-((E)-8,12-dimethyloct-
8-enyl)-pyran-2-one (4)  
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Figure 5.54.: HMBC NMR spectrum of tetrahydro-3-methoxy-5-((E)-8,12-dimethyl 
oct-8-enyl)-pyran-2-one (4)  
 
Figure 5.55.: NOESY NMR spectrum of tetrahydro-3-methoxy-5-((E)-8,12-dimethyl 
oct-8-enyl)-pyran-2-one (4)  
193 
 
Isolation and characterization of secondary metabolites from Villorita cyprinoides          Chapter 5 
Figure 5.56.: FTIR spectrum of tetrahydro-3-methoxy-5-((E)-8,12-dimethyloct-8-enyl)-
pyran-2-one (4)  
 
The IR spectrum was exhibited absorption bands at 1740 cm-1 which 
indicated the presence of pyrone ring. The presence of alkane and alkoxy stretching 
vibrations were recorded at 2922 and 1049 cm-l, respectively (Figure 5.56.).  
The mass fragmentation spectrum (Figure 5.57.) designated that the 
molecular ion peak at m/z 268 that eliminated a methoxy radical to afford an ion at m/z 
236 (a). The later seemed to undergo methyl and ethyl eliminations to acquire an ion at 
m/z 194 (b), followed two ethyl radical eliminations registering peaks at m/z 166 (c) and 
141 (d), respectively. The ion at m/z 141 (d) fragmented into m/z 113 (e) and 97 (f) by 
the removal of ethyl and methyl radicals, respectively. The fragment ion at m/z 97 (f), 
underwent removal of oxygen radical followed by the intermolecular rearrangements to 
resulted in the generation of penta-dienol ion at m/z 83 (f). The hydroxyl radical was 
eliminated from later ion followed by CH2•• elimination yielded the base peak of butene 
(i, C4H8•+) at m/z 56 (Figure 5.58.). 
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Figure 5.57.:  EIMS spectrum of tetrahydro-3-methoxy-5-((E)-8,12-dimethyloct-8-
enyl)-pyran-2-one (4)  
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Figure 5.58.: Mass fragmentation of tetrahydro-3-methoxy-5-((E)-8,12-dimethyloct-8-
enyl)-pyran-2-one (4)  
 
5.3.2.2.C. Structural characterization of compound 5 (VC2-6-6-2-2) 
Dihydro-5-(8-(9,12-dihydro-8-methyl-11-propyl-2H-pyran-8-yl)-ethyl)-
furan-2-(3H)-one (5) 
 
 
Yield 69 mg; 0.15% 
Physical description Pale brown oily 
Molecular formula C15H24O3 
Molecular mass 252.1725 
O
O
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The irregular C15 furano meroterpenoid, dihydro-5-(8-(9,12-dihydro-8-
methyl-11-propyl-2H-pyran-8-yl)ethyl)-furan-2(3H)-one (5) yielded as pale brown oily 
compound. It displayed UV absorbance (in MeOH) at λmax (log ε 2.52) 234.2 nm was 
assigned to carbonyl systems (Figure 5.59.). The purity of the compound supported by 
RP C18 HPLC using 1:4 (v/v) MeOH:MeCN (Rt 4.38) experiments (Figure 5.60.).  
 
 
Figure 5.59.: UV spectrum of dihydro-5-(8-(9,12-dihydro-8-methyl-11-propyl-2H-
pyran-8-yl)-ethyl)-furan-2-(3H)-one (5)  
 
Figure 5.60.: HPLC chromatogram of dihydro-5-(8-(9,12-dihydro-8-methyl-11-propyl-
2H-pyran-8-yl)-ethyl)-furan-2-(3H)-one (5)  
 
The irregular C15 furano meroterpenoid, (5) with molecular formula 
C15H24O3 having double bond equivalences of four (two double bonds and two ring 
moieties). The sesquiterpene based furano meroterpenoid was elucidated on the basis of 
extensive 1H-1H COSY, HSQC and HMBC analyses (Figure 5.66.-5.68.). Resonances 
for two methyls, one sp3 methine, one sp2 methine, eight sp3 methylenes and three 
quaternary (alkenic, carboxylate and oxygenated) groups were accounted in the 1H 
NMR in conjugation with 13C NMR and DEPT spectra (Table 5.9.; Figure 5.63.-5.65). 
The molecular ion peak was recorded at m/z 252 (EIMS: found m/z 252.1730 [M]+ cal. 
252.1725). The characteristic trisubstituted alkene (δH 5.35/δC 130.02 and δC 135.84), 
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one each of ester carbonyl (δC 177.63) (Huang et al., 2008), oxygenated methine (δH 
4.08/δC 68.41), and oxygenated methylene (δH 4.17, 4.14/δC 65.04) were recognized 
by HSQC resonances. The two dimensional NMR of 5 explained that it was composed 
of two parts, (A) {dihydro-furan-2(3H)-one part from C-2 to C-5} and (B) {8-(9,12-
dihydro-8-methyl-11-propyl)-2H-pyran-8-yl from C-8 to C-12 comprising C-13 to C-
16}. The ring structure A was evident by the spin system from H-3 to H-5 {δ 2.35 
(assigned to H-3)/1.65 (H-4)/4.08 (H-5)} as deduced from the 1H-1H COSY spectrum 
(Figure 5.61.A, 5.66.). In addition, HMBC couplings from δ 2.35 (H-3) to δ 177.63 (C-
2), 24.72 (C-4); δ 1.65 (H-4) to δ 177.63 (C-2) and δ 4.08 (H-5) to δ 177.63 (C-2), 33.67 
(C-3) supported the presence of dihydro-furan-2-one ring system (A) (Figure 5.61.B, 
5.68.). The two spin systems from H-9 to H-10 {δ 2.02 (H-9)/5.35 (H-10)} and H-13 to 
H-15 {δ 1.86 (H-13)/1.28 (H-14)/0.89 (H-15)} validated the partial structure of B. The 
long range HMBCs from δ 2.02 (H-9) to δ 135.84 (C-11); δ 5.35 (H-10) to δ 135.84 (C-
11); δ 1.86 (H-13) to δ 135.84 (C-11) attributed that these two spin systems were linked 
through a quaternary carbon at C-11. Furthermore, HMBC correlations from δ 2.02 (H-
9) to δ 72.12 (C-8); δ 5.35 (H-10) to δ 65.04 (C-12); δ 4.17 (H-12) to δ 72.12 (C-8); δ 
1.86 (H-13) to δ 130.02 (C-10), 135.84 (C-11) and δ 1.28 (H-14) to δ 14.11 (C-15) 
assigned 9,12-dihydro-11-propyl-2H-pyranyl framework. The methyl singlet at δ 1.25 
(H-16) was verified with its HMBC correlations to δ 72.12 (C-8) and 27.23 (C-9). The 
partial-units, (A) {dihydro-furan-2(3H)-one} and (B) {8-(9,12-dihydro-8-methyl-11-
propyl)-2H-pyran-8-yl} were deduced to be connected through ethyl linkage C-6 to C-7 
by the examination of spin system from H-5 to H-7 {δ 4.08 (H-5)/1.60 (H-6)/1.30 (H-
7)} along with 1H-13C long range correlations, such as δ 1.65 (H-4) to δ 31.93 (C-6); δ 
4.08 (H-5) to δ 31.93 (H-6); δ 1.60 (H-6) to δ 33.67 (C-3); δ 1.30 (H-7) to δ 31.93 (C-
6), 72.12 (C-8) and δ 2.02 (H-9) to δ 29.69 (C-7). This can be compared with an ionone 
derivative enclosing the partial structures, furan-2-one and cyclohexane connected 
through a vinyl linkage (Huang et al., 2016). Biologically active furanosesquiterpenes 
composed of furanone and cyclohexane ring network through ethyl linkage from marine 
invertebrates was reported (Huang et al., 2008). Another furanosesquiterpene from 
marine sponge enclosing hydorxy furanone and cyclohexane moieties were also found 
to be connected by ethyl linkage (Venkateswarlu et al., 1994). The structures of 
previously reported sesquiterpene alcohol, pelseneeriols and furanosesquiterpenoid 
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isomicrocionins were comprised of furan rings connected to cyclohexane ring through 
ethyl bond (Gaspar et al., 2005; Gaspar et al., 2008). These compounds were composed 
of cyclohexane rings, whereas the present compound (5) enclosed a pyran ring moiety. 
There is one chiral center (C-5) around the dihydro-furan-2-one ring and its relative 
orientations were determined by extensive NOESY correlations (Figure 5.62., 5.69.). 
The NOE couplings between δ 4.14 (Hα -12)/1.25 (H-16) confirmed their equiplaner 
disposition with each other, and therefore, arbitrarily considered as α-oriented with 
reference to molecular plane of reference. Furthermore, NOEs between δ 4.08 (H-
5)/5.35 (H-10)/4.17 (Hβ-12) indicated their disposition at identical molecular plane, and 
were found to be trans with α-oriented protons (Hα-12, H-16), which determined their 
β-position. Since, methyl singlet at C-8 was determined as α-disposed, the ethyl moiety 
at C-8 adopted β-orientation (Huang et al., 2008).  
 
Table 5.9.: NMR spectroscopic data of dihydro-5-(8-(9,12-dihydro-8-methyl-11-propyl 
-2H-pyran-8-yl)-ethyl)-furan-2-(3H)-one (5) in CDCl3 
C. No. 13C 1H (int.,mult.,J in Hz)a COSY HMBC 
1 - - - - 
2 177.63 - - - 
3 33.67 2.35 (2H,t) H-4 C-2,4 
4 24.72 1.65 (2H,m) H-5 C-2,3,6 
5 68.41 4.08 (1Hβ,m) H-6 C-2,3,6 
6 31.93 1.60 (2H,m) H-7 C-3,7 
7 29.69 1.30 (2H,t) - C-6,8,9 
8 72.12 - - - 
9 27.23 2.02 (2H,d) H-10 C-10,11,8,7 
10 130.02 5.35 (1Hβ, t,7.23) - C-11,12,9 
11 135.84 - - - 
12 65.04 4.17 (1Hβ,d) - C-11,8 
  4.14 (1Hα,d) - - 13 34.11 1.86 (2H,t) H-14 C-10,11,9 
14 22.69 1.28 (2H,m) H-15 C-13,15 
15 14.11 0.89 (3H,t) - C-13,14 
16 30.73 1.25 (3Hα,s) - C-8,9 
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 
500MHz, while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, 
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multiplicity and coupling constants (J=Hz) were indicated in parentheses. The 
assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and NOESY 
experiments 
 
 
                   
 
Figure 5.61.: 1H-1H COSY (A) and HMBC (B) correlations of dihydro-5-(8-(9,12-
dihydro-8-methyl-11-propyl-2H-pyran-8-yl)-ethyl)-furan-2-(3H)-one (5). The key 1H-
1H COSY couplings have been represented by the bold face bonds. The HMBC 
couplings were indicated by double barbed arrow 
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Figure 5.62.: NOESY correlations of dihydro-5-(8-(9,12-dihydro-8-methyl-11-propyl-
2H-pyran-8-yl)-ethyl)-furan-2-(3H)-one (5). The NOESY relations were represented by 
double barbed arrow 
 
 
Figure 5.63.: 1H NMR spectrum of dihydro-5-(8-(9,12-dihydro-8-methyl-11-propyl-
2H-pyran-8-yl)-ethyl)-furan-2-(3H)-one (5)  
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Figure 5.64.: 13C NMR spectrum of dihydro-5-(8-(9,12-dihydro-8-methyl-11-propyl-
2H-pyran-8-yl)-ethyl)-furan-2-(3H)-one (5)  
Figure 5.65.: 135DEPT NMR spectrum of dihydro-5-(8-(9,12-dihydro-8-methyl-11-
propyl-2H-pyran-8-yl)-ethyl)-furan-2-(3H)-one (5)  
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Figure 5.66.: 1H-1H COSY NMR spectrum of dihydro-5-(8-(9,12-dihydro-8-methyl-11-
propyl-2H-pyran-8-yl)-ethyl)-furan-2-(3H)-one (5)  
Figure 5.67.: HSQC NMR spectrum of dihydro-5-(8-(9,12-dihydro-8-methyl-11-propyl 
-2H-pyran-8-yl)-ethyl)-furan-2-(3H)-one (5)  
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Figure 5.68.: HMBC NMR spectrum of dihydro-5-(8-(9,12-dihydro-8-methyl-11-
propyl-2H-pyran-8-yl)-ethyl)-furan-2-(3H)-one (5)  
 
Figure 5.69.: NOESY NMR spectrum of dihydro-5-(8-(9,12-dihydro-8-methyl-11-
propyl-2H-pyran-8-yl)-ethyl)-furan-2-(3H)-one (5)  
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Figure 5.70.: FTIR spectrum of dihydro-5-(8-(9,12-dihydro-8-methyl-11-propyl-2H-
pyran-8-yl)-ethyl)-furan-2-(3H)-one (5)  
 
The IR spectrum was exhibited absorption bands at 1739 and 1710 cm-1, 
which indicated the presence of a lactone group and a furanone ring in it. The alkane 
(2919 and 2851 cm-l) and alkoxy (1168 and 1114 cm-l) stretching vibrations were also 
recorded for the compound (Figure 5.70.).  
 
 
Figure 5.71.: EIMS spectrum of dihydro-5-(8-(9,12-dihydro-8-methyl-11-propyl-2H-
pyran-8-yl)-ethyl)-furan-2-(3H)-one (5)  
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Figure 5.72.: Mass fragmentation pattern of dihydro-5-(8-(9,12-dihydro-8-methyl-11-
propyl-2H-pyran-8-yl)-ethyl)-furan-2-(3H)-one (5)  
 
The mass spectrum recorded its molecular ion peak at m/z 252, which was 
found to dissociate an ethyl radical to afford an ion at m/z 227 (a) for C13H23O3+ radical 
(Figure 5.71). This appeared to undergo sequential elimination of four methyl radicals 
afforded C9H12O3•+ radical with m/z 168 (f). The later underwent elimination of C2H3• 
radical, followed by hydroxy and two methyl radical to yield peaks at m/z 138 (g) 124 
(h) and 96 (j). The base peak of furanol radical was obtained at m/z 83 (k, C4H3O2+) 
from the methylfuranol radical at m/z 96 (j). The base peak of furanol ion (m/z 83, k) 
underwent fragmentation to yield butane radical (C4H9+) with m/z 57 (l) (Figure 5.72.).  
The furan enclosed metabolites were reported from Hypocrea koningii, 
Doriopsilla pelseneeri and P. canaliculus and these metabolites were found to be potent 
DPPH radical scavengers and strong anti-inflammatory agents (Ding et al., 2015; 
Gaspar et al., 2005; Wakimoto et al., 2011). The titled hexahydro isobenzofuranone (3), 
tetrahydro pyranone (4) and dihydrofurano-dihydropyran (5) derivatives isolated from 
V. cyprinoides constitute a major part in the natural products and changes in the 
substitutions or rearrangements of functional groups can lead to better antioxidant 
candidates with greater selectivity in the food supplements and functional foods along 
with anti-inflammatory effects.   
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5.3.2.3.  Structural characterization of hexahydro isochromenyl meroterpenoid 
derivatives (6-7) 
 The isochromenyl derivatives were found to be valuable bioactive 
pharmacophores with structural and functional peculiarities in the field of natural 
product research (Milan et al., 2011; Nitin et al., 2012). The 1H/3H-benzopyrans and 
hydrogenated 1H/3H-benzopyrans are the different forms of isochromene or 
isochromenone based skeletons (Boeckman et al., 1988). The α-tocopherol is a popular 
example of natural benzopyran with antioxidant properties (Kindleysides et al., 2012). 
The isochromenone secondary metabolite identified from a fungus, Camptotheca 
acuminate (Lin et al., 2011) with medicinal properties. Herein, we have characterized 
two new substituted isochromenyl analogues, such as (10E)-butyl-9-(6-ethyl-
3,4,6,7,8,8a-hexahydro-1H-isochromen-3-yl)-pent-10-enoate (6) and (12E)-(3,4,6,7,8,8a 
-hexahydro-1H-isochromen-3-yl)-methyl hept-12-enoate (7) from EtOAc:MeOH extract 
of V. cyprinoides. 
 
5.3.2.3.A. Structural characterization of compound 6 (VC3-4-3-1) 
(10E)-Butyl- 9-(6-ethyl-3,4,6,7,8,8a-hexahydro-1H-isochromen-3-yl)-pent-
10-enoate (6)  
 
 
Yield 169 mg; 0.38% 
Physical description Light yellow oily 
Molecular formula C20H32O3 
Molecular mass 320.2351 
 
The irregularly arranged C20 isochromenyl-meroterpenoid, (10E)-butyl-9-(6-
ethyl-3,4,6,7,8,8a-hexahydro-1H-isochromen-3-yl)-pent-10-enoate was found to be in 
light yellow oily nature. It displayed UV absorbance (in MeOH) at λmax (log ε 3.13) 231 
nm assigned to a chromophore with olefinic and carbonyl systems (Figure 5.73.). The 
purity of the compound supported by RP C18 HPLC using 1:4 (v/v) MeOH:MeCN (Rt 
8.31) experiments (Figure 5.74.).  
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Figure 5.73.: UV spectrum of (10E)-butyl-9-(6-ethyl-3,4,6,7,8,8a-hexahydro-1H-
isochromen -3-yl)-pent-10-enoate (6)  
Figure 5.74.: HPLC chromatogram of (10E)-butyl-9-(6-ethyl-3,4,6,7,8,8a-hexahydro-
1H-isochromen-3-yl)-pent-10-enoate (6)  
 
The irregularly arranged C20 hexahydro isochromenyl meroterpenoid, (6) 
deduced as C20H32O3 based on comprehensive NMR and mass spectroscopy. The title 
compound exhibited five indices of hydrogen deficiency, which was satisfied by three 
double bonds and two cyclic systems. The molecular ion peak at 320 (EIMS: found m/z 
320.2356 [M]+, cal. 320.2351) was recorded. The sesquiterpene type of chromenyl 
meroterpenoid determined on the basis of 1H-1H COSY, HSQC and HMBC 
experiments (Table 5.10.; Figure 5.80.-5.82). Chemical resonances for two quaternary 
(alkenic and carboxylate), three sp2 methine, three sp3 methine, ten sp3 methylenes and 
two methyls (doublets) were determined by 1H together with 13C NMR and DEPT 
experiments (Figure 5.77.-5.79.). The significant tri-substituted olefine (δH 5.36/δC 
129.93 and δC 132.04), disubstituted alkene (δH 5.40/δC 128.07 and δH 5.43/δC 
128.29), two oxygenated methylenes (δH 3.70, 3.63/δC 63.36; δH 4.20, 4.17/δC 65.14), 
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along with one each of carbonyl carbon (δC 174.34), oxygenated methine (δH 3.94/δC 
70.27), and carbonyl methylene (δH 2.86/δC 25.64) were supported with detailed 
HSQC experiments. The extensive 2D NMR experiments of 6 demonstrated that it 
enclosed 6-ethyl-hexahydro-isochromenyl ring as basic skeleton and a butyl pentenoate 
moiety bonded at C-3 position of hexahydro chromenyl ring. Greatly downfielded 1H 
NMR peaks at δ 4.17/4.20 HSQC with δC 65.14 (C-14) demonstrated the presence of 
oxygenated sp3 hybridized groups, such as ester, whereas the signals at δ 3.63-3.70 and 
3.94 HSQC with δC 63.36 (C-1) and 70.27 (C-3), respectively demonstrated the 
presence of oxygenated sp3 hybridized methylene and methine, respectively (135DEPT). 
The two oxygenated carbons at δ 63.36 (C-1) and 70.27 (C-3) implied that the oxygen 
atom found its place between the C-1 and C-3 positions, and the presence of an ether 
linkage (-CH2-O-CH<), was therefore, attributed. Four spin systems were recorded at δ 
3.70, 3.63 (H-1)/2.36 (H-8a)/1.73 (H-8)/1.62 (H-7)/2.03 (H-6)/5.36 (H-5); δ 2.03 (H-
6)/1.29 (H-18)/0.90 (H-19) due to ethyl side chain at C-6; δ 2.44 (H-4)/3.94 (H-3)/2.07 
(H-9)/5.40 (H-10) along with δ 5.43 (H-11)/2.86 (H-12), which attributed the 
pentenoate side chain at C-3; and δ 4.20, 4.17 (H-14)/1.64 (H-15)/1.32 (H-16)/0.99 (H-
17) accounting for butyl substitution (Figure 5.75.A). The bicyclic hexahydro 
chromenyl ring affirmed by HMBCs from δ 3.70 (H-1) to δ 70.27 (C-3), 132.04 (C-4a); 
δ 3.94 (H-3) to δ 132.04 (C-4a); δ 2.44 (H-4) to δ 132.04 (C-4a), 31.91 (C-8), 34.04 (C-
6); δ 5.36 (H-5) to δ 132.04 (C-4a) and δ 2.36 (H-8a) to δ 34.15 (C-4), 34.04 (C-6) 
(Figure 5.75.B). The HMBCs from δ 1.29 (H-18) to δ 34.04 (C-6) and δ 0.90 (H-19) to 
δ 22.68 (C-18), 29.65 (C-7) established the attachment of ethyl group {-CH2(18)-
CH3(19)} to C-6 of hexahydro-chromenyl ring. Other long bond connections were 
recorded from δ 2.07 (H-9) to δ 70.27 (C-3), 128.07 (C-10); δ 5.40 (H-10) to δ 27.21 
(C-9), 25.64 (C-12) and δ 2.86 (H-12) to δ 174.34 (C-13) that suggested the attachment 
of pentenoate side chain at C-3. The butyl moiety of butyl pentenoate framework was 
assigned by HMBCs at δ 4.20 (H-14) to δ 174.34 (C-13) and δ 0.99 (H-17) to δ 29.68 
(C-16). The geometrical arrangement of isolated alkene in pentenoate side chain 
calculated from their greater J values, which were δ 5.40 (J=10.52 Hz; H-10) and 5.43 
(J=10.97 Hz; H-11), thus their trans (E) configuration was established. The relative 
stereochemistries of chiral centres at H-3, H-6 and H-8a were deduced by NOESY 
(Figure 5.76., 5.83.). NOESY correlations of δ 3.63 (H-1) with δ 5.36 (H-5) and 5.40 
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(H-10) and that between δ 5.36 (H-5) and 4.17 (H-14) indicated that these protons were 
on identical face of hexahydro isochromenyl ring. Thus, these protons could be 
arbitrarily considered as α-disposed with respect to molecular plane of symmetry. 
NOESYs between δ 3.70 (H-1)/2.03 (H-6)/3.94 (H-3)/5.43 (H-11)/4.20 (H-14) 
displayed that these protons were aligned at identical molecular plane, and assigned as 
β-disposed. Based on these, side chain attachments at C-6 and C-3 positions of ring was 
located at α-face of the ring, being opposite to β-protons in that position. The protons of 
olefinic bond, -C(10)=(C11)- in side chain did not exhibit any cross peaks with each 
other in NOESY, thus their trans disposition was ascertained.  
 
Table 5.10.: NMR spectroscopic data of (10E)-butyl-9-(6-ethyl-3,4,6,7,8,8a-hexahydro-
1H-isochromen-3-yl)-pent-10-enoate (6) in CDCl3 
C. No. 13C 1H (int.,mult.,J in Hz)a COSY  HMBC 
1 63.36 3.70 (1Hβ,d) H-8a C-3,4a 
  3.63 (1Hα,d) -  -  2 -  -  -  -  
3 70.27  3.94 (1Hβ,p) H-9,4 C-4a 
4 34.15 2.44 (2H,d) -  C-5,4a,8,6 
4a 132.04 -  -  -  
5 129.93 5.36 (1Hα,d,7.72) H-6 C-4a 
6 34.04 2.03 (1Hβ,m) H-7,18  C-5,7,8 
7 29.65 1.62 (2H,m) H-8 -  
8 31.91 1.73 (2H,m) H-8a C-8a 
8a 31.51 2.36 (1H,p) -  C-4,6 
9 27.21 2.07 (2H,t) H-10 C-3,4,10,11 
10 128.07 5.40 (1Hα,q,10.52) -  C-9,12,13 
11 128.29 5.43 (1Hβ,q,10.97) H-12 C-12 
12 25.64 2.86 (2H,d) -  C-11,13 
13 174.34 -  -  -  
14 65.14 4.20 (1Hβ,t) H-15 C-13,15 
  4.17 (1Hα, t) -  -  15 24.90 1.64 (2H,m) H-16 C-16 
16 29.68 1.32 (2H,m) H-17 -  
17 14.10 0.99 (3H,t) -  C-16 
18 22.68 1.29 (2H,m) H-19 C-6 
19 14.05 0.90 (3H,t) -  C-18,7 
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 
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500MHz, while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, 
multiplicity and coupling constants (J=Hz) were indicated in parentheses. The 
assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and NOESY 
experiments 
 
 
 
 
 
Figure 5.75.: 1H-1H COSY (A) and HMBC (B) correlations of (10E)-butyl- 9-(6-ethyl-
3,4,6,7,8,8a-hexahydro-1H-isochromen-3-yl)-pent-10-enoate (6). The key 1H-1H COSY 
couplings have been represented by the bold face bonds. The HMBC couplings were 
indicated by double barbed arrow 
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Figure 5.76.: NOESY correlations of (10E)-butyl- 9-(6-ethyl-3,4,6,7,8,8a-hexahydro-
1H-isochromen-3-yl)-pent-10-enoate (6). The NOESY relations were represented by 
double barbed arrow 
 
Figure 5.77.: 1H NMR spectrum of (10E)-butyl-9-(6-ethyl-3,4,6,7,8,8a-hexahydro-1H-
isochromen-3-yl)-pent-10-enoate (6)  
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Figure 5.78.: 13C NMR spectrum of (10E)-butyl-9-(6-ethyl-3,4,6,7,8,8a-hexahydro-1H-
isochromen-3-yl)-pent-10-enoate (6)  
Figure 5.79.: 135DEPT NMR spectrum of (10E)-butyl-9-(6-ethyl-3,4,6,7,8,8a-hexa 
hydro-1H-isochromen-3-yl)-pent-10-enoate (6)  
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Figure 5.80.: 1H-1H COSY NMR spectrum of (10E)-butyl-9-(6-ethyl-3,4,6,7,8,8a-hexa 
hydro -1H-isochromen-3-yl)-pent-10-enoate (6)  
Figure 5.81.: HSQC NMR spectrum of (10E)-butyl-9-(6-ethyl-3,4,6,7,8,8a-hexahydro-
1H-isochromen-3-yl)-pent-10-enoate (6)  
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Figure 5.82.: HMBC NMR spectrum of (10E)-butyl-9-(6-ethyl-3,4,6,7,8,8a-hexahydro-
1H-isochromen-3-yl)-pent-10-enoate (6)  
Figure 5.83.: NOESY NMR spectrum of (10E)-butyl-9-(6-ethyl-3,4,6,7,8,8a-hexa 
hydro-1H-isochromen-3-yl)-pent-10-enoate (6)  
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Figure 5.84.: FTIR spectrum of (10E)-butyl-9-(6-ethyl-3,4,6,7,8,8a-hexahydro-1H-
isochromen-3-yl)-pent-10-enoate (6)  
 
The typical IR absorptions at 2974 and 2853 cm-1 were represented alkyl 
stretching vibrations along with the stretching vibrations for ester carbonyl (1711 cm-1) 
and alkoxy (1094 cm-1) groups (Figure 5.84.).  
The sequential elimination of ethyl, propyl and methyl radicals from the 
molecular ion peak (m/z 320) of the titled compound resulted in the formation of 
fragment ions with m/z 291 (a, C18H27O3+), 249 (b, C15H21O3+) and 238 (c, C14H22O3), 
respectively. The later appeared to undergo sequential elimination of hydroxyls, 
followed by methyl and ethyl radicals to yield C14H23O+ fragment with m/z 207 (e), 
C13H21O+ with 193 (f) and C11H17O+ with 165 (g). The repeated methyl radical 
elimination from ethyl-hexahydro-isochromene (g) and intramolecular rearrangements 
afforded the fragment ion peak at m/z 94 corresponding to methylcyclohexene (l, 
C7H10•+). Base peak of cyclohexene (C6H10•+) recorded at m/z 82 (m) by elimination of 
CH3• from methylcyclohexene (l). This further eliminated two methyl radicals from the 
base peak ion (m) to acquire m/z 55 (o, butene cation) (Figure 5.85.-5.86.). 
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Figure 5.85.: EIMS spectrum of (10E)-butyl-9-(6-ethyl-3,4,6,7,8,8a-hexahydro-1H-
isochromen-3-yl)-pent-10-enoate (6)  
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Figure 5.86.: Mass fragmentation pattern of (10E)-butyl-9-(6-ethyl-3,4,6,7,8,8a-
hexahydro-1H-isochromen-3-yl)-pent-10-enoate (6)  
 
5.3.2.3.B. Structural characterization of compound 7 (VC3-4-3-2) 
(12E)-(3,4,6,7,8,8a-Hexahydro-1H-isochromen-3-yl)-methylhept-12-enoate (7) 
 
 
Yield 156 mg; 0.35% 
Physical description Light yellow oily 
Molecular formula C17H26O3 
Molecular mass 278.1882 
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An irregularly arranged C17 isochromenyl meroterpenoid, (12E)-(3,4,6,7,8,8a 
-hexahydro-1H-isochromen-3-yl)-methylhept-12-enoate purified as light yellow oily 
compound. It displayed UV absorbance (in MeOH) at λmax (log ε 2.08) 229 nm assigned 
to olefinic and carbonyl systems (Figure 5.87.). The purity was supported by RP C18 
HPLC using 1:4 (v/v) MeOH:MeCN (Rt 6.66) (Figure 5.88.).  
 
 
Figure 5.87.: UV spectrum of (12E)-(3,4,6,7,8,8a-hexahydro-1H-isochromen-3-yl)-
methylhept-12-enoate (7)  
Figure 5.88.: HPLC chromatogram of (12E)-(3,4,6,7,8,8a-hexahydro-1H-isochromen-
3-yl)-methylhept-12-enoate (7)  
 
 The isochromenyl meroterpenoid, (12E)-(3,4,6,7,8,8a-hexahydro-1H-
isochromen-3-yl)-methylhept-12-enoate (7) with molecular formula of C17H26O3 was 
characterized by extensive spectroscopic experiments (Table 5.11.; Figure 5.91.-5.97.). 
The five indices of hydrogen deficiencies accounted for the molecular formula, which 
assigned three double bonds and two cyclic systems. The peak at m/z 278 was recorded 
as molecular ion peak (EIMS: found m/z 278.1886 [M]+, cal. for C17H26O3 278.1882). 
This hexahydro isochromenyl meroterpenoid proposed through extensive 1H-1H COSY, 
HSQC and HMBC experiments. The basic hexahydro isochromenyl moiety was 
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comparable to compound 6, except the absence of ethyl moiety at C-6 and presence of 
(12E)-methylhept-12-enoate side chain at C-3. The chemical shifts corresponding to 
two quaternary (ester carbonyl and olefinic), three sp2 methine, two sp3 methine, nine 
sp3 methylenes and one methyl (doublet) were identified by 1H together with 13C NMR 
and DEPT spectra. The characteristic peaks with regard to di-substituted alkene (δH 
5.30/δC 129.99 and 5.29/129.80), tri-substituted olefine (δH 5.27/δC 129.68 and δC 
135.46), ester carbon (δC 174.37), two oxygenated methylene (δH 3.59, 3.52/δC 63.35; 
δH 4.07, 4.06/δC 65.05), along with one each of oxygenated methine (δH 3.84/δC 
70.22) and carbonyl methylene (δH 2.86/δC 25.64) were supported with HSQC. The 
extensive 2D NMR experiments attributed hexahydro isochromene framework attached 
to a methyl-heptenoate at C-3 position. Four spin systems were recorded in 1H-1H 
COSY, such as δ 3.59, 3.52 (H-1)/2.26 (H-8a)/1.54 (H-8)/1.22 (H-7)/1.98 (H-6)/5.27 
(H-5); δ 2.30 (H-4)/3.84 (H-3)/4.07, 4.06 (H-9); δ 2.73 (H-11)/5.30 (H-12) and δ 5.29 
(H-13)/1.94 (H-14)/1.20 (H-15)/0.80 (H-16), which established the presence of 
hexahydro-1H-isochromen-3-yl-methylhept-12-enoate moiety (Figure 5.89.A). The 3-
methyl-isochromenyl moiety constructed on the basis of 1H-13C conjuctions from δ 3.59 
(H-1) to δ 70.22 (C-3), 65.05 (C-9); δ 3.84 (H-3) to δ 65.05 (C-9); δ 2.30 (H-4) to δ 
31.89 (C-8a); δ 1.98 (H-6) to δ 135.46 (C-4a); δ 1.54 (H-8) to δ 31.89 (C-8a), 34.14 (C-
4); δ 2.26 (H-8a) to δ 29.67 (C-7) and δ 4.07 (H-9) to δ 63.35 (C-1) (Figure 5.89.B). 
The linkage between isochromenyl and methyl groups deduced by HMBCs from δ 2.30 
(H-4) to δ 174.37 (C-10) and δ 4.07 (H-9) to δ 174.37 (C-10). The heptenoate chain 
attached at C-9 of 3-methyl-hexahydro isochromenyl through oxygen atom (-O-) was 
apparent from HMBCs, such as δ 5.30 (H-12) to δ 174.37 (C-10), 27.20 (C-14) and δ 
0.80 (H-16) to δ 27.20 (C-14). Notably, olefinic protons at δ 5.30 (H-12) and 5.29 (H-
13) displayed higher coupling constants of 10.96 and 10.53 Hz, correspondingly, hence 
the geometrical arragngement was affirmed as trans (E) for -CH(12)=CH(13)- olefinic 
linkage. The stereochemical arrangement of chiral centers at H-3 and H-8a in 7 was 
deduced by NOESY experiments (Figure 5.90., 5.97.). NOE correlations between δ 5.27 
(H-5) and δ 3.52 (Hα-1)/4.06 (Hα-9) designated that these protons were on same side of 
hexahydro isochromenyl ring, and therefore, were considered as α-disposed. NOE 
couplings between the protons at δ 3.59 (Hβ-1)/3.84 (H-3)/5.30 (H-12)/4.07 (Hβ-9) 
showed that they were disposed at the reverse side of ring system, and therefore, were 
216 
 
Isolation and characterization of secondary metabolites from Villorita cyprinoides          Chapter 5 
denoted as β-oriented with reference to the molecular plane of symmetry. Therefore, the 
side chain attachment at C-3 was on the α-face of ring, being reverse to β-protons in that 
position.  
 
Table 5.11.: NMR spectroscopic data of (12E)-(3,4,6,7,8,8a-hexahydro-1H-
isochromen-3-yl)-methylhept-12-enoate (7) in CDCl3 
C. No. 13C 1H (int.,mult.,J in Hz)a COSY HMBC 
1 63.35 3.59 (1Hβ,d) H-8a C-3,9 
  3.52 (1Hα,d) - - 2 - - - - 
3 70.22 3.84 (1H,p) H-9,4 C-9 
4 34.14 2.30 (2Hβ,d) - C-8a,10 
4a 135.46 - - - 
5 129.68 5.27 (1Hα,d,7.02) H-6 C-4 
6 31.75 1.98 (2H,m) H-7 C-5,4a 
7 29.67 1.22 (2H,m) H-8 - 
8 29.63 1.54 (2H,m) H-8a C-8a,4,7 
8a 31.89 2.26 (1H,p) - C-4,8,7 
9 65.05 4.07 (1Hβ,d) - C-3,10,1 
  4.06 (1Hα,d) - - 10 174.37 - - - 
11 24.88 2.73 (2H,d) H-12 C-10 
12 129.99 5.30 (1Hβ,q,10.96) - C-10,14 
13 129.80 5.29 (1Hα,q,10.53) H-14 C-14 
14 27.20 1.94 (2H,m) H-15 C-12,13,11,15 
15 22.66 1.20 (2H,m) H-16 C-16,14 
16 14.08 0.80 (3H,t) - C-15,14 
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 
500MHz, while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, 
multiplicity and coupling constants (J=Hz) were indicated in parentheses. The 
assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and NOESY 
experiments 
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Figure 5.89.: 1H-1H COSY (A) and HMBC (B) correlations of (12E)-(3,4,6,7,8,8a-
hexahydro-1H-isochromen-3-yl)-methylhept-12-enoate (7). The key 1H-1H COSY 
couplings have been represented by the bold face bonds. The HMBC couplings were 
indicated by double barbed arrow 
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Figure 5.90.: NOESY correlations of (12E)-(3,4,6,7,8,8a-hexahydro-1H-isochromen-3-
yl)-methylhept-12-enoate (7). The NOESY relations were represented by double barbed 
arrow  
Figure 5.91.: 1H NMR spectrum of (12E)-(3,4,6,7,8,8a-hexahydro-1H-isochromen-3-
yl)-methylhept-12-enoate (7)  
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Figure 5.92.: 13C NMR spectrum of (12E)-(3,4,6,7,8,8a-hexahydro-1H-isochromen-3-
yl)-methylhept-12-enoate (7)  
Figure 5.93.: 135DEPT NMR spectrum of (12E)-(3,4,6,7,8,8a-hexahydro-1H-iso 
chromen-3-yl)-methylhept-12-enoate (7)  
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Figure 5.94.: 1H-1H COSY NMR spectrum of (12E)-(3,4,6,7,8,8a-hexahydro-1H-iso 
chromen-3-yl)-methylhept-12-enoate (7)  
Figure 5.95.: HSQC NMR spectrum of (12E)-(3,4,6,7,8,8a-hexahydro-1H-isochromen-
3-yl)-methylhept-12-enoate (7)  
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Figure 5.96.: HMBC NMR spectrum of (12E)-(3,4,6,7,8,8a-hexahydro-1H-iso 
chromen-3-yl)-methylhept-12-enoate (7)  
Figure 5.97.: NOESY NMR spectrum of (12E)-(3,4,6,7,8,8a-hexahydro-1H-iso 
chromen-3-yl)-methylhept-12-enoate (7)  
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Figure 5.98.: FTIR spectrum of (12E)-(3,4,6,7,8,8a-hexahydro-1H-isochromen-3-yl)-
methylhept-12-enoate (7)  
 
The IR stretching vibrations corresponding to the ester carbonyl (C=O) and 
alkoxy groups were symbolized by 1711 and 1094 cm-1 bands, respectively. The 
characteristic absorptions at 2923 and 2853 cm-1 represented alkyl stretching vibrations 
(Figure 5.98.).  
Figure 5.99.: EIMS spectrum of (12E)-(3,4,6,7,8,8a-hexahydro-1H-isochromen-3-yl)-
methylhept-12-enoate (7)  
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Figure 5.100.: Mass fragmentation pattern of (12E)-(3,4,6,7,8,8a-hexahydro-1H-
isochromen-3-yl)-methylhept-12-enoate (7)  
 
The molecular ion peak was observed at m/z 278 (Figure 5.99.). The 
sequential elimination of two ethyl and two methyl radicals from the side chain moiety 
of the titled compound resulted into fragments with m/z 227 (b) and 196 (d), 
respectively. The later was seemed to undergo sequential fragmentations resulted in the 
fragment peak at m/z 111 (f). The twomethyl radical elimination from the fragment at 
m/z 111 (f) resulted in the base peak of cyclohexane (C6H11+) radical at m/z 83 (g). The 
latter on further mass fragmentation acquired a peak at m/z 56 (h), which was 
characteristic of butene (C4H8•+) (Figure 5.100.). 
The titled chromenyl derivatives constitute a major part in the natural 
products and changes in the substitution of functional groups might probably led to 
better antioxidant candidates with greater selectivity in the food supplements and 
functional foods.   
 
5.3.2.4.  Structural characterization of cholestenol derivatives (8-10) 
Sterols are the major constituents in marine invertebrates, such as corals, 
bryozoans and mollusks (Goad and Scheuer 1978). In particular, sponges, corals and 
mollusks were extensively investigated for different types of steroids (Joosse 1978; Sica 
1980). Most of the pregnanes reported to possess significant bioactivities, such as anti-
inflammatory (Chao et al., 2008) and anti-bacterial (Diaz-Marrero et al., 2011) 
activities. We herein described the NMR guided structural elucidation of one pregnane-
type steroids, 19 (10→5) abeo-20-methyl-pregn-1-en-3-yl-3β-methoxy-hex-25-enoate 
223 
 
Isolation and characterization of secondary metabolites from Villorita cyprinoides          Chapter 5 
(8) and two new cholestenol derivatives, (22E)-241-homocholesta-5,22-dien-(3β,241β)-
diol (9) and (22E),(241E)-241,242-dihomocholesta-5,22,241-trien-3β-ol (10) from V. 
cyprinoides (Figure 5.101.). 
 
 
Figure 5.101.: Sterol analogues from V. cyprinoides with bioactive potentials 
 
5.3.2.4.A. Structural characterization of compound 8 (VC2-6-5-2) 
19 (10→5) Abeo-20-methyl-pregn-1-en-3-yl-3β-methoxy-hex-25-enoate (8)  
 
 
Yield 143 mg; 0.32% 
Physical description White solid 
Molecular formula C28H44O2 
Molecular mass 412.3341 
 
 The pregnane steroid, 19 (10→5) abeo-20-methyl-pregn-1-en-3-yl-3β-
methoxy hex-25-enoate was isolated as white solid. It exhibited UV absorbance (in 
MeOH) at λmax (log ε 3.61): 222.3 nm was assigned to a chromophore with carbonyl and 
olefinic groups (Figure 5.102.). The purity of the compound was supported by RP C18 
HPLC using 3:2 (v/v) MeOH:MeCN (Rt 3.19) experiments (Figure 5.103.).  
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Figure 5.102.: UV spectrum of 19 (10→5) abeo-20-methyl-pregn-1-en-3-yl-3β-
methoxy-hex-25-enoate (8) 
 
Figure 5.103.: HPLC chromatogram of 19 (10→5) abeo-20-methyl-pregn-1-en-3-yl-
3β-methoxy-hex-25-enoate (8)   
 
 A pregnane class of steroid, 8 exhibited its molecular formula as C28H44O2 
(EIMS: found m/z 412.3347 [M+1]+, cal. for C28H44O2 412.3341). The double bond 
equivalence was calculated as seven, which included three unsaturations and four ring 
moieties. The absence of 1H NMR aromatic signals in the δ 6.5-8.5 regions confirmed 
that these cyclic rings were not related to the aromatic class of chemistry. The proton 
and carbon shift values were assigned on the basis of earlier reports (Huang et al., 2006; 
Kuo et al., 2014). The 13C NMR along with DEPT spectroscopic analyses recorded 
signals for 28 carbons, enclosing five methyls (including two singlets), ten methylenes, 
nine methines (including an oxymethine) and four quaternary carbon (including 
carbonyl carbon) (Table 5.12.; Figure 5.107.-5.108.). The proton spectrum displayed the 
occurrences of two each of terminal (δ 0.90, 0.88, d, 3H each) and tertiary methyls (δ 
0.70, 1.04, s, 3H each), one oxymethine (δ 4.62, p, 1H), along with a tri-substituted 
alkene (δ 5.39, t, 1H) (Figure 5.106.). The side chain was comprised of one terminal 
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methyl (δ 0.95, t, 3H), a carboxymethylene (δ 2.87, d, 2H) and two di-substituted alkene 
(δ 5.40, m, 1H; 5.41, m, 1H). The NMR data shared close resemblance to the basic 
skeleton of pregnane (Huang et al., 2006). Highly deshielded proton at δ 4.62 with δC 
73.66 positioned at C-3, confirmed the presence of highly oxygenated group. The -OH 
group at C-3 with δH 3.5/δC 71 was the characteristic resonances for sterols (Chen et 
al., 2014), whereas the present compound exhibited greater chemical shift value at C-3 
(δH ~4.5) than the characteristic hydroxy or methoxy groups. Therefore, it was assumed 
that C-3 position was directly bonded to strong electronegative groups, such as 
carboxylates {CH-O-(O)-C-}. The 3β-acetoxy-5,20-pregnadiene isolated from 
Scleronephthya flexilis identified as carboxylate (C-3) derivative and its chemical shifts 
at C-3 position (δH 4.60 (1H, m)/δC 73.9) was comparable with those of the titled 
compound in the same vicinity (δH 4.62 (1H, p)/δC 73.66) (Kuo et al., 2014). The 1H-
1H COSY correlations attributed for two spin systems in the pregnane skeleton and two 
spin systems in the hexenoate side chain attached at C-3. The short range couplings, 
such as δ 5.39 (H-1)/2.32, 2.29 (H-2)/4.62 (H-3)/1.72, 1.57 (H-4) and δ 1.15 (H-6)/1.32 
(H-7/0.98 (H-8)/2.08 (H-9)/1.59 (H-11)/1.35 (H-12); δ 0.98 (H-8)/1.10 (H-14)/1.86 (H-
15)/1.52 (H-16)/1.00 (H-17)/1.97 (H-20)/0.90 (H-201), 0.88 (H-21) were accounted for 
the basic tetracyclic framework (Figure 5.104.A, 5.109.). HMBC relations from δ 5.39 
(H-1) to δ 35.81 (C-9); δ 2.32 (H-2) to δ 122.57 (C-1), δ 73.66 (C-3), 139.70 (C-10); δ 
1.72 (H-4) to δ 73.66 (C-3), 139.70 (C-10); δ 1.57 (H-4) to δ 139.70 (C-10); δ 0.98 (H-
8) to δ 139.70 (C-10) confirmed the A/B ring system of 8 (Figure 5.104.B, 5.111.). 
Other couplings, such as δ 1.10 (H-14) to δ 42.32 (C-13); δ 1.52 (H-16) to δ 31.88 (C-
20); δ 1.00 (H-17) to δ 42.32 (C-13), 31.88 (C-20); δ 1.97 (H-20) to δ 56.70 (C-17); δ 
0.90 (H-201) to δ 56.70 (C-17); δ 0.88 (H-21) to δ 56.70 (C-17) supported the pregnane 
network. The singlet methyl proton at δ 0.70 (C-18) exhibited HMBC correlations with 
δC 42.32 (attributed to C-13), 21.05 (C-12) and 56.70 (C-17), thus the position of -CH3-
18 at C-13 was validated (Fang et al., 2013). The position of methyl at C-5 was 
confirmed due to the couplings from δ 1.04 (H-19) to δ 36.20 (C-5). The methyl group 
(-CH3-19) at C-10 position of the pregnane steroids (Zhao et al., 2013) was shifted to C-
5 in the titled compound (8), and therefore, it was named as 19 (10→5) abeo pregnane 
derivative. Highly deshielded 13C resonances at δ 173.28 (C-22) and 128.20 (C-
24)/132.01 (C-25) were recorded, in which the former corresponded to ester carbonyl, 
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whereas the latter was accounted for the sp2 hybridized alkenic carbons. The protons at 
δ 5.40 (H-24) and 5.41 (H-25) displayed HSQC correlation with two different 13C shifts 
at δ 128.20 (C-24) and 132.01 (C-25) with greater coupling constants (J) of 9.14 and 
9.02 Hz, respectively, that established the trans (E) configuration of the alkenic group. 
The presence of 3-methoxy-hex-25-enoate moiety was evident at C-3 by HMBC 
coupling from δ 2.32 (H-2) to δ 173.28 (C-22) and δ 1.72 (H-4) to δ 173.28 (C-22). This 
side chain embedded two spin systems, which were δ 2.87 (H-23)/5.40 (H-24) and δ 
5.41 (H-25)/2.05 (H-26)/0.95 (H-27). The presence of carbonyl carbon at δ 173.28 (C-
23) and its extended side chain were further corroborated by long range correlations, 
such as δ 2.87 (H-23) to δ 173.28 (C-22); δ 5.41 (H-25) to δ 25.64 (C-23); δ 2.05 (H-26) 
to δ 128.20 (C-24); δ 0.95 (H-27) to δ 128.20 (C-24). The relative stereochemistries of 8 
were determined by extensive NOE correlations (Figure 5.105., 5.112.). The NOEs 
among δ 5.39 (H-1)/4.62 (H-3)/1.57 (Hα-4)/2.08 (H-9)/1.10 (H-14) suggested that these 
protons were aligned in same plane, and therefore, arbitrarily assigned as α-oriented. 
NOEs found among δ 2.32 (H-2a)/1.72 (Hβ-4)/0.98 (H-8)/1.00 (H-17), which together 
with methyl  signals at δ 1.04 (H-19) and δ 0.70 (H-18) established their β-disposition.  
 
Table 5.12.: NMR spectroscopic data of 19 (10→5) abeo-20-methyl-pregn-1-en-3-yl-
3β-methoxy-hex-25-enoate (8) in CDCl3 
C. No. 13C 1H (int.,mult.,J in Hz)a COSY HMBC 
1 122.57 5.39 (1Hα,t,6.50) H-2 C-2,9 
2 38.17 2.32 (1Hβ,t) H-3 C-1,22,3,10,5 
  2.29 (1Hα,t) - - 3 73.66 4.62 (1Hα,p) H-4 - 
4 37.02 1.72 (1Hβ,d) - C-3,22,10,6 
  1.57 (1Hα,d) - C-10,6,22 5 36.2 - - - 
6 29.71 1.15 (2H,t) H-7 C-19,7 
7 31.91 1.32 (2H,m) H-8 - 
8 50.04 0.98 (1Hβ,m) H-9,14 C-10,5 
9 35.81 2.08 (1Hα,m) H-11 C-11 
10 139.70 - - - 
11 24.29 1.59 (2H,m) H-12 - 
12 21.05 1.35 (2H,m) - - 
13 42.32 - - - 
14 56.15 1.10 (1Hα,m) H-15 C-13 
15 39.53 1.86 (2H,m) H-16 C-16 
16 36.60 1.52 (2H,m) H-17 C-15,20 
17 56.70 1.00 (1Hβ,m) H-20 C-13,14,20,18 
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18 11.86 0.70 (3Hβ,s) - C-13,12,17 
19 19.33 1.04 (3Hβ,s) - C-5 
20 31.88 1.97 (1Hβ; m) H-21,201 C-17,21,201 
201 22.57 0.90 (3H,d) - C-17,21 
21 22.83 0.88 (3H,d) - C-17,201 
22 173.28 - - - 
23 25.64 2.87 (2H,d) H-24 C-24,22 
24 128.20 5.40 (1H, td, 9.14, 7.05) - - 
25 132.01 5.41 (1H, td, 9.02, 7.03) H-26 C-23 
26 28.02 2.05 (2H,m) H-27 C-25,24 
27 18.73 0.95 (3H,t)   C-26,24,25 
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 
500MHz, while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, 
multiplicity and coupling constants (J=Hz) were indicated in parentheses. The 
assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and NOESY 
experiments 
 
 
 
 
Figure 5.104.: 1H-1H COSY (A) and HMBC (B) correlations of 19 (10→5) abeo-20-
methyl-pregn-1-en-3-yl-3β-methoxy-hex-25-enoate (8). The key 1H-1H COSY 
couplings have been represented by the bold face bonds. The HMBC couplings were 
indicated by double barbed arrow 
14
18
19
20
22O
O
H
H H
H HH
 
Figure 5.105.: NOESY correlations of 19 (10→5) abeo-20-methyl-pregn-1-en-3-yl-3β-
methoxy-hex-25-enoate (8). The NOESY relations were represented by double barbed 
arrow 
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Figure 5.106.: 1H NMR spectrum of 19 (10→5) abeo-20-methyl-pregn-1-en-3-yl-3β-
methoxy-hex-25-enoate (8) 
Figure 5.107.:  13C NMR spectrum of 19 (10→5) abeo-20-methyl-pregn-1-en-3-yl-3β-
methoxy-hex-25-enoate (8) 
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Figure 5.108.: 135DEPT NMR spectrum of 19 (10→5) abeo-20-methyl-pregn-1-en-3-yl-
3β-methoxy-hex-25-enoate (8) 
Figure 5.109.:  1H-1H COSY NMR spectrum of 19 (10→5) abeo-20-methyl-pregn-1-
en-3-yl-3β-methoxy-hex-25-enoate (8) 
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Figure 5.110.: HSQC spectrum of 19 (10→5) abeo-20-methyl-pregn-1-en-3-yl-3β-
methoxy-hex-25-enoate (8) 
Figure 5.111.: HMBC NMR spectrum of 19 (10→5) abeo-20-methyl-pregn-1-en-3-yl-
3β-methoxy-hex-25-enoate (8) 
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Figure 5.112.: NOESY NMR spectrum of 19 (10→5) abeo-20-methyl-pregn-1-en-3-yl-
3β-methoxy-hex-25-enoate (8) 
 
 The IR stretching vibrations for ester carbonyl (C=O) and alkoxy 
functionalities were implied by signals at 1719 and 1050 cm-1, respectively. The 
characteristic absorption bandss at 2923 and 2855 cm-1 represented alkyl stretching 
vibrations (Figure 5.113.). 
 
Figure 5.113.: FTIR spectrum of 19 (10→5) abeo-20-methyl-pregn-1-en-3-yl-3β-
methoxy-hex-25-enoate (8) 
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The molecular ion peak was recorded at m/z 412 (Figure 5.114.). The 
sequential elimination of two methyl radicals from the side chain moiety resulted into 
fragment with m/z 380 (b, C26H36O2•+). This appeared to undergo sequential elimination 
of radicals such as C2H3•, C2H3O2•, C3H7•, two CH3•, and C2H2•• resulted into 
corresponding peaks at m/z 354 (c, C24H34O2•+), 301 (d, C22H37+), 254 (e, C19H26•+), 226 
(f, C17H22•+) and 201 (g, C15H21+), respectively. The fragment, dodecahydro-cyclopropa-
phenanthrene (g) appeared to undergo repeated fragmentations to yield 
methylenecyclohexene at m/z 94 (k, C7H10+•), which was on fragmentation of two 
molecules of methyl radical registered base ion peak at m/z 70 (C5H10•+) corresponding 
to the pentene moiety (Figure 5.115.). 
 
 
Figure 5.114.: EIMS spectrum of 19 (10→5) abeo-20-methyl-pregn-1-en-3-yl-3β-
methoxy-hex-25-enoate (8) 
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Figure 5.115.: Mass fragmentation pattern of 19 (10→5)-abeo-20-methyl-pregn-1-en-
3-yl-3β-methoxy-hex-25-enoate (8) 
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5.3.2.4.B. Structural characterization of compound 9 (VC2-5-1) 
(22E)-241-Homocholesta-5,22-dien-(3β,241β)-diol (9) 
 
Yield 134 mg; 0.30% 
Physical description White solid 
Molecular formula C28H46O2 
Molecular mass 414.3498 
 
The cholestene compound, (22E)-241-homocholesta-5,22-dien-(3β,241β)-diol 
(9) was isolated as white solid after repeated chromatographic purification techniques. It 
exhibited UV absorbance (in MeOH) at λmax (log ε 3.46) 221.5 nm, which was assigned 
to a chromophore with olefinic groups and hydroxyl systems (Figure 5.116.). The purity 
of the compound was supported by RP C18 HPLC using 3:2 MeOH:MeCN (Rt 6.00) 
experiments (Figure 5.117.).  
 
 
Figure 5.116.: UV spectrum of (22E)-241-homocholesta-5,22-dien-(3β,241β)-diol (9) 
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Figure 5.117.: HPLC chromatogram of (22E)-241-homocholesta-5,22-dien-(3β,241β)-
diol (9) 
 
The cholestenol derivative, characterized as (22E)-241-homocholesta-5,22-
dien-(3β,241β)-diol (9) was found to enclose an olefinic and hydroxyl groups in side 
chain framework attached at C-17. The molecular ion peak at m/z 414 (EIMS found m/z 
414.3504 [M]+, cal. 414.3498) along with the proton and carbon spectroscopic data 
represented its molecular formula as C28H46O2. The present compound was corroborated 
with the spectroscopic data of the sterol derivatives in the previous works (Tian et al., 
2011). The cumulative DEPT and 13C NMR analyses confirmed the occurrence of 28 
carbons, which was distributed among nine methylenes, five methyls, and eleven 
methines along with three quaternary carbons (Table 5.13.; Figure 5.122.-5.123.). 
Highly deshielded protons at δ 5.34, 5.18 and 5.17 displayed HSQC correlations with 
δC 121.70, 131.72 and 135.83, respectively, which were placed at C-6, C-22 and C-23 
positions, respectively. The lesser chemical shifts for -CH3 groups at δH 1.01 (s), 0.69 
(s), 0.84 (d), 0.86 (d) and 0.90 (d) exhibited HSQC correlation with the carbons at δC 
19.40, 11.87, 19.89, 22.69 and 17.62, respectively arranged at C-19, C-18, C-26, C-27 
and C-21, positions, in that order. The HSQC cross peaks with δH 0.92/δC 50.14, δH 
1.10/δC 56.02 and δH 0.95/δC 56.77 (Figure 5.124.) assigned the presence of 
characteristic methines (-CH-) at C-9, C-14 and 17, respectively (Reich et al., 1969). 
The 1H-1H COSY spectrum specified three spin systems in the title compound. The first 
spin system was exhibited by proton cross peaks at δ 1.85, 1.03 (H-1)/1.49, 1.83 (H-
2)/3.52 (H-3)/2.23, 2.28 (H-4) in ring A. The second spin system was found at δ 5.34 
(H-6)/1.95 (H-7)/1.51 (H-8)/0.92 (H-9)/1.47 (H-11)/1.14, 2.00 (H-12); δ 1.51 (H-
8)/1.10 (H-14)/1.08, 1.53 (H-15)/1.69 (H-16)/0.95 (H-17) in B/C/D ring along with δ 
0.95 (H-17)/1.86 (H-20)/0.90 (H-21), 5.18 (H-22), which confirmed the side chain 
attachment to parent steroid group at C-17 (Figure 5.118.A, 5.123.). Other spin system 
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was attributed to δ 5.17 (H-23)/2.03 (H-24)/3.64 (H-241)/1.52 (H-25)/0.84 (H-26), 0.86 
(H-27), which formed the part of side chain. The HMBCs from δ 1.85 (H-1) to δ 36.51 
(C-10); δ 1.49 (H-2) to δ 140.75 (C-5); δ 2.23 (H-4) to δ 36.52 (C-10); δ 5.35 (H-6) to δ 
42.30 (C-4), 36.51 (C-10); δ 1.95 (H-7) to δ 50.14 (C-9); δ 1.51 (H-8) to δ 140.75 (C-5); 
δ 0.92 (H-9) to δ 140.75 (C-5), δ 36.52 (C-10) confirmed the presence of ring A/B. 
Further HMBC cross peaks from δ 1.47 (H-11) to δ 50.14 (C-9), 19.40 (C-19); δ 1.14 
(H-12) to δ 11.87 (C-18); δ 1.10 (H-14) to δ 21.09 (C-11) and δ 0.95 (H-17) to δ 46.25 
(C-13), 56.02 (C-14) were attributed to C/D bicyclic ring system (Figure 5.118.B, 
5.125.). The long range HMBCs from δ 1.01 (H-19) to δ 36.51 (C-10), 140.75 (C-5) 
confirmed the attachment of -CH3-19 to C-10 and those between δ 0.69 (H-18) to δ 
42.81 (C-20), 46.25 (C-13) assigned the attachment of -CH3-18 to C-13. The side chain 
attachment at C-17 was corroborated with HMBC correlations from δ 1.86 (H-20) to δ 
56.77 (C-17) and δ 0.90 (H-21) to δ 56.77 (C-17). Long-range HMBC couplings from δ 
1.86 (H-20) to δ 131.72 (C-22); δ 0.90 (H-21) to δ 131.72 (C-22); δ 2.03 (H-24) to δ 
42.81 (C-20) and δ 0.86 (H-27) to δ 40.16 (C-24) were attributed to side chain moiety. 
Highly deshielded methine proton at δ 3.64 displaying HSQC with the δC 70.44 was 
accounted for the presence of a hydroxyl group and its position was attributed from the 
long distance HMBC couplings from δ 2.03 (H-24) to δ 70.44 (C-241) and δ 1.52 (H-25) 
to δ 70.44 (C-241). Thus, the side chain with one each of olefinic centre (C-22) and 
hydroxyl group (C-241) were attributed. The greater coupling constants (J) of 9.81 and 
10.44/9.61 Hz, corresponding to olefinic signals at H-22 and H-23, respectively 
suggested their trans (E) orientation. The β-orientation of -OH at C-3 was assumed from 
NOE relations, such as δ 3.52 (H-3)/2.28 (Hα-4)/1.03 (Hα-1)/1.83 (Hα-2) and δ 5.34 
(H-6)/2.28 (Hα-4) (Figure 5.119., 5.126.) (Sun et al., 2013). The intense NOE 
correlations, such as δ 1.01 (H-19)/δ 2.23 (Hβ-4)/1.51 (Hβ-8)/0.68 (H-18) corroborated 
the β-orientation of singlet methyls at H-19 and H-18 bonded to sp3 hybridized 
quaternary carbons, C-10 and C-13, respectively (Calderon et al., 2004). 
 
Table 5.13.: NMR spectroscopic data of (22E)-241-homocholesta-5,22-dien-(3β,241β)-
diol (9) in CDCl3 
C. No. 13C 
1
H (int.,mult.,J in Hz)a COSY HMBC            
1 37.27 1.85 (1Hα,t) H-2 C-3,10 
  1.03 (1Hβ,t) H-2 - 
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2 31.65 1.49 (1Hβ,m) H-3 C-3,5 
  1.83 (1Hα,m) - - 3 71.80 3.52 (1Hα,p) H-4 - 
4 42.30 2.23 (1Hβ,d) - C-3,10,5 
  2.28 (1Hα,d) - - 5 140.75 - - - 
6 121.70 5.34 (1Hα,dd,6.25, 6.31) H-7 C-4,10 
7 31.91 1.95 (1H,t) H-8 C-6,9,8 
8 28.02 1.51 (1Hβ,m) H-9,14 C-5 
9 50.14 0.92 (1Hα,m) H-11 C-10,5,14 
10 36.51 - - - 
11 21.09 1.47 (2H,m) H-12 C-9,19,12 
12 39.79 1.14 (1Hβ,t) - C-11,18 
  2.00 (1Hα,t) - - 13 46.25 - - - 
14 56.02 1.10 (1Hα,m) H-15 C-11,15 
15 24.30 1.08 (1Hβ,m) H-16 C-16 
  1.53 (1Hα,m) - - 16 28.54 1.69 (2H,m) H-17 C-15 
17 56.77 0.95 (1Hβ,m) H-20 C-13,14,15,16 
18 11.87 0.69 (3Hβ,s) - C-20,17,12,13 
19 19.40 1.01 (3Hβ,s) - C-1,10,5,9 
20 42.81 1.86 (1H,m) H-21,22 C-21,22,23,17 
21 17.62 0.90 (3Hα,d) - C-17,22 
22 131.72 5.18 (1H,t,9.81) - - 
23 135.83 5.17 (1H,td,10.44, 9.61) H-24 C-22 
24 40.16 2.03 (2H,t) H-24
1
 C-20,24
1
 
24
1
 70.44 3.64 (1Hα,m) H-25 - 
25 33.10 1.52 (1H,m) H-26,27 C-24
1
 
26 19.89 0.84 (3H,d) - C-25,27 
27 22.69 0.86 (3H,d) - C-25,26,24 
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 
500MHz, while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, 
multiplicity and coupling constants (J=Hz) were indicated in parentheses. The 
assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and NOESY 
experiments 
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Figure 5.118.: 1H-1H COSY (A) and HMBC (B) correlations of (22E)-241-homo 
cholesta-5,22-dien-(3β,241β)-diol (9). The key 1H-1H COSY couplings have been 
represented by the bold face bonds. The HMBC couplings were indicated by double 
barbed arrow 
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Figure 5.119.: NOESY correlations of (22E)-241-homocholesta-5,22-dien-(3β,241β)-
diol (9). The NOESY relations were represented by double barbed arrow 
 
Figure 5.120.: 1H NMR spectrum of (22E)-241-homocholesta-5,22-dien-(3β,241β)-diol 
(9) 
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Figure 5.121.: 13C NMR spectrum of (22E)-241-homocholesta-5,22-dien-(3β,241β)-diol 
(9) 
Figure 5.122.: 135DEPT NMR spectrum of (22E)-241-homocholesta-5,22-dien-(3β, 
241β)-diol (9) 
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Figure 5.123.: 1H-1H COSY NMR spectrum of (22E)-241-homocholesta-5,22-dien-(3β, 
241β)-diol (9) 
Figure 5.124.: HSQC NMR spectrum of (22E)-241-homocholesta-5,22-dien-(3β,241β)-
diol (9) 
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Figure 5.125.: HMBC NMR spectrum of (22E)-241-homocholesta-5,22-dien-(3β,241β)-
diol (9) 
Figure 5.126.: NOESY NMR spectrum of (22E)-241-homocholesta-5,22-dien-(3β, 
241β)-diol (9) 
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The IR stretching vibrations for C=C and alkyl moieties were implied through 
absorptions at 1663 and 2934 cm-1, respectively (Figure 5.127.). The characteristic 
absorption at 3366 cm-1 represented hydroxyl stretching vibration.  
Figure 5.127.: FTIR spectrum of (22E)-241-homocholesta-5, 22-dien-(3β, 241β)-diol (9) 
The molecular ion peak in the mass spectra was recorded at m/z 414 (Figure 
5.128.). The elimination of hydroxyl radical at C-241 of hydrocarbon chain of sterol 
reported a fragment peak at m/z 396 (a). This appeared to undergo elimination of 
angular methyl radical at C-18 and C-19 to yield a peak at m/z 369 (b, C26H41O+), which 
appeared to dissociate the methyl/ethyl radicals in the hydrocarbon tail of sterol along 
with the elimination of hydroxyl radical at C-3 to register a peak at m/z 221 (h, C17H17+) 
due to the hexahydro-cyclopenta-phenanthrene moiety. The later appeared to undergo 
sequential elimination of ions, such as CH2••, C2H3•, CH2••, C2H3•, C2H4•• and CH3• 
corresponding to the peaks at m/z 207 (i, C16H15+), 185 (j, C14H17+), 171 (k, C13H15+), 
147 (l, C11H15+), 117 (m, C9H9+) and 105 (n, C8H9+), respectively. The 
ethylidenecyclohexadiene (n) radical eliminated methyl radical to obtain a base peak of 
methylcyclohexadiene at m/z 94 (o, C7H10•+) which further dissociated two methyl 
radicals to yield pentadiene cation with m/z 67 (q) (Figure 5.129.). 
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Figure 5.128.: EIMS spectrum of (22E)-241-homocholesta-5,22-dien-(3β,241β)-diol (9) 
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Figure 5.129.: Mass fragmentation pattern of (22E)-241-homocholesta-5,22-dien-
(3β,241β)-diol (9) 
5.3.2.4.C. Structural characterization of compound 10 (VC2-4-1) 
(22E),(241E)-241,242-Dihomocholesta-5,22,241-trien-3β-ol (10) 
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Yield 195 mg; 0.43% 
Physical description White solid 
Molecular formula C29H46O 
Molecular mass 410.3549 
 
 A new cholestene compound, (22E),(241E)-241,242-dihomocholest-5,22,241-
trien-3β-ol (10) isolated as a white solid. It exhibited UV absorbance (in MeOH) at λmax 
(log ε 3.32) 220.1 nm related to alkenes (Figure 5.130.). The purity of compound was 
supported by RP C18 HPLC using 3:2 (v/v) MeOH:MeCN (Rt 8.99) experiments 
(Figure 5.131.).  
 
 
Figure 5.130.: UV spectrum of (22E),(241E)-241,242-dihomocholesta-5,22,241-trien-3β-
ol (10) 
Figure 5.131.: HPLC chromatogram of (22E),(241E)-241,242-dihomocholesta-5,22,241-
trien-3β-ol (10) 
 A cholestenol derivative, (22E),(241E)-241,242-dihomocholesta-5,22,241-
trien-3β-ol (10), with two isolated alkenes at C-22 and C-241 positions in side chain (C-
17) was identified. The molecular ion peak at m/z 410 (EIMS: found m/z 410.3555 [M]+, 
cal. for C29H46O 410.3549) along with 1H and 13C data represented its molecular 
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formula as C29H46O with seven degrees of unsaturation (three double bond and four 
rings). It exhibited six alkenic carbon signals at δ 140.75, 121.70, 131.72, 135.83, 
138.26 and 129.32 in which the signal at δ 140.75 was attributed to the alkenic 
quaternary carbon as deduced from 13C spectrum supported by DEPT analysis (Table 
5.14.; Figure 5.134.-5.5.139.). The highly deshielded protons at H-6 (δ 5.35, dd) and 
that at H-3 (δ 3.52, p) were attached to the respective carbons at δ 121.70 and 71.80, 
were attributed to >C=CH and –C(H)-OH groups, respectively (Reich et al., 1969). The 
13C signal at δ 140.75 appeared downfield, and was lesser in intensity than the olefinic 
peak at δ 121.70 due to the slow relaxation, and therefore, it was deduced to be alkenic 
quaternary carbon. The carbons that were not attached to protons, relaxed gradually and 
exhibited lesser intense peak, if relaxation delay is small (RD = 1.7 s), thus the 
closeness of protons could be determined. The greater chemical shift value of carbinol 
proton and carbon were due to the higher electron withdrawing effects of hydroxyl 
moiety at C-3, which was identified from the absence of deuterated -OH proton signal 
in NMR spectrum by deuteration of hydroxyl proton. The NMR spectral signals of the 
title cholestene framework were found to be related with previous disclosures (Tian et 
al., 2011). Five high-field methyls (-CH3) δ 0.68 (s), 1.01 (s), 0.90 (d), 0.86 (d), 0.87 (d) 
were attributed to the carbons at δ 11.87 (C-18), 19.40 (C-19), 17.62 (C-21), 19.86 (C-
26) and  22.82 (C-27), respectively; whereas the methines (-CH-) at δ 1.12  (m), 0.92 
(m) and 0.95 (m) were assigned to carbons at δ 56.02 (C-14), 50.17 (C-9) and 56.85 (C-
17), respectively in that order. The titled compound registered three significant 
quaternary carbons at δ 36.52 (C-10), 42.25 (C-13) and 140.75 (C-5), which were the 
characteristic shift signals for sterols (Reich et al., 1969). The combined DEPT and 13C 
NMR analyses confirmed that the compound enclosed 29 carbon atoms, which were 
distributed into five -CH3, nine -CH2 and twelve -CH groups. It exhibited four spin 
systems in COSY data, which include δ 1.84, 1.03 (H-1)/1.49, 1.83 (H-2)/3.52 (H-
3)/2.25, 2.28 (H-4) in the ring A, whereas the second spin arrangement enclosed 
correlations among the protons at δ 5.35 (H-6)/1.95 (H-7)/1.50 (H-8)/0.92 (H-9)/1.47 
(H-11)/1.16, 2.00 (H-12); δ 1.50 (H-8)/1.12 (H-14)/1.08, 1.53 (H-15)/1.68 (H-16)/0.95 
(H-17) in ring B/C/D along with δ 0.95 (H-17)/1.85 (H-20)/0.90 (H-21), 5.20 (H-22) 
that confirmed the attachment of side chain fragment to parent steroid moiety at C-17 
(Figure 5.132.A, 5.137.). Other two spin systems were found to enclose in the side 
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chain, which were δ 5.16 (H-23)/2.02 (H-24)/5.39 (H-241) and δ 5.03 (H-242)/1.51 (H-
25)/0.86 (H-26), 0.87 (H-27). The HMBC attachments from δ 1.84 (H-1) to δ 140.75 
(C-5), 19.40 (C-19); δ 1.49 (H-2) to δ 140.75 (C-5); δ 2.25 (H-4) to δ 121.70 (C-6), 
36.52 (C-10); δ 5.35 (H-6) to δ 42.30 (C-4), 36.52 (C-10); δ 1.95 (H-7) to δ 50.17 (C-9), 
56.02 (C-14); δ 1.50 (H-8) to δ 121.70 (C-6); δ 0.92 (H-9) to δ 31.91 (C-7), 37.26 (C-1) 
confirmed the presence of A/B ring moiety. The HMBC relations from δ 1.47 (H-11) to 
δ 50.17 (C-9), 56.02 (C-14); δ 1.16 (H-12) to δ 11.87 (C-18); δ 1.12 (H-14) to δ 50.17 
(C-9) and δ 0.95 (H-17) to δ 24.30 (C-15) attributed the C/D bicyclic moiety (Figure 
5.132.B, 5.139.). The characteristic singlet methyls of steroids at C-18 and C-19 
positions were furthermore attributed by HMBC correlations from δ 0.68 (H-18) to δ 
42.25 (C-13), 56.02 (C-14) and δ 1.01 (H-19) to δ 50.17 (C-9), 140.75 (C-5), 37.26 (C-
1), respectively in that order. The attachment of side chain at Δ17 was confirmed by 
HMBCs from δ 1.85 (H-20) to δ 56.85 (C-17) and δ 0.90 (H-21) to δ 56.85 (C-17). 
Other HMBC couplings, such as δ 0.90 (H-21) to δ 131.72 (C-22), 135.83 (C-23); δ 
5.20 (H-22) to δ 40.16 (C-24); δ 5.16 (H-23) to δ 40.16 (C-24); δ 5.39 (H-241) to δ 
135.83 (C-23); δ 5.03 (H-242) to δ 135.83 (C-23); δ 1.51 (H-25) to δ 22.82 (C-27), 
129.32 (C-242); δ 0.86 (H-26) to δ 129.32 (C-242) and δ 0.87 (H-27) to δ 33.10 (C-24) 
assigned the presence of dihomo side chain with two olefinic centres (C-22 and C-241). 
The side chain attachments (Δ20 to Δ27) could be compared readily with compounds 
discussed in earlier reports (Diaz-Marrero et al., 2003b). The greater coupling constants 
(J), 11.02 and 9.55/9.00 Hz corresponding to H-22 and H-23 alkenic protons, 
respectively along with other coupling constants (J), 10.49 and 9.04 Hz for olefinic 
protons at H-241 and H-242, respectively attributed to their E (trans) configuration, 
which were further supported by earlier studies (Goad and Akihisa 1997). The relative 
configurations were assigned by their extensive NOESY correlations (Figure 5.133., 
5.140.). The proton signal at δ 3.52 (H-3) displayed NOESY correlation with δ 5.35 (H-
6)/2.28 (H-4)/1.84 (H-1)/1.83 (H-2), which were distributed in same plane, and 
therefore, have been arbitrarily assigned to dispose at α-plane of molecule. This 
explained the β-orientation of hydroxyl at C-3 (Sun et al., 2013). The singlet methyl 
groups at δ 0.68 (attributed to H-18) and δ 1.01 (H-19) of sterol derivative were 
correlated with proton shifts at δ 2.25 (H-4)/1.50 (H-8) that accordingly suggested their 
β-disposition (Calderon et al., 2004). 
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Table 5.14.: NMR spectroscopic data of (22E),(241E)-241,242-dihomocholesta-
5,22,241-trien-3β-ol (10) in CDCl3 
C. No.  13C  1H (int.,mult.,J in Hz)a  COSY  HMBC
1 37.26  1.84 (1Hα,t) H-2  C-3,5,19 
  1.03 (1Hβ,t)  -  2 31.66  1.49 (1Hβ,m) H-3  C-4,5 
  1.83 (1Hα,m) - 
3 71.80  3.52 (1Hα,p) H-4 - 
4 42.30  2.25 (1Hβ,d) - C-3,5,6,10 
  2.28 (1Hα,d) - - 
5 140.75  - - - 
6 121.70  5.35 (1Hα,dd,6.77,5.03) H-7 C-4,10,7 
7 31.91  1.95 (1H,t) H-8 C-9,14,8 
8 28.02  1.50 (1Hβ,m) H-9,14  C-6,9 
9 50.17  0.92 (1Hα,m) H-11 C-7,1 
10 36.52  - -  -  
11 21.19  1.47 (2H,m) H-12 C-9,14  
12 39.69  1.16 (1Hβ,t) -  C-11,18  
  2.00 (1Hα,t) -  -  
13 42.25  - -  -  
14 56.02  1.12 (1Hα,m) H-15 C-9,15  
15 24.30  1.08 (1Hβ,m) H-16 -  
  1.53 (1Hα,m) -  -  
16 28.24  1.68 (2H,m) H-17 C-15  
17 56.85  0.95 (1Hβ,m) H-20 C-16,15  
18 11.87  0.68 (3Hβ,s) -  C-13,14,17,12 
19 19.40  1.01 (3Hβ,s) -  C-9,5,1  
20 42.81  1.85 (1H,m) H-21,22  C-17,21 
21 17.62  0.90 (3Hα,d) -  C-20,17,22,23 
22 131.72  5.20 (H,t,11.02) -  C-24  
23 135.83  5.16 (1H,td,9.55,9.00) H-24 C-22,24 
24 40.16  2.02 (2H,t) H-25 -  
241  138.26  5.39 (1H,q,10.49) -  C-23  
242  129.32  5.03 (1H,t,9.04) H-27 C-23  
25 33.10  1.51 (1H,m) H-28,29  C-26,27,242 
26 19.86  0.86 (3H,d) - C-25,242 
27 22.82  0.87 (3H,d) - C-25 
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 
500MHz, while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, 
multiplicity and coupling constants (J=Hz) were indicated in parentheses. The 
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assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and NOESY 
experiments 
 
 
 
 
 
 
 
Figure 5.132.: 1H-1H COSY (A) and HMBC (B) correlations of (22E),(241E)-241,242-
dihomocholesta-5,22,241-trien-3β-ol (10). The key 1H-1H COSY couplings have been 
represented by the bold face bonds. The HMBC couplings were indicated by double 
barbed arrow 
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Figure 5.133.: NOESY correlations of (22E),(241E)-241,242-dihomocholesta-5,22,241-
trien-3β-ol (10). The NOESY relations were represented by double barbed arrow 
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Figure 5.134.: 1H NMR spectrum of (22E),(241E)-241,242-dihomocholesta-5,22,241-
trien-3β-ol (10) 
Figure 5.135.: 13C NMR spectrum of (22E),(241E)-241,242-dihomocholesta-5,22,241-
trien-3β-ol (10) 
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Figure 5.136.: 135DEPT NMR spectrum of (22E),(241E)-241,242-dihomocholesta-
5,22,241-trien-3β-ol (10) 
Figure 5.137.: COSY NMR spectrum of (22E),(241E)-241,242-dihomocholesta-5,22,241 
-trien-3β-ol (10) 
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Figure 5.138.: HSQC NMR spectrum of (22E),(241E)-241,242-dihomocholesta-5,22,241 
-trien-3β-ol (10) 
Figure 5.139.: HMBC NMR spectrum of (22E),(241E)-241,242-dihomocholesta-
5,22,241-trien-3β-ol (10) 
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Figure 5.140.: NOESY spectrum of (22E), (241E)-241,242-dihomocholesta-5,22,241-
trien-3β-ol (10) 
Figure 5.141.: FTIR spectrum of (22E),(241E)-241,242-dihomocholesta-5,22,241-trien-
3β-ol (10) 
 
The IR stretching vibrations for C=C and alkyl functionalities were denoted 
by absorptions at 1663 and 2934 cm-1, respectively. The characteristic band at 3366 cm-
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1 was represented the hydroxyl moiety. All these data substantiated the structure of 
cholestene derivative (Figure 5.141.). 
The molecular ion peak was recorded in the mass spectrum at m/z 410 (Figure 
5.142.). The sequential elimination of methyl, isopropyl and two methyl radicals from 
the side chain moiety at C-17 appeared to result in the fragment peaks with m/z 395 (a, 
C28H43O+), 354 (b, C25H38O+) and 324 (d, C23H32O•+), respectively. The later appeared 
to undergo sequential elimination of ions, such as C3H5•, C2H4••, C2H2••, hydroxyl, ethyl, 
methyl, C2H3• and finally C3H6•• corresponding to peaks at m/z 284 (e, C20H28O•+), 256 
(f, C18H24O•+), 236 (g, C16H28O+), 211 (h, C16H19+), 185 (i, C14H17+), 171 (j, C13H15+), 
146 (k, C11H14+) and 112 (l, C8H16+), respectively. The ethylcyclohexane (l) fragment 
appeared to dissociate methyl radical to yield a base peak of methylenecyclohexene at 
m/z 94 (m, C7H10+), which further fragmented to pentadiene cation with m/z 67 (n) 
(Figure 5.143.). 
 
Figure 5.142.: EIMS spectrum of (22E),(241E)-241,242-dihomocholesta-5,22,241-trien-
3β-ol (10) 
253 
 
Isolation and characterization of secondary metabolites from Villorita cyprinoides          Chapter 5 
HO HO HO HO
C29H46O
m/z: 410
CH3•
C28H43O+
m/z: 395
C3H7•
C25H38O
m/z: 354
C24H35O+
m/z: 339
CH3•
HO C23H32O•+
m/z: 324
CH3•
HO
C3H5•
C20H28O•+
m/z: 284
HO
HO
C2H4••
C18H24O•+
m/z: 256
C2H2••
C16H19+
m/z: 211
HO•
C2H5•
C14H17+
m/z: 185
CH2••
C13H15+
m/z: 171
C11H14
m/z: 146
C2H3• C3H6••
CH3•
C7H10
m/z: 94
C2H2••
C5H7+
m/z: 67
a b
c
defg
h
i j k l m n
C16H27O+
m/z: 235
C8H14•+
m/z: 110
Figure 5.143.: Mass fragmentation pattern of (22E),(241E)-241,242-dihomocholesta-
5,22,241-trien-3β-ol (10) 
The steroids with diverse structures were found to exhibit interesting 
therapeutic properties (Goad and Akihisa 1997; Whitson et al., 2009). Anti-
inflammatory properties of di-unsaturated C-27 polyhydroxy sterols isolated from the 
marine gastropod, Trimusculus peruvianus (Chao et al. 2008; Diaz-Marrero et al. 
2003b; Su et al., 2008). The anti-inflammatory pregnane-type steroids from soft coral, 
Scleronephthya gracillimum were reported in prior studies (Fang et al., 2013). The 
steroids that can act as COX-2/5-LOX specific dual inhibitors will be helpful in the 
treatment of inflammatory disorders. 
5.3.3.  Bioactive (antioxidant and anti-inflammatory) potentials of secondary 
metabolites isolated from EtOAc:MeOH extract of V. cyprinoides 
5.3.3.1. Antioxidative potentials of secondary metabolites isolated from 
EtOAc:MeOH extract of V. cyprinoides 
The free radical inhibiting activities of title compounds (1 to 10) isolated 
from EtOAc:MeOH extract of V. cyprinoides were described in Table 5.15. The 
antioxidant activities of isolated compounds were determined by the in vitro DPPH and 
ABTS+ scavenging experiments. 
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Table 5.15.: In vitro antioxidant {2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2’-
azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS+) radical scavenging assays} 
activities of secondary metabolites (1-10) isolated from EtOAc:MeOH extract of V. 
cyprinoides against commercially available standard, α-tocopherol 
Compounds 
Antioxidant activities 
IC50 values (mg/mL) 
*DPPH scavenging
activity 
*ABTS+ scavenging
activity 
1 0.59 ± 0.01a 0.67 ± 0.01a 
2 0.54 ± 0.01a 0.62 ± 0.01a 
3 0.63 ± 0.04b 0.72 ± 0.02b 
4 0.71 ± 0.01b 0.76 ± 0.01b 
5 0.69 ± 0.04b 0.64 ± 0.02a 
6 0.76 ± 0.01c 0.85 ± 0.01c 
7 0.79 ± 0.04c 0.87 ± 0.02c 
8 0.86 ± 0.04d 0.94 ± 0.02d 
9 0.93 ± 0.01e 1.05 ± 0.01e 
10 0.91 ± 0.01 e 1.08 ± 0.01e 
α-tocopherol 0.65 ± 0.04b 0.76 ± 0.05 b 
The samples were analyzed in triplicate (n = 3) and expressed as mean ± standard 
deviation. Means followed by different superscripts (a-e) within the same column 
indicated signiﬁcant differences (p < 0.05). *The bioactivities were expressed as IC50 
values (mg/mL) 
The prenylated spirocyclic ether derivatives, 1 and 2 displayed significantly 
greater (p < 0.05) antioxidant activities against DPPH radical (IC50 0.59 and 0.54 
mg/mL, respectively) compared to other compounds and standard, α-tocopherol (IC50
0.65 mg/mL). However, no noteworthy dissimilarity in DPPH quenching potencies 
were observed among furano meroterpenoid derivative, 5 (IC50 0.69 mg/mL), α-pyrone, 
4 (IC50 0.71 mg/mL), hexahydrobenzo furanone, 3 (IC50 0.63 mg/mL) and α-tocopherol 
(IC50 0.65 mg/mL) (p > 0.05) (Table 5.15.). The compounds, 1-5 registered greater 
DPPH radical scavenging activity as compared to hexahydro isochromenyls, 6-7 (IC50
~0.77 mg/mL) followed by steroidal analogues, 8 (IC50 0.86 mg/mL) and 9-10 (IC50
~0.92 mg/mL), in descending order (p < 0.05).    
The prenylated spirocyclic ether derivatives, 1 and 2 (IC50 0.62-0.67 mg/mL) 
and furano meroterpenoid, 5 (IC50 0.64 mg/mL) did not display any significant 
255 
Isolation and characterization of secondary metabolites from Villorita cyprinoides          Chapter 5 
difference with each other in ABTS+ radical scavenging activity (p > 0.05). The 
compounds 1-2 and 5 exhibited significantly greater ABTS+ radical scavenging 
properties (p < 0.05) when compared to other compounds (IC50 > 0.70 mg/mL) and 
commercially available α-tocopherol (IC50 0.76 mg/mL). Significantly greater (p < 
0.05) ABTS+ radical potentials were recorded for α-pyrone derivative, 4 (IC50 0.76 
mg/mL), hexahydrobenzo furanone derivative, 3 (IC50 0.72 mg/mL) followed by 
hexahydro isochromenyls, 6-7 (IC50 ~0.86 mg/mL) and steroidal analogues, 8-10 (IC50 
0.94-1.08 mg/mL), in descending order (Table 5.15.). 
 
5.3.3.2. Anti-inflammatory potentials of secondary metabolites isolated from 
EtOAc:MeOH extract of V. cyprinoides 
The anti-inflammatory potentials of title compounds (1 to 10) isolated from 
EtOAc:MeOH extract of V. cyprinoides were described in Table 5.16. The anti-
inflammatory potentials of these compounds determined by in vitro cyclooxygenase-1/2 
(COX-1/2) and 5-lipoxygenase (5-LOX) enzyme inhibitory assays. In addition, the 
selectivity indices were calculated from the ratio of IC50 values of anti-COX-1 to IC50 
values of anti-COX-2 potentials and the values were compared among the isolated 
bioactive compounds and standard, ibuprofen in Figure 5.144. 
The spirocyclic ether derivative, 2 implied significantly greater inhibitory 
activity (p < 0.05) against pro-inflammatory COX-1 and COX-2 (IC50 0.86 and 0.65 
mg/mL, correspondingly) as compared to other studied compounds (IC50 > 0.90 and > 
0.70 mg/mL, correspondingly). No significant difference (p > 0.05) in COX-1 inhibitory 
potentials was apparent among the spirocyclic ether derivative, 1 (IC50 0.94 mg/mL), 
furano meroterpenoid, 5 (IC50 0.91 mg/mL), α-pyrone, 4 (IC50 1.00 mg/mL) and 
hexahydrobenzo furanone derivative, 3 (IC50 0.96 mg/mL) (Table 5.16.). The anti-COX-
1 potencies were significantly higher for the compounds 1-5 (p > 0.05) followed by 
those recorded with hexahydro isochromenyl derivatives, 6-7 (IC50 ~1.08 mg/mL) and 
steroidal analogues, 8-10 (IC50 1.07-1.19 mg/mL). No significant similarity (p > 0.05) 
was observed for anti-COX-2 potentials among spirocyclic ether derivatives, 1 (IC50 
0.70 mg/mL), furano meroterpenoid derivative, 5 (IC50 0.76 mg/mL) along with 
hexahydrobenzo furanone, 3 (IC50 0.74 mg/mL) (Table 5.16.). The anti-COX-2 
potentials were notably higher for the compounds, 1-3 and 5 (p > 0.05) followed by α-
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pyrone, 4 (IC50 0.89 mg/mL), hexahydro isochromenyls, 6-7 (IC50 ~0.89 mg/mL) and 
steroidal analogues, 8-10 (IC50 1.05-1.15 mg/mL). Moreover, these compounds (1-10) 
displayed greater activity against inducible COX-2 than constitutive COX-1, and 
accordingly recorded greater selectivity indices (SI, IC50 anti-COX-1/IC50 anti-COX-2 > 
1.00) than anti-inflammatory drug, ibuprofen (0.63; selective towards constitutive pro-
inflammatory enzyme COX-1) (Figure 5.144.). The selectivity index was significantly 
greater for spirocyclic ether derivatives, 1-2 (SI ~1.33) followed by the compounds, 3-7 
(SI 1.12-1.22) and 8-10 (SI 1.02-1.04).  
Table 5.16.: In vitro anti-inflammatory {cyclooxygenase-1/2 (COX-1/2) and 5-
lipoxygenase (5-LOX)) radical scavenging assays} activities of secondary metabolites 
(1-10) isolated from EtOAc:MeOH extract of V. cyprinoides against commercially 
available standard, ibuprofen 
Compounds 
Anti-inflammatory activities 
IC50 values (mg/mL) 
*COX-1 scavenging
activity 
*COX-2 scavenging
activity 
*5-LOX
scavenging activity 
1 0.94 ± 0.05a 0.70 ± 0.03ab 0.77 ± 0.02a 
2 0.86 ± 0.06b 0.65 ± 0.03b 0.75 ± 0.02a 
3 0.96 ± 0.02a 0.74 ± 0.01a 0.76 ± 0.01a 
4 1.00 ± 0.06ac 0.89 ± 0.03c 0.92 ± 0.02b 
5 0.91 ± 0.06a 0.76 ± 0.01a 0.80 ± 0.01a 
6 1.05 ± 0.05c 0.90 ± 0.03c 0.96 ± 0.02b 
7 1.09 ± 0.02c 0.89 ± 0.01c 0.98 ± 0.01b 
8 1.07 ± 0.05c 1.05 ± 0.03d 1.03 ± 0.02b 
9 1.19 ± 0.04d 1.15 ± 0.03e 1.17 ± 0.02c 
10 1.16 ± 0.04d 1.12 ± 0.05e 1.19 ± 0.03c 
Ibuprofen 0.05 ± 0.02e 0.08 ± 0.05f 0.96 ± 0.03b 
The samples were analyzed in triplicate (n = 3) and expressed as mean ± standard 
deviation. Means followed by different superscripts (a-f) within the same column 
indicated signiﬁcant differences (p < 0.05). *The bioactivities were expressed as IC50 
values (mg/mL) 
Spirocyclic ether derivatives, 1-2 (IC50 0.75-0.77 mg/mL), hexahydrobenzo 
furanone, 3 (IC50 0.76 mg/mL) and furano meroterpenoid derivative, 5 (IC50 0.80 
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mg/mL) did not display any significant difference with each other with regard to anti-5-
LOX properties (p > 0.05). These compounds showed significantly greater (p < 0.05) 
activity when compared to other compounds and ibuprofen (IC50 > 0.90 mg/mL). The α-
pyrone derivative, 4 (IC50 0.92 mg/mL), hexahydro isochromenyls, 6-7 (IC50 ~0.97 
mg/mL) and sterol analogues, 8 (IC50 1.03 mg/mL) were showed anti-5-LOX activities 
greater than or comparable to the standard, ibuprofen (IC50 0.96 mg/mL) (Table 5.16.). 
Figure 5.144.: A comparison of selectivity indices (IC50 of anti-COX-1/IC50 of anti-
COX-2) calculated for the secondary metabolites (1-10) isolated from EtOAc:MeOH 
extract of V. cyprinoides along with commercially available standard, ibuprofen 
The commercially available NSAIDs, such as ibuprofen, were reported to 
inhibit both pro-inflammatory COX-1 and COX-2. The lesser selectivity ratio (anti-
COX-1IC50/anti-COX-2IC50) of the NSAIDs also explained the larger selective 
inhibition of constitutive COX-1 that can cause severe side effects such as gastric 
related health problems (Laneuville et al., 1994). Therefore, the search for compounds 
with specificity towards COX-2 inhibition was preferred due to the lesser 
gastrointestinal difficulties and safer therapeutic profiles. The greater selectivity index 
of the secondary metabolites (1-10) isolated from EtOAc:MeOH extract of V. 
cyprinoides (SI > 1.02) appropriately explained its specific inhibition towards COX-2 
activity than COX-1, and therefore, can be suggested as potential anti-inflammatory 
lead molecules (Figure 5.144.). 
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5.3.4.  Structure-activity relationship analysis of secondary metabolites isolated 
from EtOAc:MeOH extract of V. cyprinoides 
5.3.4.1.  Structure-activity relationship analysis of secondary metabolites from 
EtOAc:MeOH extract of V. cyprinoides using various molecular 
parameters 
The free radical scavenging and anti-inflammatory properties of the title 
compounds (1-10) were correlated between their structures and corresponding 
hydrophobic (log Pow) and electronic (tPSA/Pl) factors along with the steric bulk 
(MR/MV/Pr) to explain their bioactivities (Chakraborty et al., 2016d; Lipinski 2000). 
The molecular descriptor values for bioactive secondary metabolites isolated from V. 
cyprinoides (1-10) and commercially available products, α-tocopherol and ibuprofen 
were tabulated in the Table 5.17.  
The hydrophobicity factor (logarithmic scale of the octanol-water partition 
coefﬁcient, log Pow) was considered to be useful in predicting the antioxidant potentials 
of compounds. A drug with log Pow value lesser than 5 has been considered to possess a 
balanced hydrophobic-lipophilic properties leading to an effective intermembrane 
permeability (Lipinski and Hopkins 2004). The log Pow values of spirocyclic ether 
derivatives, 1-2 (log Pow 3.32-3.79), hexahydrobenzo furanone, 3 (log Pow 1.81), α-
pyrone, 4 (log Pow 3.59), furano meroterpenoid derivative, 5 (log Pow 2.25) and 
hexahydro isochromenyl analogues, 6-7 (log Pow 3.11-4.00) were found to be within the 
acceptable limits for optimum hydrophobic-lipophilic properties (Lipinski and Hopkins 
2004). The hydrophobicity of title compounds, 1-10 were found to be lesser (log Pow < 
7.6) when compared to the reference, α-tocopherol (log Pow 9.98) (Table 5.17.). The 
greater antioxidant activity of the compounds, 1-5 and their acceptable lipophilic levels 
demonstrated their potential utilities as selective pharmacophore molecules. The 
importance of hydrophobicity to determine the inter-membrane permeability and 
antioxidative properties was previously illustrated (Ishige et al., 2001). The signiﬁcantly 
greater hydrophobicity of α-tocopherol thus, explained its lesser antioxidant properties. 
Further, the bioactivities of the isolated compounds were correlated with their steric 
bulk values, such as molar refractivity (MR), molar volume (MV) and parachor (Pr) 
values. The lower steric parameters of titled secondary metabolites, 1-2 (MR 106-119 
cm3/mol; MV 348-371 cm3; Pr 876-959 cm3), irregular meroterpenoids, 3-5 (MR 71-78 
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cm3/mol; MV 251-278 cm3; Pr 595-665 cm3) and hexahydro isochromenyl derivatives, 
6-7 (MR 81-95 cm3/mol; MV 268-317 cm3; Pr 665-783 cm3) appropriately explained 
their relatively lesser steric hindrance and greater antioxidative activities compared to α-
tocopherol with greater steric bulk (MR 135.06 cm3/mol; MV 462.7 cm3; Pr 1123 cm3) 
values.  
The electronic property of a compound could be directly correlated to its 
greater free radical scavenging and anti-inﬂammatory activities (Chakraborty et al., 
2017c). Notably, α-tocopherol recorded lesser values of total polar surface area, tPSA 
(29.46) compared to the spirocyclic ether derivatives, 1-2 (tPSA > 55), irregular 
meroterpenoids, 4-5 (tPSA 35.53) and hexahydro isochromenyl derivatives, 6-7 (tPSA 
35.53), which signiﬁed their greater electronic interaction resulting in potentially higher 
free radical scavenging activities.  
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Table 5.17.: The molecular descriptors of secondary metabolites from EtOAc:MeOH extract of V. cyprinoides (1-10) and commercially 
available products 
Electronic Steric Hydrophobic 
tPSA Pl (X10-24 cm3) MR (cm3/mol) MV (cm3) Pr (cm3) Log Pow 
1 
55.76 41.51 106.90 348.1 876.8 3.79 
2 
75.99 45.75 119.01 371.7 959.6 3.32 
3 
72.83 30.43 78.14 263.6 659.4 1.81 
4 
35.53 30.64 78.72 278.0 665.0 3.59 
5 
35.53 27.89 71.22 251.1 595.8 2.25 
6 
35.53 37.14 95.91 317.4 783.4 4.00 
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O
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7 
35.53 31.64 81.93 268.1 665.2 3.11 
    8 
26.30 49.49 126.91 405.8 1011.1 7.21 
9 
40.46 49.96 128.28 398.7 1015.5 6.33 
10 
20.23 51.16 132.76 410.3 1028.2 7.59 
O
HO
α-tocopherol 
29.46 53.54 135.06 462.7 1123.0 9.98 
O
OH
Ibuprofen 
37.30 23.96 60.44 200.1 499.3 3.75 
tPSA: Topological Polar Surface Area; Pl: polarizability; MR: molar refractivity; MV: molar volume; Pr: parachor; Log Pow: logarithm of 
octanol-water coefficient. The molecular descriptors were calculated by using ChemDraw® Ultra (CambridgeSoft Corporation, Cambridge, 
MA, USA; ver. 8.0) and ACD ChemSketch (Advanced Chemistry Development, Inc., Canada; vers. 12.0) softwares 
HO
HO
OH
O
O
O
O
O
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Likewise, the studied compounds, 1 (tPSA 55.76), 2 (tPSA 75.99) and 3 
(tPSA 72.83) displayed greater tPSA values when compared to reference, ibuprofen 
(tPSA 37.30) consequently, echoed its signiﬁcantly higher inhibiting activities towards 
pro-inﬂammatory 5-LOX (IC50 anti-5-LOX 0.75-0.77 mg/mL) than ibuprofen (IC50 0.96 
mg/mL). The electronic property determined by polarizability factor, Pl was found to be 
greater for title compounds, 1-10 (Pl > 26) as compared to that recorded with ibuprofen 
(Pl 23.96). The polarizability factor registered for spirocyclic ether derivatives (1-2), 
hexahydro isochromenyls (6-7), irregular meroterpenoids (3-5) and steroidal analogues 
(8-10) were found to be 41-45, 31-37, 27-30 and 49-51, respectively (Table 5.17.). The 
hydroxy and oxaspiro-dec-diene in 1-2, hydroxy hexahydro-oxoisobenzofuranyl 
skeleton of 3, methoxy pyran ring in 4, pyran-furanone moiety in 5 and hexahydro 
isochromenyl in 6-7 appeared to play predominant roles to increase the electron 
delocalizations and provide free hydrogens to efficiently neutralize the free radicals by 
hydrogen atom transfer (HAT) mechanism, which in turn, appeared to diminish the 
inﬂammatory responses (Chakraborty et al., 2016d). The presence of greater numbers of 
electron withdrawing groups and centre of unsaturations, such as oxo-pyran, furanones, 
hydroxyl, carboxylates and furanyl moieties in compounds 1-3 appeared to increase its 
electronic properties (tPSA1-3 > 55) than other compounds in the series (tPSA4-10 20-
35). Greater number of electronegative centers enhances its higher bioactive properties 
due to effective electron transfer (Cai et al., 2006). Therefore, greater electronic 
property of 2 appropriately manifested its superior bioactivities compared to other 
compounds in the series.  
Free radical formation and accumulation in body was the focal cause for 
various oxidative stress induced disorders, for instance, inﬂammation, and therefore, the 
antioxidant property of a compound can appropriately describe its anti-inﬂammatory 
activity. Recent studies indicated that the selective inhibition of 5-LOX is a preferred 
mechanism to inhibit inﬂammatory responses in metabolic systems (Martel-Pelletier et 
al., 2003). Principally, ibuprofen showed signiﬁcantly lesser activity against 5-LOX 
enzyme compared to the compounds isolated from V. cyprinoides in this study. 
Furthermore, the signiﬁcantly greater selectivity indices of compounds 1 to 10 
compared to ibuprofen demonstrated their capacities to selectively inhibit inducive 
inﬂammatory response. The primary origin of inﬂammatory response was found to be 
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due to the excessive free radical species. A statistically signiﬁcant similarity between 
the capacity of the compounds puriﬁed in the present study to suppress free radicals and 
pro-inﬂammatory COX-2 and 5-LOX further corroborated the closer relation between 
oxidative stress and inﬂammatory response. Based on these results, greater antioxidant 
or anti-inﬂammatory activities were observed for compounds, 1-5, especially 
spirocyclic ether derivatives, 2. It can therefore, be inferred that the radical scavenging 
or anti-inﬂammatory activity of compound 2 is primarily caused by the oxaspiro-dec-
diene, hydroxyl and ester moieties present in it. Bioactive potentials of the studied 
compounds were corroborated with their molecular descriptor values and suggested its 
greater selectivity as pharmacophore molecules. 
5.3.4.2.  Suggested antioxidative mechanism of secondary metabolites isolated 
from V. cyprinoides in the DPPH radical model system 
The compound 1 comprised of two antioxidant reaction centres and 
compound 2 enclosed three reaction sites of bioactivity (Figure 5.145.). The two 
primary reaction centres were similar for both the compounds. The alkenic proton at C-
8 in the oxaspiro[4.5]dec-3,8-dienyl group contributed in the extended conjugation, and 
thus can be easily transferred to the DPPH radical. The proton at C-12 (in the of side 
chain) assisting in keto-enol resonance with the adjacent >C=O group (at C-13) leading 
to the formation of CH=C(-OH)- moiety by relocating the proton at C-12 to DPPH 
radical. The second one was related to the proton in the hydroxyl attached at C-16 
position in the side chain. In compound 2, one reaction center was at C-8 in conjugation 
with the proton at C-11 (in the side chain) assisted in keto-enol resonance with the 
adjacent >C=O group (at C-12) leading to the formation of CH=C(-OH)- moiety (Figure 
5.145.). This was found to be the primary active reaction site for transferring the protons 
to neutralize the DPPH radical. The remaining two reaction sites were related to the 
protons in the hydroxyl groups located at C-17 and C-19 positions in the side chain. 
Thus, the greater DPPH scavenging potentials of compound 2 (IC50 0.54 mg/mL) 
compared to that exhibited by 1 (IC50 0.59 mg/mL) was correlated with the suggested 
antioxidative mechanism in DPPH radical model. 
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Figure 5.145.: Suggested antioxidative mechanism of spirocyclic ether derivatives (1-2) 
in DPPH radical model system 
The compound 3 was found to comprise with three active antioxidant reaction 
centers (Figure 5.146.). The hydroxy hexahydro oxoisobenzofuranyl ring of 3 enclosed 
one active center in extended alkenic conjugation along with hydroxyl group and the 
second one was related to the ester group in the ring. The proton at olefinic group (C-6) 
appeared to take part in extended conjugation, and intramolecular rearrangement, to 
ebable interacting with the DPPH radical. The proton at C-3a (in the ring junction 
linked to the furanone group) might probably assist in keto-enol resonance with the 
adjacent >C=O group (at C-3) leading to the formation of CH=C(-OH)- moiety by 
relocating the proton to DPPH radical. The third active site was found to be in the ethyl 
pentanoate side chain. The proton at C-11 (in the side chain next to ester linkage) might 
assist in keto-enol resonance with the adjacent >C=O group (at C-10) leading to the 
formation of CH=C(-OH)- moiety by transferring the proton to neutralize the DPPH 
radical. These three reaction centres might participate in the resonance stabilization, and 
therefore, appeared to exhibit primary role stabilizing the DPPH radical. 
Compound 4 comprises a tetrahydro-3-methoxy-pyranone conjugated system 
as the basic skeleton that can potentially transfer proton from C-3 to DPPH radical 
(HAT mechanism) to form 3-methoxy-dihydro-pyranol (Figure 5.146.). The proton at 
C-3 could be involved in keto-enol resonance by relocating the proton at C-3 to DPPH 
radical. Likewise, two bioactive reaction centers at C-2 and C-3 with hydroxyl (keto to 
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hydroxyl) groups might play predominant role to enhance the radical scavenging ability 
of compound 4.  
The dihydro-pyran and dihydro-furanone were the two active centers in 5 
(Figure 5.146.). The readily available proton at C-3 was transferred to DPPH radical 
and appeared to undergo resonance stabilization with keto group at C-2 (dihydro-
furanone) leading to the formation of hydroxyl group (dihydro-furanol). Similarly, the 
protons in dihydro-pyran ring of 5 might be relocated and resonance stabilized to form 
hydroxyl group at C-8 that could potentially scavenge the free radicals.  
Figure 5.146.: Suggested antioxidative mechanism of irregular meroterpenoid 
derivatives (3-5) in DPPH radical model system 
The compounds, 6 and 7 were found to comprise two reaction sites each, 
whereas one of them were located in the hexahydro isochromenyl ring and the other at 
the carboxylate group (Figure 5.147.). The protons at C-12 and C-11 of compounds 6 
and 7, respectively appeared to participate in the keto-enol delocalization with the 
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neighboring >C=O group resulting in the formation of -CH-(OH)- moiety by the 
replacement of proton to DPPH radical. The presence of hydroxyl containing 
compounds were effective in neutralizing the free radical species in the biological 
system (Derochette et al., 2014), and this could be attributed to the antioxidant 
properties of hexahydro isochromenyl compounds. 
Figure 5.147.: Suggested antioxidative mechanism of hexahydro isochromenyl 
derivatives (6-7) in DPPH radical model system 
The cholestenol derivative, 8 possess two active sites, whereas one of them 
were located at the ester group in the side chain was found to be primary active site and 
the second one was related to olefinic proton at C-1 in extended conjugation (Figure 
5.148.). The compounds, 9 and 10 enclosed identical antioxidative reaction centers at 
hydroxyl attached position, C-3 in conjugation with olefinic proton at C-6. The free 
electron pair of the -OH may not effectively participate in the resonance with the 
tetracyclic ring (Figure 5.148.). The protons of -CHOH group located at C-3 position of 
9 and 10 are weakly acidic in nature, and therefore, might form a weakly stabilized 
diphenyl picryl-hydrazine (DPPH-H). The compound 9 contained an additional reaction 
center in the side chain (related to hydroxyl), and that could potentially transfer protons 
to the DPPH radical through the keto-enol resonance stabilization.  
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Figure 5.148.: Suggested antioxidative mechanism of cholestenol derivatives (8-10) in 
DPPH radical model system 
The proposed antioxidative mechanism of titled secondary metabolites (1-10) 
from V. cyprinoides in DPPH radical model system corroborated with the in vitro DPPH 
radical scavenging assay. The spirocyclic ether derivative, 2 was found to possess 
greater number of active antioxidant reaction centers and electronegative groups in 
extended conjugation. Accordingly, it can potentially transfer H atom to neutralize the 
DPPH radical to form resonance stabilized structures, consequently demonstrated its 
greater antioxidant activity. Similarly, the spirocyclic ether derivative, 1 and 
hexahydrobenzo furanone derivative, 3 were found to comprise primarily active 
reaction centres along with electronegative groups, which might actively interact with 
the DPPH radical. 
5.3.5.  In silico molecular docking studies of selected compounds (1-5) from V. 
cyprinoides 
The molecular docking studies were revealed the interactions between the 
selected compounds from V. cyprinoides with the active sites of target pro-
inflammatory COX-2 and 5-LOX. The molecular docking studies were performed for 
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the ten compounds against COX-2 and 5-LOX enzymes, respectively and their RMSD 
results were analyzed. The docked conformations with lowest binding energies 
(compounds 1-5) were selected for docking visualization to calculate the number of 
hydrogen bonds and the molecular binding interactions with the active sites of COX-2 
and 5-LOX. The number of hydrogen bonds, hydrogen bonded amino acid residues, 
binding energy, docking score, inhibition constant, intermolecular energy and torsional 
free energy between the compounds 1-5 and the active sites of COX-2 and 5-LOX 
enzymes were recorded in the Table 5.18. and 5.19., respectively. 
In silico molecular docking studies of the selected compounds with COX-2 
receptor revealed that all the docked ligands might bind with the targets and exhibited 
lowest binding energies ranging from -7.06 to -8.98 kcal/mol along with lowest docking 
scores of -7.60 to -10.85 kcal/mol (Table 5.18.). Particularly, irregular spirocyclic ether 
derivative, 2 registered lowest binding energy and docking score of -8.98 and -10.85 
kcal/mol, respectively followed by spirocyclic ether derivative, 1 (-8.72 and -10.26 
kcal/mol, respectively) and hexahydrobenzo furanone derivative, 3 (-7.39 and -8.70 
kcal/mol, respectively). The enzyme inhibition constants, Ki was found to be lesser for 
compound 2 (1.01 μM) followed by 1 (1.31 μM) and 3 (3.82 μM) when compared to 4-
5 (5.38-6.68 μM). Also, the intermolecular energy and torsional free energies were 
found to be lesser for irregular spirocyclic ether derivatives, 1-2 (-10.21 to -10.97 and 
1.39 to 1.49 kcal/mol, respectively) followed by hexahydrobenzo furanone, 3 (-8.88 and 
-1.49 kcal/mol, respectively) (Table 5.18.). These results demonstrated the lowest 
binding energy and docking score of 2 that in turn, indicated its greater enzyme 
inhibition activities against COX-2. The compound 2 has showed four H-bond residues 
such as LEU 224.B, GLU 126.A (two H-bonds), TRP 125.A (Figure 5.149.B) in the 
active pocket site whereas, the compound 1 exerted two hydrogen bonding interactions 
with GLU 222.B (Figure 5.149.A). The compounds 3 (ARG 319.B, THR 223.B, LEU 
131.A (two H-bonds); Figure 5.149.C) and 4 (GLN 227.B, THR 223.B, GLU 222.B, 
ARG 319.B; Figure 5.149.D) displayed four hydrogen bonds whereas, compound 5 
showed three hydrogen bonded residues (ARG 319.B (two H-bonds), GLY 227.B; 
Figure 5.149.E). The greater number of hydrogen bonds in the active site of COX-2 and 
the lower values of docking parameters (binding energy, docking energy and inhibition 
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constant) recorded for 2 was found to be coherent with its greater bioactive potentials 
obtained from the in vitro COX-2 inhibition assay (IC50 0.65 mg/mL).  
Figure 5.149.: The molecular binding interactions of compounds (A) 1, (B) 2, (C) 3, 
(D) 4 and (E) 5 in the active site of cyclooxygenase (COX-2) were comprehended from 
the docking studies. The orange and blue coloured bonds were indicated the H-bonding 
correlations with COX-2 
The molecular docking studies of compounds (1-5) with pro-inflammatory 5-
LOX revealed their lowest binding energies ranging from -1.75 to -7.58 kcal/mol along 
with lowest docking scores of -2.15 to -9.20 kcal/mol (Table 5.19.). Notably, the 
spirocyclic ether derivative, 2 registered lesser binding energy and docking score of -
7.58 and -9.20 kcal/mol, respectively followed by those of hexahydrobenzo furanone, 3 
(-5.49 and -6.26 kcal/mol, respectively) and spirocyclic ether derivative, 1 (-5.06 and -
8.54 kcal/mol, respectively). The inhibition constants, Ki was found to be lesser for 2 
(2.78 μM) followed by those of 3 (2.90 μM) and 1 (3.32 μM) when compared to those 
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recorded by 4-5 (7.34-8.21 μM). The intermolecular energy and torsional free energies 
were found to be lesser for compounds 1-3 (-6.28 to -9.37 and 1.49 to 1.79 kcal/mol, 
respectively). These results appropriately substantiated the greater enzyme inhibition 
activities of compound 2 against 5-LOX.  
Figure 5.150.: The molecular binding interactions of compounds (A) 1, (B) 2, (C) 3, 
(D) 4 and (E) 5 in the active site of lipoxygenase (5-LOX) were comprehended from the 
docking studies. The orange and blue coloured bonds were indicated the H-bonding 
correlations with 5-LOX 
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Table 5.18.: Number of hydrogen bonds, hydrogen bonded (H-bonded) amino acid residue, binding energy, docking score, inhibition 
constant, intermolecular energy and torsional free energy between the ligands (compounds 1-5) and the active sites of COX-2 
Ligands †No. ofH-bonds 
#H-bonded amino 
acid residues 
*Binding
energy
(kcal/mol) 
*Docking
score 
(kcal/mol) 
*Inhibition
constant, Ki 
(µM) 
*Intermolecular
energy 
(kcal/mol) 
*Torsional
free energy 
(kcal/mol) 
1 2 GLU 222.B GLU 222.B -8.72 -10.26 1.31 -10.21 1.49 
2 4 
LEU 224.B 
GLU 126.A 
GLU 126.A 
TRP 125.A 
-8.98 -10.85 1.01 -10.97 1.39 
3 4 
ARG 319.B 
THR 223.B 
LEU 131.A 
LEU 131.A 
-7.39 -8.70 3.82 -8.88 1.49 
4 4 
GLN 227.B 
THR 223.B 
GLU 222.B 
ARG 319.B 
-7.06 -8.69 6.68 -8.85 1.79 
5 3 
ARG 319.B 
ARG 319.B 
GLY 227.B 
-7.19 -7.60 5.38 -7.79 1.60 
†Molecular docking studies were carried out using the software Autodock 4. #Hydrogen bonding interactions between protein and ligand. 
*Values were obtained from the energy minimization based calculations
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Table 5.19.: Number of hydrogen bonds, hydrogen bonded (H-bonded) amino acid residue, binding energy, docking score, inhibition 
constant, intermolecular energy and torsional free energy between the ligands (compounds 1-5) and the active sites of 5-LOX 
Ligands †No. ofH-bonds 
#H-bonded amino 
acid residues 
*Binding
energy
(kcal/mol) 
*Docking
score 
(kcal/mol) 
*Inhibition
constant, Ki 
(µM) 
*Intermolecular
energy 
(kcal/mol) 
*Torsional
free energy 
(kcal/mol) 
1 1 ILE 765.A -5.06 -8.54 3.32 -8.57 1.49 
2 3 
LEU 622.A 
GLU 625.A 
ILE 624.A 
-7.58 -9.20 2.78 -9.37 1.79 
3 3 
SER 768.A 
SER 768.A 
LEU 764.A 
-5.49 -6.26 2.90 -6.28 1.79 
4 1 SER 768.A -5.62 -7.07 7.34 -7.12 1.49 
5 1 ASN 713.A -1.75 -2.15 8.21 -2.45 1.69 
†Molecular docking studies were carried out using the software Autodock 4. #Hydrogen bonding interactions between protein and ligand. 
*Values were obtained from the energy minimization based calculations.
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The compounds, 2 and 3 on molecular docking simulation displayed four 
hydrogen bonded residues, named LEU 622.A, GLU 625.A, ILE 624.A (Figure 
5.150.B) and SER 768.A (two H-bonds), LEU 764.A, respectively (Figure 5.150.C) in 
the active pocket site, whereas 1 (ILE 765.A; Figure 5.150.A), 4 (SER 768.A; Figure 
5.150.D) and 5 (ASN 713.A; Figure 5.150.E) displayed one hydrogen bonding each. 
The greater number of hydrogen bonds in the active site of 5-LOX and lesser values of 
binding energy/docking energy obtained for 1, 3 and 4 were found to be linear with the 
greater in vitro anti-5-LOX potentials (IC50 0.75-0.77 mg/mL). 
The docking study of selected compounds (1-5) isolated from V. cyprinoides 
on binding sites of 5-LOX and COX-2 showed that these ligands were dual COX-2/5-
LOX inhibitors. The good binding interactions of the ligands with the target pro-
inflammatory enzymes were explained the significant biological activity of the 
compounds, 1 through 5 isolated in the present study. Also, it revealed the specificity of 
these compounds with COX-2 and 5-LOX enzymes that in turn, suggested their greater 
selectivities towards the target anti-inflammatory properties. 
 
5.4. Conclusions 
The ethyl acetate:methanol extract of venerid bivalve clam, Villorita 
cyprinoides was chromatographically fractionated to acquire bioactive secondary 
metabolites, which were classified under various classes of chemistries, such as 
irregular spirocyclic ether derivatives (1-2), irregular meroterpenoids (3-5), 
isochromenyl analogues (6-7) and cholestenol derivatives (8-10). The chemical 
structures of these previously undescribed specialized metabolites were resolved by 
detailed spectroscopic analysis.  
The titled compounds were assessed for antioxidant (DPPH and ABTS+ 
scavenging) and anti-inflammatory (COX-1, COX-2 and 5-LOX inhibition) properties. 
The compounds, 16-hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-
10-propanoate (1), (E)18-ethyl-17,19-dihydroxyhept-14-enyl-(2-ethyl-2,6-dimethyl-1-
oxaspiro[4.5]dec-3,8-dien)-10-acetate (2) and 8-(1,3,3a,4,5,7a-hexahydro-1-(hydroxy 
methyl)-3-oxoisobenzofuran-4-yl)-ethyl pentanoate (3) were exhibited comparatively 
greater pro-inﬂammatory 5-lipoxygenase (5-LOX) inhibition potential (IC50 0.75-0.77 
mg/mL) in consonant with signiﬁcantly greater anti-inﬂammatory selectivity indices 
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(SI, anti-cyclooxygense-1IC50/anti-cyclooxygense-2IC50 > 1.10) than that displayed by 
non-steroidal anti-inﬂammatory drug, ibuprofen (IC50 0.96 mg/mL, SI < 1). Likewise, 
the irregular meroterpenoids (4-5) and hexahydro isochromenyl derivatives (6-7) were 
exhibited comparable pro-inﬂammatory 5-lipoxygenase (5-LOX) inhibition potentials 
(IC50 0.80-0.98 mg/mL) to that displayed by the reference, ibuprofen (IC50 0.96 mg/mL) 
and signiﬁcantly greater anti-inﬂammatory selectivity indices (SI > 1.10) than ibuprofen 
(SI < 1).  
The antioxidant activities of the spirocyclic ether derivatives 1-2, as 
determined by DPPH and ABTS+ inhibitory activities (IC50 0.54-0.59 and 0.62-0.67 
mg/mL, respectively) were appeared to be greater than those recorded with 
commercially available α-tocopherol (IC50 0.65 and 0.76 mg/mL, correspondingly). The 
compounds, 3, 4 and 5 were displayed comparable antioxidant potentials (IC50 0.63-
0.71 and 0.64-0.76 mg/mL, correspondingly) to α-tocopherol. Structure activity 
correlation studies displayed that antioxidative and anti-inflammatory pluralities of 
studied compounds were linearly related to the electronic factors, whereas steric bulk 
and hydrophobic parameters were inversely correlated. The proposed antioxidative 
mechanisms of titled secondary metabolites in DPPH radical model system could be 
corroborated with the in vitro DPPH radical scavenging assay. These mechanisms 
further supported the greater antioxidant potentials of the spirocylic ether derivative, 2 
followed by hexahydrobenzo furanone, 3 and spirocylic ether derivative, 1, which can 
easily dislocate the DPPH radical in the system. The docking studies of selected 
compounds (1-5) from V. cyprinoides on the binding sites of 5-LOX and COX-2 
demonstrated their COX-2/5-LOX dual inhibitory action, particularly, the inhibitory 
action of spirocylic ether derivative, 2. The binding interactions explained their 
significant biological activity and revealed the specificity of the titled compounds 
towards pro-inflammatory COX-2 and 5-LOX enzymes. Utilization of the hitherto 
undescribed compounds isolated from V. cyprinoides predominantly, spirocyclic ether 
derivatives could effectively substitute the commercially available synthetic 
antioxidative food additives and can act as potential anti-inflammatory pharmacophore 
leads. 
 
 
275 
 
CHAPTER 6 
ISOLATION AND CHARACTERIZATION OF 
SECONDARY METABOLITES FROM 
PAPHIA MALABARICA 
Contents 
6.1.  Background 
6.2.  Materials and methods 
6.3.  Results and discussion 
6.4.  Conclusions 
6.1. Background 
The oxidative stress in the cell organelles stimulate several unfavourable 
effects in our body leading to various ailments, particularly ageing, hypertension, 
inflammatory reactions, diabetes, cancer, etc., that were found to depend on the 
accumulation of reactive oxygen species (Lushchak 2011). Thus, there is an increased 
interest in pharmacological agents that can control or quench the free radicals from 
accumulating in the biological systems. The natural products from marine or estuarine 
organisms, such as bivalves were adapted to the adverse living conditions in their 
ecosystems. These organisms were reported to biosynthesize bioactive secondary 
metabolites as an adaptive mechanism and recognized as valuable pharmacophores for 
use against various oxidative stress and inflammatory disorders (Gonzalez et al., 2015). 
The recent research efforts on natural bioactives with lesser side effects and improved 
effectiveness over synthetics are concerted from the marine/estuarine bivalve mollusks 
with greater radical quenching potentials, to sustain in their unfavourable habitats. 
Bivalve mollusks are traditional seafoods with wide variety of bioactive secondary 
metabolites and considered as valuable nutritional and commercial resources 
(Chakraborty et al., 2014a; Chakraborty et al., 2016a; Chakraborty et al., 2016b 
Wakimoto et al., 2011).  
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 The mollusks were reported for the occurrence of several bioactive small 
molecular weight secondary metabolites belonging to heterocyclics, chromenes, 
pyranoids, terpenes and sterols with diverse biological functions such as antioxidative, 
anti-diabetic, anti-inflammatory, etc. (Appleton et al., 2002; Wu et al., 2013). Ciavatta 
et al., (2011) reported pyranoid cladiellane diterpene derivatives from mollusk, 
Tritoniopsis elegans. The mollusk, Kelletia kelletii was reported for anti-bacterial 
compounds, such as erythrityl-tetrakis-hydroxybenzoate and 2-deoxy-D-ribityl-tetrakis-
hydroxybenzoate which enclosed benzoate frameworks in their chemical structure 
(Tymiak and Rinehart 1983). The steroidal alkaloids, steroid-amino acid conjugates, 
spiro A/B ring containing steroids were isolated from marine organisms (Amagata et al., 
2003; Su et al., 2007). 
 Paphia malabarica (Veneridae) is a filter feeding organism which mainly 
scattered in the southwestern coasts of India. The EtOAc:MeOH (1:1, v/v) solvent 
extract of P. malabarica was showed promising anti-inflammatory and antioxidative 
potencies by different in vitro experiments. In this point of view, this chapter was 
directed towards the isolation and characterization of bioactive secondary metabolites 
from the EtOAc:MeOH extract of P. malabarica by repeated chromatographic 
fractionation techniques. The characterized secondary metabolites were classified under 
various classes of compounds, such as aryl polyketide derivatives (1-3), tetrahydro 
chromenyl analogues (4-5), isopimarane norditerpenoid (6), meroterpeno pyranoids (7-
8) and cholestenol derivatives (9-10). The titled compounds were characterized by
various spectroscopic techniques, such as nuclear magnetic resonance (NMR) including 
one and two dimensional (2D NMR) experiments, FTIR and mass analyses. A putative 
biosynthetic pathways catalyzed by polyketide synthase leading to the formation of 
three aryl polyketide compounds were used to corroborate the structural attributions of 
compounds, 1-3. The chromatographic fractions and pure compounds were evaluated 
for their in vitro anti-inflammatory and free radical inhibition potentials. The target 
bioactivities of titled compounds were correlated with their structural parameters using 
different physicochemical descriptors, such as hydrophobic parameter, electronic 
descriptor variables and steric factors. This chapter also proposed putative antioxidative 
mechanisms for the titled bioactive secondary metabolites (1-10) in the DPPH radical 
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model system. The modes of inhibitions of 5-LOX/COX-2 enzymes by candidate 
compounds were determined by molecular docking simulations. 
6.2.  Materials and methods 
6.2.1.  Chemicals, reagents and instrumentations 
 The chemicals, reagents and instrumentations were utilized as mentioned in 
the section 5.2.1. under Chapter 5. 
6.2.2.  Chromatographic analyses 
6.2.2.A.  Column chromatography (CC) 
 The column chromatographic experimentations were used as mentioned in the 
section 5.2.2.A. under Chapter 5.  
6.2.2.B.  Flash chromatography 
 The fractions were resolved by flash chromatography as mentioned in the 
section 5.2.2.B. under Chapter 5. 
6.2.2.C.  Thin layer chromatography (TLC) 
 The thin layer chromatographic techniques and preparative thin layer 
chromatographic methods were performed as mentioned in the section 5.2.2.C. under 
Chapter 5. 
6.2.2.D.  High pressure liquid chromatography (HPLC) 
 The preparatory high pressure liquid chromatography (HPLC) and analytical 
high pressure liquid chromatography (HPLC) systems were used as explained in the 
section 5.2.2.D. under Chapter 5. 
6.2.3.  Spectrophotometric analyses 
 The UV-VIS spectrophotometric experimentations were carried out as 
mentioned in the section 5.2.3. under Chapter 5.   
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6.2.4.  Spectroscopic analyses 
6.2.4.A.  Fourier transform infrared (FTIR) spectroscopy 
 The Fourier transform infrared (FTIR) analyses were carried out as explained 
in the section 5.2.4.A. under Chapter 5. 
6.2.4.B.  Mass spectrometry 
 The mass spectrometry experiments were executed by the technique as 
demonstrated in the section 5.2.4.B. under Chapter 5. 
6.2.4.C.  Nuclear magnetic resonance (NMR) spectroscopy 
 The one and two dimensional NMR experimentations were carried out as 
explained in the section 5.2.4.C. under Chapter 5. 
6.2.5.  Animal material and extraction 
 The shell-on samples of P. malabarica (10 kg) were freshly aquired from 
their natural habitat at the Ashtamudi Lake (8°59’ N and 76°36’ E) located along the 
southwest coast of Arabian Sea. After cleaning the external matters, P. malabarica 
(Figure 6.1.) were transported to laboratory in ice boxes. The shell-on samples were 
thoroughly washed in running distilled water and the edible flesh (6 kg) was manually 
taken from shells without applying heat. The edible flesh samples were thereafter 
homogenized by grinding before being kept for overnight in the deep freezer (ultra-low 
temperature freezer, Eppendorf, Hamburg, Germany) for freezing at -80°C. The 
contents were thereafter lyophilized by freeze drier (Alpha 1-4 LD plus, Martin Christ, 
Germany; Scanvac, CoolsafeTM Denmark) for 48 h to yield the freeze dried clam 
samples (1500 g; yield 25 g/100 g on dry weight). This was powdered and stored in 
vacuum packed polyethylene biohazard autoclave bags (FisherbrandTM, Fischer 
Scientific) in the deep freezer at -80°C until further processing. The dried clam powder 
was used for the solvent extraction. 
The lyophilized powder (1500 g) of bivalve clam material was homogenized 
with ethyl acetate:methanol (EtOAc:MeOH, 1:1, v/v) by sonication (Elma, Hohentwiel, 
Germany) followed by shaking (Orbital shaker, Labline, India) in the presence of 
nitrogen for 4 h. This procedure was continued for three to four times to afford 
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maximum bioactive components in crude extract. The extracts were then filtered 
through filter paper (Whatman No. 1) using Na2SO4 (30 g) to obtain the clarified 
filtrates. The solvent filtrates were concentrated (40°C) in the rotary evaporator 
(Heidolph, Germany; IKA, Germany) to afford concentrated extracts of P. malabarica. 
The extracts were completely dried in the rotational vacuum concentrators (RVC, 
Martin Christ, Germany) to yield corresponding solvent extracts of P. malabarica (55 g; 
3.67 g/100 g yield on dry weight basis). The solvent extract was kept under an inert 
nitrogen atmosphere and used for the chromatographic purifications to isolate bioactive 
principles.  
 
Figure 6.1.: The fresh shelled P. malabarica samples collected from the estuarine 
waters of Ashtamudi Lake (8°59’ N and 76°36’ E) located along the southwest coast of 
Arabian Sea, India 
 
6.2.6. Chromatographic purification of pure compounds from P. malabarica 
 The crude extract of P. malabarica (50.0 g) was partitioned by repeated 
column chromatographic experiments over adsorbent silica. The schematic diagram 
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showing the purification of EtOAc:MeOH extract of P. malabarica was shown in 
Figure 6.2. The extract was made into slurry with silica (60-120 mesh, 6 g) and pre-
packed into a column (1000 mm X 40 mm) enclosing silica gel as adsorbent (60-120 
mesh). The column was initiated with 100% n-hexane followed by EtOAc and methanol 
to obtain six different factions (PM1 to PM6). The column fractions were assessed for 
anti-inflammatory and antioxidant activities. The fractions, PM3, PM4 and PM6 were 
subjected to further chromatographic fractionation due to its relatively greater 
antioxidant and anti-inflammatory activities compared to other fractions.  
 The fraction, PM3 (6.42 g; 12.84%) was carried out to vacuum liquid 
chromatography on a glass column (450 mm X 30 mm) packed with silica (230-400 
mesh). The polarity of eluent was regularly increased by the addition of n-
hexane/EtOAc/MeOH to endow 21 fractions of 32 mL each and were compiled to 8 
groups (PM3-1 to PM3-8) based upon TLC (n-hexane:EtOAc, 9:1, v/v) experiments. 
Fraction, PM3-3 (1.52 g; 3.04%) eluted with 10% n-hexane:EtOAc (v/v) was flash 
chromatographed (Biotage AB SP1-B1A, 230-400 mesh, 12 g; Biotage AB, Uppsala, 
Sweden) on a silica gel column at a collection UV wavelength of 254 nm. The eluent 
polarity was initiated from 100% n-hexane followed by EtOAc and MeOH to furnish a 
total of 55 fractions (9 mL each), which were pooled to four fractions (PM3-3-1 through 
PM3-3-4) based on analytical TLC (n-hexane:EtOAc, 9:1, v/v). The fraction, PM3-3-1 was 
further fractionated over preparatory TLC on silica gel GF254 using n-hexane:EtOAc 
(49:1, v/v) afforded compound 10 (82 mg; 0.16%) as major component. The solvents 
were evaporated and assessed for TLC (silica GF254; n-hexane:EtOAc, 95:5, v/v) to 
confirm its purity. The fraction, PM3-3-2 was further fractionated over preparatory TLC 
on silica gel GF254 using n-hexane:EtOAc (46:4, v/v) afforded compound 9 (148 mg; 
0.30%), as major component. The TLC of this fraction over silica gel GF254 using 10% 
n-hexane:EtOAc (v/v) supported its purity. The sub-fraction PM3-1 (1.5 g; yield 3.00%) 
was found to be mixture and exhibited higher bioactivity. It was further resolved by 
flash chromatography (BiotageAB SP1-B1A, Sweden) on 230-400 mesh silica at 256 
nm (collection wavelength) with increasing eluent polarity of n-hexane/EtOAc/MeOH 
to furnish 15 fractions (8 mL each), which were combined into PM3-1-1 and PM3-1-2 sub-
fractions based on analytical TLC (n-hexane:EtOAc, 23:2, v/v) and RP C18 HPLC (3:2 
MeOH/MeCN). The sub-fraction, PM3-1-2 (668 mg; 1.34%) on preparatory TLC (silica 
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GF254) using n-hexane:EtOAc (24:1 v/v) yielded pure compound 5 (90 mg; 0.18%), and 
checked for its purity on TLC (GF254) using n-hexane:EtOAc (9:1 v/v). The sub-
fraction, PM3-1-1 was further purified by preparatory TLC (on silica gel GF254) using n-
hexane:EtOAc (24:1, v/v) to purify compound 3 (75 mg; 0.15%), which was 
homogenous on TLC (1:19, v/v, EtOAc/n-hexane) and RP C18 HPLC (MeOH/MeCN, 
3:2, v/v).  
 The fraction, PM4 (eluted at 70% EtOAc:n-hexane, v/v) was selected for 
further purification to afford pure bioactive metabolites since the percentage yield (3.53 
g; 7.06%) and bioactive potentials were significantly higher. This fraction was flash 
chromatographed (Biotage AB SP1-B1A, Uppsala, Sweden) on a silica gel column 
(Biotage, 230-400 mesh, 12 g, Biotage No. 25+M) at a collection UV wavelength of 258 
nm and a monitor wavelength of 264 nm with a step gradient elution of n-
hexane/EtOAc/MeOH to afford 29 fractions (10 mL each), which were pooled to seven 
fractions (PM4-1 to PM4-7) based upon analytical TLC. The purification of sub-fraction, 
PM4-2 over preparatory TLC (GF254) using n-hexane:EtOAc (47:3, v/v) yielded 
compound 4 (110 mg; 0.22%) as major component. The TLC analysis over silica (n-
hexane:EtOAc; 17:3, v/v) was supported its purity. The sub-fraction, PM4-1 was further 
fractionated over PTLC on silica gel GF254 using n-hexane:EtOAc (49:1, v/v) to afford 
compound 8 (90 mg; 0.18%; 94% purity by RP C18 HPLC, MeOH:MeCN, 3:2 v/v) as 
major component, which was homogenous by TLC (Si gel GF254 15 mm; 100% n-
hexane, Rf: 0.75). The fraction, PM4-3 was fractionated over preparatory TLC over silica 
GF254 using n-hexane:EtOAc (22:3, v/v) to yield compound 7 (118 mg; 0.24%; 97% 
purity by C18 HPLC RP, MeOH:MeCN, 3:2, v/v) as the main component. Evaporation 
of solvents from the fractions followed by TLC (silica GF254 using 5% EtOAc:n-hexane, 
v/v) analysis were confirmed its purity. The fraction, PM4-4 was further fractionated by 
PTLC over silica gel (GF254) using n-hexane/EtOAc (43:7, v/v) to achieve the title 
compound 6 (95 mg; 0.19%) and its TLC analysis over silica gel using 15% EtOAc/n-
hexane (v/v) confirmed its purity. Fraction, PM4-5 (1.15 g) was flash chromatographed 
(collection wavelength of 254 nm) on silica gel using gradient elution of n-hexane/EtOAc 
to acquire 10 fractions (13 mL each), which were combined to three (PM4-5-1-PM4-5-3) 
fractions after TLC (3:17, v/v, EtOAc:n-hexane). The bioactive sub-fraction, PM4-5-3 was 
found to be a mixture, and therefore, fractionated by PTLC with EtOAc:n-hexane solvent 
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system (10:90, v/v) to acquire 1 (65 mg; 0.13%). The purity of 1 was supported by TLC 
using 3% EtOAc/n-hexane (v/v) along with RP C18 HPLC (3:2, v/v, MeOH:MeCN) 
experiments. 
 
Figure 6.2.: Schematic diagram of purification of EtOAc:MeOH extract of P. 
malabarica. CC-column chromatography; FC-flash chromatography; PTLC-preparative 
thin layer chromatography; TLC-thin layer chromatography; E-ethyl acetate; H-n-
hexane; M-methanol. The coloured boxes represented the pure compounds and were 
characterized by detailed spectroscopic experiments 
 
  The fraction, PM6 (18.0 g; 36.0%) was subjected to chromatographic 
fractionation on column (45 cm X 3 cm) packed with silica (60-120 mesh, 8 g). A 
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gradient elution of n-hexane/EtOAc/MeOH afforded 65 column fractions (16 mL each), 
which were compiled to 6 pooled fractions after TLC analysis (PM6-1-PM6-6). The sub-
fraction PM6-3 (2136 mg, eluted with 100% EtOAc) was appeared to be a mixture and 
therefore, chosen for flash chromatography on a silica gel column (Biotage, 230-400 mesh, 
12 g, Biotage No. 25+M) connected with UV detector (collection wavelength of 260 nm) 
using n-hexane and EtOAc to yield 7 sub-fractions (11 mL each). These were combined to 
three sub-fractions (PM6-3-1 to PM6-3-3) after TLC (20% EtOAc:n-hexane, v/v) and RP C18 
HPLC (3:2, v/v, MeOH/MeCN). Repeated preparatory thin layer chromatographic 
fractionation of bioactive sub-fraction, PM6-3-1 using EtOAc:n-hexane (40:60, v/v) 
yielded 2 (92 mg; 0.18%) as pure compound, which was homogenous on thin layer 
chromatography (1:4, v/v, EtOAc/n-hexane) and RP C18 HPLC (MeOH/MeCN, 3:2, 
v/v). 
 
6.2.7. Physicochemical data of bioactive secondary metabolites from 
EtOAc:MeOH extract of P. malabarica 
6.2.7.1.  Physicochemical data of compound 1 (PM4-5-3-1)  
 13-(Methoxycarbonyl)-11-((E)-18-ethylhexa-16,19-dienyl)-12-propylcyclo 
hex-10-enyl)-methyl-4-hydroxy benzoate: Brown oily; UV (MeOH) λmax (log ε): 
286.0 nm (3.90); TLC (Si gel GF254 15 mm; 3:17, v/v, EtOAc/n-hexane) Rf: 0.61; Rt (RP 
C18 HPLC, 3:2, v/v, MeOH:MeCN): 6.79 min; IR (cm-1) (stretching ν,bending δ, 
rocking ρ): 3349 (br, O-Hν), 2919, 2851 (C-Hν), 1709 (C=Oν), 1683 (C=Cν), 1575, 
1593 (C=Cν), 1483 (C-Hδ), 1374 (C-Hρ), 1203 (C-Oν), 1184, 1140 (C-Cν), 971 (=C-
Hδ), 841, 802, 722 (C-Hρ). 1H (500 MHz, CDCl3): δ 8.10 (1H, s), 7.52 (1H, d, J=10.48 
Hz), 7.36 (1H, t, J=7.89 Hz), 7.12 (1H, d, J=9.36 Hz), 5.82 (1H, p, J=11.26 Hz), 5.36 
(1H, t, J=10.46 Hz), 5.35 (1Hβ, d, J=8.95 Hz), 5.34 (1H, q, J=10.48 Hz), 4.97 (2H, dd, 
J=16.45, 12.31 Hz), 4.08 (2H, d), 3.70 (3H, s), 2.85 (2H, dd), 2.62 (1Hα, m), 2.31 (1Hα, 
m), 2.03 (1Hβ, m), 2.02 (1Hβ, m), 1.33 (2H, t), 1.32 (2H, m), 1.31 (2H, m), 1.28 (2H, 
m), 0.98 (3H, t), 0.88 (3H, t); 13C (125 MHz, CDCl3): δ 174.89, 167.98, 155.50, 146.92, 
139.28, 137.23, 136.47, 133.63, 129.74, 129.73, 129.73, 128.25, 124.45, 114.06, 67.55, 
50.55, 33.82, 31.93, 31.44, 30.20, 29.66, 29.36, 27.23, 25.63, 22.69, 19.23, 14.12; 
COSY and HMBC data were given in Table 6.6. EIMS: found m/z 440.2565 [M]+, cal. 
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for C27H36O5 440.2563 (Δ 0.91 ppm). HRESI-MS (positive mode) m/z: for C27H37O5 
441.2641 [M+H]+). 
 
6.2.7.2.  Physicochemical data of compound 2 (PM6-3-1-1) 
 Isobutyl-13-(6-(benzoyloxy)-10-methylpentyl)-tetrahydro-13-methyl-2H-
pyran-17-carboxylate: Yellow oily; UV (MeOH) λmax (log ε): 261.0 nm (3.50); TLC 
(Si gel GF254 15 mm; 1:4, v/v, EtOAc/n-hexane) Rf: 0.57; Rt (RP C18 HPLC, 3:2, v/v, 
MeOH:MeCN): 5.32 min; IR (cm-1): 2959, 2930 (C-Hν), 1722 (C=Oν), 1599, 1580 
(C=Cν), 1448 (C-Hδ), 1380 (C-Hρ), 1276 (C-Oν), 1072, 1039 (C-Cν), 741 (C-Hδ), 703, 
651 (C-Hρ).1H (500 MHz, CDCl3): δ 7.65 (1H, d, J=7.15 Hz), 7.64 (1H, d, J=9.17 Hz), 
7.46 (1H, t, J=8.58 Hz), 7.45 (1H, t, J=9.53 Hz), 7.45 (1H, d, J=10.21 Hz), 5.10 (1Hβ, 
dd), 4.23 (2H, t), 4.02 (2H, d), 1.97 (1H, m), 1.64 (2H, m), 1.61 (1Hα, m), 1.27 (1Hβ, 
m), 1.52 (2H, t), 1.47 (2H, m), 1.37 (1Hα, m),1.34 (2H, m), 1.26 (2H, m), 1.18 (3Hβ, s), 
0.92 (3H, d), 0.91 (3H, d), 0.88 (3Hβ, d); 13C (125 MHz, CDCl3): δ 167.69, 167.01, 
132.32, 130.90, 130.83, 130.74, 128.81, 128.71, 72.38, 71.77, 67.23, 65.51, 38.05, 
31.92, 30.57, 29.69, 27.73, 26.20, 22.69, 19.75, 19.16, 19.13, 18.81, 13.77; COSY and 
HMBC data were given in Table 6.7. EIMS: found m/z 404.2567 [M]+, cal. for C24H36O5 
404.2563 (Δ 0.99 ppm). HRESI-MS (positive mode) m/z: for C24H37O5 405.2641 
[M+H]+). 
 
6.2.7.3.  Physicochemical data of compound 3 (PM3-1-1-1) 
 (E)-12-(17-Ethyl-tetrahydro-16-hydroxy-15-(methylpentanoate)-14-oxo-
2H-pyran-13-yl)-9-methylbut-11-enyl benzoate: Pale yellow oily; UV (MeOH) λmax 
(log ε): 274.0 nm (3.80); TLC (Si gel GF254 15 mm; 1:19, v/v, EtOAc/n-hexane) Rf: 
0.75; Rt (RP C18 HPLC, 3:2, v/v, MeOH:MeCN): 6.28 min; IR (cm-1): 3308 (br, O-Hν), 
2921, 2852 (C-Hν), 1724 (C=Oν), 1607 (C=Cν), 1509 (C=Cν), 1457 (C-Hδ), 1374 (C-
Hρ), 1280 (C-Oν), 1165, 1125 (C-Cν), 988 (=C-Hδ), 826 (C-Hδ), 742 (C-Hδ). 1H (500 
MHz, CDCl3): δ 7.72 (1H, d, J=7.48 Hz), 7.71 (1H, d, J=8.57 Hz), 7.54 (1H, dd, J=9.46 
Hz), 7.53 (1H, dd, J=8.24 Hz), 7.51 (1H, dd, J=7.59 Hz), 5.37 (1H, t, J=9.86 Hz), 5.35 
(1H, t, J=9.54 Hz), 5.27 (1Hα, dt), 4.32 (1Hα, t), 4.15 (1Hα, dd), 4.29 (1Hβ, dd), 4.09 
(2H, d), 2.85 (1Hβ, t), 2.31 (2H, t), 2.03 (1Hβ, m), 1.73 (1Hβ, p), 1.61 (2H, p), 1.45 
(2H, m), 1.30 (2H, m), 1.26 (2H, m), 0.98 (3Hα, d), 0.96 (3H, t), 0.89 (3H, t); 13C (125 
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MHz, CDCl3): δ 173.25, 172.83, 167.68, 132.33, 130.88, 130.88, 130.88, 129.92, 
129.80, 128.83, 128.70, 71.78, 68.88, 65.54, 62.09, 34.05, 30.58, 29.70, 27.73, 25.63, 
24.82, 22.69, 19.19, 19.16, 14.11, 13.72; COSY and HMBC data were given in Table 
6.8. EIMS: found m/z 460.2466 [M]+, cal. for C26H36O7 460.2461 (Δ 1.1 ppm). HRESI-
MS (positive mode) m/z: for C26H37O7 461.2539 [M+H]+). 
 
6.2.7.4.  Physicochemical data of compound 4 (PM4-2-1) 
 61-(3-((E)-31b-(Furan-2’-yl)-prop-31b-en-31-yl)-4a,5,6,8a-tetrahydro-8-
methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate: Brown oily; UV (MeOH) 
λmax (log ε): 284.0 nm (3.98), 286.0 nm (3.90); TLC (3:17, v/v, EtOAc/n-hexane) Rf: 
0.38; Rt (RP C18 HPLC, MeOH:MeCN, 3:2, v/v): 12.92 min; IR (cm-1): 2922, 2853 (C-
Hν), 1737 (C=Oν), 1481 (C-Hδ), 1365, 1257 (C-Hρ), 1161 (C-Oν), 1079 (C-Hδfuran), 
967, 879, 801 (=C-Hδ), 720 (C-Hρ); 1H (500 MHz, CDCl3): δ 7.46 (1H, d, J=9.91 Hz), 
7.29 (1H, d, J=5.51 Hz), 7.07 (1H, t, J=10.48 Hz), 6.92 (1Hβ, s), 5.30 (1H, d, J=11.20 
Hz), 5.27 (1H, d, J=11.00 Hz), 4.22 (1H, dd), δ 4.08 (1H, dd), 4.00 (2H, t), 2.78 (1Hβ, 
t), 2.54 (1Hβ, dt), 2.24 (2H, m), 1.98 (1Hα, m), 1.95 (1Hβ, m), 1.54 (2H, m), 1.51 (2H, 
m), 1.38 (2H, t), 1.36 (3Hβ, s), 1.26 (3Hα, s), 1.21 (2H, m), 0.81 (3H, d), 0.81 (3H, d); 
13C (125 MHz, CDCl3): δ 173.30, 152.10, 147.00, 135.80, 131.10, 130.80, 128.80, 
124.70, 124.40, 123.90, 119.10, 64.60, 62.10, 36.50, 34.30, 31.90, 31.40, 30.23, 30.22, 
30.21, 29.30, 27.21, 25.92, 22.70, 14.18, 14.10; COSY and HMBC data were given in 
Table 6.9. EIMS: found m/z 412.2616 [M]+, cal. for C26H36O4 412.2613 (Δ 0.72 ppm). 
HRESI-MS (positive mode) m/z: for C26H37O4 413.2692 [M+H]+). 
 
6.2.7.5.  Physicochemical data of compound 5 (PM3-1-2-2) 
 7-(2’-Ethyl-1’-hydroxynonan-2’-yl)-6,7,8,8a-tetrahydro-3H-isochromen-
1-(5H)-one: Yellow oily: UV (MeOH) λmax (log ε): 277.0 nm (3.99); TLC (1/9, v/v, 
EtOAc/n-hexane) Rf: 0.48; Rt (RP C18 HPLC, 3:2, v/v, MeOH:MeCN): 3.80 min; IR 
(cm-1): 3433 (br, O-Hν), 2922, 2852 (C-Hν), 1736 (C=Oν), 1481, 1414 (C-Hδ), 1376 
(C-Hρ), 1163, 1096 (C-Oν), 976 (=C-Hδ), 721 (C-Hρ); 1H (500 MHz, CDCl3): δ 5.34 
(1Hα, t, J=9.85 Hz), 4.28 (1Hα, d), 4.14 (1Hβ, d), 3.48 (2H, s), 2.31 (2H, t), 2.30 (1Hβ, 
t), 2.01 (2H, t), 1.60 (2H, m), 1.33 (1Hβ, m), 1.29 (2H), 1.28 (2H), 1.28 (2H), 1.28 (2H), 
1.27 (2H), 1.25 (2H), 1.25 (2H), 0.88 (3H, t), 0.86 (3H, t); 13C (125 MHz, CDCl3): δ 
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173.30, 144.40, 130.80, 61.90, 50.60, 42.40, 38.20, 34.00, 34.00, 31.90, 31.70, 29.60, 
29.30, 29.20, 29.10, 27.20, 24.80, 22.60, 22.50, 14.10; COSY and HMBC data were 
given in Table 6.10. EIMS: found m/z 322.2512 [M]+, cal. for C20H34O3 322.2508 (Δ 1.2 
ppm). HRESI-MS (positive mode) m/z: for C20H35O3 323.2586 [M+H]+). 
 
6.2.7.6.  Physicochemical data of compound 6 (PM4-4-1) 
 18 (4→14),19 (4→8) Bis-abeo-nor-isopimarane-1,5-diene-3-yl-3β-methoxy-
propyl pentanoate: White solid; melting point (m.p.) 172°C (decom.); UV (MeOH) λmax 
(log ε): 270.0 nm (3.12); TLC (Si gel GF254 15 mm; 15% EtOAc:n-hexane, v/v) Rf: 
0.65; Rt (RP C18 HPLC, 3:2, v/v, MeOH:MeCN): 3.85 min; IR (cm-1): 2922, 2853 (C-
Hν), 1722 (C=Oν), 1642 (C=Cν), 1375, 1260, 1035 (C-Oν); 1H (CDCl3, 500 MHz): δ 
5.37 (1H, t, J=7.24 Hz), 5.38 (1H, t, J=8.51 Hz), 5.34 (1H, t, J=6.61 Hz), 4.15 (2H, t), 
3.64 (2H, t), 3.53 (1H, td), 2.81 (1H, dd), 2.33 (2H, t), 2.29 (2H, d), 2.01 (2H, d), 1.85 
(1H, m), 1.83 (1H, t), 1.63 (2H, m), 1.61 (2H, m), 1.49 (1H, m), 1.44 (2H, m), 1.15 (2H, 
d), 1.12 (1H, m), 1.08 (1H, t), 1.01 (3H, s), 0.91 (1H, m), 0.89 (3H, t), 0.87 (3H, t), 0.86 
(3H, d), 0.68 (3H, s); 13C (125 MHz, CDCl3): δ 178.23, 140.72, 130.01, 129.71, 121.72, 
71.83, 68.35, 65.03, 56.77, 50.14, 42.32, 42.24, 39.52, 37.25, 36.50, 33.87, 31.93, 
29.70, 28.23, 24.75, 22.82, 22.69, 21.09, 19.39, 18.72, 14.11, 11.86; COSY and HMBC 
data were given in Table 6.11. EIMS: found m/z 416.3295 [M]+, cal. for C27H44O3, 
416.3290 (Δ 1.2 ppm). HRESI-MS (positive mode) m/z: for C27H45O3 417.3367 
[M+H]+). 
 
6.2.7.7.  Physicochemical data of compound 7 (PM4-3-1) 
 1’-((10E)-10-(10-(Pentan-4-yl)-cyclohex-4-enyl)-allyloxy)-tetrahydro-
2’,2’-dimethyl-2H-pyran: Light green solid; m.p. 148.7°C (decom.); UV (MeOH) λmax 
(log ε): 260.0 nm (3.46); TLC (Si gel GF254 15 mm; 5% EtOAc:n-hexane, v/v) Rf: 0.43; 
Rt (RP C18 HPLC, 3:2, v/v, MeOH:MeCN): 22.18 min; IR (cm-1): 2932, 2860 (C-Hν), 
1661 (C=Cν), 1455 (C-Hδ), 1372, 1241, 1187, 1108, 1042 (C-Oν), 965 (=C-Hδ), 803 
(C-Hρ). 1H (500 MHz, CDCl3): δ 5.38 (1H, t, J=8.50), 5.35 (1H, t, J=9.21), 5.34 (1H, t, 
J=9.22), 4.59 (1H, s), 4.14 (1H, d), 4.12 (1H, d), 3.64 (2H, t), 2.35 (1H, t), 2.31 (2H, m), 
2.02 (2H, d), 1.99 (2H, t), 1.63 (2H, m), 1.57 (2H, m), 1.55 (2H, m), 1.48 (3H, s), 1.46 
(3H, s), 1.43 (2H, m), 1.42 (2H, m), 0.89 (3H, t), 0.87 (3H, t); 13C (125 MHz, CDCl3): δ 
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143.18, 139.27, 127.67, 124.47, 68.39, 65.05, 63.11, 39.07, 34.37, 32.84, 31.93, 30.25, 
30.09, 29.62, 29.37, 27.23, 25.74, 22.69, 22.69, 14.15, 14.15; COSY and HMBC data 
were given in Table 6.12. EIMS: found m/z 320.2718 [M]+, cal. for C21H36O2 320.2715 
(Δ 0.93 ppm). HRESI-MS (positive mode) m/z: for C21H37O2 321.2794 [M+H]+). 
 
6.2.7.8.  Physicochemical data of compound 8 (PM4-1-1) 
 2-((E)-Deca-1,8-dien-10-yl)-11,12-dihydro-13-propyl-2H-pyran: Yellow 
solid; m.p. 169.6°C (decom.); UV (MeOH) λmax (log ε): 265.0 nm (3.37); TLC (Si gel 
GF254 15 mm; 100% n-hexane, v/v) Rf: 0.75; Rt (RP C18 HPLC, 3:2, v/v, 
MeOH:MeCN): 20.52 min; IR (cm-1): 2955, 2921, 2852 (C-Hν), 1641 (C=Cν), 1462 (C-
Hδ), 1376, 1259, 1200, 1098, 1034 (C-Oν), 992 (=C-Hδ), 802, 721, 636 (C-Hρ). 1H 
(500 MHz, CDCl3): δ 6.96 (1H, s), 5.81 (1H, p, J=10.24, 6.90 Hz), 5.35 (1H, t, J=10.68, 
5.52 Hz), 5.01 (1H, m, J=14.52 Hz), 4.94 (1H, m, J=10.21 Hz), 4.68 (1H, t), 2.06 (2H, 
t), 2.03 (2H, t), 2.02 (2H, t), 1.97 (2H, t), 1.58 (2H, m), 1.44 (3H, s), 1.37 (2H, m), 1.36 
(2H, m), 1.30 (2H, m), 1.26 (2H, m), 0.88 (3H, t); 13C (125 MHz, CDCl3): δ 139.27, 
130.38, 129.91, 123.34, 114.06, 112.37, 108.30, 37.11, 33.83, 31.94, 30.41, 29.71, 
29.52, 29.37, 28.97, 26.72, 22.70, 14.12; COSY and HMBC data were given in Table 
6.13. EIMS: found m/z 262.2300 [M]+, cal. for C18H30O 262.2297 (Δ 1.1 ppm). HRESI-
MS (positive mode) m/z: for C18H31O 263.2375 [M+H]+). 
 
6.2.7.9.  Physicochemical data of compound 9 (PM3-3-2-1) 
 (22E)-241,242-Methyldihomocholesta-5,22-dien-3β-ol: White solid; m.p. 
140.7°C; [α]26D 18.6o (CHCl3, c0.012); UV (MeOH) λmax (log ε): 228.9 (1.74); TLC (Si 
gel GF254 15 mm; 10:90, v/v, EtOAc:n-hexane) Rf: 0.48; Rt (RP C18 HPLC, 6:4, v/v, 
MeOH:MeCN): 5.33 min; IR (cm-1): 3427 (br, O-Hν), 2945 (C-Hν), 1664 (C=Cν), 1459, 
1374, 1332 (C-Hρ), 1243, 1188, 1122 (C-Cν), 881 (=C-Hδ), 835, 806, 733, 596 (C-Hρ); 
1H (500 MHz, CDCl3): δ 5.35 (1Hα, dd, J=5.28, 3.58 Hz), 5.18 (1Hα, dd, J=12.41, 6.09 
Hz), 5.17 (1H, dt, J=16.10, 7.31 Hz), 3.50 (1Hα, p), 2.28 (1Hα, d), 2.24 (1Hβ, d), 2.03 
(2H, m), 2.01 (1Hβ, t), 1.96 (1Hα, t), 1.86 (1Hα, t), 1.85 (2H, m), 1.83 (1Hβ, t), 1.82 
(1H, m), 1.57 (1Hβ, m), 1.56 (1Hβ, m), 1.52 (1Hα, m), 1.50 (1Hβ, m), 1.49 (2H, m), 
1.35 (1Hβ, m), 1.25 (2H, m), 1.15 (1Hα, t), 1.10 (1Hβ, m), 1.08 (1Hα, t), 1.06 (1Hα, m), 
1.01 (3Hβ, s), 1.00 (1H, m), 0.96 (1Hα, m), 0.93 (1Hβ, m), 0.92 (3Hα, d), 0.91 (3Hα, d), 
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0.87 (3H, d), 0.86 (3H, d), 0.68 (3Hβ, s); 13C (125 MHz, CDCl3): δ140.76, 135.83, 
131.71, 121.71, 71.81, 56.70, 56.16, 50.14, 46.05, 42.54, 42.33, 42.32, 41.90, 39.72, 
37.22, 36.50, 35.72, 31.91, 31.83, 28.42, 28.22, 28.02, 24.26, 22.69, 21.14, 20.53, 
19.89, 19.40, 18.39, 11.68; COSY and HMBC data were given in Table 6.14. EIMS: 
found m/z 426.3868 [M]+, cal. for C30H50O 426.3862 (Δ 1.4 ppm). HRESI-MS (positive 
mode) m/z: for C30H51O 427.3910 [M+H]+). 
 
6.2.7.10.  Physicochemical data of compound 10 (PM3-3-1-1) 
 23-Gem-dimethylcholesta-5-en-3β-ol: White solid; m.p. 139.4°C; [α]26D 
16.4o (CHCl3, c0.015); UV (MeOH) λmax (log ε): 226.4 (1.36); TLC (Si gel GF254 15 
mm; 5:95, v/v, EtOAc:n-hexane) Rf: 0.39; Rt (RP C18 HPLC, 6:4, v/v, MeOH:MeCN): 
5.99 min; IR (cm-1): 3427 (br O-Hν), 2945 (C-Hν), 1664 (C=Cν), 1374, 1332 (C-Hρ), 
1243, 1188 (C-Cν), 881 (=C-Hδ), 835, 733 (C-Hρ); 1H (500 MHz, CDCl3): δ 5.35 (1H, 
dd, J=5.13, 3.36 Hz), 3.50 (1Hα, p), 2.29 (1Hα, d), 2.25 (1Hβ, d), 2.01 (1Hβ, t), 1.98 
(1Hα, t), 1.85 (1Hα, m), 1.84 (1Hβ, t), 1.83 (2H, t), 1.59 (3H, s), 1.56 (1Hα, t), 1.52 
(1Hβ, t), 1.50 (1Hβ, m), 1.49 (1H, m), 1.46 (2H, q), 1.35 (1Hβ, m), 1.30 (2H, d), 1.25 
(3H, s), 1.15 (1Hα, t), 1.14 (2H, d), 1.10 (1Hα, m), 1.08 (1Hα, t), 1.06 (1Hβ, m), 1.02 
(1Hβ, m), 1.01 (3Hβ, s), 0.95 (1Hα, t), 0.92 (3Hα, d), 0.91 (1Hβ, m), 0.87 (3H, d), 0.86 
(3H, d), 0.68 (3Hβ, s); 13C (125 MHz, CDCl3): δ 140.76, 121.72, 71.82, 56.72, 56.11, 
50.14, 46.06, 42.52, 42.31, 39.79, 39.61, 37.22, 36.52, 36.27, 36.22, 35.71, 31.91, 
31.66, 29.72, 28.33, 28.01, 24.21, 23.83, 22.82, 21.09, 19.41, 19.31, 18.72, 11.87; 
COSY and HMBC HMBC data were given in Table 6.15. EIMS: found m/z 414.3868 
[M]+, cal. for C29H50O, 414.3862 (Δ 1.4 ppm). HRESI-MS (positive mode) m/z: for 
C29H51O 415.3940 [M+H]+). 
 
6.2.8.  Determination of bioactive potentials  
6.2.8.1.  In vitro antioxidant assays  
6.2.8.1.A. 1,1-Diphenyl-2-picryl-hydrazil (DPPH) radical scavenging assay 
 The antioxidant activities of various chromatographic fractions and pure 
compounds isolated from the EtOAc:MeOH extracts of P. malabarica were measured 
using stable free radical, DPPH as explained in the sections 4.2.4.1.2.A. under Chapter 4. 
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6.2.8.1.B.  2,2’-Azino-bis-3-ethylbenzothiozoline-6-sulfonic acid diammonium salt 
(ABTS+) radical scavenging assay 
 The free radical quenching potentials of chromatographic fractions and pure 
compounds isolated from EtOAc:MeOH extracts of P. malabarica were evaluated by 
ABTS+ decolourization assay as explained in the sections 4.2.4.1.2.B. under Chapter 4. 
 
6.2.8.2.  In vitro anti-inflammatory assays 
6.2.8.2.A.  Cyclooxygenases (COX) inhibition assay 
 The cyclooxygenase inhibitory experiments of chromatographic fractions 
along with pure compounds isolated from EtOAc:MeOH extracts of P. malabarica were 
carried out as explained in the sections 4.2.4.2.1.under Chapter 4.  
 
6.2.8.2.B. 5-Lipoxygenase (5-LOX) inhibition assay   
 The 5-lipoxygenase inhibitory activity of chromatographic fractions and pure 
compounds isolated from EtOAc:MeOH extracts of P. malabarica were carried out as 
explained in the sections 4.2.4.2.2.under Chapter 4. 
 
6.2.9.  The structure-activity relationship analyses of secondary metabolites 
isolated from EtOAc:MeOH extract of P. malabarica 
 The structure-activity relationship analyses of bioactive secondary 
metabolites isolated EtOAc:MeOH extract of P. malabarica and standards (α-
tocopherol and ibuprofen) were analyzed as explained in the section 5.2.9. under 
Chapter 5. 
 
6.2.10.  In silico molecular modeling  
 The in silico molecular modeling of secondary metabolites isolated 
EtOAc:MeOH extract of P. malabarica were performed by the method described in the 
sections 5.2.10.1. to 5.2.10.3. under Chapter 5.  
 
6.2.11. Statistical analysis 
 Statistical analysis was carried out as detailed in section 5.2.11. under Chapter 
5. 
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6.3. Results and discussion 
6.3.1.  Chromatographic fractionation, bioactive potentials and spectroscopic 
analysis of  intermediate fractions from EtOAc:MeOH extract of P. 
malabarica 
6.3.1.1.  Chromatographic fractionation and bioactive potentials of intermediate 
fractions from EtOAc:MeOH extract of P. malabarica 
   The chromatographic fractionation of EtOAc:MeOH extract of P. malabarica 
afforded six pooled sub-fractions, named PM1 to PM6 based upon TLC (9:1, n-
hexane:EtOAc, v/v) and RP C18 HPLC (MeOH/acetonitrile, 3:2, v/v) experiments. 
Also, six sub-fractions were checked for their target bioactive potentials against free 
radicals and pro-inflammatory enzymes. The yield and bioactivities of six column 
fractions were given in Table 6.1. The percentage yields of sub-fractions, PM1 (5.80 g), 
PM2 (8.66 g), PM3 (6.42 g), PM4 (3.53 g), PM5 (1.70 g) and PM6 (18.0 g) were found to 
be 11.60%, 17.32%, 12.84%, 7.06%, 3.40% and 36.00%, respectively. The sub-
fractions PM3, PM4 and PM6 were exhibited significantly greater (p < 0.05) DPPH 
radical scavenging potentials and their IC50 values were found to be 0.73, 0.68 and 0.83 
mg/mL, respectively when compared to PM1 (IC50 1.32 mg/mL), PM2 (IC50 1.68 mg/mL) 
and PM5 (IC50 1.55 mg/mL). Similarly, the ABTS+ inhibitory effects were significantly 
greater (p < 0.05) for PM3 (IC50 0.94 mg/mL), PM4 (IC50 0.95 mg/mL) and PM6 (IC50 
0.84 mg/mL) when compared to PM1 (IC50 1.53 mg/mL), PM2 (IC50 1.90 mg/mL) and 
PM5 (IC50 2.22 mg/mL). The anti-inflammatory potentials against COX-2 and 5-LOX 
enzymes were found to be significantly greater (p < 0.05) for the sub-fractions, PM3, 
PM4 and PM6 and their IC50 values were ranged from 0.88-0.92 and 0.84-0.89 mg/mL, 
respectively when compared to other sub-fractions (PM1, PM2 and PM5). The sub-
fractions, PM1, PM2 and PM5 were registered IC50 values of > 1.55 and > 1.70 mg/mL, 
respectively for COX-2 and 5-LOX inhibitions. Hence, the sub-fractions PM3, PM4 and 
PM6 were regarded as appropriate for sequential fractionation to obtain potential 
bioactive compounds. 
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Table 6.1.: Yield and bioactive (antioxidant and anti-inflammatory) potentials of sub-
fractions of EtOAc:MeOH extract of P. malabarica 
Sub-
fractions 
#Yield 
Bioactive potentials  (IC50 values) 
Antioxidant Anti-inflammatory 
g % *DPPH *ABTS+ *COX-2 *5-LOX 
PM1 5.80 11.60 1.32 ± 0.04a 1.53 ± 0.05a 1.72 ± 0.06a 1.79 ± 0.07a 
PM2 8.66 17.32 1.68 ± 0.04b 1.90 ± 0.10b 1.60 ± 0.17a 1.72 ± 0.11a 
PM3 6.42 12.84 0.73 ± 0.03cd 0.94 ± 0.07c 0.89 ± 0.03b 0.87 ± 0.01b 
PM4 3.53 7.06 0.68 ± 0.03d 0.95 ± 0.05c 0.88 ± 0.03b 0.84 ± 0.01b 
PM5 1.70 3.40 1.55 ± 0.05b 2.22 ± 0.02d 1.94 ± 0.01c 1.96 ± 0.10c 
PM6 18.00 36.00 0.83 ± 0.03c 0.84 ± 0.07c 0.92 ± 0.03b 0.89 ± 0.01b 
#The percentage of yield was calculated on the basis of crude EtOAc:MeOH extract 
(50.0 g EtOAc:MeOH crude extract weight). *The IC50 values were reported as mg/mL. 
The samples were analyzed in triplicate (n=3) and expressed as mean ± standard 
deviation. Means followed by different superscripts (a-d) within same column indicate 
significant differences (p < 0.05)  
 
6.3.1.2.  Spectroscopic analysis of intermediate fractions from EtOAc:MeOH 
extract of P. malabarica 
  The intermediate sub-fractions (PM1-PM6) were subjected to 1H NMR 
analysis (Figure 6.3.) to acquire proton integral values corresponding to characteristic 
functional group signals (Table 6.2.). The proton integrals for fraction, PM3 at δ 0.1-2.0 
(saturated hydrocarbons), 2.0-2.5 (Ar-CH and acetylinic groups), 2.5-3.5 (-CH-C=O and 
-CH-Ar), 3.5-4.5 (electronegative groups) and 4.5-6.5 (vinylic, conjugated) were found 
to be 106.93, 14.04, 1.78, 1.76 and 3.13, respectively. Likewise, the proton integrals in 
regions δ 0.1-2.0, 2.0-2.5, 2.5-3.5, 3.5-4.5 and 4.5-6.5 were found to be 76.71, 5.60, 
1.66, 3.05 and 2.70, respectively for PM4 and 42.24, 4.07, 15.56, 3.28 and 18.14, 
respectively for PM6. The sub-fractions, PM1, PM2 and PM5 was registered lesser proton 
integrals in the regions of δ 2.0-2.5, 3.5-4.5 and 4.5-6.5, which were found to be 1.4-3.2, 
0.26-1.1 and 0.11-2.5, respectively. In general, PM3, PM4 and PM6 were displayed 
significantly greater proton integrals than PM1, PM2 and PM5 when the potentially 
electronegative regions, δ 3.5-4.5 due to auxochromes and at δ 2.0-2.5 due to -CH2=CH-
CH3 groups were taken into consideration. The signals at δ 0.1-2.0 were found to be 
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more prominent in fraction PM3 (106.93), PM4 (76.71) and PM6 (42.24) which could be 
attributed to methylene [-(CH2)n] envelope or end methyls in long alkyl chains. 
   
 
Figure 6.3.: 1H NMR spectra of intermediate sub-fractions of (A) PM1, (B) PM2, (C) 
PM3, (D) PM4, (E) PM5 and (F) PM6 from EtOAc:MeOH extract of P. malabarica with 
integration values 
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 The greater radical scavenging properties of PM3, PM4 and PM6 might be 
attributed to greater electron donating methoxy/hydroxyl groups (δ 3.5-4.5) whereas 
PM1, PM2 and PM5 were recorded comparatively lesser number of olefinic/oxygenated 
groups, and therefore, exhibited significantly lesser bioactivities. The sub-fraction, PM6 
displayed intense signals and greater number of proton integrals at δ 2.5-3.5 and 4.5-6.5 
that ascribed to alkenic and electronegative auxochromes, such as alkoxy/alkyl 
halide/functionalized hydride H of the substituted alkanols followed by PM3 and PM4. 
In general, the fractions PM3, PM4 and PM6 derived from EtOAc:MeOH extract of P. 
malabarica showed greater proton integrals than other column fractions when these 
potentially electronegative regions were taken into consideration. A significant co-
linearity was found among bioactive potentials and deshielded electronegative 
functionalities present in the intermediate fractions of EtOAc:MeOH extract of P. 
malabarica.  
 The proton NMR based bioactivity analyses of intermediate fractions (PM1-
PM6) suggested that the sub-fractions, PM3, PM4 and PM6 could be considered as 
promising candidate fractions for further chromatographic purifications to isolate 
bioactive principles. 
 
Table 6.2.: Types and integral values of protons obtained from the 1H NMR spectra of 
sub-fractions of EtOAc:MeOH extract of P. malabarica 
 Proton integral (ΣH) 
Proton signal (δ) PM1 PM2 PM3 PM4 PM5 PM6 
0.1-2.0 45.14 18.00 106.93 76.71 21.00 42.24 
2.0-2.5 2.33 3.23 14.04 5.60 1.40 4.07 
2.5-3.5 0.69 1.70 1.78 1.66 0.25 15.56 
3.5-4.5 1.13 0.86 1.76 3.05 0.26 3.28 
4.5-6.5 1.61 2.58 3.13 2.70 0.11 18.14 
6.5-8.5 0.05 0.01 0.51 0.09 0.00 0.11 
 
6.3.1.3.  Isolation of bioactive secondary metabolites from EtOAc:MeOH extract 
of P. malabarica 
   The sub-fractions, such as PM3, PM4 and PM6 were selected as candidate 
fractions for the isolation of bioactive compounds. The yield (in mg and in %), retention 
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factor (Rf), bioactivities (antioxidant/anti-inflammatory) of each column/flash/PTLC 
sub-fractions obtained from the candidate fractions were recorded in Table 6.3.-6.5. 
 The fraction, PM3 (6.42 g; 12.84%) was subjected to vacuum liquid 
chromatography using the step-wise elution of n-hexane/EtOAc/MeOH to furnish 8 sub-
groups, PM3-1 to PM3-8. Among these, column fractions, such as PM3-3 (1.52 g; 3.04%) 
and PM3-1 (1.50 g; 3.00%) were exhibited significantly higher antioxidant activities with 
respect to scavenge DPPH (IC50 0.99 and 0.65 mg/mL, respectively) and ABTS+ (IC50 
0.94 and 0.69 mg/mL, respectively) radicals. The anti-inflammatory effects were also 
greater for PM3-3 (IC50 anti-COX-2 0.98 and IC50 anti-5-LOX 1.03 mg/mL) and PM3-1 
(IC50 anti-COX-2 0.71 and IC50 anti-5-LOX 0.73 mg/mL) when compared to other 
fractions (IC50 > 1.00 mg/mL). 
The sub-fraction, PM3-3 was flash chromatographed using n-hexane/ EtOAc/ 
MeOH to yield four sub-fractions (PM3-3-1 through PM3-3-4) (Table 6.3.). The fraction, 
PM3-3-1 (189 mg; 0.38%) and PM3-3-2 (246 mg; 0.49%) were exhibited significantly 
greater antioxidant activities (IC50 DPPH inhibition 1.06 and 0.95 mg/mL, respectively; 
IC50 ABTS+ inhibition (1.08 and 0.97 mg/mL, respectively) radicals. The anti-
inflammatory effects were greater for PM3-3-1 (IC50 anti-COX-2 1.21 mg/mL and IC50 
anti-5-LOX 1.10 mg/mL) and PM3-3-2 (IC50 anti-COX-2 1.01 mg/mL and IC50 anti-5-
LOX 1.10 mg/mL) when compared to other fractions (IC50 > 1.00 mg/mL for anti-COX-
2 and anti-5-LOX). The fractions, PM3-3-1 and PM3-3-2 were fractionated over 
preparatory TLC to afford pure compounds, 10 (PM3-3-1-1; 82 mg; yield 0.16%) and 9 
(PM3-3-2-1; 148 mg; yield 0.30%). 
 The sub-fraction, PM3-1 was flash chromatographed using n-hexane/ 
EtOAc/MeOH to furnish two fractions (PM3-1-1-PM3-1-2) (Table 6.3.). The fractions, 
PM3-1-1 (654 mg; 1.31%) and PM3-1-2 (668 mg; 1.34%) were displayed higher 
antioxidant (IC50 ~0.72 and ~0.83 mg/mL, respectively) and anti-inflammatory (IC50 
~0.76 and ~0.93 mg/mL, respectively) potentials. The sub-fraction, PM3-1-1 was purified 
through PTLC using n-hexane:EtOAc (24:1, v/v) to yield compound 3 (PM3-1-1-1; 75 
mg; yield 0.15%) along with a mixture, PM3-1-1-2 (409 mg; 0.82%). Likewise, the sub-
fraction PM3-1-2 purified through PTLC using n-hexane:EtOAc (24:1, v/v) to yield 
compound 5 (PM3-1-2-2; 90 mg; 0.18%) along with a mixture, PM3-1-2-1 (406 mg; 0.81%). 
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Table 6.3.: Yield (in mg and in %), retention factor (Rf), bioactivities (antioxidant/anti-inflammatory) of column/flash/PTLC 
fractions obtained from the sub-fraction, PM3 of EtOAc:MeOH extract of P. malabarica  
#Yield Rf 
*Bioactive potentials  (IC50 value; mg/mL)
Antioxidant Anti-inflammatory 
mg % DPPH ABTS+ COX-2 5-LOX 
PM3 CC (n-hexane/EtOAc/MeOH) 6420 12.84 0.73 ± 0.03 0.94 ± 0.07 0.89 ± 0.03 0.87 ± 0.01 
PM3-1 (2% n-hexane) 1500 3.00 0.65 ± 0.01 0.69 ± 0.02 0.71 ± 0.02 0.73 ± 0.02 
PM3-2 (6% EtOAc:n-hexane) 513 1.03 2.35 ± 0.05 2.42 ± 0.04 2.16 ± 0.04 2.12 ± 0.00 
PM3-3 (10% EtOAc:n-hexane) 1520 3.04 0.99 ± 0.02 0.94 ± 0.01 0.98 ± 0.00 1.03 ± 0.02 
PM3-4 (15% EtOAc:n-hexane) 640 1.28 1.17 ± 0.08 2.35 ± 0.05 1.85 ± 0.04 1.07 ± 0.01 
PM3-5 (25% EtOAc:n-hexane) 227 0.45 2.42 ± 0.04 2.12 ± 0.00 1.42 ± 0.03 1.26 ± 0.07 
PM3-6 (50% EtOAc:n-hexane) 540 1.08 1.92 ± 0.04 2.16 ± 0.04 1.25 ± 0.00 1.21 ± 0.02 
PM3-7 (90% EtOAc:n-hexane) 329 0.66 1.55 ± 0.03 1.23 ± 0.05 1.17 ± 0.08 1.69 ± 0.01 
PM3-8 (50% EtOAc:MeOH) 260 0.52 1.84 ± 0.03 1.36 ± 0.04 1.76 ± 0.02 1.68 ± 0.09 
PM3-1 FC (n-hexane/EtOAc/MeOH) 1500 3.00 
PM3-1-1 654 1.31 0.70 ± 0.01 0.72 ± 0.01 0.71 ± 0.03 0.80 ± 0.02 
PM3-1-2 668 1.34 0.85 ± 0.04 0.82 ± 0.02 0.91 ± 0.01 0.95 ± 0.01 
PM3-1-1 PTLC (4% EtOAc:n-hexane) 654 1.31 
PM3-1-1-1 (Compound 3) 75 0.15 0.75 0.59 ± 0.06 0.69 ± 0.06 0.68 ± 0.06 0.76 ± 0.06 
PM3-1-1-2  409 0.82 0.32 1.76 ± 0.02 1.45 ± 0.01 1.36 ± 0.04 1.68 ± 0.09 
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PM3-1-2 PTLC (4% EtOAc:n-hexane) 668 1.34 
PM3-1-2-1  406 0.81 0.64 0.99 ± 0.00 1.05 ± 0.05 1.03 ± 0.04 1.04 ± 0.05 
PM3-1-2-2 (Compound 5) 90 0.18 0.48 0.73 ± 0.07 0.79 ± 0.07 0.85 ± 0.07 0.82 ± 0.07 
PM3-3 FC (n-hexane/EtOAc/MeOH) 1520 3.04 
PM3-3-1 189 0.38 1.06 ± 0.03 1.08 ± 0.02 1.21 ± 0.01 1.10 ± 0.02 
PM3-3-2 246 0.49 0.95 ± 0.01 0.97 ± 0.02 1.01 ± 0.04 1.10 ± 0.07 
PM3-3-3 423 0.85 2.32 ± 0.01 2.26 ± 0.04 2.45 ± 0.05 2.49 ± 0.04 
PM3-3-4 467 0.93 1.37 ± 0.08 1.36 ± 0.07 1.75 ± 0.04 1.99 ± 0.04 
PM3-3-1 PTLC (2% EtOAc:n-hexane) 189 0.38 
PM3-3-1-1 (Compound 10) 82 0.16 0.39 1.01 ± 0.09 1.12 ± 0.09 1.15 ± 0.09 1.02 ± 0.09 
PM3-3-2 PTLC (2% EtOAc:n-hexane) 246 0.49 
PM3-3-2-1 (Compound 9) 148 0.30 0.48 0.81 ± 0.09 0.98 ± 0.09 0.92 ± 0.09 0.96 ± 0.09 
#The percentage of yield was calculated on the basis of crude EtOAc:MeOH extract (50.0 g EtOAc:MeOH crude extract weight). 
CC-column chromatography; FC-flash chromatography; PTLC-preparative thin layer chromatography; EtOAc-ethyl acetate; 
MeOH-methanol.The samples were analyzed in triplicate (n=3) and expressed as mean ± standard deviation. *The IC50 values 
were reported as mg/mL   
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The fraction PM4 (3.53 g; 7.06%) was flash chromatographed with gradient elution 
of n-hexane/EtOAc/MeOH to aquire seven (PM4-1 to PM4-7) fractions based on TLC (Table 
6.4). The percentage yields for sub-fractions, PM4-1 (716 mg), PM4-2 (896 mg), PM4-3 (794 
mg), PM4-4 (531 mg) and PM4-5 (362 mg) were 1.43%, 1.79%, 1.59%, 1.06% and 0.72%, 
respectively, and these were found to be greater when compared to PM4-6 (65 mg; 0.13%) 
and PM4-7 (0.79 g; 0.16%).  The sub-fractions, PM4-1 to PM4-5 were recorded higher 
antioxidant potentials against DPPH and ABTS+ radicals with lower IC50 values (0.75-0.95 
and 0.78-1.01 mg/mL, respectively) when compared to those recorded with PM4-6-PM4-7 (> 
1.20 mg/mL). Similarly, the COX-2 and 5-LOX inhibitory potentials were found to be 
greater for PM4-1 to PM4-5 (IC50 0.79-0.97 and 0.79-1.10 mg/mL, respectively) compared to 
those recorded with PM4-6-PM4-7 (IC50 > 1.45 and > 1.55 mg/mL, respectively). 
 The sub-fraction, PM4-1 was further fractionated over PTLC on silica gel using n-
hexane:EtOAc (49:1, v/v) to yield the compound 8 (PM4-1-1; 90 mg; 0.18%) as major 
component. The fractionation of PM4-3 over PTLC utilizing n-hexane:EtOAc (22:3, v/v) 
afforded compound 7 (PM4-3-1; 118 mg; 0.24%). The fraction, PM4-4 was further purified by 
PTLC over silica gel (GF254) using n-hexane/EtOAc (43:7, v/v) to afford compound 6 
(PM4-4-1; 95 mg; 0.19%). The purification of sub-fraction, PM4-2 over preparatory TLC 
(GF254) using n-hexane:EtOAc (47:3 v/v) was yielded compound 4 (PM4-2-1; 110 mg; 
0.22%) as major component with bioactive potentials (Table 6.4.). The fraction, PM4-5 was 
flash chromatographed using gradient elution of n-hexane/EtOActo acquire three sub-groups 
(PM4-5-1-PM4-5-3). The yields of the sub-fractions, PM4-5-1 (64 mg; 0.13%) and PM4-5-2 (0.82 
mg; 0.16%) were found to be lesser and recorded lower bioactive potentials when compared to 
PM4-5-3. The bioactive sub-fraction, PM4-5-3 (139 mg; 0.28%) was isolated by PTLC using 
EtOAc:n-hexane (10:90, v/v) solvent system to acquire compound 1 (PM4-5-3-1; 65 mg; 0.13%) 
(Table 6.4.). 
298 
Isolation and characterization of secondary metabolites from Paphia malabarica          Chapter 6 
Table 6.4.: Yield (in mg and in %), retention factor (Rf), bioactivities (antioxidant/anti-inflammatory) of column/flash/PTLC 
fractions obtained from the sub-fraction, PM4 of EtOAc:MeOH extract of P. malabarica 
#Yield 
Rf 
*Bioactive potentials  (IC50 value; mg/mL)
Antioxidant Anti-inflammatory 
mg % DPPH ABTS+ COX-2 5-LOX 
PM4 FC (n-hexane/EtOAc/MeOH) 3530 7.06 0.68 ± 0.03 0.95 ± 0.05 0.88 ± 0.03  0.84 ± 0.01 
PM4-1 716 1.43 0.90 ± 0.03 0.98 ± 0.01 0.95 ± 0.04 1.03 ± 0.04 
PM4-2 896 1.79 0.75 ± 0.01 0.78 ± 0.02 0.79 ± 0.02 0.79 ± 0.01 
PM4-3 794 1.59 0.95 ± 0.02 1.01 ± 0.01 0.97 ± 0.06 1.10 ± 0.02 
PM4-4 531 1.06 0.80 ± 0.01 0.82 ± 0.01 0.91 ± 0.03 0.90 ± 0.02 
PM4-5 362 0.72 0.83 ± 0.04 0.86 ± 0.02 0.86 ± 0.01 0.85 ± 0.01 
PM4-6 65 0.13 1.23 ± 0.05 1.36 ± 0.04 1.45 ± 0.01 1.55 ± 0.03 
PM4-7 79 0.16 1.69 ± 0.01 1.68 ± 0.09 1.76 ± 0.02 1.84 ± 0.03 
PM4-1 PTLC (2% EtOAc:n-hexane) 716 1.43 
PM4-1-1 (Compound 8) 90 0.18 0.75 0.78 ± 0.06 0.92 ± 0.06 0.95 ± 0.06 1.02 ± 0.06 
PM4-2 PTLC (6% EtOAc:n-hexane) 896 1.79 
PM4-2-1 (Compound 4) 110 0.22 0.38 0.56 ± 0.06 0.67 ± 0.06 0.72 ± 0.06 0.76 ± 0.07 
PM4-3 PTLC (12% EtOAc:n-hexane) 794 1.59 
PM4-3-1 (Compound 7) 118 0.24 0.43 0.76 ± 0.06 0.96 ± 0.06 0.92 ± 0.06 1.06 ± 0.07 
PM4-4 PTLC (14% EtOAc:n-hexane) 531 1.06 
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PM4-4-1 (Compound 6) 95 0.19 0.65 0.65 ± 0.06 0.78 ± 0.06 0.82 ± 0.06 0.75 ± 0.07 
PM4-5 FC (n-hexane/EtOAc/MeOH) 362 0.72 
PM4-5-1 64 0.13 1.05 ± 0.01 1.04 ± 0.00 1.02 ± 0.02 1.03 ± 0.01 
PM4-5-2 82 0.16 1.04 ± 0.01 1.03 ± 0.04 1.03 ± 0.01 1.09 ± 0.04 
PM4-5-3 139 0.28 0.75 ± 0.01 0.86 ± 0.02 0.86 ± 0.01 0.90 ± 0.04 
PM4-5-3 PTLC (10% EtOAc:n-hexane) 139 0.28 
PM4-5-3-1 (Compound 1) 65 0.13 0.61 0.65 ± 0.06 0.74 ± 0.06 0.74 ± 0.06 0.81 ± 0.07 
#The percentage of yield was calculated on the basis of crude EtOAc:MeOH extract (50.0 g EtOAc:MeOH crude extract weight). 
CC-column chromatography; FC-flash chromatography; PTLC-preparative thin layer chromatography; EtOAc-ethyl acetate; 
MeOH-methanol.The samples were analyzed in triplicate (n=3) and expressed as mean ± standard deviation. *The IC50 values 
were reported as mg/mL  
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Table 6.5.: Yield (in mg and in %), retention factor (Rf), bioactivities (antioxidant/anti-inflammatory) of column/flash/PTLC 
fractions obtained from the sub-fraction, PM6 of EtOAc:MeOH extract of P. malabarica 
#Yield Rf 
*Bioactive potentials  (IC50 value; mg/mL)
Antioxidant Anti-inflammatory 
mg % DPPH ABTS+ COX-2 5-LOX 
PM6 CC (n-hexane/EtOAc/MeOH) 18000 36.00 0.83 ± 0.03 0.84 ± 0.07 0.92 ± 0.03 0.89 ± 0.01 
PM6-1 (2% n-hexane) 1123 2.25 1.05 ± 0.06 1.09 ± 0.05 1.23 ± 0.01 1.25 ± 0.02 
PM6-2 (6% EtOAc:n-hexane) 841 1.68 1.12 ± 0.00 1.16 ± 0.04 1.35 ± 0.08 1.42 ± 0.04 
PM6-3 (10% EtOAc:n-hexane) 2136 4.27 0.85 ± 0.00 0.86 ± 0.01 0.92 ± 0.03 0.96 ± 0.04 
PM6-4 (15% EtOAc:n-hexane) 1258 2.52 1.07 ± 0.01 1.21 ± 0.02 1.25 ± 0.00 1.42 ± 0.03 
PM6-5 (25% EtOAc:n-hexane) 1943 3.89 2.12 ± 0.00 2.16 ± 0.04 2.35 ± 0.05 2.42 ± 0.04 
PM6-6 (50% EtOAc:n-hexane) 1569 3.14 1.17 ± 0.08 1.26 ± 0.07 1.85 ± 0.04 1.92 ± 0.04 
PM6-3 FC (n-hexane/EtOAc/MeOH) 2136 4.27 
PM6-3-1 746 1.49 0.82 ± 0.01 0.80 ± 0.03 0.90 ± 0.02 0.94 ± 0.02 
PM6-3-2 568 1.14 1.95 ± 0.05 1.25 ± 0.04 1.55 ± 0.00 1.75 ± 0.03 
PM6-3-3 345 0.69 1.95 ± 0.08 1.95 ± 0.02 1.85 ± 0.03 1.55 ± 0.04 
PM6-3-1 PTLC (40% EtOAc:n-hexane) 746 1.49 
PM6-3-1-1 (Compound 2) 92 0.18 0.57 0.79 ± 0.02 0.76 ± 0.01 0.89 ± 0.03 0.92 ± 0.01 
#The percentage of yield was calculated on the basis of crude EtOAc:MeOH extract (50.0 g EtOAc:MeOH crude extract weight). 
CC-column chromatography; FC-flash chromatography; PTLC-preparative thin layer chromatography; TLC-thin layer 
chromatography; EtOAc-ethyl acetate; MeOH-methanol. The samples were analyzed in triplicate (n=3) and expressed as mean ± 
standard deviation. *The IC50 values were recorded as mg/mL   
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The fraction, PM6 (18.0 g; 36.0%) was subjected to chromatographic 
fractionation using n-hexane/EtOAc/MeOH step-wise elution to yield pooled fractions, 
named as PM6-1-PM6-6 (Table 6.5.). The sub-fraction, PM6-3 (2136 mg; 4.27%) was 
registered greater bioactive potentials (IC50 0.85, 0.86, 0.92 and 0.96 mg/mL for DPPH, 
ABTS+, COX-2 and 5-LOX inhibitory potentials, respectively) when compared to other 
fractions (IC50 values > 1.05 mg/mL). The sub-fraction, PM6-3 was appeared to be a 
mixture, and chosen for flash chromatography using n-hexane/EtOAc to yield three pooled 
fractions (PM6-3-1-PM6-3-3). Repeated PTLC fractionation of PM6-3-1 (746 mg; 1.49%) using 
EtOAc:n-hexane (40:60, v/v) yielded 2 (PM6-3-1-1; 92 mg; 0.18%) as pure compound. 
6.3.2.  Spectroscopic analysis of bioactive secondary metabolites from 
EtOAc:MeOH extract of P. malabarica 
Repetitive chromatographic fractionations of EtOAc:MeOH extract of the edible 
parts of P. malabarica yielded candidate bioactive secondary metabolites. The structures of 
identified metabolites were ascribed through extensive one (1H, 13C and 135DEPT NMR) 
and two (1H-1H COSY, HSQC, HMBC and NOESY) dimensional spectroscopic analyses 
combined with mass and FTIR experiments. The bioactive secondary metabolites isolated 
and characterized from the EtOAc:MeOH extract of P. malabarica were classified under 
various classes, such as aryl polyketide derivatives (1-3), tetrahydro chromenyl derivatives 
(4-5), isopimarane norditerpenoid (6), meroterpeno pyranoids (7-8) and cholestenol 
analogues (9-10). 
6.3.2.1.  Structural characterization of aryl polyketide derivatives (1-3) 
Polyketide compounds with their pleotropic molecular frameworks and 
functional properties were reported in previous literatures and an attractive choice of 
natural product chemists. Polyketides characterize a wide range of natural products that 
usually contain multiple carbonyl groups (C=O) possessing variety of bio-potential 
functionalities, such as antioxidant, anti-bacterial, anti-inflammatory, anti-cholesterol, etc. 
They were biosynthesized by decarboxylative condensation of carboxylic acids through 
polyketide synthase (PKS) enzymes, which were classified into type-1, 2 and 3. Type-1 
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PKS was found to be an assembly of polypeptides similar to type-1 fatty acid synthase 
(FAS) and which consists of various enzyme domains (acyltransferase, ketoreductase etc.) 
to form diverse polyketide structures (Yu et al., 2012). Type-2 PKS class belonged to type-
2 FAS which was responsible for the biosynthesis of aromatic polyketides (Zhan 2009) 
whereas type-3 PKS catalyzed the formation of pyrones, chalcones, resorcinolic lipids and 
polypropionates (Yu et al., 2012). Among all these, aryl polyketides were widely studied 
due to the promising bio-potentials. Also, these were an interesting class of compounds due 
to the presence of aromatic functionalities that can enhance its electronic properties (Zhan 
2009). Notably, the polyketide compounds exhibited keto-enol resonance stabilization with 
adjacent >C=O group leading to -CH=C(-OH)- moiety. The greater resonance stabilization, 
presence of aromatic groups and ease of H-atom release onto DPPH radical to form stable 
DPPH were the prominent reasons for antioxidative properties of these aryl polyketides.  
 Several polyketides were reported from marine resources (Chakraborty et al., 
2017b), especially from marine shelled mollusks, such as gastropods/bivalves with 
potential antioxidant activities (Terlau and Olivera 2004). Pyrones, aryls, polypropionates 
and other related polyketides were previously reported from soft bodied mollusks (Di 
Marzo et al., 1991). These polyketides were significant of marine mollusks and which were 
produced by the mollusk itself as part of their defense or communication (Davies-Coleman 
and Garson 1998; Vardaro et al., 1992). There were few reports available for the 
occurrence of aryl enclosed polyketides in mollusks (Cutignano et al., 2008) whereas, these 
were frequent in marine algae or mollusk associated bacteria (Blunt et al., 2011; 
Chakraborty et al., 2016d). Most of the reported polyketides were pyrone and 
polypropionate types for example polyketides reported from mollusks, Cyerce cristallina 
and Onchidium sp. (Davies-Coleman and Garson 1998; Di Marzo et al., 1991). This is the 
first report of characterization of three new variants of aryl polyketides, featuring the aryl 
substituent from marine bivalve clam with potential bioactivities. Fewer studies were 
concentrated on small molecular bioactive secondary metabolites, such as phenolics, aryl 
derivatives, benzoates, and pyranoids from bivalves (Sala et al., 2007). However, there 
have been sustained efforts to isolate newer chemistries of polyketides with bioactive 
properties compared to previously described molecules. Herein, we focused the structural 
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characterization of three aryl polyketide derivatives (1-3) from P. malabarica. Putative 
biosynthetic pathways catalyzed by polyketide synthase leading to the formation of 
polyketide compounds were used to corroborate the structural attributions. 
 
6.3.2.1.A. Structural characterization of compound 1 (PM4-5-3-1) 
(13-(Methoxycarbonyl)-11-((E)-18-ethylhexa-16,19-dienyl)-12-
propylcyclohex-10-enyl)-methyl-4-hydroxy benzoate (1) 
 
 
Yield 65 mg; 0.13% 
Physical description Brown oily 
Molecular formula C27H36O5 
Molecular mass 440.2563 
  The compound 1 was characterized as a hydroxy benzoate metabolite and 
purified as brown oily compound with molecular formula as C27H36O5. It exhibited UV 
absorbance (in MeOH) at λmax (log ε 3.90) 286.0 nm was assigned to a chromophore with 
ester carbonyl and olefinic groups (Figure 6.4.). The purity of the compound was supported 
by RP C18 HPLC experiments using MeOH:MeCN (3:2, v/v) (Rt 6.79) solvent system 
(Figure 6.5.). 
 
  
Figure 6.4.: UV spectrum of (13-(methoxycarbonyl)-11-((E)-18-ethylhexa-16,19-dienyl)-
12-propylcyclohex-10-enyl)-methyl-4-hydroxy benzoate (1) 
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Figure 6.5.: HPLC chromatogram of (13-(methoxycarbonyl)-11-((E)-18-ethylhexa-16,19-
dienyl)-12-propylcyclohex-10-enyl)-methyl-4-hydroxy benzoate (1)  
  
 The 13C NMR spectrum of compound 1 displayed 27 peaks, whereas the 
multiplicities, such as five quarternary, twelve -CH, seven -CH2 and three -CH3 were 
confirmed by 135DEPT experiment (Figure 6.9.-6.10.). The double bond equivalence was 
recorded as ten including eight double bonds and two ring moieties. Greater chemical shift 
values and coupling constants of four aromatic resonances at δ 8.10 (H-5, s), 7.12 (d, 
J=9.36 Hz, H-3), 7.36 (t, J=7.89 Hz, H-2) and 7.52 (d, J=10.48 Hz, H-1) designated the 
meta disubstituted aryl ring, and these attributions were corroborated by previous studies 
(Chakraborty et al., 2016d; Khan et al., 2015). The 1H NMR spectrum displayed resonances 
at ~δ 5.3 (proton integral of 3) representing non-conjugated trans diene with greater J 
values (Table 6.6.; Figure 6.8.). The deshielded signal at δ 4.08 (d) was attributed to 
carboxy methylene and that at δ 3.70 (s) was related to the carboxy methyl groups 
(Chakraborty et al., 2016d). The cyclohex-10-enyl ring enclosed 1H NMR signals at δ 2.02 
(H-9), 5.35 (J=8.95 Hz, H-10), 2.31 (H-12), 1.33 (H-14) and 2.62 (H-13) along with an 
alkenic quaternary carbon at C-11 (δ 146.92). The 1H spectrum suggested the presence of 
trans monosubstituted olefinic moiety due to the signals at δ 5.82 (p) and 4.97 (dd) with 
greater coupling constants (J=11.26 and 16.45 Hz, respectively). Further, HMBC 
correlations from δ 2.03 (H-18) to δ 114.06 (C-20); δ 1.31 (H-21) to δ 129.74 (C-17), 
139.28 (C-19); δ 0.88 (H-22) to δ 31.93 (C-18); δ 1.28 (H-24) to δ 146.92 (C-11) and δ 
3.70 (H-27) to δ 174.89 (C-26) confirmed the presence of 13-(methoxycarbonyl),11-(18-
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ethylhexa-16,19-dienyl) and 12-propyl side chain attachments in 1 (Figure 6.6.B; Figure 
6.13.). These attributions further corroborated by the four spin systems in 1H-1H COSY 
which were H-1 to H-3 (δ 7.52/7.36/7.12) in aryl ring, H-8 (δ 4.08)/2.02 (H-9)/5.35 (H-10) 
and δ 2.02 (H-9)/1.33 (H-14)/2.62 (H-13)/2.31 (H-12)/1.32 (H-23)/1.28 (H-24)/0.98 (H-25) 
in 12-propylcyclohex-10-enyl-9-methyl group, H-15 to H-16 (δ 2.85/5.34), H-17 to H-20 (δ 
5.34/2.03/5.82/4.97) together with δ 2.03 (H-18)/1.31 (H-21)/0.88 (H-22) in 18-ethylhexa-
16,19-dienyl moiety (Figure 6.6.A; Figure 6.11.). The relative stereochemistries at C-9, C-
18, C-12 and C-13 were deduced from NOESY interactions (Figure 6.7.; Figure 6.14.). The 
proton resonances at δ 2.02 (H-9) and 2.03 (H-18) displayed NOE cross peaks with δ 5.35 
(H-10) and these were disposed in the similar plane, and therefore, considered as β-
oriented. Intense NOE correlations among δ 2.31 (H-12) and 2.62 (H-13) inferred the 
orientation of protons in an identical plane of reference. However, these protons did not 
show NOE connections with the β-protons at H-9/H-18, therefore, attributed to α-oriented. 
The acetoxy (-COOCH3) group at C-13 was considered as β-oriented being opposite to α-
disposed proton at C-13.   
 
Table 6.6.: NMR spectroscopic data of (13-(methoxycarbonyl)-11-((E)-18-ethylhexa-16,19 
-dienyl)-12-propylcyclohex-10-enyl)-methyl-4-hydroxy benzoate (1) in CDCl3 
C. No.  13C  1H NMR (int.,mult.,J in Hz)a COSY  HMBC            
1  136.47  7.52 (1H,d,10.48)  H-2  C-7  
2  128.25  7.36 (1H,t,7.89)  H-3  -  
3  124.45  7.12 (1H,d,9.36)  -  -  
4  155.50  -  -  -  
5  137.23  8.10 (1H,s)  -  C-7  
6  133.63  -  -  -  
7  167.98  -  -  -  
8  67.55  4.08 (2H,d)  H-9  C-7  
9  27.23  2.02 (1Hβ,m)  H-10,14  C-10  
10  129.73  5.35 (1Hβ,d,8.95)  -  -  
11  146.92  -  -  -  
12  33.82  2.31 (1Hα,m)  H-13,23  C-26,24,9,15  
13  30.20  2.62 (1Hα,m)  H-14  -  
14  29.36  1.33 (2H,t)  -  C-13,12  
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15  25.63  2.85 (2H,dd)  H-16  -  
16  129.73  5.34 (1H,q,10.48)  -  C-15  
17  129.74  5.36 (1H,t,10.46)  H-18  -  
18  31.93  2.03 (1Hβ,m)  H-19,21  C-19,20  
19  139.28  5.82 (1H,p,11.26)  H-20  -  
20  114.06  4.97 (2H,dd,16.45,12.31)  -  -  
21  22.69  1.31 (2H,m)  H-22  C-17,19  
22  14.12  0.88 (3H,t)   C-18, 21  
23  31.44  1.32 (2H,m)  H-24  -  
24  29.66  1.28 (2H,m)  H-25  C-11  
25  19.23  0.98 (3H,t)  -  -  
26  174.89  -  -  -  
27  50.55  3.70 (3H,s)     C-26  
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 500MHz, 
while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, multiplicity and 
coupling constants (J=Hz) were indicated in parentheses. The assignments were made with 
the aid of the 1H-1H COSY, HSQC, HMBC and NOESY experiments 
 
 
 
 
 
 
Figure 6.6.: 1H-1H COSY (A) and HMBC (B) correlations of (13-(methoxycarbonyl)-11-
((E)-18-ethylhexa-16,19-dienyl)-12-propylcyclohex-10-enyl)-methyl-4-hydroxy benzoate 
(1). The key 1H-1H COSY couplings have been represented by the bold face bonds. The 
HMBC couplings were indicated by double barbed arrow 
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Figure 6.7.: NOESY correlations of (13-(methoxycarbonyl)-11-((E)-18-ethylhexa-16,19-
dienyl)-12-propylcyclohex-10-enyl)-methyl-4-hydroxy benzoate (1). The NOESY relations 
were represented by double barbed arrow 
 
Figure 6.8.: 1H NMR spectrum of (13-(methoxycarbonyl)-11-((E)-18-ethylhexa-16,19-
dienyl)-12-propylcyclohex-10-enyl)-methyl-4-hydroxy benzoate (1) 
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Figure 6.9.: 13C NMR spectrum of (13-(methoxycarbonyl)-11-((E)-18-ethylhexa-16,19-
dienyl)-12-propylcyclohex-10-enyl)-methyl-4-hydroxy benzoate (1) 
Figure 6.10.: 135DEPT NMR spectrum of (13-(methoxycarbonyl)-11-((E)-18-ethylhexa-
16,19-dienyl)-12-propylcyclohex-10-enyl)-methyl-4-hydroxy benzoate (1) 
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Figure 6.11.: 1H-1H COSY NMR spectrum of (13-(methoxycarbonyl)-11-((E)-18-ethyl 
hexa-16,19-dienyl)-12-propylcyclohex-10-enyl)-methyl-4-hydroxy benzoate (1) 
Figure 6.12.: HSQC NMR spectrum of (13-(methoxycarbonyl)-11-((E)-18-ethylhexa-
16,19-dienyl)-12-propylcyclohex-10-enyl)-methyl-4-hydroxy benzoate (1) 
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Figure 6.13.: HMBC NMR spectrum of (13-(methoxycarbonyl)-11-((E)-18-ethylhexa-
16,19-dienyl)-12-propylcyclohex-10-enyl)-methyl-4-hydroxy benzoate (1) 
Figure 6.14.: NOESY NMR spectrum of (13-(methoxycarbonyl)-11-((E)-18-ethylhexa-
16,19-dienyl)-12-propylcyclohex-10-enyl)-methyl-4-hydroxy benzoate (1) 
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Figure 6.15.: FTIR spectrum of (13-(methoxycarbonyl)-11-((E)-18-ethylhexa-16,19-
dienyl)-12-propylcyclohex-10-enyl)-methyl-4-hydroxy benzoate (1) 
 
 The compound 1 exhibited ester carbonyl stretching vibration (1709 cm-1)  along 
with quarternary carbon signals due to δ 167.98 and 174.89 (-COOCH3). The IR frequency 
at ~1580 and 3349 cm-1 represented the aromatic alkene and broad hydroxyl stretching 
vibrations, respectively. The stretching vibrations at 2919 and 2851 cm-1 denoted the C-H 
alkyl absorptions. The C-C stretching vibrations at 1184-1140 cm-1and C-H bending 
vibrations at 1483 cm-1 were apparent (Figure 6.15.). 
 The compound 1 recorded its molecular ion peak at m/z 440 (found m/z 440.2565 
[M]+, cal. for C27H36O5 440.2563) in the mass spectrum (Figure 6.16.) that underwent 
elimination of methoxy radical followed by methyl, CHO•, butyl and methyl radicals were 
yielded the fragmented ions at m/z 409 (b), 395 (c), 366 (d), 311 (e) and 297 (f), 
respectively. The latter ion on sequential fragmentations exhibited peaks at m/z 270 (g, 
significant peak), 244 (h), 204 (j), 191 (k, but-9-enyl-4-hydroxy benzoate), 177 (l, butyl 
benzoate) and 160 (m). The fragment, m further fragmented to n with m/z 146 which 
signified to vinyl benzoate radical on removal of methyl radical. The benzene cation was 
reported at m/z 77 (q) from the fragment, p on CHO2• radical elimination and which was 
considered as the base peak of compound 1 (Figure 6.17.). 
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Figure 6.16.: EIMS spectrum of (13-(methoxycarbonyl)-11-((E)-18-ethylhexa-16,19-
dienyl)-12-propylcyclohex-10-enyl)-methyl-4-hydroxy benzoate (1)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.17.: Mass fragmentation pattern of (13-(methoxycarbonyl)-11-((E)-18-ethylhexa-
16,19-dienyl)-12-propylcyclohex-10-enyl)-methyl-4-hydroxy benzoate (1) 
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6.3.2.1.1. Biogenic origin of the polyketide synthase (PKS) catalyzed aryl polyketide 
derivative (1) 
 The PKS-bound malonate and 3-ethylpent-4-enethioate clusters were the 
building blocks to initiate the formation of the intermediate 5-ethyl-3-oxohept-6-enethioate 
bound to the biosynthetic enzyme cascade. Subsequent rearrangements and intramolecular 
cyclizations of the latter afforded PKS-bound methyl-3-((E)-4-ethylhexa-2,5-dienyl)-5-
(hydroxymethyl)-2-propylcyclohex-3-enecarboxylate. The latter appeared to undergo 
nucleophilic attack at hydroxyl end (situated terminally) on PKS activated carbonyl carbon 
of 3-hydroxy benzothioate. Subsequent elimination of acyl carrier protein (ACP)/KS-
enzyme cascade by thiolase appeared to result in the formation of 1 (Figure 6.18.). 
 
Figure 6.18.: Schematic representation of biosynthetic pathway of (13-(methoxycarbonyl)-
11-((E)-18-ethylhexa-16,19-dienyl)-12-propylcyclohex-10-enyl)-methyl-4-hydroxy 
benzoate (1) 
 
6.3.2.1.B. Structural characterization of compound 2 (PM6-3-1-1) 
Isobutyl-13-(6-(benzoyloxy)-10-methylpentyl)-tetrahydro-13-methyl-2H-
pyran-17-carboxylate (2) 
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Sample yield 92 mg; 0.18% 
Physical description Yellow oily 
Molecular formula C24H36O5 
Molecular mass 404.2563 
 
  The titled benzoate derivative (2) was purified as yellowish oil, and elucidated as 
C24H36O5 with detailed NMR/mass spectroscopy and compared with earlier works 
(Chakraborty et al., 2016d; Chakraborty et al., 2017c). It exhibited UV absorbance (in 
MeOH) at λmax (log ε 3.50) 261.0 nm, and was assigned to a chromophore with ester 
carbonyl and olefinic groups (Figure 6.19.). The purity of the compound was supported by 
RP C18 HPLC experiments using 3:2 (v/v) MeOH:MeCN (Rt 5.32) solvent system (Figure 
6.20.).  
 
 
Figure 6.19.: UV spectrum of isobutyl-13-(6-(benzoyloxy)-10-methylpentyl)-tetrahydro-
13-methyl-2H-pyran-17-carboxylate (2) 
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Figure 6.20.: HPLC chromatogram of isobutyl-13-(6-(benzoyloxy)-10-methylpentyl)-tetra 
hydro-13-methyl-2H-pyran-17-carboxylate (2) 
    
 The NMR signals in aromatic region confirmed the presence of benzyl group and 
greater chemical shift of aromatic quartenary carbon at C-6 (δ 132.32) was attributed to 
adjacent -C(=O)-O- moiety at C-7 (δ 167.69) (Table 6.7.; Figure 6.23.-6.24.). The protons 
at δ 4.23 and 4.02 displayed HSQC correlations with δ 65.51 (C-8) and 71.77 (C-19), 
respectively, and were adjacent to carbonyls at C-7 and C-18, respectively (HMBCs). The 
IR stretching vibration due to aromatic alkene (1599 cm-1) and 13C/1H (δ 130-128/7.45-
7.65) peaks (HSQC) including the aromatic quaternary carbon at δ 132.32 unambiguously 
established the presence of aromatic moiety in 2 (Huong et al., 2004) (Figure 6.27.). Seven 
degrees of unsaturations were recorded, and among which four were related to aryl, one 
was due to the pyran ring and the remaining two were accounted for the double bonds 
(C=O). The multiplicities of carbons were established from 135DEPT spectrum, which 
recognized the possibilities of seven methylenes (-CH2), four methyls (-CH3), three 
methines (-CH) (one oxygenated) along with three quaternary positions. The HMBC 
correlations due to the aromatic protons δ 7.65 (H-1) and δ 7.45 (H-4) to C-7 (δ 167.69) 
confirmed the occurrence of monosubstituted benzoyloxy group. The 1H NMR signal at δ 
5.10 (-CH-) exhibiting HSQC with δC 72.38 (C-17) was placed between the oxygen atom 
and carbonyl (-C=O) group of isobutyl-carboxylate chain. The one bond 1H-1H COSY 
recorded four spin systems, which were attributed to δ 7.65 (H-1)/7.45 (H-2) in the benzyl 
ring, δ 4.23 (H-8)/1.64 (H-9)/1.37 (H-10)/1.26 (H-11), 0.88 (H-24); δ 1.26 (H-11)/1.52 (H-
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12) in methylpentyl chain, δ 1.47 (H-14)/1.34 (H-15)/1.61, 1.27 (H-16)/5.10 (H-17) in pyran 
ring and δ 4.02 (H-19)/1.97 (H-20)/0.92 (H-21), 0.91 (H-22) in isobutyl end (Figure 6.21.A, 
6.26.). The HMBC couplings from δ 4.23 (H-8) to δ 167.69 (C-7), 19.75 (C-10); δ 1.64 (H-
9) to δ 13.77 (C-24); δ 1.37 (H-10) to δ 65.51 (C-8); δ 1.52 (H-12) to δ 67.23 (C-13); δ 1.26 
(H-11) to δ 38.05 (C-14), 67.23 (C-13); δ 1.18 (H-23) to δ 67.23 (C-13), 19.75 (C-10) and δ 
0.88 (H-24) to δ 19.75 (C-10), 30.57 (C-9) unambiguously established the 13-(6-
(benzoyloxy)-10-methylpentyl)-tetrahydro-13-methyl-2H-pyran moiety in 2 (Figure 6.21.B, 
6.28.). This pyran  moiety attached to the isobutyl-carboxylate at C-17 was predicted from 
intense HMBC cross peaks due to δ 5.10 (H-17) to δ 71.77 (C-19), 167.01 (C-18) together 
with δ 4.02 (H-19) to δ 167.01 (C-18), 19.16 (C-21), 19.13 (C-22) and δ 1.97 (H-20) to δ 
19.13 (C-22) thus establishing the structure of 2 (Chakraborty et al., 2017b). Relative 
spatial configuration of the stereochemical centres at C-17 and C-10 were appropriately 
described by NOESY correlations (Figure 6.22., 6.29.). The NOE couplings between δ 1.37 
(H-10) and 1.61 (H-16) attributed that these were located in similar plane and considered as 
α-disposed. NOE connections among the protons at δ 5.10 (H-17)/1.27 (H-16)/0.88 (H-
24)/1.18 (H-23) assigned them in identical plane of symmetry, whereas these protons did not 
display NOE cross peaks with the α-oriented H-10 and H-16 protons, and therefore, 
considered as β-disposed. 
 
Table 6.7.: NMR spectroscopic data of isobutyl-13-(6-(benzoyloxy)-10-methylpentyl)-tetra 
hydro-13-methyl-2H-pyran-17-carboxylate (2) in CDCl3 
C. No  13C  1H (int.,mult.,J in Hz)a COSY  HMBC            
1  128.81  7.65 (1H,d,7.15)  H-2  C-2,7  
2  130.83  7.45 (1H,t,9.53)  -  C-1  
3  130.74  7.46 (1H,t,8.58)  -  -  
4  130.90  7.45 (1H,d,10.21)  H-5  C-7  
5  128.71  7.64 (1H,d,9.17)  -  -  
6  132.32  -  -  -  
7  167.69  -  -  -  
8  65.51  4.23 (2H,t)  H-9  C-7,9,10  
9  30.57  1.64 (2H,m)  H-10  C-8,10,24  
10  19.75  1.37 (1Hα,m)  H-11,24  C-8,9,24,13,12  
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11  31.92  1.26 (2H,m)  H-12  C-10,13,14  
12  26.20  1.52 (2H,t)  -  -  
13  67.23  -  -  -  
14  38.05  1.47 (2H,m)  H-15  C-15  
15  18.81  1.34 (2H,m)  H-16  -  
16  22.69  1.61 (1Hα,m)                             1.27 (1Hβ,m)  H-17  C-17  
17  72.38  5.10 (1Hβ,dd)  -  C-18,19  
18  167.01  -  -  -  
19  71.77  4.02 (2H,d)  H-20  C-18,20,21,22  
20  27.73  1.97 (1H,m)  H-21,22  C-22  
21  19.16  0.92 (3H,d)  -  C-19,20  
22  19.13  0.91 (3H,d)  -  C-20  
23  29.69  1.18 (3Hβ,s)  -  C-10, 13  
24  13.77  0.88 (3Hβ,d)  -  C-9,10  
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 500MHz, 
while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, multiplicity and 
coupling constants (J=Hz) were indicated in parentheses. The assignments were made with 
the aid of the 1H-1H COSY, HSQC, HMBC and NOESY experiments 
 
 
 
 
Figure 6.21.: 1H-1H COSY (A) and HMBC (B) correlations of isobutyl-13-(6-
(benzoyloxy)-10-methylpentyl)-tetrahydro-13-methyl-2H-pyran-17-carboxylate (2). The 
key 1H-1H COSY couplings have been represented by the bold face bonds. The HMBC 
couplings were indicated by double barbed arrow 
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Figure 6.22.: NOESY correlations of isobutyl-13-(6-(benzoyloxy)-10-methylpentyl)-tetra 
hydro-13-methyl-2H-pyran-17-carboxylate (2). The NOESY relations were represented by 
double barbed arrow 
 
Figure 6.23.: 1H NMR spectrum of isobutyl-13-(6-(benzoyloxy)-10-methylpentyl)-tetra 
hydro-13-methyl-2H-pyran-17-carboxylate (2) 
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Figure 6.24.: 13C NMR spectrum of isobutyl-13-(6-(benzoyloxy)-10-methylpentyl)-tetra 
hydro-13-methyl-2H-pyran-17-carboxylate (2) 
Figure 6.25.: 135DEPT NMR spectrum of isobutyl-13-(6-(benzoyloxy)-10-methylpentyl)-
tetrahydro-13-methyl-2H-pyran-17-carboxylate (2) 
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Figure 6.26.: 1H-1H COSY NMR spectrum of isobutyl-13-(6-(benzoyloxy)-10-methyl 
pentyl)-tetrahydro-13-methyl-2H-pyran-17-carboxylate (2) 
Figure 6.27.: HSQC NMR spectrum of isobutyl-13-(6-(benzoyloxy)-10-methylpentyl)-
tetrahydro-13-methyl-2H-pyran-17-carboxylate (2) 
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Figure 6.28.: HMBC NMR spectrum of isobutyl-13-(6-(benzoyloxy)-10-methylpentyl)-
tetrahydro-13-methyl-2H-pyran-17-carboxylate (2) 
Figure 6.29.: NOESY NMR spectrum of isobutyl-13-(6-(benzoyloxy)-10-methylpentyl)-
tetrahydro-13-methyl-2H-pyran-17-carboxylate (2) 
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  The compound 2 exhibited ester carbonyl stretching vibrations at 1722 cm-1 
along with aromatic alkenic stretching vibrations at ~1585 cm-1. The stretching vibration 
bands at 2959, 2930 cm-1 denoted the C-H alkyl absorptions. The C-H bending and rocking 
absorption bands were appeared at 1448 and 703-651 cm-1, respectively (Figure 6.30.). 
 
Figure 6.30.: FTIR spectrum of isobutyl-13-(6-(benzoyloxy)-10-methylpentyl)-tetrahydro-
13-methyl-2H-pyran-17-carboxylate (2) 
 
 The compound 2 was registered the molecular ion peak at m/z 404 (found m/z 
404.2567 [M]+, cal. for C24H36O5 404.2563), which on fragmentation of propyl radical and 
two sequential methoxy radicals yielded ions at m/z 361 (b), 333 (c) and 303 (d), 
respectively. The later was found to fragmented at m/z 284 (e), 256 (f), 232 (g) and 191 (h) 
on removal of methyl, two repeated units of C2H4•• and C2H4O•• radicals, respectively. The 
ethyl benzoate radical was recorded at m/z 149 (j) from isopentyl benzoate (m/z 191, h) on 
elimination of propyl moiety, which was further fragmented at m/z 121 (k, benzoate cation) 
on C2H5• elimination. The fragment, k eliminated carboxylate radical to acquire base peak at 
m/z 77 (l) which was corresponded to benzene cation (Figure 6.31., 6.32.). 
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Figure 6.31.: EIMS spectrum of isobutyl-13-(6-(benzoyloxy)-10-methylpentyl)-tetrahydro-
13-methyl-2H-pyran-17-carboxylate (2) 
 
 
 
 
 
 
 
Figure 6.32.: Mass fragmentation pattern of isobutyl-13-(6-(benzoyloxy)-10-
methylpentyl)-tetrahydro-13-methyl-2H-pyran-17-carboxylate (2) 
  
6.3.2.1.2. Biogenic origin of the polyketide synthase (PKS) catalyzed aryl polyketide 
derivative (2) 
 The PKS-bound malonate and isobutoxycarbonyl moieties were the building 
blocks to initiate the formation of 2-(isobutoxycarbonyl)-ethanethiote, which has been the 
backbone for the biosynthesis of 2 (Figure 6.33.). 2-(Isobutoxycarbonyl)-ethanethiote 
bound to PKS enzyme cascade underwent several rearrangements to yield isobutyl-2,11-
dihydroxy-9-methyl-6-oxoundecanoate, which on elimination of hydroxyl group followed 
by intramolecular cyclization afforded isobutyl-tetrahydro-6-hydroxy-6-(5-hydroxy-3-
methylpentyl)-2H-pyran-2-carboxylate. The later on methyl transferase and enolreductase 
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catalyzed condensation with benzothioate bound to PKS acquired compound 2 
(Chakraborty et al., 2017b). 
 
Figure 6.33.: Schematic representation of biosynthetic pathway of isobutyl-13-(6-
(benzoyloxy)-10-methylpentyl)-tetrahydro-13-methyl-2H-pyran-17-carboxylate (2) 
 
6.3.2.1.C. Structural characterization of compound 3 (PM3-1-1-1) 
(E)-12-(17-Ethyl-tetrahydro-16-hydroxy-15-(methyl pentanoate)-14-oxo-2H-
pyran-13-yl)-9-methylbut-11-enyl benzoate (3) 
 
 
Sample yield 75 mg; 0.15% 
Physical description Pale yellow oily 
Molecular formula C26H36O7 
Molecular mass 460.2461 
 
Compound 3 was puified as pale yellow oily compound and its molecular 
formula determined as C26H36O7. It exhibited UV absorbance (in MeOH) at λmax (log ε 
3.80) 274.0 nm was assigned to a chromophore with ester carbonyl and olefinic groups 
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(Figure 6.34.). The RP C18 HPLC experiments using MeOH:MeCN (3:2, v/v) (Rt 6.28) was 
supported its purity (Figure 6.35.). 
 
 
Figure 6.34.: UV spectrum of (E)-12-(17-ethyl-tetrahydro-16-hydroxy-15-(methyl 
pentanoate)-14-oxo-2H-pyran-13-yl)-9-methylbut-11-enyl benzoate (3) 
Figure 6.35.: HPLC chromatogram of (E)-12-(17-ethyl-tetrahydro-16-hydroxy-15-(methyl 
pentanoate)-14-oxo-2H-pyran-13-yl)-9-methylbut-11-enyl benzoate (3)   
  
 The characteristic 13C NMR signals registered at δ 167.68, 172.83 and 173.25 
were due to ester {-C(=O)-O-} moieties in which the former belonged to an aromatic ester, 
whereas the other two were attributed to cyclic or straight chain ester groups. These 
attributions were appropriately supported by the presence of strong carbonyl IR stretching 
band (1724 cm-1) along with1H/13C NMR signals at δ 4.09/71.78 and δ 4.32/65.54 (due to 
326 
 
Isolation and characterization of secondary metabolites from Paphia malabarica           Chapter 6 
strong electron withdrawing effect of oxygen) (Table 6.8.). The presence of benzyl moieties 
were ascribed by characteristic peaks at δ 7.50-7.72 in 1H NMR and their HSQC relations 
with carbon atoms at δ 128-132 (Figure 6.38., 6.39., 6.42.). The 1H NMR of 3 exhibited 
two olefinic signals at δ 5.35 (J=9.54 Hz) and 5.37 (J=9.86 Hz), which revealed the 
presence of trans oriented (E) vicinal olefinic protons. The title compound exhibited nine 
degrees of unsaturation in which four were recognized to aromatic ring, whereas remaining 
five related to double bonds.  
 The aromatic signals in 1H NMR spectrum appeared to be doublets/double 
doublets with five proton integral, which attributed to the monosubstituted benzyl 
framework (Chakraborty et al., 2017a). The 13C NMR at δ 132.33 was suggested to the 
quaternary carbon in aromatic ring and its downfield shift was attributed to the presence of 
strong electron withdrawing ester group {-C(=O)-O-} at δ 167.68 (Huong et al., 2004). The 
deshielded methine proton at δ 4.32 (corresponded to δC 65.54, HSQC) was geminal to the 
hydroxyl group, and was enclosed in oxo-2H-pyran ring. The occurance of hydroxyl group 
was further confirmed by broad stretching vibration band at 3308 cm-1 and deuterium 
exchange {D2O (deuterium oxide)-1H NMR} experiment. The attachment of carbonyl 
group to aryl skeleton was supported by intense HMBC cross peaks from δ 7.71 (H-1) to δ 
167.68 (C-7) that established that the benzoate moiety was connected to the oxo-2H-pyran 
group through the 9-methylbut-11-ene moiety (Figure 6.36.B, 6.43.). The long range HMBC 
correlations from δ 4.09 (H-8) to δ 167.68 (C-7), 27.73 (C-9), 19.16 (C-10); δ 2.03 (H-9) to 
δ 129.92 (C-12); δ 0.98 (H-10, -CH3) to δ 71.78 (C-8); δ 5.35 (H-11) to δ 27.23 (C-9) 
attributed the presence of 9-methylbut-11-ene moiety in 3 (Figure 6.36.B). Its attachment to 
oxo-2H-pyran was confirmed by long range HMBCs among δ 2.85 (H-13) and δ 129.80 (C-
11). This structure enclosed five spin sytems, δ 7.71 (H-1)/7.51 (H-2); 7.53 (H-4)/7.72 (H-
5) in benzene ring and δ 4.09 (H-8)/2.03 (H-9)/0.98 (H-10), 5.35 (H-11) in 9-methylbut-11-
enyl chain network. The spin systems, δ 5.37 (H-12)/2.85 (H-13) and δ 4.15, 4.29 (H-
20)/5.27 (H-15)/4.32 (H-16)/1.73 (H-17)/1.45 (H-18)/0.96 (H-19) were attributed to 17-
ethyl-tetrahydro-16-hydroxy-15-methyl-14-oxo-2H-pyran (Figure 6.36.A, 6.41.), and these 
assignments were comparable with lactone ring system of previously described benzoates 
(Huong et al., 2004). Intense correlations at δ 2.31 (H-22)/1.61 (H-23)/1.30 (H-24)/1.26 (H-
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25)/0.89 (H-26) were substantiated the presence of pentanoate side chain. The relative 
stereochemistries at C-17, C-16, C-13, C-9 and C-15 were predicted from nuclear 
overhauser effect spectroscopy (NOESY) cross peaks (Figure 6.37., 6.44.). Likewise, NOE 
correlations were obvious between δ 4.32 (H-16)/5.27 (H-15)/4.15 (Hα-20), which depicted 
that these protons were located at similar plane of geometry and α-orientated. The NOE 
peaks between δ 2.03 (H-9)/1.73 (H-17)/4.29 (Hβ-20)/2.85 (H-13) were indicated that these 
were equiplaner, and disposed at the β-plane of reference. Furthermore, the hydroxyl group 
(at C-16) was placed at the β-plane of reference, and was disposed at the opposite plane of 
the α-oriented proton at δ 4.32 (Hα-16) and methyl group at C-9, being trans to Hβ-9. 
Table 6.8.: NMR spectroscopic data of (E)-12-(17-ethyl-tetrahydro-16-hydroxy-15-(methyl 
pentanoate)-14-oxo-2H-pyran-13-yl)-9-methylbut-11-enyl benzoate (3) in CDCl3 
C. No  13C 1H (int.,mult.,J in Hz)a COSY  HMBC           
1 128.83  7.71 (1H,d,8.57) H-2 C-7,2 
2 130.88  7.51 (1H,dd,7.59) - C-1 
3 130.88  7.54 (1H,dd,9.46) - - 
4 130.88  7.53 (1H,dd,8.24) H-5 - 
5 128.7  7.72 (1H,d,7.48) - - 
6 132.33  - - - 
7 167.68  - - - 
8 71.78  4.09 (2H,d) H-9 C-7,9,10 
9 27.73  2.03 (1Hβ,m) H-10,11  C-12 
10  19.16  0.98 (3Hα,d)  - C-8 
11  129.8  5.35 (1H,t,9.54) -  C-9 
12  129.92  5.37 (1H,t,9.86) H-13  - 
13  25.63  2.85 (1Hβ,t)  -  C-11 
14 172.83 - -  - 
15  68.88  5.27 (1Hα,dt)  H-16,20 
16  65.54  4.32 (1Hα,t)  H-17 C-14,17,18,20 
17  30.58  1.73 (1Hβ,p)  H-18 C-16,18,19 
18  19.19  1.45 (2H,m)  H-19 
19  13.72  0.96 (3H,t)  -  - 
20  62.09  4.15 (1Hα,dd)           - C-14,21,16 
4.29 (1Hβ,dd) 
21 173.25 - - - 
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22  34.05  2.31 (2H,t)  H-23 C-21,23,24 
23  24.82  1.61 (2H,p) H-24 
24 29.7 1.30 (2H,m) H-25 C-23 
25  22.69  1.26 (2H,m) H-26 C-24, 
26  14.11  0.89 (3H,t) - C-24,25 
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 500MHz, 
while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, multiplicity and 
coupling constants (J=Hz) were indicated in parentheses. The assignments were made with 
the aid of the 1H-1H COSY, HSQC, HMBC and NOESY experiments 
Figure 6.36.: 1H-1H COSY(A) and HMBC (B)  correlations of (E)-12-(17-ethyl-tetrahydro-
16-hydroxy-15-(methylpentanoate)-14-oxo-2H-pyran-13-yl)-9-methylbut-11-enyl benzoate 
(3). The key 1H-1H COSY couplings have been represented by the bold face bonds. The 
HMBC couplings were indicated by double barbed arrow 
Figure 6.37.: NOESY correlations of (E)-12-(17-ethyl-tetrahydro-16-hydroxy-15-(methyl 
pentanoate)-14-oxo-2H-pyran-13-yl)-9-methylbut-11-enyl benzoate (3). The NOESY 
relations were represented by double barbed arrow 
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Figure 6.38.: 1H NMR spectrum of (E)-12-(17-ethyl-tetrahydro-16-hydroxy-15-(methyl 
pentanoate)-14-oxo-2H-pyran-13-yl)-9-methylbut-11-enyl benzoate (3) 
Figure 6.39.: 13C NMR spectrum of (E)-12-(17-ethyl-tetrahydro-16-hydroxy-15-(methyl 
pentanoate)-14-oxo-2H-pyran-13-yl)-9-methylbut-11-enyl benzoate (3) 
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Figure 6.40.: 135DEPT NMR spectrum of (E)-12-(17-ethyl-tetrahydro-16-hydroxy-15-
(methylpentanoate)-14-oxo-2H-pyran-13-yl)-9-methylbut-11-enyl benzoate (3) 
Figure 6.41.: 1H-1H COSY NMR spectrum of (E)-12-(17-ethyl-tetrahydro-16-hydroxy-15-
(methylpentanoate)-14-oxo-2H-pyran-13-yl)-9-methylbut-11-enyl benzoate (3) 
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Figure 6.42.: HSQC NMR spectrum of (E)-12-(17-ethyl-tetrahydro-16-hydroxy-15-
(methylpentanoate)-14-oxo-2H-pyran-13-yl)-9-methylbut-11-enyl benzoate (3) 
Figure 6.43.: HMBC NMR spectrum of (E)-12-(17-ethyl-tetrahydro-16-hydroxy-15-
(methylpentanoate)-14-oxo-2H-pyran-13-yl)-9-methylbut-11-enyl benzoate (3) 
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Figure 6.44.: NOESY NMR spectrum of (E)-12-(17-ethyl-tetrahydro-16-hydroxy-15-
(methylpentanoate)-14-oxo-2H-pyran-13-yl)-9-methylbut-11-enyl benzoate (3) 
Figure 6.45.: FTIR spectrum of (E)-12-(17-ethyl-tetrahydro-16-hydroxy-15-(methyl 
pentanoate)-14-oxo-2H-pyran-13-yl)-9-methylbut-11-enyl benzoate (3) 
 
  The compound 3 exhibited ester carbonyl stretching vibrations at 1724 cm-1 and 
hydroxyl stretching vibrations at 3308 cm-1. The stretching vibrations at 2921-2852 cm-1 
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denoted the C-H alkyl absorptions. The C-H bending and rocking absorption bands were 
appeared at 1457 and 742 cm-1 (Figure 6.45.). 
 The compound 3 recorded its molecular ion peak at m/z 460 (EIMS: found m/z 
460.2466 [M]+, cal. for C26H36O7 460.2461) (Figure 6.46.) that belived to undergo three 
sequential fragmentation of ethyl radical to get ion fragments at m/z 431 (b), 403 (c) and 
375 (d), respectively. The ion fragment at d showed fragmentation by the removal of 
hydroxyl and C2H3O2• radicals to obtain peaks at m/z 355 (e) and 295 (f), respectively 
which was on fragmentation yielded a fragment at m/z 281 (g) along with the removal of 
CH2•• radical. The molecular ion, g resulted in the fragmented ions at m/z 213 (h) and 203 (j) 
on elimination of C3H3O2•• and methyl radicals, respectively. The significant peak of vinyl 
benzoate cation at m/z 147 (1k) and a stable benzoate ion at m/z 121 (l) were appeared on 
subsequent elimination of C4H7• and C2H3• radicals from the fragment j. The base peak was 
apparent at m/z 77 (m) for benzene cation on elimination of carboxyl radical from the 
fragment, l (m/z 121) (Figure 6.47.). 
Figure 6.46.: EIMS spectrum of (E)-12-(17-ethyl-tetrahydro-16-hydroxy-15-(methyl 
pentanoate)-14-oxo-2H-pyran-13-yl)-9-methylbut-11-enyl benzoate (3) 
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Figure 6.47.: Mass fragmentation pattern of (E)-12-(17-ethyl-tetrahydro-16-hydroxy-15-
(methylpentanoate)-14-oxo-2H-pyran-13-yl)-9-methylbut-11-enyl benzoate (3) 
 
6.3.2.1.3. Biogenic origin of the polyketide synthase (PKS) catalyzed aryl polyketide 
derivative (3) 
 The putative biosynthetic pathway of aryl polyketide 3 was postulated. The 
intermediate polyketide, 3-ethyl-6-(hexanoyloxy)-4,5-dihydroxy-2-((E)-but-1-enyl-3-
methyl-hydroxy)-hexane thioate connected to polyketide synthase (PKS) enzyme cascade 
appeared to undergo intramolecular cyclization to 4-ethyl-tetrahydro-3-((E)-4-hydroxy-3-
methyl-but-1-enyl)-6-(hydroxymethyl)-2H-pyran-2,5-diol. The latter compound undergoes 
intramolecular rearrangement yielding 4-ethyl-tetrahydro-5-hydroxy-3-((E)-4-hydroxy-3-
methylbut-1-enyl)-6-(hydroxy-methyl)-pyran-2-one. The ketosynthatase (KS)-catalyzed 
condensation of 4-ethyl-tetrahydro-5-hydroxy-3-((E)-4-hydroxy-3-methylbut-1-enyl)-6-
(hydroxymethyl)-pyran-2-one and PKS-bound benzothioate through nucleophilic attack of 
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terminal hydroxyl of the latter resulted in the formation of titled compound on subsequent 
elimination of PKS-thiolase (Figure 6.48.) (Chakraborty et al., 2017b; Chakraborty et al., 
2017c). 
 
 
Figure 6.48.: Schematic representation of biosynthetic pathway of (E)-12-(17-ethyl-tetra 
hydro-16-hydroxy-15-(methylpentanoate)-14-oxo-2H-pyran-13-yl)-9-methylbut-11-enyl 
benzoate (3) 
  
 Polyketide group of compounds constitute a versatile class of secondary 
metabolites in marine organisms with diverse bioactivities (Chakraborty et al., 2016d; 
Chakraborty et al., 2017b). Despite the fact that microbial polyketide compounds are of 
immense health signiﬁcance, the occurrence of this group of compounds in marine 
mollusks, one of the afﬂuent origin of functional leads, remained predominantly 
uninvestigated. In particular, hypothetical biosynthetic routes leading to the formation of 
polyketide compounds were described in the previous literatures (Chakraborty et al., 
2017b). Successive decarboxylative Claisen condensations between various extenders and 
polyketide skeletons followed by chain enlargements by discrete enzymesappeared to 
biosynthesize structurally diverse molecules, such as aryl polyketide derivatives isolated 
from P. malabarica. The putative PKS enzyme cascade assisted biosynthetic pathways of 
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title compounds, and accordingly confirmed the structural features of previously 
undisclosed aryl polyketide derivatives (1-3). This is the ﬁrst report of characterization of 
three new variants of aryl substituted polyketide derivatives from mollusks with potential 
antioxidative and anti-inﬂammatory properties for use as functional food ingredients. 
 
6.3.2.2.  Structural characterization of tetrahydro chromenyl derivatives (4-5) 
 
Figure 6.49.: Tetrahydro chromenyl derivatives from P. malabarica with bioactive 
potentials 
 
 Naturally and synthetically identified chromene derivatives are valuable 
pharmacophores, which exhibit important structural and functional peculiarities in natural 
product research and also reported for biological activities, such as antioxidant (Milan et 
al., 2011), anti-inflammatory (Nitin et al., 2012), anti-bacterial and anti-tumour properties 
(Smith et al., 1998). The benzopyrans or pyranones, hydrogenated benzopyrans or pyrones, 
cyclohexane δ-lactones are the different forms of chromene or chromenone based skeletons 
(Boeckman et al., 1988). The α-tocopherol is a prominent example of naturally occurring 
chromene (benzopyran) with significant antioxidant properties and is commercially 
exploited to prevent lipid peroxidation in food (Kindleysides et al., 2012). A medicinally 
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important isochromenone secondary metabolite was identified from a fungus, Camptotheca 
acuminate (Lin et al., 2011) and the hydrogenated chromenone from marine green alga 
were reported (El-Beih et al., 2007). The extensive investigation of naturally derived 
chromenyl compounds with varying substitutions is imperative to the invention of potential 
pharmacophore templates for upcoming functional foods, nutraceutical supplements and to 
prevent peroxide formations in foods. Herein, we have characterized two new substituted 
tetrahydro chromenyl derivatives with hitherto unreported furanyl-2H-chromenyl skeletons 
(4) and isochromen-(5H)-one (5) from EtOAc:MeOH extract of P. malabarica. 
 
6.3.2.2.A. Structural characterization of compound 4 (PM4-2-1) 
61-(3-((E)-31b-(Furan-2’-yl)-prop-31b-en-31-yl)-4a,5,6,8a-tetrahydro-8-
methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate (4) 
 
 
Sample yield 110 mg; 0.22% 
Physical description Brown oily 
Molecular formula C26H36O4 
Molecular mass 412.2613 
 
 The compound, 61-(3-((E)-31b-(furan-2’-yl)-prop-31b-en-31-yl)-4a,5,6,8a-tetra 
hydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate (4) was isolated as brown 
oily upon repetitive fractionation. It exhibited UV absorbance (in MeOH) at λmax (log ε 3.98 
and 3.90) 284.0 and 286.0 nm assigned to a chromophore with ester carbonyl, furanyl and 
olefinic groups (Figure 6.50.). The purity of compound 4 was supported by RP C18 HPLC 
experiments using 3:2 (v/v) MeOH:MeCN (Rt 12.92) solvent system (Figure 6.51.).  
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Figure 6.50.: UV spectrum of 61-(3-((E)-31b-(furan-2’-yl)-prop-31b-en-31-yl)-4a,5,6,8a-tetra 
hydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate (4) 
 
Figure 6.51.: HPLC chromatogram 61-(3-((E)-31b-(furan-2’-yl)-prop-31b-en-31-yl)-4a,5,6, 
8a-tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate (4) 
  
 The molecular ion peak was registered at m/z 413 (HRESIMS: found m/z 
413.2694 [M+1]+, cal. for C26H37O4 413.2692), which supported the chemical composition 
of 4 as C26H36O4 (molecular mass: 412.2614) with nine double bond equivalences 
corresponding to five alkenic and one carbonyl, and three rings. The presence of aromatic 
ring was confirmed by three noteworthy peaks (δ 7.07, 7.29, 7.46; each with 1H) exhibiting 
HSQC correlations with the carbons at δ 124.45, 123.97 and 119.10, respectively (Table 6.9.; 
Figure 6.52., 6.53., 6.58.). The quaternary carbon at δ 152.12 (C-2’) was exhibited 
significant downfield shift, and attributed to the carbon adjacent to an electronegative 
oxygen atom, which supported the possible substitution at C-2’ of the furan ring system. 
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The long range HMBCs from δ 7.07 (H-4’) to δ 123.97 (C-5’), 152.12 (C-2’) further 
confirmed the presence of furan ring system (Figure 6.59.). The 1H NMR spectrum was 
exhibited a highly deshielded singlet at δ 6.92 (assigned to H-31b) showing intense HSQC 
interaction with the carbon at δ 124.76 (-CH-), which confirmed the presence of an alkenic 
proton attached to the highly electronegative centre of furan ring system. These attributions 
were supported by the previously described chemical shift values of Hypofuran B (Ding et 
al., 2015). The side chain attachment to furan at C-2’ was established from the HMBC 
correlations between δ 6.92 (H-31b) to δ 152.12 (C-2’), 123.97 (C-5’) and that between δ 
6.92 (H-31b) to δ 30.20 (C-31a), 135.88 (C-31) established the presence of 31b-(furan-2’-yl)-
prop-31b-en-31-yl framework with methyl (-CH3) at its C-31a position (δH 1.26/δC 30.20, s). 
These correlations were further confirmed the attachment of second carbon of prop-31b-ene 
to the C-3 of tetrahydro chromene. The 1H NMR was enclosed two doublets at δ 4.08 and 
4.22, which exhibited HSQC correlation with carbon at δ 62.10. The greater chemical shifts 
of these protons (δ 4.08 and 4.22) were attached to same carbon atom was probably due to 
the presence of strong electronegative moieties, such as oxygen/olefines. The olefinic 
signals at δ 5.30/128.80 (assigned to C-4 of tetrahydro chromene) was identified by the 
comparison of olefinic protons of benzopyran moiety in 6-acetyl-7-hydroxy-2,2-
dimethylchromene isolated from Calea pinnatifida, in which H-4 proton appeared at highly 
downfielded region (δ 6.28) due to the adjacent benzene ring (Lima et al., 2015). Likewise, 
the pyran moiety of 24-O-ethylmanoalide from marine sponge Luffariella variabilis 
exhibited comparable 1H and 13C NMR shifts at C-2 to C-4 positions of title compound 
(Bialecki et al., 2008). HMBC correlations from δ 4.08 (H-2) to δ 147.06 (C-3); δ 4.22 (H-
2) to δ 128.80 (C-4), 135.88 (C-31) were further affirmed the presence of tetrahydro 
benzopyran framework. 1H-1H COSY correlations confirmed that the protons at C-6 and C-
8 positions were attached to the ethyl (-CH2-CH2-) and methyl {δ 1.36 (s)/δ 30.21} groups, 
respectively. The greater chemical shift of proton at δ 4.00 corresponding to δ 64.63 (C-61a) 
was due to the vicinity of oxygenated end of carboxylate group present at δ 173.34 (-C(O)-
O) (attributed to C-1’’). The HSQC spectrum was showed correlation between proton at δ 
2.24 with the carbon at δ 34.30 that was found to be at the carbonyl (C=O) end. This 
compound enclosed three spin systems, such as H-3’ to H- 5’ {δ 7.46 (H-3’)/7.07 (H-
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4’)/7.29 (H- 5’)} in the furan ring; δ 5.30 (H-4)/2.54 (H-4a)/1.38 (H-5)/1.95 (H-6)/5.27 (H-
7); δ 2.54 (H-4a)/2.78 (H-8a); δ 1.95 (H-6)/1.54 (H-61)/4.00 (H-61a) for 61-tetrahydro-8-
methyl-2H-chromen-6-yl)-ethyl moiety, and H-2’’ to H-6’’(δ 2.24 (H-2’’)/1.51 (H-
3’’)/1.21 (H-4’’)/1.98 (H-5’’)/0.81 (H-5’’a, H-6’’) for 5’’-methyl-hexanoate side chain 
(Figure 6.52.A, 6.57.). The long range HMBC correlations between δ 2.54 (H-4a) to δ 
31.44 (C-8a); δ 1.38 (H-5) to δ 36.52 (C-4a); δ 2.78 (H-8a) to δ 36.52 (C-4a), 131.16 (C-8), 
130.87 (C-7); δ 1.36 (H-81) to δ 131.16 (C-8), 31.44 (C-8a), 36.52 (C-4a); δ 1.54 (H-6a) to 
δ 31.94 (C-5); δ 4.00 (H-61) to δ 25.93 (C-61), 27.23 (C-6) were supported the presence of 
61-(4a,5,6,8a-tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl fragment (Figure 6.52.B, 6.59.). 
The HMBC correlations between δ 4.00 (H-61a) to δ 173.34 (C-1’’); δ 2.24 (H-2’’) to δ 
173.34 (C-1’’); δ 0.81(H-6’’) to δ 22.70 (C-4’’), 29.37 (C-3’’) accounted for the presence 
of 61-ethyl-5’’-methyl-hexanoate moiety. Likewise, the main carbon connectivity of 4, 
featuring tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate framework 
was established. The relative configurations of the chiral carbons of 4 were established by 
detailed NOESY (Figure 6.60.). NOESY correlations between δ 1.36 (H-81) to δ 2.54 (H-
4a); δ 2.78 (H-8a) to δ 1.95 (H-6) and δ 6.92 (H-31b) to δ 1.36 (H-81), indicated that these 
protons were co-facial, and β-orientated (Figure 6.53.). Consequently, the NOESYs 
between δ 7.29 (H-5’) to δ 1.26 (H-31a) and from δ 1.26 (H-31a) to δ 1.98 (H-5’’) were 
showed that these protons disposed at opposite plane of reference to that of H-4a/H-8a, 
therefore, assigned to be α-oriented. Detailed NOE assignments predicted that the protons 
at ring junctions (C-8a)/(C-4a) and chiral proton at C-6 were disposed at identical plane of 
symmetry of title compound, and considered as β-oriented. Based on these, the bulky 61-
ethyl-5’’-methyl-hexanoate group at C-6 position was found to dispose at different plane of 
reference to that of H-4a/H-8a, and α-oriented.  
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Table 6.9.: NMR spectroscopic data of 61-(3-((E)-31b-(furan-2’-yl)-prop-31b-en-31-yl)-4a,5, 
6,8a-tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate (4) in CDCl3 
C. No.  13C  1H (int.,mult.,J in Hz)a COSY  HMBC  
1  -  -  -  -  
2  62.10  4.08 (1H,dd)  -  C-3  
  4.22 (1H,dd)  -  C-4,31 
3  147.06  -  -  -  
31  135.88  -  -  -  
31a 30.20  1.26 (3Hα,s)  -  C-31,3  
31b 124.76  6.92 (1Hβ,s)  -  C-2’,5’,31a, 31 
4  128.80  5.30 (1H,d,11.20)  H-4a  C-31 
4a  36.52  2.54 (1Hβ,dt)  H-5,8a  C-8a  
5  31.94  1.38 (2H,t)  H-6  C-4a  
6  27.23  1.95 (1Hβ,m)  H-61,7   
61  25.93  1.54 (2H,m)  H-61a C-5  
61a 64.63  4.00 (2H,t)  -  C-6a,6,1’’  
7  130.87  5.27 (1H,d,11.00)  -  -  
8  131.16  -  -  -  
8a  31.44  2.78 (1Hβ,t)  -  C-4a,8,7  
81  30.21  1.36 (3Hβ,s)  -  C-8,8a,4a  
1’  -  -  -  -  
2’  152.12  -  -  -  
3’  119.10  7.46 (1H,d,9.91)  H-4’   
4’  124.45  7.07 (1H,t,10.48)  H-5’  C-5’,2’ 
5’  123.97  7.29 (1H,d,5.51)  -  -  
1’’  173.34  -  -  -  
2’’  34.30  2.24 (2H,m)  H-3’’  C-1’’  
3’’  29.37  1.51 (2H,m)  H-4’’  -  
4’’  22.70  1.21 (2H,m)  H-5’’  -  
5’’  30.20  1.98 (1Hα,m)  H-5’’a,6’’  -  
5’’a  14.10  0.81 (3H,d)  -  C-4'',3’’  
6’’  14.10  0.81 (3H,d)  -  C-3’’  
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 500MHz, 
while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, multiplicity and 
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coupling constants (J=Hz) were indicated in parentheses. The assignments were made with 
the aid of the 1H-1H COSY, HSQC, HMBC and NOESY experiments 
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Figure 6.52.: 1H-1H COSY (A) and HMBC (B) correlations of 61-(3-((E)-31b-(furan-2’-yl)-
prop-31b-en-31-yl)-4a,5,6,8a-tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-
hexanoate (4). The key 1H-1H COSY couplings have been represented by the bold face 
bonds. The HMBC couplings were indicated by double barbed arrow 
Figure 6.53.: NOESY correlations of 61-(3-((E)-31b-(furan-2’-yl)-prop-31b-en-31-yl)-4a,5, 
6,8a-tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate (4). The NOESY 
relations were represented by double barbed arrow 
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Figure 6.54.: 1H NMR spectrum of 61-(3-((E)-31b-(furan-2’-yl)-prop-31b-en-31-yl)-4a,5,6, 
8a-tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate (4) 
Figure 6.55.: 13C NMR spectrum of 61-(3-((E)-31b-(furan-2’-yl)-prop-31b-en-31-yl)-4a,5,6, 
8a-tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate (4) 
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Figure 6.56.: 135DEPT NMR spectrum of 61-(3-((E)-31b-(furan-2’-yl)-prop-31b-en-31-yl)-
4a,5,6,8a-tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate (4) 
Figure 6.57.: 1H-1H COSY NMR spectrum of 61-(3-((E)-31b-(furan-2’-yl)-prop-31b-en-31-
yl)-4a,5,6,8a-tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate (4) 
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Figure 6.58.: HSQC NMR spectrum of 61-(3-((E)-31b-(furan-2’-yl)-prop-31b-en-31-yl)-
4a,5,6,8a-tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate (4) 
Figure 6.59.: HMBC NMR spectrum of 61-(3-((E)-31b-(furan-2’-yl)-prop-31b-en-31-yl)-
4a,5,6,8a-tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate (4) 
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Figure 6.60.: NOESY NMR spectrum of 61-(3-((E)-31b-(furan-2’-yl)-prop-31b-en-31-yl)-
4a,5,6,8a-tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate (4) 
Figure 6.61.: FTIR spectrum of 61-(3-((E)-31b-(furan-2’-yl)-prop-31b-en-31-yl)-4a,5,6,8a-
tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate (4) 
 
   IR spectrum indicated the presence of carbonyl and ester stretchings, which were 
represented by the bending vibrations at 1737 and 1161 cm-1, respectively. Notably, the 
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intense IR peak at 1079 cm-1 represented the C-H bending vibrations of the furan ring. The 
stretching vibration bands at 2922, 2853 cm-1 denoted the occurances of C-H alkyl 
absorptions. The C-H bending and rocking absorption bands were appeared at 1481 and 
720 cm-1 (Figure 6.61.). 
 
Figure 6.62.: EIMS spectrum of 61-(3-((E)-31b-(furan-2’-yl)-prop-31b-en-31-yl)-4a,5,6,8a-
tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate (4) 
 
Figure 6.63.: Mass fragmentation pattern of 61-(3-((E)-31b-(furan-2’-yl)-prop-31b-en-31-yl)-
4a,5,6,8a-tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate (4) 
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The molecular ion peak at m/z 413 was appeared to yield fragment ions at m/z 
400 (a), 368 (b), 354 (c) and 340 (d) (Figure 6.63.-6.64.). The elimination of vinylfuran 
and furan radical from the fragment ion at m/z 340 yielded the fragments with m/z 281 (e) 
and 221 (g). Subsequent fragmentation of the fragment ion at m/z 221 (g) resulted into 
radicals at m/z 207 (l), 147 (i), 114 (m), 96 (h) and 73 (k) (but-2-en-1-ol). Notably, the 
fragment ion at m/z 73 (C3H5O2•+) appeared as base peak (de Carvalhoa et al., 2001). 
 
6.3.2.2.B. Structural characterization of compound 5 (PM3-1-2-2) 
7-(2’-Ethyl-1’-hydroxynonan-2’-yl)-6,7,8,8a-tetrahydro-3H-isochromen-1-(5H)-
one (5) 
 
 
Sample yield 90 mg; 0.18% 
Physical description Yellow oily 
Molecular formula C20H34O3 
Molecular mass 322.2508 
  
 The compound, 7-(2’-Ethyl-1’-hydroxynonan-2’-yl)-6,7,8,8a-tetrahydro-3H-
isochromen-1-(5H)-one, is an isochromenone derivative (5) was isolated as a yellowish oil 
compound. It exhibited UV absorbance (in MeOH) at λmax (log ε 3.99) 277.0 nm was 
assigned to a chromophore with ester carbonyl groups (Figure 6.65.). The purity of the 
compound was supported by RP C18 HPLC experiments using 3:2 (v/v) MeOH:MeCN (Rt 
3.80) solvent system (Figure 6.66.). 
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Figure 6.64.: UV spectrum of 7-(2’-ethyl-1’-hydroxynonan-2’-yl)-6,7,8,8a-tetrahydro-3H-
isochromen-1-(5H)-one (5) 
Figure 6.65.: HPLC chromatogram of 7-(2’-ethyl-1’-hydroxynonan-2’-yl)-6,7,8,8a-tetra 
hydro-3H-isochromen-1-(5H)-one (5) 
   
 Aromatic region (δ 6.5-8.5) of the compound 5 did not exhibit any notable signals, 
which confirmed the absence of aromatic moiety (Figure 6.68.). The molecular ion peak at 
m/z 322 (EIMS: found m/z 322.2512 [M]+, cal. 322.2508) supported the elemental 
composition of 5 as C20H34O3 with 4 degrees of double bond equivalence (one each of alkene 
and C=O alongside two rings) based on the characteristic chemical shifts of protons and 
carbons (1H and 13C NMR) and previously reported NMR values (Table 6.10.) (Li et al., 
2015). The 13C NMR exhibited a peak at δ 173.34 (Figure 6.69.), which has been confirmed 
as quaternary carbon based on DEPT analysis (Figure 6.70.). It was evident from the fact 
that the chemical shift in the range δ 170-185 apparently forms a part of carbonyl group, 
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preferably an ester moiety, and thus the carbon at δ 173.34 was attributed to C-1. These 
chemical shift assignments were in accordance with those reported for previously described 
6-hydroxy-5-methylramulosin (El-Beih et al., 2007). The proton attached next to the 
oxygen of ester group was highly deshielded and registered higher chemical shift of about δ 
4.0-4.5, due to the intense electron withdrawing ability of -C(O)O- group. Thus, the highly 
deshielded 1H signal at δ 4.28/4.14 exhibited HSQC with δ 61.93 (attributed to C-3) that 
correspond to the methylene group residing next to an ester linkage (Figure 6.72.). An 
intense 1H-1H COSY correlation with the protons at δ 5.34 (H-4) to those at δ 4.28/4.14 
(assigned as H-3) further affirmed this attributions (Figure 6.71., 6.66.A). The protons at C-
3 also exhibited long range HMBC correlation with the carbon at δ 173.34 (C-1) (Figure 
6.66.B, 6.73.). The 13C peak appeared at δ 130.89 (C-4) and 144.43 represented a double 
bond. The highly deshielded proton at δ 5.34 (J=9.85 Hz, 1H) attached to the carbon at δ 
130.89 (HSQC) was noted. The relatively greater downfield shift of δ 144.43 (attributed to 
C-4a) referred to a quaternary carbon next to the double bond in the pyranone ring. 
Notably, the 13C NMR signal appeared at downfield region (δ 144.43) was less intense than 
the adjacent peak at δ 130.89, because of slow relaxation, and therefore, confirmed as a 
quaternary carbon. These attributions were corroborated with previous study, which 
explained that the olefinic proton exhibited resonances at δ 5.0-5.6 (br, J > 5 Hz) due to 
>C=CH-CH2 moiety (Goad and Akihisa 1997). The moderately deshielded proton at δ 2.0-
2.4 was due to the presence of electron withdrawing groups, and thus, it was inferred that 
the attachment of carbon atom of carbonyl (>C=O) to methine (-CH-) proton exerted a 
downfield shift of δ 1.0 than the typical chemical shift of -CH- proton. HMBC correlations 
determined the proton signal at δ 2.30 (assigned to H-8a) was attached to the carbon of -
C=O (C-1). Further the HMBC correlation between δ 2.30 (H-8a) and δ 144.43, attributed 
to C-4a, confirmed the presence of hexacyclic ring system with carboxylate moiety 
(pyranone). The proton at δ 2.31, which was found to be present next to quaternary alkenic 
carbon (C-4a) exhibited intense 1H-1H COSY correlations between δ 2.31 (H-5)/1.60 (H-
6)/1.33 (H-7)/2.01 (H-8)/2.30 (H-8a), which supported the presence of adjacent protons 
from H-5 to H-8a (Figure 6.71.). Furthermore, HMBC correlations from δ 2.31 (H-5) to δ 
173.34 (C-1), 27.22 (C-8), 144.43 (C-4a); δ 1.60 (H-6) to δ 173.34 (C-1), 34.04 (C-7); δ 
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2.01 (H-8) to δ 144.43 (C-4a), 130.89 (C-4) and δ 2.30 (H-8a) to δ 27.22 (C-8) were 
unambiguously determined the occurrence of another hexacyclic ring (Figure 6.73.). Thus, 
the bicyclic system with carboxylate moiety in compound 5 was evident, which was 
characterized as 6,7,8,8a-tetrahydro-3H-isochromen-1-(5H)-one, and can be related to the 
literature of pyrones isolated from marine source (Kim et al., 2014). The previous study on 
isolation of δ-lactone isochromanone was supported the numbering and framework of 
elucidated compound (Li et al., 2015). The HMBC correlations from δ 1.33 (H-7) to δ 
29.69 (C-4’); δ 1.60 (H-6) to δ 31.77 (C-3’) and δ 2.01 (H-8) to δ 31.77 (C-3’) were 
supported the side chain extended from C-7 of tetrahydro isochromenone moiety. The side 
chain enclosed a highly downfield singlet at δ 3.48 (H-1’) was due to a secondary carbon (δ 
50.69) attached to the hydroxyl group. The low-field aliphatic resonances from H-3’ 
through H-9’ (δ 1.25, 1.28, 1.29, 1.28, 1.27, 1.28 and 0.88, respectively) were accounted for 
the nonane side chain of 5. An ethyl group attached at δ 42.41 (C-2’) was showed COSY 
from δ 1.25 (H-21a) to δ 0.86 (H-21b) and HMBC from δ 0.86 (H-21b) to δ 31.92 (C-21a). 
The HMBC correlations between δ 1.25 (H-21a) to δ 50.69 (C-1’), 0.86 (H-21b), 50.69 (C-
1’) and from δ 1.28 (H-4’) to δ 50.69 (C-1’) were supported the positions of hydroxyl and 
ethyl groups. The total number of carbon atoms were found to be 20 from detailed 13C and 
DEPT analysis, in which two -CH3, twelve -CH2 and three -CH groups were apparent. The 
relative configurations of the chiral carbons, C-8a and C-7 were deduced by detailed 
NOESY experiments (Figure 6.74.). NOESY correlations were apparent between δ 4.28 
(H-3)/5.34 (H-4) and δ 4.14 (H-3)/2.30 (H-8a)/1.33 (H-7), although no correlations were 
evident between δ 4.28 (H-3) and 2.30 (H-8a) (Figure 6.67.). The protons at ring junction 
(C-8a) and the side chain attached to the chiral carbon (C-7) were disposed at the identical 
plane of reference of 5, and considered to be oriented at the β position, whereas the protons 
at H-3 (δ 4.28) implied at the α-position. These correlations further confirmed that the 
bulky side chain bearing 2’-ethyl-1’-hydroxynonanyl moiety was α-oriented.  
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Table 6.10.: NMR spectroscopic data of 7-(2’-ethyl-1’-hydroxynonan-2’-yl)-6,7,8,8a-
tetrahydro-3H-isochromen-1-(5H)-one (5) in CDCl3 
C. No.  13C  1H (int.,mult.,J in Hz)a COSY  HMBC  
1  173.34  -  -  -  
2  -  -  -  -  
3  61.93  4.28 (1Hα,d)  H-4  C-1  
  4.14 (1Hβ,d)  H-4  C-1  
4  130.89  5.34 (1Hα, t,9.85)  -  -  
4a  144.43  -  -  -  
5  34.00  2.31 (2H,t)  H-6  C-1,8,4a  
6  24.80  1.60 (2H,m)  H-7  C-1,7,3’  
7  34.04  1.33 (1Hβ,m)  H-8  C-4’  
8  27.22  2.01 (2H,t)  H-8a  C-4a,4,3’ 
8a  38.20  2.30 (1Hβ,t)  -  C-8,4a  
1’  50.69  3.48 (2H,s)  -  C-3’,2’ 
2’ 42.41  -  -  -  
2’a  31.92  1.25 (2H)  H-2’b  C-1’,2’  
2’b  22.60  0.86 (3H,t)  -  C-1’,2’a  
3’  31.77  1.25 (2H)  -  -  
4’ 29.69  1.28 (2H)  -  C-8’,3’,1’ 
5’ 29.30  1.29 (2H)  -  C-9’’  
6’  29.20  1.28 (2H)  -  -  
7’  29.10  1.27 (2H)  -  -  
8’  22.50  1.28 (2H)  H-9’  -  
9’  14.10  0.88 (3H,t)  -  C-8’  
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 500MHz, 
while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, multiplicity and 
coupling constants (J=Hz) were indicated in parentheses. The assignments were made with 
the aid of the 1H-1H COSY, HSQC, HMBC and NOESY experiments 
 
 
 
 
Figure 6.66.: 1H-1H COSY (A) and HMBC (B) correlations of 7-(2’-ethyl-1’-hydroxy 
nonan-2’-yl)-6,7,8,8a-tetrahydro-3H-isochromen-1-(5H)-one (5). The key 1H-1H COSY 
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couplings have been represented by the bold face bonds. The HMBC couplings were 
indicated by double barbed arrow 
Figure 6.67.: NOESY correlations of 7-(2’-ethyl-1’-hydroxynonan-2’-yl)-6,7,8,8a-tetra 
hydro-3H-isochromen-1-(5H)-one (5). The NOESY relations were represented by double 
barbed arrow 
Figure 6.68.: 1H NMR spectrum of 7-(2’-ethyl-1’-hydroxynonan-2’-yl)-6,7,8,8a-tetra 
hydro-3H-isochromen-1-(5H)-one (5) 
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Figure 6.69.: 13C NMR spectrum of 7-(2’-ethyl-1’-hydroxynonan-2’-yl)-6,7,8,8a-tetra 
hydro-3H-isochromen-1-(5H)-one (5) 
 
Figure 6.70.: 135DEPT NMR spectrum of 7-(2’-ethyl-1’-hydroxynonan-2’-yl)-6,7,8,8a-tetra 
hydro-3H-isochromen-1-(5H)-one (5) 
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Figure 6.71.: 1H-1H COSY NMR spectrum of 7-(2’-ethyl-1’-hydroxynonan-2’-yl)-6,7,8, 
8a-tetrahydro-3H-isochromen-1-(5H)-one (5) 
Figure 6.72.: HSQC NMR spectrum of7-(2’-ethyl-1’-hydroxynonan-2’-yl)-6,7,8,8a-tetra 
hydro-3H-isochromen-1-(5H)-one (5) 
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Figure 6.73.: HMBC NMR spectrum of 7-(2’-ethyl-1’-hydroxynonan-2’-yl)-6,7,8,8a-tetra 
hydro-3H-isochromen-1-(5H)-one (5) 
Figure 6.74.: NOESY NMR spectrum of 7-(2’-ethyl-1’-hydroxynonan-2’-yl)-6,7,8,8a-tetra 
hydro-3H-isochromen-1-(5H)-one (5) 
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Figure 6.75.: FTIR spectrum of 7-(2’-ethyl-1’-hydroxynonan-2’-yl)-6,7,8,8a-tetrahydro-
3H-isochromen-1-(5H)-one (5) 
 
The distinctive IR absorption peak at 3433 cm-1 indicated O-H stretching 
vibration.The C-H bending and rocking absorption bands were appeared at 1481-1414 and 
721 cm-1 (Figure 6.75.). The carbonyl and alkyl stretching vibrations at 1736 and 
2922/2852 cm-1, respectively concurred with the structure of 5.  
The mass and fragmentation pattern for compound 5 was given in Figure 6.76., 
6.77. The titled compound initially fragmented ethyl radical to yiled a fragment ion at m/z 
294 (a). The later underwent successive side chain elimination of methyl, propyl and 
hydroxyl radicals resulting in fragments with m/z 280 (b), 239 (c), and 221 (d), 
respectively. The fragment ion, 7-butyl-tetrahydro-3H-isochromen-1-(5H)-one at m/z 208 
(e) were formed from m/z 221 (d) by removal of a CH3• radical. The base peak was 
recorded at m/z 73 (i, vinyl formate) that was obtained by the successive fragmentation of 
fragment ion at m/z 208. This base peak was typical to the presence of isochromenone 
moiety (de Carvalhoa et al., 2001). 
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Figure 6.76.: EIMS spectrum of 7-(2’-ethyl-1’-hydroxynonan-2’-yl)-6,7,8,8a-tetrahydro-
3H-isochromen-1-(5H)-one (5) 
Figure 6.77.: Mass fragmentation pattern of 7-(2’-ethyl-1’-hydroxynonan-2’-yl)-6,7,8,8a-
tetrahydro-3H-isochromen-1-(5H)-one (5) 
Notably, the basic structural framework of 5 was showed signiﬁcant similarity 
with α-tocopherol, whereas the benzopyran moiety (of α-tocopherol) was substituted by the 
hydrogenated benzopyran ring of 5. However, compound 4 enclosed a hydrogenated 
benzopyranone moiety with an electronegative heterocyclic centre, a furan ring, and 
therefore, exhibited greater antioxidative activities. The isochromenone moiety in 5 showed 
structural similarities with bioactive ramulosin derivative, isolated from Codium fragile 
(El-Beih et al., 2007). Antioxidative roridin was identiﬁed from marine sponges and 
characterized to enclose a chromene moiety (Xu et al., 2006). The isolation and 
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characterization of bioactive natural chromanones and chromenes consisting of benzene 
ring have been identiﬁed and reported (Ballio et al., 1966). Likewise, furan containing 
metabolites from Hypocrea koningii, furanoid terpenes from sea slug Doriopsilla 
pelseneeri and furan fatty acids from P. canaliculus were found to be potent DPPH radical 
scavengers and anti-inﬂammatory agents (Ding et al., 2015; Gaspar et al., 2005; Wakimoto 
et al., 2011). These results showed the importance and greater utilities of chromene and 
isochromenone containing compounds as rancidity deterring agents in food systems.  
6.3.2.3.  Structural characterization of isopimarane norditerpenoid derivative (6) 
Isopimarane and pimarane metabolites were classified as significantly important 
class of diterpenoids with interesting pharmacological properties, like anti-diabetic, 
antioxidant and anti-microbial activities, and reported in marine organisms (Porto et al., 
2009; Sun et al., 2012). Although, rare in occurrence, three cytotoxic isopimarane 
diterpenoids from Excoecaria acerifolia (Huang et al., 2013) and brominated pimaranes 
from Laurencia obtusa (Takeda et al., 1990) were previously reported. An ent-pimarane 
diterpenoid tedanol was isolated from the marine sponge Tedania ignis and was reported to 
possess potential anti-inflammatory activity against COX-2 enzyme (Costantino et al., 
2009). The bioactive diterpenoids with pimarane skeletons were also described from the 
marine mollusks, A. dactylomela (Schmitz et al., 1982) and A. pulmonica (Bian et al., 
2014). Herein, we have described the characterization of new rearranged isopimarane 
norditerpenoid with bioactive potentials. 
6.3.2.3.A. Structural characterization of compound 6 (PM4-4-1) 
18 (4→14),19 (4→8) Bis-abeo-nor-isopimarane-1,5-dien-3-yl-3β-methoxy 
propyl pentanoate (6) 
Sample yield 95 mg; 0.19% 
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Physical description White solid 
Molecular formula C27H44O3
Molecular mass 416.3290 
The repeated chromatographic separation of EtOAc/MeOH extract of P. 
malabarica yielded a C19 isopimarane norditerpenoid derivative (6), as white solid. It 
exhibited UV absorbance (in MeOH) at λmax (log ε 3.12) 270.0 nm was assigned to a 
chromophore with ester carbonyl and olefinic groups (Figure 6.78.). The purity of the 
compound was supported by RP C18 HPLC experiments using 3:2 (v/v) MeOH:MeCN (Rt 
3.85) (Figure 6.79.). 
Figure 6.78.: UV spectrum of 18 (4→14),19 (4→8) bis-abeo-nor-isopimarane-1,5-dien-3-yl 
-3β-methoxy propyl pentanoate (6) 
Figure 6.79.: HPLC chromatogram of 18 (4→14),19 (4→8) bis-abeo-nor-isopimarane-1,5-
dien-3-yl-3β-methoxy propyl pentanoate (6)  
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The title compound recorded its molecular ion peak at m/z 416 (EIMS: found m/z 
416.3295 [M]+, cal. for C27H44O3, 416.3290). The 1H and 13C NMR analyses confirmed the 
elemental composition as C27H44O3 having six degree of unsaturation related to two double 
bonds, three ring systems and a carboxylate group (Table 6.11.; Figure 6.82.-6.83). The 13C 
NMR and DEPT data along with HSQC established the presence of 19 carbons including 
four methyls, five methylenes, seven methines (in which one is oxygenated at δ 71.83) and 
three quaternary carbons, suggesting that the title compound was a norditerpene (Figure 
6.83., 6.84., 6.86). Notably, ent-pimarane diterpenoid skeleton isolated from Siegesbeckia 
orientalis with 20 carbons including methyl (-CH3) group at C-10 was not apparent in the 
title compound, thus confirming the presence of norditerpenoid functionality (Wang et al., 
2009). A downfield shift of δH 3.53 attached to δC 71.83 was due to the presence of 
oxygenated functionality at C-3. The characteristic quaternary carbon with greater chemical 
shift at δ 140.72 (C-5) was apparent as a result of adjacent vinylic group at δH 5.34/δC 
121.72 (C-6) (Sun et al., 2012). The COSY spectrum was exhibited six spin systems, which 
include δ 5.37 (H-1)/2.81 (H-10); δ 5.38 (H-2)/3.53 (H-3)/2.29 (H-4); δ 5.34 (H-6)/2.01 (H-
7); δ 0.91 (H-9)/1.49, 1.85 (H-11)/1.83, 1.08 (H-12); δ 1.12 (H-14)/0.86 (H-18); δ 1.15 (H-
15)/0.89 (H-16) (Figure 6.80.A, 6.85.). The HMBC correlations from δ 5.37 (H-1) to δ 31.93 
(C-11); δ 5.38 (H-2) to δ 42.24 (C-4); δ 2.29 (H-4) to δ 140.72 (C-5), 121.72 (C-6), 71.83 (C-
3); δ 2.01 (H-7) to δ 121.72 (C-6) and δ 0.91 (H-9) to δ 36.50 (C-13), 56.77 (C-14) were 
revealed the presence of tricyclic norditerpene framework (Figure 6.80.B, 6.87.). The 
NOESY correlations between δ 1.01 (H-19)/0.68 (H-17) were confirmed the relative 
configuration of the chiral centre as β and other correlation between δ 5.35 (H-6)/2.01 (H-
7)/3.53 (H-3)/2.29 (H-4) established that H-6 and H-3 were α-configured (Figure 6.81., 
6.88.). This stereochemical arrangement specifically at H-17 and H-15 (β and α, respectively) 
was comparable with the isolated isopimarane diterpenoids (Xia et al., 2015). The bulky -O-
propyl pentanoate group appeared to be equatorially disposed, and therefore, the proton at 
the junction point (C-3) might be axial and α-oriented. The presence of NOEs among the 
methyl at C-14 and methine proton at H-3 belonging to the substituted rearranged 
isopimarane skeleton situated at the junction point connected with -O-propyl pentanoate 
was apparent. The stereochemistry of oxygenated derivative at C-3 was further confirmed 
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as β based upon literature study of oxygenated pimarane (Sun et al., 2012) and isopimarane 
diterpenes (Huang et al., 2013). The usual gem-dimethyl group (C-18 and C-19) found at 
C-4 position in isopimarane and 20-nor-isopimarane diterpenoids (Wang et al., 2011) were 
absent at C-4 in the title compound. However, the -CH3 groups, such as C-18 and C-19 
were appeared at C-14 and C-8 positions, respectively, and therefore, it can be classified as 
18 (4→14),19 (4→8) bis-abeo-nor-isopimarane. The 3β-methoxy propyl pentanoate was 
recognized at C-3 by long range coupling from δ 5.38 (H-2) to δ 29.70 (C-21) and δ 3.64 
(H-20) to δ 71.83 (C-3). This linear chain enclosed two spin systems such as δ 3.64 (H-
20)/1.61 (H-21)/4.15 (δ H-22) in propyl moiety and δ 2.33 (H-24)/1.63 (H-25)/1.44 (H-
26)/0.87 (H-27) in pentanoate chain. The ester carbon, δ 178.23 at C-23 of pentanoate chain 
was verified by HMBCs, such as δ 2.33 (H-24) to δ 24.75 (C-25), 178.23 (C-23); δ 1.63 (H-
25) to δ 33.87 (C-24), 178.23 (C-23) and δ 1.44 (H-26) to δ 33.87 (C-24), 24.75 (C-25).
Table 6.11.: NMR spectroscopic data of 18 (4→14),19 (4→8) bis-abeo-nor-isopimarane-
1,5-dien-3-yl-3β-methoxy propyl pentanoate (6) in CDCl3 
C. No.  13C 1H (int.,mult.,J in Hz)a  COSY HMBC 
1 129.71  5.37 (1H,t,7.24) H-10 C-11 
2 130.01  5.38 (1H,t,8.51) H-3 C-4,21 
3 71.83  3.53 (1Hα,td)  H-4 - 
4 42.24  2.29 (2H,d)  - C-5,6,3 
5 140.72  -  - - 
6 121.72  5.34 (1H,t,6.61) H-7 - 
7 39.52  2.01 (2H,d)  - C-6 
8 42.32  -  - - 
9 50.14  0.91 (1H,m)  H-11 C-13,14 
10 28.23  2.81 (1H,dd)  - C-14 
11 31.93  1.49 (1Hβ,m)  H-12 - 
1.85 (1Hα,m) - - 
12 37.25  1.83 (1H,t)  - - 
1.08 (1H,t)  - - 
13 36.50  -  - - 
14 56.77  1.12 (1Hβ,m) H-18 - 
15 22.69  1.15 (2H,d)  H-16 C-18,19 
16 14.11  0.89 (3H,t)  - C-18,19 
17 11.86  0.68 (3Hα,s)  - C-12,14,8 
18 22.82  0.86 (3H,d)  - C-19,11,8 
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19 19.39  1.01 (3Hα,s) - C-16,13,9,5 
20 68.35  3.64 (2H,t) H-21 C-3 
21 29.7  1.61 (2H,m) H-22 - 
22 65.03  4.15 (2H,t) - - 
23 178.23  - - - 
24 33.87  2.33 (2H,t) H-25 C-25,23 
25 24.75  1.63 (2H,m) H-26 C-24,23 
26 21.09  1.44 (2H,m) H-27 C-24,25 
27 18.72  0.87 (3H,t) - - 
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 500MHz, 
while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, multiplicity and 
coupling constants (J=Hz) were indicated in parentheses. The assignments were made with 
the aid of the 1H-1H COSY, HSQC, HMBC and NOESY experiments 
Figure 6.80.: 1H-1H COSY (A) and HMBC (B) correlations of 18 (4→14),19 (4→8) bis-
abeo-nor-isopimarane-1,5-dien-3-yl-3β-methoxy propyl pentanoate (6). The key 1H-1H 
COSY couplings have been represented by the bold face bonds 
Figure 6.81.: NOESY correlations of 18 (4→14),19 (4→8) bis-abeo-nor-isopimarane-1,5-
dien-3-yl-3β-methoxy propyl pentanoate (6). The NOESY relations were represented by 
double barbed arrow 
OO
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Figure 6.82.: 1H NMR spectrum of 18 (4→14),19 (4→8) bis-abeo-nor-isopimarane-1,5-
dien-3-yl-3β-methoxy propyl pentanoate (6) 
Figure 6.83.: 13C NMR spectrum of 18 (4→14),19 (4→8) bis-abeo-nor-isopimarane-1,5-
dien-3-yl-3β-methoxy propyl pentanoate (6) 
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Figure 6.84.: 135DEPT NMR spectrum of 18 (4→14),19 (4→8) bis-abeo-nor-isopimarane-
1,5-dien-3-yl-3β-methoxy propyl pentanoate (6) 
Figure 6.85.: 1H-1H COSY NMR spectrum of 18 (4→14),19 (4→8) bis-abeo-nor-
isopimarane-1,5-dien-3-yl-3β-methoxy propyl pentanoate (6) 
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Figure 6.86.: HSQC NMR spectrum of 18 (4→14),19 (4→8) bis-abeo-nor-isopimarane-1,5-
dien-3-yl-3β-methoxy propyl pentanoate (6) 
Figure 6.87.: HMBC NMR spectrum of 18 (4→14),19 (4→8) bis-abeo-nor-isopimarane-
1,5-dien-3-yl-3β-methoxy propyl pentanoate (6) 
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Figure 6.88.: NOESY NMR spectrum of 18 (4→14),19 (4→8) bis-abeo-nor-isopimarane-
1,5-dien-3-yl-3β-methoxy propyl pentanoate (6) 
Figure 6.89.: FTIR spectrum of 18 (4→14),19 (4→8) bis-abeo-nor-isopimarane-1,5-dien-3-
yl-3β-methoxy propyl pentanoate (6) 
 
 The distinctive IR stretching absorption bands at 2922 and 1722 cm-1 recognized 
C-H and C=O vibrations, respectively, whereas those at 1375, 1260 cm-1 revealed the 
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presence of C-O bending vibrations, thereby substantiated the structure of the title 
compound. The absence of IR stretching absorption bands near 3500 cm-1 (assigned to 
hydroxyl) proposed the absence of characteristic hydroxyl moiety at C-3. Thus, the 
substitution or derivatisation of hydroxyl moiety at C-3 position with -O-propyl pentanoate 
chain was further confirmed (Figure 6.89.). 
 Fragmentation of molecular ion with m/z 416 (Figure 6.90.) was perceived to be 
accompanied by the loss of a C-4 fragment (butyl radical) resulting in an ion at m/z 359 (a), 
and has been ascribed to 18 (4→14),19 (4→8) bis-abeo-nor-isopimarane-1,5-diene-3-yl-3β-
methoxy formate. The fragment ion at m/z 286 (c) undergo fragmentation to obtain 
fragment peak at m/z 256 (d, 18 (4→14),19 (4→8) bis-abeo-nor-isopimarane-1,5-diene), 
which on subsequent rearrangement yielded the fragments with m/z 229 (e), 206 (f) and 185 
(g) (Figure 6.91.) that was comparable with earlier reports (Bromann et al., 2014). The base 
peak was apparent at m/z 57 (e, butane cation).  
Figure 6.90.: EIMS spectrumof 18 (4→14),19 (4→8) bis-abeo-nor-isopimarane-1,5-diene-
3-yl-3β-methoxy propyl pentanoate (6) 
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Figure 6.91.: Mass fragmentation pattern of 18 (4→14),19 (4→8) bis-abeo-nor-
isopimarane-1,5-diene-3-yl-3β-methoxy propyl pentanoate (6) 
 
Previous reports of isopimarane and their derivatives from the natural resources 
has been envisaged their bioactive potential and pharmacological effects. The potential 
antioxidative property of entpimara-8(14),15-diene was demonstrated DPPH scavenging 
activity (Bromann et al., 2014). The anti-bacterial potentials of rare pimarane derivatives 
with cyclopropane rings at C-3 and C-4 from the isolates of A. pulmonica were reported 
(Bian et al., 2014). The titled C19 isopimarane norditerpenoid enclosed with a straight 
chain of 3-methoxy propyl pentanoate at the C-3 position of isopimarane skeleton thus, 
accounted for its potential activity. The ent-pimarane derivative isolated from T. ignis 
(sponge) exhibited in vivo inhibitory properties towards COX-2 and iNOS expressions 
(Costantino et al., 2009). The pimarane diterpenoid, libertellenones (anti-cancer agent) (Oh 
et al., 2005) and C-19 diterpenoid pimarane were identified from Ephemerantha fimbriata 
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(Ma et al., 1998). The isolated isopimarane norditerpenoid can be a potential lead 
pharmacophore for therapeutic investigations. The compound 6 represented as the first 
description of isopimarane norditerpenoid possessing the bis-abeo C19 norditerpenoid 
framework from a natural bivalve source.  
 
6.3.2.4.  Structural characterization of meroterpeno pyranoids (7-8) 
 Pyran derivatives, an important category of organic compounds, which proved to 
constitute an important class of heterocycle and were found to occur in marine organisms 
that attracted a great deal of interest due to their pharmacological potentials (Ciavatta et al., 
2011; Cueto et al., 1998a). The occurrence of pyranoids in biological system and their role 
as precursors in the production of pharmacologically active metabolites as anti-fungal, anti-
inflammatory, anti-microbial and anti-cancer compounds from natural and synthetic origin 
(Arora and Mathur 1963; Goel and Ram 2009). The pyranoid cladiellane diterpenes were 
isolated from mollusk, Tritoniopsis elegans (Ciavatta et al., 2011) and naturally occurring 
1-(6-butyl-3,4-dihydro-2H-pyran-2yl)-pentanone was reported from marine invertebrate, 
Neosadocus maximus (Rocha et al., 2011). Polyoxygenated monoterpenes, pantopyranoids 
A-C and pantoisofuranoids A-C and monoterpenes with tetrahydrofuran ring were isolated 
from marine algae Pantoneura plocamioides (Cueto and Darias 1996; Cueto et al., 1998b). 
In view of this, two unprecedented meroterpeno pyranoids, 1’-((10E)-10-(10-(pentan-4-yl)-
cyclohex-4-enyl)-allyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran (7) and 2-((E)-deca-1,8-
dien-10-yl)-11,12-dihydro-13-propyl-2H-pyran (8) were isolated from P. malabarica. 
 
6.3.2.4.A. Structural characterization of compound 7 (PM4-3-1) 
1’-((10E)-10-(10-(Pentan-4-yl)-cyclohex-4-enyl)-allyloxy)-tetrahydro-2’,2’-
dimethyl-2H-pyran (7) 
 
 
Sample yield 118 mg; 0.24% 
O
O
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Physical description Light green solid 
Molecular formula C21H36O2 
Molecular mass 320.2715 
  
 The naturally occurring C21 prenylated bisabolene type meroterpenoid, 1’-((10E)-
10-(10-(pentan-4-yl)-cyclohex-4-enyl)-allyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran (7), 
was isolated as light green solid. It exhibited UV absorbance (in MeOH) at λmax (log ε 3.46) 
260.0 nm assigned to olefinic groups (Figure 6.92.). The purity of compound was supported 
by RP C18 HPLC using 3:2 (v/v) MeOH:MeCN (Rt 22.18) experiments (Figure 6.93.).  
 
 
Figure 6.92.: UV spectrum of 1’-((10E)-10-(10-(pentan-4-yl)-cyclohex-4-enyl)-allyloxy)-
tetrahydro-2’,2’-dimethyl-2H-pyran (7) 
Figure 6.93.: HPLC chromatogram of 1’-((10E)-10-(10-(pentan-4-yl)-cyclohex-4-enyl)-
allyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran (7) 
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 The molecular ion peak was recorded at m/z 320 (EIMS: found m/z 320.2718 
[M]+, cal. for C21H36O2 320.2715) and 1H-13C spectroscopic details established the 
elemental composition as C21H36O2 with four double bond equivalence enclosing two 
double bonds and two cyclic systems. The singlet at δ 4.59 (assigned to C-1’) attributed to 
the methine (-CH) group, in which the upfield shift of the corresponding carbon (δ 68.39) 
was due to the electronegative -O-C moiety (Table 6.12., Figure 6.96.-6.97.). This carbon 
(C-1’) was also attached to an oxygenated side chain as apparent from the HMBC 
correlations. The long range couplings from δ 4.59 (H-1’) to δ 25.74 (C-41), 39.07 (C-2’), 
30.25 (C-2’a), 30.09 (C-2’b) proved that it was a part of pyran moiety. The 1H-1H COSY 
revealed that the presence of four spin systems, H-3’ to H-6’ {(δ 1.63, 1.66 (H-3’)/1.55, 
1.56 (H-4’)/3.64 (H-5’)} in the pyran ring, H-11 to H-12 {(δ 4.12, 4.14 (H-12)/5.35 (H-
11)} in the allyloxy chain, H-5 to H-9 {δ 2.02 (H-5)/2.35 (H-6)/1.57, 1.59 (H-7)/1.99, 2.00 
(H-8)/5.34 (H-9)} including H-6 to H-10 {δ 2.35 (H-6)/5.38 (H-10)} in the cyclohexenyl 
ring and from H-1 to H-3 consisting of H-3/H-13/ H-14 {δ 2.31 (H-3)/1.43 (H-13)/0.89 (H-
14); δ 0.87 (H-1)/1.42 (H-2)/2.31 (H-3)} in the isopentanyl side chain (Figure 6.94.A, 
6.99.). Two intense singlet protons due to methyl (-CH3) at δ 1.48 and 1.46 showed HSQC 
correlation with δ 30.25 (C-2’a) and 30.09 (C-2’b), respectively, which were attached to a 
quaternary carbon at δ 39.07 (Figure 6.100.). This was apparent from the HMBC 
correlations, δ 1.46/1.48 (C-2’a/2’b) to δ 63.11 (C-5’), 39.07 (C-2’), which proved the 
attachment of dimethyl groups to the pyran ring (Figure 6.94.B, 6.101.). The HMBC 
relations between δ 1.55 (H-4’) to δ 29.62 (C-3’), 30.25 (C-2’a), 30.09 (C-2’b) and δ 3.64 
(H-5’) to δ 25.74 (C-4’) established the pyran moiety. The attachment of carbon atom in the 
allyloxy side chain to pyran network was evident. The methine (-CH) groups, δH 5.38/δC 
139.27 and δH 5.35/δC 127.67 at H-10 and H-11, respectively with large coupling constants 
(J=8.5 and 9.2, respectively) was revealed its trans (E) geometry (assigned to C10=C11). 
The cyclohexenyl ring system enclosed -C=CH moiety in which the olefinic quaternary 
carbon (-C=) registered higher chemical shift of δ 143.18 (C-4) compared to the methine 
(=CH; δ 124.47) and a pentanyl group attached to the quaternary carbon attributed to C-12. 
This cyclic system was exhibited HMBCs from δ 5.38 (H-10) to δ 31.93 (C-5) and δ 2.35 
(H-6) to δ 29.37 (C-7). The spectroscopic data for quarternary oleﬁnic carbon at δ 143.18 
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(C-4) and the methine at δ 68.39 (C-1’) were comparable with 1-(6-butyl-3,4-dihydro-2H-
pyran-2yl)-pentanone (Rocha et al., 2011). The HMBC couplings from δ 0.89 (H-14) to δ 
22.69 (C-13); δ 1.43 (H-13) to δ 34.37 (C-3), 143.18 (C-4), 31.93 (C-5); δ 1.42 (H-2) to δ 
34.37 (C-3), 143.18 (C-4); δ 0.87 (H-1) to δ 34.37 (C-3), 22.69 (C-2) were confirmed the 
attachment of isopentanyl moiety to the cyclohexenyl ring. The 13C and DEPT NMR 
identified 21 carbons, in which four CH3, nine CH2, six CH were accounted. The relative 
stereochemistries of 7, mainly at C-1’ and C-6 protons, δ 4.59 and 2.35 were confirmed 
from NOESY (Figure 6.95., 6.102.). The NOEs between δ 1.55 (H-4’)/4.59 (H-1’)/2.35 (H-
6)/2.00 (H-8) and δ 2.35 (H-6)/4.12 (H-12) demonstrated that these protons were in the 
same plane of geometry and α-disposed. Further, NOEs among the protons δ 1.99 (H-8), 
1.66 (H-3’), 4.14 (H-12) and 1.46 (H-2’b, CH3) showed that they were disposed in the 
identical plane of geometry, and disposed at β-orientation. The methyl protons at δ 1.46 (H-
2’b) was found to be β disposed with the reference plane due to NOEs with δ 4.14 (Hβ-12), 
and not with the protons at δ 4.59 (Hα-1’) and 2.39 (Hα-6). This was further explained the 
trans orientation of the methine and methyl groups at C-6 and C-2’b positions of 7. 
 
Table 6.12.: NMR spectroscopic data of 1’-((10E)-10-(10-(pentan-4-yl)-cyclohex-4-enyl)-
allyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran (7) in CDCl3 
C. No.  13C  1H (int.,mult.,J in Hz)a COSY  HMBC  
1  14.15  0.87 (3H,t)  H-2  C-2,3  
2  22.69  1.42 (2H,m)  H-3  C-3,4  
3  34.37  2.31 (2H,m)  H-13  -  
4  143.18  -  -  -  
5  31.93  2.02 (2H,d)  H-6  -  
6  32.84  2.35 (1Hα,t)  H-7,10  C-7  
7  29.37  1.57 (1H,m)  H-8  -  
  1.59 (1H,m)  -  -  
8  27.23  1.99 (1Hβ,t)  H-9  -  
  2.00 (1Hα,t)  -  -  
9  124.47  5.34 (1H,t,9.22)  -  -  
10  139.27  5.38 (1H,t,8.50)  -  C-5  
11  127.67  5.35 (1H,q,9.21)  H-12  -  
12  65.05  4.12 (1Hα,d)  -  C-11, 2’  
  4.14 (1Hβ,d)  -  C-1’  
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13  22.69  1.43 (2H,m)  H-14  C-3,4,5  
14  14.15  0.89 (3H,t)  -  C-13,3  
1’  68.39  4.59 (1Hα,s)  -  C-4’,12,2’,2’a,2’b  
2’  39.07  -  -  -  
2’a  30.25  1.48 (3Hα,s)  -  C-5’,2’  
2’b  30.09  1.46 (3Hβ,s)  -  C-5’,3’  
3’  29.62  1.63 (1Hα,m)  H-4’  -  
  1.66 (1Hβ,m)  -  -  
4’  25.74  1.55 (1Hα,m)  H-5’  C-3’,2’a,2’b  
  1.56 (1Hβ,m)  -  -  
5’  63.11  3.64 (2H,t)  -  C-4’  
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 500MHz, 
while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, multiplicity and 
coupling constants (J=Hz) were indicated in parentheses. The assignments were made with 
the aid of the 1H-1H COSY, HSQC, HMBC and NOESY experiments 
 
 
 
 
Figure 6.94.: 1H-1H COSY (A) and HMBC (B) correlations of 1’-((10E)-10-(10-(pentan-4-
yl)-cyclohex-4-enyl)-allyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran (7). The key 1H-1H 
COSY couplings have been represented by the bold face bonds. The HMBC couplings were 
indicated by double barbed arrow 
 
 
 
 
 
Figure 6.95.: NOESY correlations of 1’-((10E)-10-(10-(pentan-4-yl)-cyclohex-4-enyl)-
allyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran (7). The NOESY relations were represented 
by double barbed arrow 
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Figure 6.96.: 1H NMR spectrum of 1’-((10E)-10-(10-(pentan-4-yl)-cyclohex-4-enyl)-
allyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran (7) 
Figure 6.97.: 13C NMR spectrum of 1’-((10E)-10-(10-(pentan-4-yl)-cyclohex-4-enyl)-
allyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran (7) 
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Figure 6.98.: 135DEPT NMR spectrum of 1’-((10E)-10-(10-(pentan-4-yl)-cyclohex-4-enyl)-
allyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran (7) 
Figure 6.99.: 1H-1H COSY NMR spectrum of 1,-((10E)-10-(10-(pentan-4-yl)-cyclohex-4-
enyl)-allyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran (7) 
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Figure 6.100.: HSQC NMR spectrum of 1’-((10E)-10-(10-(pentan-4-yl)-cyclohex-4-enyl)-
allyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran (7) 
Figure 6.101.: HMBC NMR spectrum of 1’-((10E)-10-(10-(pentan-4-yl)-cyclohex-4-enyl)-
allyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran (7) 
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Figure 6.102.: NOESY NMR spectrum of 1’-((10E)-10-(10-(pentan-4-yl)-cyclohex-4-
enyl)-allyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran (7) 
 
  The characteristic IR absorptions at 2932-2860 cm-1 were due to C-H alkane 
stretching, whereas olefinic (C=C) stretching and =C-H bending were represented by 1661 
and 965 cm-1 absorption bands, respectively. The characteristic absorption at 1456 cm-1 was 
indicated for C-H groups (Figure 6.103.). 
 
Figure 6.103.: FTIR spectrum of 1’-((10E)-10-(10-(pentan-4-yl)-cyclohex-4-enyl)-
allyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran (7) 
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 The molecular ion peak at m/z 320 was appeared to undergo elimination of one -
C2H5 group to yield 1’-(10-(3-propylcyclohexyl)propoxy)-tetrahydro-2’,2’-dimethyl-2H-
pyran (a, m/z 296). The elimination of -C3H7 group from the fragment ion at m/z 296 
yielded the fragment with m/z 253 (b, attributed to 1’-(3-cyclohexylpropoxy)-tetrahydro-
2’,2’-dimethyl-2H-pyran) and m/z 254 (c, 1’-(4-methyloctyloxy)-tetrahydro-2’,2’-dimethyl-
2H-pyran). The elimination of one -CH3 group from the fragment ion at m/z 254 yielded the 
fragments with m/z 238 (d, 1’-(4-methylenehept-1-enyloxy)-tetrahydro-2’,2’-dimethyl-2H-
pyran). The elimination of  -C3H5 group from the fragment ion at m/z 238 yielded the 
fragments with m/z 198 (e, 1’-(pent-2-enyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran) and 
m/z 184 (f, 1’-(butoxy)-tetrahydro-2’,2’-dimethyl-2H-pyran), which on subsequent 
rearrangement yielded the fragments at m/z 142 (h, 1’-(allyloxy)-tetrahydro-2H-pyran), 102 
(j, tetrahydro-2H-pyran-2-ol), 86 (pentan-1-ol) and 73 (l, but-3-en-1-ol). The fragment peak 
at m/z 85 (k, tetrahydro-2H-pyran) appeared as base peak of 7 (Figure 6.104., 6.105.). 
 
Figure 6.104.: EIMS spectrum of 1’-((10E)-10-(10-(pentan-4-yl)-cyclohex-4-enyl)-
allyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran (7) 
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Figure 6.105.: Mass fragmentation pattern of 1’-((10E)-10-(10-(pentan-4-yl)-cyclohex-4-
enyl)-allyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran (7) 
 
6.3.2.4.B. Structural characterization of compound 8 (PM4-1-1) 
2-((E)-Deca-1,8-dien-10-yl)-11,12-dihydro-13-propyl-2H-pyran (8)  
 
 
Sample yield 90 mg; 0.18% 
Physical description Yellow solid 
Molecular formula C18H30O 
Molecular mass 262.2297 
 
 The compound 8, 2-((E)-deca-1,8-dien-10-yl)-11,12-dihydro-13-propyl-2H-
pyran, a new C18 sesquiterpenoid with prenylated irregular framework, was isolated as 
yellow solid. It exhibited UV absorbance (in MeOH) at λmax (log ε 3.37) 265.0 nm assigned 
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to a chromophore with olefinic groups (Figure 6.106.). The purity of the compound was 
supported by RP C18 HPLC experiments using 3:2 (v/v) MeOH:MeCN (Rt 20.52) (Figure 
6.107.). 
 
 
Figure 6.106.: UV spectrum of 2-((E)-deca-1,8-dien-10-yl)-11,12-dihydro-13-propyl-2H-
pyran (8) 
Figure 6.107.: HPLC chromatogram of 2-((E)-deca-1,8-dien-10-yl)-11,12-dihydro-13-
propyl-2H-pyran (8)   
  
 The title compound was exhibited a molecular ion peak at m/z 262 (EIMS: found 
m/z 262.2300 [M]+, cal. for C18H30O 262.2297), along with 1H and 13C NMR spectra, 
signifying the elemental composition as C18H30O with four degrees of unsaturation 
associated with three double bonds and one ring system (Table 6.13.; Figure 6.110.-6.111.). 
382 
 
Isolation and characterization of secondary metabolites from Paphia malabarica           Chapter 6 
The 1H-1H COSY couplings from δ 4.68 (assigned to H-10)/δ 1.58, 1.60 (H-11)/δ 2.02, 
2.00 (H-12) were apparent (Figure 6.108.A, 6.113.). The downfield methine (-CH) at δ 4.68 
was found to be a triplet, HSQC with δ 108.30 was attributed to the part of a pyran ring 
system (Figure 6.114.). The quaternary carbon at C-13 (δ 112.37) was recognized as the 
junction point of pyran ring system and the propyl moiety. However, the lower chemical 
shift value of quaternary carbon predicted that it might be adjacent to highly electron 
withdrawing group with high downfield shift at δC 123.34/δH 6.96. The higher chemical 
shift of this alkenic proton was due to the neighboring oxygen atom and found to be a 
singlet proton, but not related to an aromatic ring. The HMBC relation from δ 6.96 
(assigned as H-14) to δ 108.30 (C-10), 112.37 (C-13); δ 4.68 (H-10) to δ 112.37 (C-13); δ 
1.58 (H-11) to δ 29.71 (C-12) and δ 2.02 (H-12) to δ 108.30 (C-10) were established the 
2H-pyran ring system (Figure 6.108.B, 6.115.). The signal at δ 112.37 (assigned to C-13) 
attached to a propyl side chain was evident from the HMBC relations from the protons of 
propyl moiety to the pyran ring. The two methylenes at δ 37.11 (C-15), 22.70 (C-16) and 
methyl at δ 14.12 (C-17) were in good concurrence with previously reported 2H-pyranoid, 
1-(6-butyl-3,4-dihydro-2H-pyran-2-yl)-pentanone (Rocha et al., 2011). The long couplings 
from δ 2.02 (H-12) to δ 37.11 (C-15), 22.70 (C-16); δ 1.37 (H-16) to δ 29.71 (C-12) and δ 
6.96 (H-14) to δ 37.11 (C-15) were confirmed the attachment to pyran moiety and 1H-1H 
COSY correlations between δ 2.03 (H-15)/1.37 (H-16)/0.88 (H-17) were established the 
propyl side chain. The proton at δ 4.68 (H-10) was exhibited HMBC relations with δ 
129.91 (C-9) which implied the attachment to the alkenic quaternary carbon of deca-1,8-
dien-10-yl side chain. The signal at δ 129.91 was found to be due to the quaternary carbon, 
and was attached to an alkenic proton, δ 5.35 (corresponding to 13C NMR signal at δ 130.38 
at C-8 position) (Wang et al., 2010a). The singlet proton at δ 1.44 (H-18) was attached to δ 
30.41 exhibiting HMBC relations to δ 129.91 (C-9), 130.38 (C-8), 31.94 (C-7), 108.30 (C-
10). It was found that the groups of carbons from C-1 to C-9 were linearly aligned as 
assigned by 1H-1H COSY correlation analyses. The 1H-1H COSY correlations from δ 4.94, 
5.10 (H-1)/5.81 (H-2)/2.06 (H-3)/1.36 (H-4)/1.26 (H-5)/1.30 (H-6)/1.97 (H-7)/5.35 (H-8) 
and long range HBMC correlations from δ 1.97 (H-7) to δ 130.38 (C-8), 129.91 (C-9), 
108.30 (C-10); δ 1.26 (H-5) to δ 33.83 (C-3), 29.37 (C-4), 28.97 (C-6); δ 2.06 (H-3) to δ 
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139.27 (C-2), 114.06 (C-1); δ 5.81 (H-2) to δ 114.06 (C-3) and δ 5.01, 4.94 (H-1) to δ 
139.27 (C-2), 33.83 (C-3) unambiguously confirmed the presence of side straight chain of 
8. The >CH2 group at δ 5.01 and δ 4.94 were found to be significantly downfielded due to 
its terminal position and the presence of highly downfielded alkene (-CH=, δ 5.81). The 
geometrical arrangement of these alkenic protons was confirmed from their J values, which 
were 5.81 (J=10.24 Hz), 5.01 (J=14.51, 6.90 Hz) and 4.94 (J=10.22, 6.41 Hz), thus 
established the trans (E) configuration comparable with a related compound, lobatriene, 
identified from soft coral, (Govindam et al., 2012). The 13C NMR spectrum of this 
compound in combination with DEPT were indicated the presence of a total of 18 carbons, 
which enclosed two CH3, ten CH2, and four CH groups. The relative stereochemistries of 
the chiral centre of 8, particularly that of C-10 carrying the methine proton, δ 4.68 (1H, t) 
was deduced from the NOESY spectrum (Figure 6.109., 6.116.). NOE crelations among the 
protons, δ 1.60 (H-11)/4.94 (H-1)/5.81 (H-2)/2.00 (H-12)/4.68 (H-10)/5.35 (H-8) suggested 
the closeness of these groups and their α-position. Further NOE couplings were observed 
between the protons at δ 1.58 (H-11)/2.02 (H-12)/5.01 (H-1)/1.44 (H-18)/6.96 (H-14) 
which suggested that these were on the similar of plane of the molecule, and disposed in β-
orientation. Additionally, the large coupling constant of 10.2 Hz (each) between the 
pertinent olefinic protons at 5.81 (related to H-2α) and δ 5.35 (assigned to H-8α, bearing 
C8-C9 double bond) revealed that they were disposed on the same plane of geometry, all 
these effects were in accord with the observed J values and, thus indicated the 
stereochemistry. The protons at δ 1.44 (CH3, s, C-18) was found to be situated at β-position 
because of NOE relationship with δ 6.96 (Hβ-14, s), and has no NOE associations with the 
protons at δ 4.94 (Hα-1) and 4.68 (Hα-10) which suggested the cis-orientation for the 
methyl groups at C-18 and olefinic proton at C-14, and that these groups must be disposed 
on the β-side. The H-10 should be trans orientation with the methyl protons at C-18 and 
olefinic proton at C-14 since there was no cross peak could be detected between the H-14 
and H-10 in NOESY experiment. 
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Table 6.13.: NMR spectroscopic data of 2-((E)-deca-1,8-dien-10-yl)-11,12-dihydro-13-
propyl-2H-pyran (8) in CDCl3 
C. No.  13C  1H (int.,mult.,J in Hz)a COSY  HMBC  
1  114.06  5.01 (1Hβ,m,14.51,6.90)  H-2  C-2  
  4.94 (1Hα,m,10.22,6.41)  - C-3,2  
2  139.27  5.81 (1Hα,m,10.24)  H-3  C-3  
3  33.83  2.06 (2H,t)  H-4  C-2,1  
4  29.37  1.36 (2H,m)  H-5  -  
5  29.52  1.26 (2H,m)  H-6  C-3,4,6  
6  28.97  1.30 (2H,m)  H-7  -  
7  31.94  1.97 (2H,t)  H-8  C-9,8,2  
8  130.38  5.35 (1Hα,t,10.6,5.5)  - -  
9  129.91  -  -  -  
10  108.30  4.68 (1Hα,t)  H-11  C-13,9  
11  26.72  1.58 (1Hβ,m)  H-12  C-12  
  1.60 (1Hα,m)  -  -  
12  29.71  2.02 (1Hβ,t)  -  C-15,16,10  
  2.00 (1Hα,t)  -  -  
13  112.37  -  -  -  
14  123.34  6.96 (1Hβ,s)  -  C-15,13,10  
15  37.11  2.03 (2H,t)  H-16  -  
16  22.70  1.37 (2H,m)  H-17  C-12  
17  14.12  0.88 (3H,t)  -  C-16  
18  30.41  1.44 (3Hβ,s)  -  C-9,10,8,7  
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 500MHz, 
while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, multiplicity and 
coupling constants (J=Hz) were indicated in parentheses. The assignments were made with 
the aid of the 1H-1H COSY, HSQC, HMBC and NOESY experiments 
 
 
 
 
Figure 6.108.: 1H-1H COSY (A) and HMBC (B) correlations of 2-((E)-deca-1,8-dien-10-
yl)-11,12-dihydro-13-propyl-2H-pyran (8). The key 1H-1H COSY couplings have been 
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represented by the bold face bonds. The HMBC couplings were indicated by double barbed 
arrow 
 
 
 
 
 
 
Figure 6.109.: NOESY correlations of 2-((E)-deca-1,8-dien-10-yl)-11,12-dihydro-13-
propyl-2H-pyran (8). The NOESY relations were represented by double barbed arrow  
 
Figure 6.110.: 1H NMR spectrum of 2-((E)-deca-1,8-dien-10-yl)-11,12-dihydro-13-propyl-
2H-pyran (8) 
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Figure 6.111.: 13C NMR spectrum of 2-((E)-deca-1,8-dien-10-yl)-11,12-dihydro-13-
propyl-2H-pyran (8) 
Figure 6.112.: 135DEPT NMR spectrum of 2-((E)-deca-1,8-dien-10-yl)-11,12-dihydro-13-
propyl-2H-pyran (8) 
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Figure 6.113.: 1H-1H COSY NMR spectrum of 2-((E)-deca-1,8-dien-10-yl)-11,12-dihydro-
13-propyl-2H-pyran (8) 
Figure 6.114.: HSQC NMR spectrum of 2-((E)-deca-1,8-dien-10-yl)-11,12-dihydro-13-
propyl-2H-pyran (8) 
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Figure 6.115.: HMBC NMR spectrum of 2-((E)-deca-1,8-dien-10-yl)-11,12-dihydro-13-
propyl-2H-pyran (8) 
Figure 6.116.: NOESY NMR spectrum of 2-((E)-deca-1,8-dien-10-yl)-11,12-dihydro-13-
propyl-2H-pyran (8) 
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Figure 6.117.:  FTIR spectrum of 2-((E)-deca-1,8-dien-10-yl)-11,12-dihydro-13-propyl-
2H-pyran (8) 
The IR spectrum revealed the presence of olefinic (C=C) and alkyl (C-H) 
vibrations were represented by the 1641 and 1462 cm-1 absorption bands, respectively. The 
absorption bands at 2955/2852 cm-1 indicated C-H stretching vibration (Figure 6.117.), 
thereby corroborated the prenylated pyranoid framework. 
Figure 6.118.: EIMS spectrum of 2-((E)-deca-1,8-dien-10-yl)-11,12-dihydro-13-propyl-
2H-pyran (8) 
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Figure 6.119.: Mass fragmentation pattern of 2-((E)-deca-1,8-dien-10-yl)-11,12-dihydro-
13-propyl-2H-pyran (8) 
 
The mass spectrum exhibited molecular ion peak at m/z 262, which appeared to 
undergo elimination of methyl radical to yield a radical ion fragment at m/z 247 (a, 
dihydro-2-(nona-1,8-dienyl)-13-propyl-2H-pyran). The latter underwent fragmentation by 
eliminating .CH3 and .C2H3 radicals to obtain fragment peaks at m/z 233 (d, 13-ethyl-
dihydro-2-(nona-1,8-dienyl)-2H-pyran) and m/z 220 (b, 2-(hept-1-enyl)-9,10-dihydro-11-
propyl-2H-pyran), respectively. Fragmentation of the ion at m/z 220 (b) was perceived to be 
accompanied by the loss of a C-3 fragment resulting in an ion at m/z 179 (c), which on 
subsequent rearrangement yielded the fragments at m/z 110 (f, 5-methylhex-5-en-2-ol) and 
97 (g, dihydro-5-methyl-2H-pyran). The latter eliminated CH2O radical to yield m/z 66 (j, 
penta-1,3-diene). The fragment peak at 85 (tetrahydro-2H-pyran ion) was found to be the 
base peak (Figure 6.118.-6.119.). 
The pyran derivatives, 2-((E)-deca-1,8-dien-10-yl)-11,12-dihydro-13-propyl-2H-
pyran (8) and 1’-((10E)-10-(10-(pentan-4-yl)-cyclohex-4-enyl)-allyloxy)-tetrahydro-2’,2’-
dimethyl-2H-pyran (7) represent the first description of meroterpeno pyranoids possessing 
the C18 sesquiterpenoid with prenylated irregular farnesene framework and C21 prenylated 
bisabolene-type meroterpenoid with the allyloxy linkage coordinating between the C14 
meroterpene and substituted terahydropyran system from a natural source. These 
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unprecedented meroterpeno pyranoids from P. malabrica has bioactive potential as natural 
antioxidant and anti-inflammatory pharmacophore. 
 
6.3.2.5.  Structural characterization of cholestenol derivatives (9-10) 
 Sterols were known as the bioactive lipid metabolites, and found as major 
constituents in marine invertebrates, such as sponges, bryozoans and mollusks (Goad and 
Scheuer 1978). More than 200 sterols of 3β-hydroxy-Δ5 (or saturated) cholestane nucleus 
and a C8-C10 side chain occurring in marine organisms were reported (Sarma et al., 2005). 
In particular, sponges and mollusks were extensively investigated for diferent types of 
steroids than invertebrates of other phyla (Joosse 1978; Sica 1980). Among different groups 
of steroids, poly-oxygenated tetracyclic nucleus with varying degrees of unsaturation and 
atypical side chain substitution (D’Auria et al., 1993), 3β-cholestane esters, steroids with 
spiro ring system (Su et al., 2007) and bicyclo[4.4.1] or bicyclo[4.3.1] A/B steroids were 
predominant among the compounds isolated from marine organisms (Amagata et al., 2003; 
Wang et al., 2015). We herein described isolation and structure elucidation of two new 
sterol derivatives, (22E)-241,242-methyldihomocholesta-5,22-dien-3β-ol (9) and 23-gem-
dimethylcholesta-5-en-3β-ol (10) from P. malabarica. 
 
6.3.2.5.A. Structural characterization of compound 9 (PM3-3-2-1) 
(22E)-241, 242-Methyldihomocholesta-5,22-dien-3β-ol (9) 
 
 
Sample yield 148 mg; 0.30% 
Physical description White solid 
Molecular formula C30H50O 
Molecular mass 426.3862 
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 The (22E)-241,242-methyldihomocholesta-5,22-dien-3β-ol (9), a new substituted 
dihomocholestadienol, was purified as white solid. The ultraviolet absorbance at λmax (log ε 
1.74) 228.9 nm has been assigned to be chromophores with olefinic system (Figure 6.120.). 
The purity of the compound was supported by RP C18 HPLC experiments using 6:4 (v/v) 
MeOH:MeCN (Rt 5.33) (Figure 6.121.). 
 
  
Figure 6.120.: UV spectrum of (22E)-241,242-methyldihomocholesta-5,22-dien-3β-ol (9) 
Figure 6.121.: HPLC chromatogram of (22E)-241,242-methyldihomocholesta-5,22-dien-
3β-ol (9) 
 
 Its mass spectrum exhibited a molecular ion peak at m/z 426 (EIMS: found m/z 
426.3868 [M]+, cal. 426.3862), which in combination with its 1H and 13C NMR data (Table 
6.14.) indicated the elemental composition of (22E)-241,242-methyldihomocholest-5,22-dien-
3β-ol (9) as C30H50O with six degrees of unsaturation containing two double bonds and four 
ring systems (Figure 6.124., 6.125.). The 13C spectrum of 9 in combination with DEPT 
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experiments were indicated the occurrence of 30 carbon atoms including one carbinol 
carbons at δ 71.81 and olefinic carbons at δ 140.76, 121.71, 135.83 and 131.72. A total 
number of six methyl carbons, ten methylene and eleven methinegroups were recorded 
(Figure 6.125., 6.126.). Since no aromatic signals were recorded in the 1H data, these peaks 
appeared downfield above δ 130 were assigned to the olefinic carbons in the 13C spectrum. 
The olefinic signal at δ 140.76 was appeared at the far downfield region and less intense 
than other peak at δ 121.71, because of slow relaxation, it must be a quaternary carbon. The 
intense olefinic signals at δ 131.72 and 135.83 might be due to the fact that these are less 
substituted carbons and sterically less crowded. The similarity in chemical shift apparently 
indicated these as sp2 hybridized (-CH=CH-) and shifted more upfield relative to the sp 
hybridized carbon atom. The broad IR absorptions at 3427 cm-1 was due to O-H vibrations, 
which has been supported by the 1H signal at δ 3.50. The presence of olefinic protons was 
suggested by 1H signals at δ 5.35 (1H, dd) with a coupling constant of 5.28 and 3.58 Hz. 
This supported the presence of E-geometrical isomer of the olefinic proton (C-6). The 1H, 
13C and HSQC experiments (Figure 6.128.) attributed the parent steroid nucleus with C-3 
hydroxyl at δ 3.50 (δ 71.81) and C5-C6 double bond at δ 5.35 were similar to those 
reported in the earlier studies (Wilson et al., 1996). The COSY correlations were confirmed 
between δ 1.83, 1.08 (assigned to H-1)/1.50, 1.82 (H-2)/3.50 (H-3)/2.24, 2.28 (H-4); δ 5.35 
(H-6)/1.96, 1.56 (H-7)/0.93 (H-8) and δ 0.96 (H-9)/1.49 (H-11)/2.01, 1.15 (H-12) (Figure 
6.127.) along with their H-C connectivities were proposed from the HSQCs and HMBCs 
(Figure 6.128., 6.129.). The 13C NMR signals at C-22 and C-23 (δ 135.83 and 131.72, 
respectively) in combination with the HSQC experiments (δ 5.18 and 5.17) assigned the 
olefinic (-HC=CH-) group at the side chain. The large coupling constants, (J) 12.4 and 16.1 
Hz of the olefinic protons at H-22 and H-23, respectively attributed to its trans (E-form) 
configuration, as supported by the previous studies (Goad and Akihisa 1997). The 
occurrence of olefinic proton at Δ22 (δ 5.18 (H-22) and 5.17 (H-23)) was further confirmed 
by the long range HMBC correlations from δ 0.91 (H-21) to δ 131.72 (C-23) and from δ 
1.10 (H-17) to δ 135.83 (C-22) (Figure 6.122.B) along with one bond 1H-1H COSY 
relations such as δ 1.86 (H-20)/5.18 (H-22); δ 5.17 (H-23)/2.03 (H-24)/1.25 (H-241)/1.35 
(H-242)/0.92 (H-243), 1.52 (H-25) and δ 1.52 (H-25)/0.86 (H-26), 0.87 (H-26) (Figure 
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6.122.A, 6.127.) (Tian et al., 2011). The HMBC relations from δ 1.35 (H-242) to δ 22.69 
(C-27) and from δ 2.03 (H-24) to δ 28.02 (C-25) supported the occurrence of side chain 
framework attached to the parent steroid skeleton. Further the long range HMBC 
correlations such as δ 2.24 (H-4) to δ 31.80 (C-2), 121.71 (C-6), 36.50 (C-10); δ 5.35 (H-6) 
to δ 36.50 (C-10); δ 1.96 (H-7) to δ 140.76 (C-5), 121.71 (C-6); δ 1.83 (H-1) to δ 71.81 (C-
3), 36.50 (C-10); δ 1.49 (H-11) to δ 56.70 (C-14) assigned to the tricyclic framework. 1H-
1H COSYs were observed among the protons at δ 1.00 (H-14)/1.57, 1.06 (H-15)/1.85 (H-
16)/1.10 (H-17). Further the HMBC correlations such as δ 1.00 (H-14) to δ 46.05 (C-8), 
50.14 (C-9) and C-H connectivities between δ 1.10 (H-17) and δ 135.83 (C-22), 56.70 (C-
14) confirmed the side chain framework. Six methyl groups, including the two angular -
CH3 groups (δ 0.91 and 0.68) were located at the ring junction of A/B and C/D gave rise to 
sharp peaks at shielded region. The HMBCs between δ 1.01 (H-19) to δ 37.20 (C-1), 31.80 
(C-2) and 140.76 (C-5) also attributed the occurrence of C-19 methyl at C-10. The 
stereochemistries of chiral centers, particularly at C-3, C-17, C-20, C-8 and C-14 were 
deduced from NOESY (Figure 6.130., 6.123.). NOE couplings were apparent among Hα-
3/Hα-6 suggested the α-side of the molecule. The C-3 hydroxyl group is equatorial and β-
oriented (Sun et al., 2013). NOE correlations between Hα-6/Hα-14 indicated that these 
groups on their α-disposition. The methine proton at C-21 did not exhibit NOE interactions 
with Me-18 and Me-19, which were at the β-face of the molecule, thereby indicating that 
H-21 was at α-position. Based on the interpretations, the compound was deduced as (22E)-
241,242-methyldihomocholesta-5,22-dien-3β-ol. 
 
Table 6.14.: NMR spectroscopic data of (22E)-241,242-methyldihomocholesta-5,22-dien-
3β-ol (9) in CDCl3 
C. No.  13C  1H (int.,mult.,J in Hz)a COSY  HMBC  
1  37.22  1.83 (1Hβ,t)  H-2  C-10,3  
  1.08 (1Hα,t)  -  C-3  
2  31.83  1.50 (1Hβ,m)  H-3  C-3  
  1.82 (1H,m)  -  C-5  
3  71.81  3.50 (1Hα,p)  H-4  - 
4  42.33  2.24 (1Hβ,d)  -  C-3,5,6  
  2.28 (1Hα,d)  -  C-10,2  
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5  140.76  -  -  - 
6  121.71  5.35 (1Hα,dd,5.28,3.58)  H-7  C-10,7  
7  31.91  1.56 (1Hβ,m)  -  C-5,6  
  1.96 (1Hα,t)  -  - 
8  46.05  0.93 (1Hβ,m)  -  C-7  
9  50.14  0.96 (1Hα,m)  H-11  - 
10  36.50  -  -  - 
11  21.14  1.49 (2H,m)  H-12  C-12,14  
12  39.72  2.01 (1Hβ,t)  -  C-13  
  1.15 (1Hα,t)  -  C-20,9  
13  42.32  -  -  - 
14  56.70  1.00 (1H,m)  H-15  C-8,9,20  
15  24.26  1.57 (1Hβ,m)  H-16  C-16,13  
  1.06 (1Hα,m)  -  - 
16  28.22  1.85 (2H,m)  H-17  - 
17  56.16  1.10 (1Hβ,m)  -  C-22,14,20,18,16  
18  11.68  0.68 (3Hβ,s)  -  C-12,20  
19  19.40  1.01 (3Hβ,s)  -  C-5,2,1  
20  42.54  1.86 (1Hα,t)  H-22  - 
21  18.39  0.91 (3Hα,d)  -  C-23  
22  135.83  5.18 (1H,dd,12.41,6.09)  -  - 
23  131.72  5.17 (1H,dt,16.10,7.31)  H-24  - 
24  41.90  2.03 (2H,m)  H-241 C-25  
241  28.42  1.25 (2H,m)  H-242 - 
242  35.72  1.35 (1Hβ,m)  H-243,25  C243,27,25  
243  20.53  0.92 (3Hα,d)  -  - 
25  28.02  1.52 (1Hα,m)  H-26,27  C-26,27  
26  19.89  0.86 (3H,d)  -  - 
27  22.69  0.87 (3H,d)  -  - 
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 500MHz, 
while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, multiplicity and 
coupling constants (J=Hz) were indicated in parentheses. The assignments were made with 
the aid of the 1H-1H COSY, HSQC, HMBC and NOESY experiments 
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Figure 6.122.: 1H-1H COSY (A) and HMBC (B) correlations of (22E)-241,242-methyl 
dihomocholesta-5,22-dien-3β-ol (9). The key 1H-1H COSY couplings have been 
represented by the bold face bonds. The HMBC couplings were indicated by double barbed 
arrow 
 
 
 
 
Figure 6.123.: NOESY correlations of (22E)-241,242-methyldihomocholesta-5,22-dien-3β-
ol (9). The NOESY relations were represented by double barbed arrow 
Figure 6.124.: 1H NMR spectrum of (22E)-241,242-methyldihomocholesta-5,22-dien-3β-ol 
(9) 
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Figure 6.125.: 13C NMR spectrum of (22E)-241,242-methyldihomocholesta-5,22-dien-3β-ol 
(9) 
Figure 6.126.: 135DEPT NMR spectrum of (22E)-241,242-methyldihomocholesta-5,22-
dien-3β-ol (9) 
398 
 
Isolation and characterization of secondary metabolites from Paphia malabarica           Chapter 6 
Figure 6.127.: 1H-1H COSY NMR spectrum of (22E)-241,242-methyldihomocholesta-5,22-
dien-3β-ol (9) 
Figure 6.128.: HSQC NMR spectrum of (22E)-241,242-methyldihomocholesta-5,22-dien-
3β-ol (9) 
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Figure 6.129.: HMBC NMR spectrum of (22E)-241,242-methyldihomocholesta-5,22-dien-
3β-ol (9) 
Figure 6.130.: NOESY NMR spectrum of (22E)-241,242-methyldihomocholesta-5,22-dien-
3β-ol (9) 
400 
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 The IR absorption peak at 3427 cm-1 for hydroxyl and at 1664 cm-1 to olefinic 
(C=C) functionalities were recognized. The FTIR absorption bands at 1459, 1332 (C-H 
rocking), 1243, 1122 (C-C stretch) and 881 (=C-H bend) cm-1 substantiated the structure 
(Figure 6.131.). 
 
Figure 6.131.: FTIR spectrum of (22E)-241,242-methyldihomocholesta-5,22-dien-3β-ol (9) 
  
 The molecular ion peak at m/z 426 (C30H50O•+, [M]+) was appeared to eliminate 
one molecule of water and an isopropyl group to yield 241,242-methyldihomocholesta-5,22-
trien-3β-ol (h) (m/z 409), which underwent side chain elimination followed by 
rearrangement at ring D to afford a fragment with m/z 229 (i). The fragment ion at m/z 357 
were formed from m/z 411 (241,242-methyldihomocholesta-5,22-dien-3β-ol), through a 
Retro-Diels-Alder mechanism. Fragmentation of the ion at m/z 366 (b) was perceived to be 
accompanied by the loss of a C-6 fragment (assigned to hex-1-ene ion) resulted in an ion at 
m/z 285 (c), which on successive rearrangement afforded fragments at m/z 177 (d), 135 (e), 
and 69 (f). It is of note that the fragment ion at m/z 69 (C5H8•+) appeared as base peak of 9 
(Figure 6.132., 6.133.). 
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Figure 6.132.: EIMS spectrum of (22E)-241,242-methyldihomocholesta-5,22-dien-3β-ol (9) 
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Figure 6.133.: Mass fragmentation pattern of (22E)-241,242-methyldihomocholesta-5,22-
dien-3β-ol (9) 
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6.3.2.5.B. Structural characterization of compound 10 (PM3-3-1-1) 
23-Gem-dimethylcholesta-5-en-3β-ol (10) 
 
 
Sample yield 82 mg; 0.16% 
Physical description White solid 
Molecular formula C29H50O 
Molecular mass 414.3862 
   
 The 23-gem-dimethylcholesta-5-en-3β-ol (10) is a new cholestenol derivative, in 
which the side chain at C-17 contains a gem dimethyl group at C-23 position. It was 
isolated as white solid upon repeated chromatography. It exhibited UV absorbance (in 
MeOH) at λmax (log ε 1.36) 226.4 nm assigned to olefinic groups (Figure 6.134.). The purity 
of the compound was supported by RP C18 HPLC experiments using 6:4 (v/v) 
MeOH:MeCN (Rt 5.99) (Figure 6.135.). 
 
 
Figure 6.134.: UV spectrum of 23-gem-dimethylcholesta-5-en-3β-ol (10) 
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Figure 6.135.: HPLC chromatogram of 23-gem-dimethylcholesta-5-en-3β-ol (10)   
 
The molecular ion peak at m/z 414 (EIMS: found m/z 414.3868 [M]+, cal. for 
C29H50O, 414.3862) along with 1H and 13C data (Table 6.15.) was proposed the elemental 
composition of C29H50O as 23-gem-dimethylcholesta-5-en-3β-ol (10) with five degrees of 
unsaturation containing one double bond and four ring systems. The NMR signal and peak 
characteristics of 10 were closely related to 9. The main difference found in the 1H 
spectrum was the occurrence of an additional double bond which was between C-22 and C-
23 in 9. Previous works on 1H and 13C NMR spectroscopy established the characteristic 
chemical shifts of various types of protons and carbons of steroids; and based on these data 
steroid shift assignments were made for the present study. The absence of the characteristic 
aromatic proton signals in the 1H NMR spectrum confirmed that the four cyclic rings were 
not of aromatic origin (Figure 6.138.). The 1H NMR spectrum contains several overlapping 
second order multiplets with the type ABCDEF. The olefinic signals appeared at δ 140.76 
and 121.72 in the 13C NMR spectrum were indicated a double bond (Figure 6.139.). The 
relatively downfield shift at δ 140.76 was referred to quaternary carbon adjacent to a double 
bond in the cyclic ring. The highly deshielded 1H signal at Δ5 (H-6, δ 5.35, dd), which was 
found to be a double doublet due to the adjacent δ 1.98 and 1.52 protons attached to carbon 
(C-7, δ 31.91) with coupling constant of 5.24 and 3.36 Hz. The presence of an olefinic 
group in the carbocyclic ring was identified by comparison with cholestene analogues as 
detailed in a previous literature (Reich et al., 1969). An earlier study of steroid derivatives 
were explained the olefinic proton resonances in the region δ 5.0-5.6 (br, J=5 Hz) due to 
the >C=CH-CH2 skeleton (Goad and Akihisa 1997). The proton at H-3 (δ 3.50) attached to 
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tertiary carbon (δ 71.82) attributed to hydroxyl group (-OH) was apparent due to pentet 
splitting pattern in the downfield. The downfield shift of carbinol carbon at C-3 was the 
result of a greater electron-withdrawing power of the hydroxyl group. It is of note that for 
the axial cyclohexanols, there is a δ 1 downfield shift of C-3, probably because of smaller 
1, 3 interaction of the -OH group with the H-3 relative to the hydroxyl group. Further 
specific deuteration of the hydroxyl proton was used for identifying the C-3 carbon. The 
signal for deuterated -OH proton essentially disappeared. The spectroscopic analysis of 1H, 
13C along with 1H-1H COSY, HSQC and HMBC relations  allowed  the  elucidation of  a 
cholestene  network with δ 5.35 (H-6) as double bond (δ 121.72) and 3.50 (H-3) hydroxyl 
(δ 71.8), which was consistent with the  literature study (Tian et al., 2011) (Figure 6.138.-
6.143.). The COSYs δ 1.85, 1.08 (H-1)/1.50, 1.85 (H-2)/3.50 (H-3)/2.25, 2.29 (H-4) and δ 
5.35 (H-6)/1.98, 1.52 (H-7)/0.91 (H-8) were supported the presence of adjacent protons 
from H-1 to H-4 and H-6 to H-8, respectively (Figure 6.136.A). The HMBC correlations 
from δ 2.25/2.29 (H-4) to δ 31.66 (attributed to C-2), 71.82 (C-3), 140.76 (C-5), 121.72 (C-
6), 36.52 (C-10) and those from δ 5.35 (H-6) to δ 42.31 (C-4), 31.91 (C-7), 36.52 (C-10) 
were supported the bicyclic framework (Figure 6.136.B). The three high-field methine (-
CH-) protons, δ 0.95, 1.10 and 1.02 were allocated to carbons at C-9, C-14 and C-17 
positions, respectively. The two quaternary carbons (C-10 and C-13) were attributed to 
characteristic chemical shift and signal pattern of steroids (Reich et al., 1969). The COSY 
relations, such as δ 0.95 (H-9)/1.46 (H-11)/2.01, 1.15 (H-12) and δ 1.10 (H-14)/1.56, 1.06 
(H-15)/1.83 (H-16)/1.02 (H-17) established the presence of ring C (hexacyclic) and D 
(cyclopentane), respectively. The HMBCs from δ 1.46 (H-11) to δ 42.52 (C-13); δ 
2.01/1.15 (H-12) to δ 42.50 (C-13); δ 0.91 (H-8) to δ 56.11 (C-14) appropriately supported 
the attachment of hexacyclic ring, C; whereas the correlations from δ 1.83 (H-16) to δ 
42.52 (C-13); δ 1.10 (H-14) to δ 28.33 (C-16); δ 1.56 (H-15) to δ 28.33 (C-16) 
unambiguously described the attachment of cylcopentane (D) moiety in compound 10 as 
also established by preceding literatures (Diaz-Marrero et al., 2003b). The C-4 proton has 
been flanked on both side by downfield shifting of functional groups (OH at C-3 and C=C 
at C-5, 6) and the two H-4 protons are pulled downfield to δ 2.25-2.29 away from the pack 
of overlapped resonances in 1H spectrum. The 13C signal at far downfield region (δ 140.76) 
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was less intense (shorter) than other peak at δ 121.72, due to slow relaxation, it must be 
quaternary carbon. It is of note that the closeness of protons is the basic modes of relaxation 
of 13C nuclei, and therefore, carbons not bonded to protons were relax more slowly, 
therefore recorded a less intense peaks (RD = 1.7 s relaxation delay is short). The more 
substituted carbon (at C-5) was more desheilded relative to C-6 due to steric crowding 
effects. The resonances of the cholestene side chain (C-20 to C-27) can readily be identified 
by comparison with 2,6-dimethyloctane as a model compound as detailed in a previous 
literature (Reich et al., 1969) and confirmed by 1H-1H COSY. The 1H-1H COSY 
connections among δ 1.02 (H-17) and 1.35 (H-20) along with their HSQC values confirmed 
the attachment of side chain, C-20 at C-17 (Diaz-Marrero et al., 2003b). The HMBCs from 
δ 1.02 (H-17) to δ 18.72 (C-21) and from δ 0.92 (H-21) to δ 42.52 (C-13), 36.27 (C-20) 
further supported the presence of side chain attachment to the sterol moiety. The two 
quaternary carbons, C-10 and C-13 were assigned using a long range 1H-13C correlation 
spectrum. A two bond correlation to the methyl protons in each case yields the assignment 
of C-10 at δ 36.52 and C-13 at δ 42.52. The structure contained four singlets which made 
the compound different from other reported steroids from mollusks (Santalova et al., 2007). 
The 1H spectrum displayed seven upfield methyl signals at δ 1.01 (s), 0.68 (s), 1.59 (s), 
1.25 (s), 0.92 (d), 0.86 (d) and 0.87 (d), which were found to exhibit connectivities with 
carbons at δ 19.41, 11.87, 28.01, 29.72, 18.72, 19.31 and 22.82, respectively based on 
HSQC. The numbers of carbon atoms were confirmed as 29 through 13C and DEPT 
analysis in which seven -CH3, ten -CH2 and eight -CH groups with total proton integral of 
51.93. The methyl groups, including two gem-dimethyl groups give rise to sharp peak at 
shielded region. The configurations at individual carbons were determined by using the 
detailed NOESY (Figure 6.144., 6.137.). In NOESY, the proton δ 3.50 (H-3) exhibited 
correlation with δ 5.35 (H-6)/δ 2.29 (Hα-4), and therefore, have been considered as α-
protons, which in turn indicated the β-disposition of -OH at C-3  (Sun et al., 2013; Tian et 
al., 2011). The methyl groups (H-18 and H-19) of cholestene derivative were correlated 
with δ 2.25 (Hβ-4)/2.01 (Hβ-12)/0.91 (H-8)/1.35 (H-20), which apparently suggested their 
β-orientation, and the attributions were supported by literature reports (Calderon et al., 
2004; Tian et al., 2011).  
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Table 6.15.: NMR spectroscopic data of 23-gem-dimethylcholesta-5-en-3β-ol (10) in 
CDCl3 
C. No. 13C 1H (int.,mult.,J in Hz)a COSY HMBC  
1 37.22 1.84 (1Hβ,t) H-2 C-3 
  1.08 (1Hα,t) - - 
2 31.66 1.50 (1Hβ,m) H-3 - 
  1.85 (1Hα,m) - C-5 
3 71.82 3.50 (1Hα,p) H-4 - 
4 42.31 2.25 (1Hβ,d) - C-5,6,3 
  2.29 (1Hα,d) - C-2, 10 
5 140.76 - - - 
6 121.72 5.35 (1H,dd,5.13,3.36) H-7 C-4,10,7 
7 31.91 1.52 (1Hβ,t) H-8 - 
  1.98 (1Hα,t) - - 
8 46.06 0.91 (1Hβ,m) - C-4,7 
9 50.14 0.95 (1Hα,t) H-11 - 
10 36.52 - - - 
11 21.09 1.46 (2H, q) H-12 C-13 
12 39.79 2.01 (1Hβ,t) - C-13 
  1.15 (1Hα,t) - - 
13 42.52 - - - 
14 56.11 1.10 (1Hα,m) H-15 C-16 
15 24.21 1.06 (1Hβ,m) H-16 C-16 
  1.56 (1Hα,t) - - 
16 28.33 1.83 (2H,t) H-17 C-13 
17 56.72 1.02 (1Hβ,m) H-20 C-21 
18 11.87 0.68 (3Hβ,s) - C-13,12,17 
19 19.41 1.01 (3Hβ,s) - C-5,1,9 
20 36.27 1.35 (1Hβ,m) H-22 - 
21 18.72 0.92 (3Hα,d) - C-13,20 
22 36.22 1.14 (2H,d) - C-24,25 
23 39.61 - - - 
231 28.01 1.59 (3H,s) - C-25 
232 29.72 1.25 (3H,s) - C-23 
24 23.83 1.30 (2H,d) H-25 C-232 
25 35.71 1.49 (1H,m) H-26,27 - 
26 19.31 0.86 (3H,d) - C-26 
27 22.82 0.87 (3H,d) - C-20 
1H NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spectrometer 
(Bruker, Karlsruhe, Germany) in CDCl3 as aprotic solvent at ambient temperature with 
TMS as the internal standard (δ 0 ppm). The 1H NMR spectra were recorded at 500MHz, 
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while the 13C NMR spectra were recorded at 125MHz. aValues in ppm, multiplicity and 
coupling constants (J=Hz) were indicated in parentheses. The assignments were made with 
the aid of the 1H-1H COSY, HSQC, HMBC and NOESY experiments 
Figure 6.136.: 1H-1H COSY (A) and HMBC (B) correlations of 23-gem-dimethylcholesta-
5-en-3β-ol (10). The key 1H-1H COSY couplings have been represented by the bold face 
bonds. The HMBC couplings were indicated by double barbed arrow 
Figure 6.137.: NOESY correlations of 23-gem-dimethylcholesta-5-en-3β-ol (10). The 
NOESY relations were represented by double barbed arrow 
Figure 6.138.: 1H NMR spectrum of 23-gem-dimethylcholesta-5-en-3β-ol (10) 
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Figure 6.139.: 13C NMR spectrum of 23-gem-dimethylcholesta-5-en-3β-ol (10) 
Figure 6.140.: 135DEPT NMR spectrum of 23-gem-dimethylcholesta-5-en-3β-ol (10) 
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Figure 6.141.: 1H-1H COSY NMR spectrum of 23-gem-dimethylcholesta-5-en-3β-ol (10) 
Figure 6.142.: HSQC NMR spectrum of 23-gem-dimethylcholesta-5-en-3β-ol (10) 
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Figure 6.143.: HMBC NMR spectrum of 23-gem-dimethylcholesta-5-en-3β-ol (10) 
Figure 6.144.: NOESY NMR spectrum of 23-gem-dimethylcholesta-5-en-3β-ol (10) 
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Figure 6.145.: FTIR spectrum of 23-gem-dimethylcholesta-5-en-3β-ol (10) 
 
 The olefinic (C=C) and alkyl (C-H) groups IR stretching vibrations were 
represented by the 1664 and 2945 cm-1 absorption bands, respectively. The absorption at 
3427 cm-1 indicated O-H stretching vibration. The FTIR peaks at 1243-1188 (C-C stretch) 
cm-1 were substantiated the substituted cholestene structure (Figure 6.145.). 
 
Figure 6.146.: EIMS spectrum of 23-gem-dimethylcholesta-5-en-3β-ol (10) 
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Figure 6.147.: Mass fragmentation pattern of 23-gem-dimethylcholesta-5-en-3β-ol (10) 
 
The molecular ion peak at m/z 414 appeared to undergo elimination of one 
molecule of water to yield 23-gem-dimethylcholesta-2,5-diene (10) (m/z 396). One of the 
most general types of fragmentation in substituted C-17 steroids was the removal of side 
chain which led to an copious ion at m/z 255 in the corresponding spectra. The side chain 
elimination (2,4,4-trimethylheptane) from the fragment ion at m/z 396 yielded the fragment 
with m/z 255 (s), which on successive rearrangements yielded the fragments at m/z 163 (t), 
95 (v), 81 (w) and 69 (x). The molecular ion peak at 69 (x) was found to be the base peak 
and corresponding to penta-1,4-diene. The ion at m/z 345 formed from m/z 399 (23-gem-
dimethylcholesta-2-ene), through a Retro-Diels-Alder mechanism. Further decomposition 
of the ion at m/z 399 was perceived by the loss of C-18 methyl and resulted in ion at m/z 
203. The molecular ion peak at m/z 264 (y) resulted from the fragmentation of ions through 
elimination of water molecule and side chain (Figure 6.146., 6.147.). 
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More signifcantly, the marine-derived steroids with their diverse structures were 
found to exhibit interesting therapeutic properties (Goad and Akihisa 1997; Whitson et al., 
2009). Anti-inflammatory properties of steroidal compounds isolated from marine 
invertebrates against pro-inflammatory COX-2 and cytokines were reported in earlier 
literatures (Chao et al., 2008; Su et al., 2008; Thao et al., 2013) for example, inhibitory 
effect of di-unsaturated C-27 polyhydroxy sterols isolated from marine gastropod, 
Trimusculus peruvianus (Diaz-Marrero et al., 2003b). Consequently, the detection and 
identification of COX-2/5-LOX-specifc inhibitors could have a potentially profound impact 
on the treatment of a number of inflammatory disorders. 
6.3.3.  Bioactive (antioxidant and anti-inflammatory) potentials of secondary 
metabolites isolated from EtOAc:MeOH extract of P. malabarica 
6.3.3.1.  Antioxidative potentials of secondary metabolites (1-10) isolated from 
EtOAc:MeOH extract of P. malabarica 
 The free radical inhibiting activities of title compounds (1-10) isolated from 
EtOAc:MeOH extract of P. malabarica were described in Table 6.16. The antioxidant 
activities of isolated compounds were determined by in vitro DPPH and ABTS+ scavenging 
experiments. 
The hydroxy oxo-pyran enclosed benzoate derivative, compound 3 (IC50 0.59 
mg/mL) and furanyl-2H-tetrahydro chromenyl derivative, 4 (IC50 0.56 mg/mL) did not 
display any significant difference among each other in DPPH radical scavenging activity (p 
> 0.05). The compounds 3-4 were appeared to exhibit significantly greater DPPH 
scavenging activity when compared to other compounds and commercially available α-
tocopherol (IC50 0.65 mg/mL) (Table 6.16.). No significant difference in scavenging DPPH 
radical for isopimarane norditerpenoid derivative, 6 (IC50 0.65 mg/mL) and hydroxy 
benzoate metabolite, 1 (IC50 0.65 mg/mL) compared to those displayed by the 
commercially available antioxidant, α-tocopherol (IC50 0.65mg/mL) (p > 0.05) was 
apparent. Other compounds, such as benzoate derivative 2 (IC50 0.79 mg/mL), 3H-
isochromenone derivative, 5 (IC50 0.73 mg/mL), meroterpeno pyranoid derivatives, 7-8 
(IC50 ~0.77 mg/mL) along with substituted dihomocholestadienol, 9 (IC50 0.81 mg/mL) did 
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not display significant differences among each other in DPPH radical scavenging activity (p 
> 0.05), and which were found to be significantly (p < 0.05) greater when compared to 23-
gem-dimethyl cholestenol derivative, 10 (IC50 1.01 mg/mL).   
 
Table 6.16.: In vitro antioxidant {2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2’-azino-
bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS+) radical scavenging assays} 
bioactivities of secondary metabolites (1-10) isolated from EtOAc:MeOH extract of P. 
malabarica against commercially available standard, α-tocopherol 
Compounds 
Antioxidant activities IC50 values (mg/mL) 
*DPPH scavenging 
activity 
*ABTS+ scavenging 
activity 
1 0.65 ± 0.06a 0.74 ± 0.06a 
2 0.79 ± 0.02bd 0.76 ± 0.01a 
3 0.59 ± 0.06c 0.69 ± 0.06b 
4 0.56 ± 0.06c 0.67 ± 0.06b 
5 0.73 ± 0.07b 0.79 ± 0.07a 
6 0.65 ± 0.06a 0.78 ± 0.06a 
7 0.76 ± 0.06bd 0.96 ± 0.06c 
8 0.78 ± 0.06bd 0.92 ± 0.06c 
9 0.81 ± 0.09d 0.98 ± 0.09c 
10 1.01 ± 0.09e 1.12 ± 0.09d 
α-tocopherol 0.65 ± 0.04a 0.76 ± 0.05a 
The samples were analyzed in triplicate (n = 3) and expressed as mean±standard deviation. 
Means followed by different superscripts (a-e) within the same column indicated signiﬁcant 
differences (p < 0.05). *The bioactivities were expressed as IC50 values (mg/mL) 
 
Likewise, hydroxy oxo-pyran enclosed benzoate derivative, compound 3, (IC50 
0.69 mg/mL) and furanyl-2H-tetrahydro chromenyl derivative, 4 (IC50 0.67 mg/mL) did not 
display any significant difference each other in ABTS+ radical scavenging activity (p > 
0.05). The compounds 3 and 4 were exhibited significantly greater ABTS+ radical 
scavenging effects (p < 0.05) when compared to other compounds and commercially 
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available α-tocopherol (IC50 0.76 mg/mL). No significant difference in scavenging ABTS+ 
radical for isopimarane norditerpenoid derivative, 6 (IC50 0.78 mg/mL), benzoate derivative 
2 (IC50 0.76 mg/mL), 3H-isochromenone derivative, 5 (IC50 0.79 mg/mL) and hydroxy 
benzoate metabolite, 1 (IC50 0.74 mg/mL) equated to those displayed by the commercially 
available antioxidant, α-tocopherol (IC50 0.76 mg/mL) were apparent (p > 0.05) (Table 
6.16.). These compounds (1-6) were exhibited significantly greater ABTS+ radical 
scavenging potentials (p < 0.05) when compared to meroterpeno pyranoid derivatives, 7-8 
(IC50 0.92-0.96 mg/mL) and substituted dihomocholestadienol, 9 (IC50 0.98 mg/mL). No 
significant dissimilarity (p > 0.05) was apparent for compounds 7-9 (IC50 ~0.95 mg/mL) 
and, which seemed to be higher when compared to 23-gem-dimethyl cholestenol derivative, 
10 (IC50 1.12 mg/mL) (p < 0.05). 
 
6.3.3.2. Anti-inflammatory potentials of secondary metabolites (1-10) isolated from 
EtOAc:MeOH extract of P. malabarica 
The anti-inflammatory potentials of title compounds (1-10) isolated from 
EtOAc:MeOH extract of P. malabarica were described in Table 6.17. The anti-
inflammatory potentials of isolated compounds were determined by the in vitro 
cyclooxygenase-1/2 and 5-lipoxygenase enzyme inhibitory assays. In addition, the 
selectivity indices were calculated from the ratio of IC50 values of anti-COX-1 to IC50 
values of anti-COX-2 potentials and the values were compared among the isolated 
bioactive compounds and standard, ibuprofen (Figure 6.145). 
The hydroxy oxo-pyran enclosed benzoate derivative, 3 (IC50 0.83 mg/mL) and 
hydroxy benzoatemetabolite, 1 (IC50 0.89 mg/mL) were  represented significantly greater (p 
< 0.05) inhibitory activity against COX-1 compared to benzoate derivative 2 (IC50 0.95 
mg/mL), furanyl-2H-tetrahydro-chromenyl derivative, 4 (IC50 0.94 mg/mL), 3H-
isochromenone derivative, 5 (IC50 1.01 mg/mL), and isopimarane norditerpenoid 
derivative, 6 (IC50 0.96 mg/mL). The anti-COX-1 potentials were significantly higher (p < 
0.05) for compounds 1-6 when compared to meroterpeno pyranoids, 7-8 (IC50 ~1.06 
mg/mL) and cholestenol derivatives, 9-10 (IC50 1.11-1.27 mg/mL). The hydroxy benzoate 
derivative, 3 (IC50 0.68 mg/mL) was registered greater anti-COX-2 potentials followed by 
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hydroxy benzoate, 1 (IC50 0.74 mg/mL) and furanyl-2H-tetrahydro-chromenyl, 4 (IC50 0.72 
mg/mL). The anti-COX-2 potentials were significantly greater for compounds, 1, 3 and 4 (p 
< 0.05) when compared to 3H-isochromenone derivative, 5 (IC50 0.85 mg/mL) benzoate 
derivative 2 (IC500.89 mg/mL) and isopimarane norditerpenoid, 6 (IC50 0.82 mg/mL) 
followed by the compounds, 7-9 (IC50 ~0.93 mg/mL) and 23-gem-dimethyl cholestenol 
derivative, 10 (IC50 1.15 mg/mL), in descending order. In addition, these compounds, 1-10 
were exhibited greater activity against COX-2 than COX-1, and consequently recorded 
greater selectivity indices (SI, IC50anti-COX-1/IC50anti-COX-2 > 1.05) than ibuprofen 
(0.63; selective towards constitutive pro-inflammatory enzyme COX-1), a commercial anti-
inflammatory drug (Figure 6.148.). The selectivity index was greater for compound, 4 (SI 
1.31) followed by 1 (SI 1.20), 3 (SI 1.22), 9 (SI 1.21) and compounds 5-8, 10 (SI ~1.15) 
and 2 (SI 1.07), in descending order.    
Likewise, hydroxy oxo-pyran enclosed benzoate derivative, compound 3, 
isopimarane norditerpenoid derivative, 6 and furanyl-2H-tetrahydro chromenyl derivative, 
4 did not display any significant difference among each other for anti-5-LOX potentials 
(IC50 0.75-0.76 mg/mL; p > 0.05). The anti-5-LOX activities of these compounds were 
significantly greater when compared to other compounds and ibuprofen (IC50 > 0.77 
mg/mL; p < 0.05). Also, the compounds, hydroxy benzoate metabolite, 1 (IC50 0.81 
mg/mL), 3H-isochromenone derivative, 5 (IC50 0.82 mg/mL) were displayed greater anti-5-
LOX activity than that exhibited by the reference inhibitor, ibuprofen whereas, the 
compounds 2 and 9 were showed activity comparable to ibuprofen (IC50 0.96 mg/mL) 
(Table 6.17.). 
It is of note that the NSAIDs are used for moderating the pathogenesis due to 
inflammatory pain and arthritis (Quan et al., 2008), although these drugs were reported to 
cause deleterious side effects, such as gastric ulcers, CVD and toxicosis on the various 
organs (Schnitzer et al., 1999). Notably, the adverse implications of NSAIDs were reported 
to be due to greater anti-COX-1 properties. COX-1 is produces prostaglandins (PGs) which 
protect the stomach and kidney from damage (Chakraborty et al., 2014a). COX-2 is 
induced by inflammatory stimuli and produces PGs which contributed to the swelling and 
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pain of inflammation. The systemic inhibition of the COX-1 leads to a subsequent 
reduction in cytoprotective PGs required for an effective mucosal defense. 
 
Table 6.17.: In vitro anti-inflammatory {cyclooxygenase-1/2 (COX-1/2) and 5-
lipoxygenase (5-LOX)) scavenging assays} bioactivities of secondary metabolites (1-10) 
isolated from EtOAc:MeOH extract of P. malabarica against commercially available 
standard, ibuprofen 
Compounds 
Anti-inflammatory activities  
IC50 values (mg/mL) 
*COX-1 scavenging 
activity 
*COX-2 scavenging 
activity 
*5-LOX scavenging 
activity 
1 0.89 ± 0.05a 0.74 ± 0.06a 0.81 ± 0.07a 
2 0.95 ± 0.01b 0.89 ± 0.03b 0.92 ± 0.01b 
3 0.83 ± 0.06a 0.68 ± 0.06c 0.76 ± 0.06c 
4 0.94 ± 0.03a 0.72 ± 0.06a 0.76 ± 0.07c 
5 1.01 ± 0.07b 0.85 ± 0.07b 0.82 ±  0.07a 
6 0.96 ± 0.06b 0.82 ± 0.06b 0.75 ± 0.07c 
7 1.05 ± 0.01c 0.92 ± 0.06d 1.06 ± 0.07d 
8 1.07 ± 0.02c 0.95 ± 0.06d 1.02 ± 0.06d 
9 1.11 ± 0.06d 0.92 ± 0.09d 0.96 ± 0.09b 
10 1.27 ± 0.07d 1.15 ± 0.09e 1.02 ± 0.09d 
Ibuprofen 0.05 ± 0.02e 0.08 ± 0.05f 0.96 ± 0.03b 
The samples were analyzed in triplicate (n = 3) and expressed as mean ± standard 
deviation. Means followed by different superscripts (a-f) within the same column indicated 
signiﬁcant differences (p < 0.05). *The bioactivities were expressed as IC50 values 
(mg/mL) 
 
The main undesirable effects of synthetic drugs were due to the inhibition of 
COX-1, whereas the beneficial effects were due tothe inhibition of COX-2. Therefore, the 
selective COX-2 inhibitors with higher COX-2/COX-1 ratio than NSAIDs seem to be safer. 
Selective inhibition of COX-2 also provided selective anti-inflammatory effects with 
reduced organ toxicity risks associated with the COX-1 inhibition. It is of note that the 
simultaneous inhibition of 5-LOX/COX-2 is important to allow synthesis of lipoxins to 
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resolve inflammation and attenuate any remaining leukotriene effect. As a result, medical 
researchers are looking for safer, more efficacious alternatives to both the traditional 
NSAIDs. It is therefore, necessary to find suitable medications that can inhibit 5-LOX and 
COX-2 simultaneously while maintaining COX1/2 ratio below the threshold limit 
(preferably lesser than 1.0) for targeted and selective activities against inflammatory 
response. Apparently, a greater selectivity index (anti-COX-1IC50/anti-COX-2IC50) of the 
pharmacophores also signified their greater selectivity profile. The greater selectivity index 
of the secondary metabolites (1-10) isolated from EtOAc:MeOH extract of P. malabarica 
(SI > 1.07) (Figure 6.148) explained its greater selectivity profiles than the nonsteroidal 
anti-inflammatory drug based therapies (e.g., selectivity index of ibuprofen 0.63) (Botting 
2006). 
Figure 6.148.: A comparison of selectivity indices (IC50 of anti-COX-1/IC50 of anti-COX-
2) of were calculated for the secondary metabolites (1-10) isolated from EtOAc:MeOH
extract of P. malabarica along with commercially available standard, ibuprofen 
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6.3.4.  Structure-activity relationship analysis of secondary metabolites from 
EtOAc:MeOH extract of P. malabarica 
6.3.4.1.  Structure-activity relationship analysis of secondary metabolites from 
EtOAc:MeOH extract of P. malabarica using various molecular parameters 
The radical scavenging and anti-inflammatory properties of title compounds (1-
10) were correlated between their structures and corresponding hydrophobic (log Pow),
steric (MR/MV/Pr) and electronic (tPSA/Pl) factors to explain their bioactivities 
(Chakraborty et al., 2017b; Lipinski 2000). The molecular descriptor values for secondary 
metabolites isolated from P. malabarica (1-10) and reference compounds, α-tocopherol and 
ibuprofen were tabulated in the Table 6.18.  
The hydrophobicity of the title compounds, 1-10 were found to be lesser (log Pow 
< 8.3) when compared to commercially used antioxidant α-tocopherol (log Pow 9.98). The 
hydroxy oxo-pyran enclosed benzoate derivative (3), furanyl-2H-tetrahydro chromenyl (4) 
and 3H-isochromenone (5) exhibited lesser log Pow values, which were 4.81, 4.44 and 4.82, 
respectively and found to be within the acceptable limits (recommended log Pow 2-5) for 
optimum hydrophobic-lipophilic properties when compared to α-tocopherol (log Pow 9.98) 
(Lipinski 2000). The log Pow for titled isopimarane norditerpenoid (6), benzoate derivatives 
(1-2) and meroterpeno pyranoids, 7-8 were calculated as 6.30, 5.26-6.13 and 5.41-6.05, 
respectively which was the ratio of 1-octanol to water partition coefficient (Table 6.18.). 
Antioxidant activities of compounds, 1-6 were greater and their optimum hydrophilic-
lipophilic balance demonstrated its utility as a selective pharmacophore. The 
hydrophobicities of title compounds 1-10 were found to inversely proportional to their 
intermembrane permeability and bioavailability, which in turn, might negatively affect their 
bioactivities (Ishige et al., 2001). The signiﬁcantly greater hydrophobicity of α-tocopherol 
thus might explain its lesser antioxidant effects than those displayed by title compounds. 
The bio-potencies of isolated compounds were correlated with their steric bulk values 
{molar refractivity (MR); molar volume (MV); parachor (Pr)}. The greater steric bulk of α-
tocopherol (MR 135.06 cm3/mol; MV 462.7 cm3; Pr 1123 cm3) than those recorded with 
regard to studied metabolites, 1-8 (MR 85-129 cm3/mol; MV 297-416 cm3; Pr 696-1046 
420 
Isolation and characterization of secondary metabolites from Paphia malabarica           Chapter 6 
cm3) might possibly explain the relatively lesser bulk hindrance and the greater 
antioxidative activities of title compounds (Table 6.18.).  
It is of note that greater the electronic property, higher is the free radical 
scavenging and anti-inﬂammatory activities (Chakraborty et al., 2017c). Notably, the lesser 
electronic property of α-tocopherol based on total polar surface area, tPSA (29.46) 
compared to aryl polyketide derivatives, 1-3 (tPSA > 60) and tetrahydro chromenyl 
derivatives 4-5 (tPSA 44-46) signiﬁed the greater electronic interaction of compounds 1-5 
resulting in potentially higher free radical scavenging activities. The compound, hydroxy 
oxo-pyran bearing benzoate derivative, 3 recorded grater tPSA value of 99.13 followed by 
1 (tPSA 72.83) and 2 (tPSA 61.83), which was correlated with the greater antioxidative 
potential of 3 (IC50 < 0.70 mg/mL). Likewise, the studied compounds, 1-5 were displayed 
greater tPSA values compared to ibuprofen (tPSA 37.30), which accordingly explained its 
signiﬁcantly higher inhibiting activities towards pro-inﬂammatory 5-LOX (IC50 anti-5-
LOX 0.76-0.92 mg/mL) against ibuprofen (IC50 0.96 mg/mL). The electronic property 
determined by polarisability factor, Pl was found to be greater for the title compounds, 1-10 
(Pl > 30) when compared to ibuprofen (Pl 23.96). Similar to the tPSA values, aryl 
polyketides, 1 (Pl 50.33), 3 (Pl 50.06) recorded greater Pl values followed by tetrahydro 
chromenyl derivative, 4 (Pl 47.85) and aryl polyketide, 2 (Pl 44.89) (Table 6.18.). The 
hydroxy oxo-pyran moiety in 3, hydroxy benzoate skeleton of 1, benzoate moiety in 2 and 
furanyl-chromenyl skeleton in 4 appeared to increase the electron delocalizations and 
provide free hydrogens to effectively neutralize the free radicals by hydrogen atom transfer 
(HAT) reaction, which in turn, might possibly minimize the inﬂammatory responses. The 
presence of greater numbers of electron-withdrawing groups and centre of unsaturations, 
such as oxo-pyran, hydroxyl, carboxylates, furanyls, pyrans and aryl moieties in 
compounds, 1-5 were appeared to increase its electronic property (tPSA1-5 > 40) than other 
compounds in the series (tPSA6 35.53). Greater number of electronegative centers could be 
added towards higher bioactive properties due to effective electron-transfer (Cai et al., 
2006). Therefore, greater electronic property of 3 appropriately manifested its greater 
bioactivities compared to those displayed by other compounds.  
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Table 6.18.: The molecular descriptors of secondary metabolites from EtOAc:MeOH extract of P. malabarica (1-10) and 
commercially available products 
Electronic Steric Hydrophobic 
tPSA Pl (X10-24cm3) MR (cm3/mol) MV (cm3) Pr (cm3) Log Pow 
    1 
72.83 50.33 129.38 416.9 1034.3 6.13 
   2 
61.83 44.89 113.39 389.6 956.9 5.26 
  3 
99.13 50.06 125.15 403.7 1046.5 4.81 
   4 
44.76 47.85 122.74 394.5 970.7 4.44 
5 
46.53 37.10 94.22 315.2 790.8 4.82 
6 
35.53 38.93 125.96 337.2 814.6 6.30 
OH
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O
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  7 
18.46 38.93 100.50 337.2 814.6 6.05 
8 
9.23 33.33 85.53 297.5 696.7 5.41 
9 
20.23 53.02 136.17 433.7 1078.7 8.23 
     10 
20.23 51.23 130.01 424.1 1049.3 8.19 
O
HO
α-tocopherol 
29.46 53.54 135.06 462.7 1123 9.98 
O
OH
Ibuprofen 
37.30 23.96 60.44 200.1 499.3 3.75 
tPSA: Topological Polar Surface Area; Pl: polarizability; MR: molar refractivity; MV: molar volume; Pr: parachor; Log Pow: 
logarithm of octanol-water coefficient. The molecular descriptors were calculated by using ChemDraw® Ultra (CambridgeSoft 
Corporation, Cambridge, MA, USA; version 8.0) and ACD ChemSketch (Advanced Chemistry Development, Inc., Canada; 
version 12.0) softwares 
O
O
O
HO
HO
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The antioxidant activity of title compounds, especially 1-6 were greater than or 
comparable to α-tocopherol, even though the acceptable lipophilic levels of the former 
demonstrated it’s utility as a selective pharmacophore. Notably, more than 25% of the 
drugs approved by USFDA were reported to deviate from the boundaries prescribed by 
Lipinski rule, and this might lead to the undesirable characteristics, such as lesser 
selectivity and undesirable side effects (Petit et al., 2012). This attributions have been 
clearly deﬁned by the signiﬁcantly lesser selectivity indices of the synthetic NSAIDs 
(ibuprofen, selectivity index lesser than 0.7). The hydrophobic parameter, log Pow appeared 
to play a predominant role in determining the anti-inﬂammatory properties, particularly due 
to the increase in log Pow resulting in lesser COX-2/5-LOX activities as in 3 and 4 (log Pow 
4.44-4.82). Hydrophobic molecular descriptor (log Pow) and H-bonding capacity or 
electronic properties (tPSA/Pl) appeared to be closely associated to the pharmacological 
properties and intermembrane permeability. An earlier literature indicated the close 
relationship between log Pow and tPSA (Egan and Lauri 2002). It is apparent that the 
compounds with signiﬁcantly lesser hydrophobicity could be effectively separated in 
lipophilic segment of the biological membrane network, and unsuccessful to travel across 
the hydrophilic part of membrane complex resulting in lesser penetration through the 
membrane barrier (Wils et al., 1994). A balanced lipophilic-lipophobic index is essentially 
vital for imparting the target activity and bioavailability of the pharmacophores.  
6.3.4.2.  Suggested antioxidative mechanism of secondary metabolites from 
EtOAc:MeOH extract of P. malabarica in the DPPH radical model system 
The titled three aryl polyketide derivatives, particularly compound 3 was 
contained a conjugated system that could easily transfer H atom (by hydrogen atom 
transfer, HAT) to DPPH radical and could form resonance stabilized compounds, thus 
demonstrating their greater DPPH radical scavenging activity (IC50 0.59 mg/mL). The 
resonance stabilized forms of three polyketides that would be rearranged intramolecularly 
and their interaction with the DPPH radical were given in the Figure 6.149. Notably, in the 
case of compound 3, there were three reaction sites of antioxidative centres, in which two 
were at keto (C=O) group. The compound 2 enclosed one active site at keto position, 
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whereas compound 1 was consisted of two reaction sites in which one was at the keto 
centre. Apparently, these compounds were exhibited keto-enol resonance stabilization with 
the adjacent >C=O group leading to CH=C(-OH)- moiety. The greater resonance 
stabilization, presence of aromatic groups and the ease of H-atom release onto the DPPH 
radical to form stable DPPH were the prominent reasons for the antioxidative properties of 
these three aryl polyketide derivatives (1-3).  
Figure 6.149.: Suggested antioxidative mechanism of aryl polyketides (1-3) in DPPH 
radical model system 
Compound 4 was found to contain a conjugated system as 3-(31b-(furan-2’-yl)-
prop-31b-en-31-yl)-dihydro-2H-pyran that could easily transfer a H atom (by hydrogen atom 
transfer, HAT) at C-4a of the tetrahydro-2H-chromene framework onto the DPPH radical to 
form resonance stabilized 3-(31b-(furan-2’-(5H)-ylidene)-propan-31b-ylidene)-3,6-dihydro-
2H-pyran skeleton. This might explain the potential DPPH (IC500.56 mg/mL) radical 
scavenging activity of 4. The acidic proton at C-2 of tetrahydro-8-methyl-2H-chromene, 
has been abstracted by DPPH radical by HAT to yield resonance stabilized 61-(3-((E)-31b-
(furan-2’-yl)-prop-31b-en-31-yl)-6,8a-dihydro-8-methyl-5H-chromen-6-yl)-ethyl-5’’-methyl 
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-hexanoate that would be rearranged intramolecularly, and could interact with the DPPH 
radical (Figure 6.150.). Notably, in the case of compound 4, there have been two sites of 
antioxidative reaction centres, one at 3-(31b-(furan-2’-yl)-prop-31b-en-31-yl)-dihydro-2H-
pyran, whereas the other was at –CH-C(=O)O- moiety of the ethyl-5-methylhexanoate 
fragment. Apparently, the proton at C-2’’ (in the side chain linked to the tetrahydro 
chromenyl group) might possibly assist in keto-enol resonance with the adjacent >C=O 
group (at C-1’’) leading to the formation of CH=C(-OH)- moiety by relocating the proton 
at C-2’’ to DPPH radical. However, the second site of antioxidative reaction centre did not 
effectively participate in the resonance stabilization, and therefore, appeared to exhibit 
secondary role to stabilize the DPPH radical. 
Compound 5 did not possess the extended conjugation, and therefore, could not 
efﬁciently transfer an H atom onto the DPPH radical, leading to its lesser antioxidant 
activity (IC50 0.73 mg/mL) than those displayed by compound 3-4 (IC50 < 0.60 mg/mL). 
Compound 5 was found to possess tetrahydro-3H-isochromen-1(5H)-one moiety, where the 
oleﬁnic (C=C), and -C(=O)O- groups were located in isolation, and not in extended 
conjugation. Although the proton at C-8a could potentially form the enolic -C=C(OH)-O- 
in 6H-pyran-1-ol skeleton by DPPH aided abstraction of the acidic proton (C-8a), the 
abstraction capacity (acidity) of the proton has been weaker, apparently due to lesser 
electron delocalization. The presence of the free -CH2OH group, and the free electron pair 
of the -OH might not effectively participate in the resonance with the tetrahydro chromenyl 
ring (Figure 6.150.). The proton of -CH2OH group at the side chain methylnonanol moiety 
was weakly acidic in nature, and therefore, appeared to form feebly stabilized diphenyl 
picryl-hydrazine (DPPH-H).  
Compound 6 was found to possess two active sites of antioxidant reaction 
centres, one at the carboxylate linkeage in the O-propyl pentanoate chain and the second 
one was located at the -CH-CH=CH-CH(-O-) moiety in cyclic ring. Apparently, the proton 
in the side chain linked to the ester group might possibly assist in keto-enol resonance with 
adjacent >C=O group leading to the formation of CH=C(-OH)- moiety by relocating the 
proton to DPPH radical. The second site of antioxidative reaction centre at the oleﬁnic 
(C=C) and -C(-O-) groups have been located in conjugation and could easily transfer the 
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acidic proton to DPPH radical through electron delocalization. Likewise, the antioxidant 
property of 6 was supported by the suggested mechanism in DPPH model (Figure 6.151.). 
Figure 6.150.: Suggested antioxidative mechanism of tetrahydro chromenyl derivatives (4-
5) in DPPH radical model system
Figure 6.151.: Suggested antioxidative mechanism of isopimarane derivative (6) in DPPH 
radical model system 
The compound, 7 was comprised a reaction center in the non-conjugated alkenic 
system and the compound, 8 enclosed the active center in the pyranyl moiety by the 
delocalization of protons in their vicicnity. The protons were not in extended conjugation in 
both the compounds (7-8) and cannot effectively participate in resonance stabilization. 
Therefore, forms a feebly stabilized DPPH-H and recorded a lower DPPH radical 
scavenging potential (IC50 0.76-0.78 mg/mL) (Figure 6.152). 
The cholestenol derivatives, 9-10 were found to possess one reaction centres at 
the hydroxyl attached position (C-3) in conjugation with olefinic proton at C-6. The free 
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electron pair of the -OH might not effectively participate in the resonance with the 
tetracyclic ring (Figure 6.153.). The protons of -CHOH group located at C-3 position of 
compounds, 9 and 10 have been weakly acidic in nature, and therefore, might form a 
weakly stabilized diphenyl picryl-hydrazine (DPPH-H).  
Figure 6.152.: Suggested antioxidative mechanism of meroterpeno pyranoids (7-8) in 
DPPH radical model system 
Figure 6.153.: Suggested antioxidative mechanism of cholestenol derivatives (9-10) in 
DPPH radical model system 
The proposed antioxidative mechanisms of the titled secondary metabolites (1-
10) from P. malabarica in DPPH radical model system were corroborated with the in vitro
DPPH radical scavenging model system. The aryl polyketide derivative, 3 was found to 
contain greater number of active antioxidant reaction centres and possess more number of 
electronegative groups in conjugation. As a result, it could easily transfer H atom to 
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neutralize the DPPH radical to form resonance stabilized structures, consequently 
demonstrating its greater antioxidant activity. Likewise, both the aryl polyketide, 1 and 
tetrahydro chromenyl derivative, 4 were found to comprise two reaction centres and could 
easily interact with the DPPH radical, thus the antioxidant potentials were correlated with 
the suggested mechanism. 
6.3.5.  In silico molecular docking studies of selected compounds (1-4, 6) from P. 
malabarica 
The molecular docking studies were revealed the interactions between the 
selected compounds from P. malabarica with the active sites of target enzymes. The 
molecular docking studies were performed for the compounds isolated from P. malabarica, 
against pro-inflammatory COX-2 and 5-LOX enzymes, respectively, and their RMSD 
results were analyzed. The docked conformations with lowest binding energies (compounds 
1-4, 6) were selected for docking visualization to calculate the number of hydrogen bonds 
and the molecular binding interactions with the active sites of COX-/5-LOX. The number 
of hydrogen bonds, hydrogen bonded amino acid residues, binding energy, docking score, 
inhibition constant, intermolecular energy and torsional free energy between the 
compounds 1-4, 6 and the active sites of COX-2/5-LOX were recorded in Table 6.19. and 
6.20., respectively. 
In silico molecular docking studies of selected compounds with COX-2 receptor 
were revealed that all the docked ligands were bound with the targets. It exhibited lowest 
binding energies ranging from -7.80 to -9.01 kcal/mol and lowest docking scores of -10.73 
to -12.22 kcal/mol (Table 6.18.). Particularly, hydroxy oxo-pyran benzoate derivative, 3 
was registered lowest binding energy and docking score of -9.01 and -12.22 kcal/mol, 
respectively followed by hydroxy benzoate metabolite, 1 (-8.91 and -11.17, respectively) 
and furanyl-2H-tetrahydro chromenyl derivative, 4 (-8.81 and -11.14 kcal/mol, 
respectively). The enzyme inhibition constants, Ki was found to be lesser for compound 4 
(1.71 μM) than those recorded by 3 (3.59 μM), 1 (3.30 μM), 2 (6.52 μM) and 6 (7.30 μM), 
in descending order. Also, the intermolecular energy and torsional free energies were found 
to be lesser for 1, 3 and 4 (-10.26 to -12.27 and 2.28 to 2.39 kcal/mol, respectively). The 
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results were demonstrated the lowest binding energy and docking score of compounds 3 
and 4, which in turn, indicated their greater enzyme inhibition activities against pro-
inflammatory inducing enzyme COX-2.  
The compound 1 on molecular docking studies against COX-2 were exhibited six 
hydrogen bonded residues, such as SER 129.A, TRP 125.A, ARG 319.B, GLN 227.B, TYR 
220.B, GLY 221.8 (Figure 6.154.A) in active pocket site whereas, compound 2 (TRP 
125.A, ASN 130.A, ASP 215.B; Figure 6.154.B) and 3 (ASN 130.A, LEU 131.A, LEU 
210.B, LEU 224.B; Figure 6.154.C) exerted four H-bonds each in active site of COX-2. 
The compounds 4 (LEU 224.B, ARG 319.B; Figure 6.154.D) exhibited two H-bonds 
whereas, 5 showed five H-bond residues (ARG 319.B, SER 129.A, GLU 222.B, THR 
223.B; Figure 6.154.E). The greater number of hydrogen bonds in active site of COX-2 and 
lesser values of docking parameters (binding energy, docking energy and inhibition 
constant) were recorded for 3 and 4 and found to be consistent with their greater bio-
potentials obtained from in vitro anti-COX-2 assay (IC50 0.68-0.72 mg/mL). 
The molecular docking studies of compounds (1-4, 6) with pro-inflammatory 5-
LOX were revealed their lowest binding energies ranging from 9.55 to 11.02 kcal/mol 
along with lowest docking scores of 13.24 to 14.41 kcal/mol (Table 6.19.). Notably, 
hydroxy oxo-pyran enclosed benzoate derivative, 3 was registered lesser binding energy 
and docking score of 9.55 and 13.24 kcal/mol, respectively followed by that of hydroxy 
benzoate metabolite, 1 (9.89 and 13.42 kcal/mol, respectively). The enzyme inhibition 
constants, Ki was found to be lesser for compound 3 (7.12 μM) than those recorded by 4 
(7.20 μM), 1 (7.56 μM), 4 (7.34 μM) and 6 (8.21 μM), in descending order. The 
intermolecular energy and torsional free energies were found to be lesser for compounds 1 
and 3 (13.27 to 13.50 and 2.28 to 2.39 kcal/mol, respectively) (Table 6.19.). These results 
were substantiated the greater enzyme inhibition activities of 3 against pro-inflammatory 5-
LOX. 
The compound 1 on molecular docking simulation against 5-LOX was displayed 
three hydrogen bonded residues, such as SER 281.A, GLN 574.A, GLY 569.A (Figure 
6.155.A), whereas compound 2 displayed four hydrogen bonds at GLY 570.A, SER 281.A, 
SER 768.A, SER 768.A, respectively (Figure 6.155.B) in the active pocket of enzyme. 
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Moreover, the compounds 3 (ILE 765.A, SER 768.A; Figure 6.155.C) and 6 (ILE 765.A, 
SER 281.A; Figure 6.155.D) were exhibited two hydrogen bonds (indicated in parenthese), 
whereas, compound, 4 exhibited one hydrogen bond (ILE 765.A; Figure 6.155.E). The 
greater number of hydrogen bonds in the active site of 5-LOX and lesser values of binding 
energy/docking energy obtained for 2 and 3 were found to be linear with the greater in vitro 
anti-5-LOX potentials (IC50 0.75-0.81 mg/mL). 
Figure 6.154. The molecular binding interactions of compounds (A) 1, (B) 2, (C) 3, (D) 4 
and (E) 6 in the active site of cyclooxygenase (COX-2) were comprehended from the 
docking studies. The orange and blue coloured bonds were indicated the H-bonding 
correlations with COX-2 
431 
Isolation and characterization of secondary metabolites from Paphia malabarica          Chapter 6 
Figure 6.155. The molecular binding interactions of compounds (A) 1, (B) 2, (C) 3, (D) 4 
and (E) 6 in the active site of lipoxygenase (5-LOX) were comprehended from the docking 
studies. The orange and blue coloured bonds were indicated the H-bonding correlations 
with 5-LOX 
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Table 6.19.: Number of hydrogen bonds, hydrogen bonded (H-bonded) amino acid residue, binding energy, docking score, inhibition 
constant, intermolecular energy and torsional free energy between the ligands (compounds 1-4, 6) and the active sites of COX-2 
Ligands †No. ofH-bonds 
#H-bonded amino 
acid residues 
*Binding
energy
(kcal/mol) 
*Docking
score 
(kcal/mol) 
*Inhibition
constant,
Ki (µM)
*Intermolecular
energy 
(kcal/mol) 
*Torsional
free energy 
(kcal/mol) 
1 6 
SER 129.A 
TRP 125.A 
ARG 319.B 
GLN 227.B 
TYR 220.B 
GLY 221.8 
-8.91 -11.17 3.30 -11.29 2.39 
2 4 
TRP 125.A 
TRP 125.A 
ASN 130.A 
ASP 215.B 
-7.80 -10.73 7.30 -9.79 2.98 
3 4 
ASN 130.A 
LEU 131.A 
LEU 210.B 
LEU 224.B 
-9.01 -12.22 3.59 -12.27 2.28 
4 2 LEU 224.B ARG 319.B -8.81 -11.14 1.71 -10.26 2.39 
6 5 
ARG 319.B 
ARG 319.B  
SER 129.A 
GLU 222.B 
THR 223.B 
-8.46 -11.01 6.52 -11.15 2.68 
†Molecular docking studies were carried out using the software Autodock 4. #Hydrogen bonding interactions between protein and 
ligand.*Values were obtained from the energy minimization based calculations  
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Table 6.20.: Number of hydrogen bonds, hydrogen bonded (H-bonded) amino acid residue, binding energy, docking score, 
inhibition constant, intermolecular energy and torsional free energy between the ligands (compounds 1-4, 6) and the active sites 
of 5-LOX 
Ligands †No. ofH-bonds 
#H-bonded amino 
acid residues 
*Binding
energy
(kcal/mol) 
*Docking
score 
(kcal/mol) 
*Inhibition
constant,
Ki (µM)
*Intermolecular
energy 
(kcal/mol) 
*Torsional
free energy 
(kcal/mol) 
1 3 
SER 281.A 
GLN 574.A 
GLY 569.A 
9.89 13.42 7.56 13.50 2.39 
2 4 
GLY 570.A 
SER 281.A 
SER 768.A 
SER 768.A 
10.11 14.07 10.32 14.09 2.98 
3 2 ILE 765.A SER 768.A 9.55 13.24 7.12 13.27 2.28 
4 1 ILE 765.A 10.79 14.41 7.20 14.61 2.39 
6 2 ILE 765.A SER 281.A 11.02 13.28 10.09 13.34 2.68 
†Molecular docking studies were carried out using the software Autodock 4. #Hydrogen bonding interactions between protein 
and ligand.*Values were obtained from the energy minimization based calculations  
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The docking studies of selected compounds (1-4, 6) isolated from P. malabrica 
on the binding sites of 5-LOX/COX-2 showed that these ligands were potential 
inflammatory inhibitors and it could act as dual 5-LOX/COX-2 inhibitors. The 5-LOX and 
COX-2 enzymes were reported to be the inductive pro-inflammatory enzymes, and their 
expression was found to be upregulated in response to inflammatory stimuli. Apparently, 
simultaneous inhibition of COX-2 and 5-LOX is vital to arrest the inflammatory response 
in affected individuals. Notably, the binding interactions were explained the significant 
biological activity of studied compounds. Also, the molecular docking interactions were 
appropriately visualized the specificity of titled compounds with COX-2 and 5-LOX 
enzymes, which in turn, ascertained their greater selectivity, in particular, with reference to 
the compounds, 3 and 4. 
 
6.4. Conclusions 
 The rich diversity of venerid bivalve clam, P. malabarica in the coastal and 
marine waters of Kerala represented an unexploited reservoir of bio-potent compounds with 
valuable pharmaceutical and biomedical use, even though, the scientific investigations to 
acknowledge the health benefits of these species are confined. The present study is the first 
of its kind to extensively study this low-value bivalve clam to isolate specialized 
metabolites of potential pharmacological significance, and characterize in detail by 
extensive spectroscopic experiments. The ethyl acetate:methanol extract of P. malabarica 
was chromatographically fractionated to acquire bioactive secondary metabolites which 
were classified under various classes belonging to aryl polyketide derivatives (1-3), 
tetrahydro chromenyl derivatives (4-5), isopimarane norditerpenoid (6), meroterpeno 
pyranoids (7-8) and cholestenol analogues (9-10). The chemical structures of the previous 
undescribed specialized metabolites were resolved by detailed spectroscopic analysis. 
Putative biosynthetic pathways catalyzed by polyketide synthase leading to the formation 
of the title polyketide compounds unambiguously validated the structural attributions of 
compounds 1-3.   
The isolated compounds were evaluated for its antioxidant (DPPH and ABTS+ 
scavenging) and anti-inflammatory (COX-1/COX-2/5-LOX inhibition) potentials. The 
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compounds, (E)-12-(17-ethyl-tetrahydro-16-hydroxy-15-(methyl pentanoate)-14-oxo-2H-
pyran-13-yl)-9-methyl-but-11-enyl benzoate (3) and 61-(3-((E)-31b-(furan-2’-yl)-prop-31b-
en-31-yl)-tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-hexanoate (4) exhibited 
greater pro-inﬂammatory 5-lipoxygenase (5-LOX) inhibition potential (IC50 0.76 mg/mL) 
than that displayed by ibuprofen (IC50 0.96 mg/mL) in consonant with signiﬁcantly greater 
anti-inﬂammatory selectivity indices (SI > 1.20) than latter (ibuprofen SI < 1), which 
inferred the greater selectivity of 3 and 4. The aryl polyketides (13-(methoxycarbonyl)-11-
((E)-18-ethylhexa-16,19-dienyl)-12-propylcyclohex-10-enyl)-methyl-4-hydroxy benzoate 
(1), isobutyl-13-(6-(benzoyloxy)-10-methylpentyl)-tetrahydro-13-methyl-2H-pyran-17-
carboxylate (2), tetrahydro chromenyl derivative, 7-(2’-ethyl-1’-hydroxynonan-2’-yl)-
tetrahydro-3H-isochromen-1-(5H)-one (5) and isopimarane norditerpenoid, 18 (4→14),19 
(4→8) bis-abeo-nor-isopimarane-1,5-diene-3-yl-3β-methoxy propyl pentanoate (6) reported 
comparable pro-inﬂammatory 5-lipoxygenase (5-LOX) inhibition potential (IC50 0.75-0.92 
mg/mL) to ibuprofen (IC50 0.96 mg/mL) and signiﬁcantly greater anti-inﬂammatory 
selectivity indices (SI > 1.05) than the latter (SI < 1). Further, the docking study of selected 
compounds (1-4, 6) on COX-2 and 5-LOX binding sites displayed that the titled ligands 
were good inflammatory inhibitors of COX-2/5-LOX enzymes. The specificity of titled 
compounds with COX-2 and 5-LOX enzymes explained their greater anti-inflammatory 
selectivity profiles, partuclarly of aryl polyketide, 3. 
The antioxidant activities of the compound 3 and 4, as determined by 2,2-
diphenyl-1-picrylhydrazyl and 2,2’-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) 
radical scavenging activities (IC50 0.56-59 and 0.67-0.69 mg/mL, respectively) were greater 
than those recorded with commercially with α-tocopherol (IC50 0.65 and 0.76 mg/mL, 
respectively). The compounds, 1, 2, 5 and 6 displayed comparable antioxidant potentials 
(IC50 0.66-0.79 and 0.74-0.79 mg/mL, respectively) to α-tocopherol. Structure activity 
correlation studies displayed that the antioxidative and anti-inﬂammatory properties of the 
title compounds were directly proportional to their electronic properties and inversely with 
the hydrophobic and steric bulk characteristics. The proposed antioxidative mechanisms of 
the reported metabolites in DPPH radical model system were positively correlated with the 
in vitro DPPH radical scavenging assay. This mechanism further supported the greater 
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antioxidant potentials of the aryl polyketide derivatives (compounds 3 and 1) followed by 
tetrahydro chromenyl derivative, 4 which were found to effectively quench the DPPH free 
radical. 
Polyketide compounds along with the tetrahydro chromenyl derivatives bearing 
pleotropic molecular frameworks and functional properties were reported in previous 
literatures, and therefore, are the attractive choices of natural product chemists to develop 
cardinal bioactive pharmacophores in present-day drug discovery. However, there are 
sustained efforts to isolate newer chemistries of these groups of compounds with higher 
bioactive properties compared to previously described molecules. Accordingly, 
investigations with regard to modern functional food research are concentrated to identify 
and evolve chromene and polyketide derivatives with greater bioactive properties. The 
previously undescribed aryl polyketides and tetrahydro chromenyl analogues isolated from 
P. malabarica could effectively be utilized as naturally derived antioxidants to improve the 
shelf-life of food ingredients and to prevent the oxidative stress induced inﬂammatory 
diseases. 
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  SUMMARY  
  
Mollusks are traditional seafoods with wide variety of bioactive secondary 
metabolites, in which bivalve clams found in the marine and estuarine habitats were 
considered to be valuable marine resources of nutritional and commercial importance 
(Wakimoto et al., 2011). The bivalve clams contributed a significant role in the total 
fish catch of coastline areas of India and were recognized as predominant seafood 
resources with traditional health food applications among the coastal populace of the 
southwest coast of India. Bivalve clams considered as low-value by-catch species, even 
though these coastal fishery resources held a cardinal part of the aggregate edible 
mollusks, and preferred food items among the coastal population due to their nutritional 
importance and easy availability. Among different bivalve clam species, Villorita 
cyprinoides (black clam) and Paphia malabarica (yellow-foot clam) are the common 
resources, abundantly available in the coastal regions of southwest coast of India, and 
their cultivation methodologies have been developed and standardized. Considering the 
promising perspective for the utilization of these groups of bivalve clams, and limited 
research reports on their utilization as potential health foods, their nutritional and 
pharmaceutical potential began to receive considerable attention. A number of research 
publications related to nutritional significance, bio-potent functionalities together with 
isolation, identification and characterization of previously unidentified chemistries from 
bivalve clams demonstrated their broader possibilities in the pharmaceutical chemistry 
research and related applications (Blunt et al., 2015; Mohite et al., 2009; Tsai et al., 
2008; Wei et al., 2007). Earlier reports suggested the relevance of bivalves as natural 
bio-potential products, health food supplements, nutraceuticals, food additives and 
pharmacophores for human well-being (Watanabe et al., 2012).   
The free radical generation and oxidative stress is one of the major concerns 
in the present day life leading to various health problems. The reactive oxygen species 
were found to be the mediators of various disorders, such as inflammations, 
atherosclerosis, cancer, diabetes, ulcers, hypertension etc. (Stefanis et al., 1997). 
Reactive oxygen species were found to generate signals to activate the pro-
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inflammatory mediators like COX, LOX isoforms, cytokines, interleukins and 
chemokines, which develop acute or chronic inflammations. The action of free radicals 
can be effectively suppressed by various antioxidant supplements. The commercially 
available antioxidants were reported to be carcinogenic and can lead to organ damages 
(Schnitzer et al., 1999). Likewise, the non-steroidal anti-inflammatory (NSAIDs) 
medicines used to treat inflammatory ailments were associated with mild to severe 
damages of gastrointestinal tract (Weil et al., 1995). In these circumstances, target 
specified antioxidative and anti-inflammatory compounds from natural resources have 
been acknowledged to overcome the adverse effects of synthetics. It is to note that the 
marine organisms were endowed with complex defense pathways to challenge their 
oxidative stress conditions and to help them synthesizing various specialized and potent 
bioactive secondary metabolites (Chainy et al., 2016). The soft tissued bivalve clams 
have been adapted to extreme unfavourable conditions, even though they were not 
reported for cellular damages. Therefore, it was believed that the cells of these sessile 
organisms were significant producers of diverse classes of specialized bioactive 
metabolites with pharmaceutical significance. It is important to note that small 
molecular weight compounds constitute a major share of bioactives in the marine 
organisms (Blunt et al., 2015). It is, therefore, imperative to explore these molecules 
due to their greater bioactivities against various pharmacological models, and also 
relative ease to synthesize these molecules in laboratory conditions. The potential 
bioactive templates can also be used as intermediates to synthesize drug 
candidates/drug-like molecules. Even though, the ratios of marine natural products that 
can be established into drugs are relatively lesser, it is apparent that the cumulative 
numbers of bioactive components will be permitted for the curing of human diseases. 
The promising perspective of bivalve clams, V. cyprinoides (family, Corbiculidae) and 
P. malabarica (family, Veneridae) as potential health foods, the investigations of their 
pharmaceutical applications began to receive substantial consideration. Therefore, the 
isolation and characterization of low molecular weight bioactive metabolites from the 
commonly available bivalve clams, V. cyprinoides and P. malabarica have vital role in 
the development of functional foods and pharmaceutical lead templates.  
 The investigation of the nutritional compositions of V. cyprinoides and P. 
malabarica in the current study appropriately established their dietary qualities as 
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functional food candidates. The greater contents of polyunsaturated fatty acids 
(34.33%), especially, eicosapentaenoic acid (EPA, 7.68%), docosahexaenoic acid 
(DHA, 14.35%), balanced n-3/n-6 fatty acid proportion (2.31%) and DHA/EPA (1.88%) 
were characterized for P. malabarica compared to V. cyprinoides (∑PUFA 18.46%; 
EPA 3.57%; DHA 3.22%; ∑n-3/∑n-6 0.77 and DHA/EPA 0.91%). The balanced 
essential/non-essential amino acid ratio (> 1.0 mg/100 g wet weight) and vitamin D3 (> 
160 IU) contents in the edible portion of these bivalve clams were recognized these 
species as high value health food components. The favourable sodium to potassium 
ratio (Na/K > 1.0) and calcium-phosphorus contents (Ca+P > 550 mg/100 g wet weight) 
along with greater selenium concentrations (Se > 25 μg/100 g wet weight) showed that 
these bivalves were good sources of well-balanced diet. The present study demonstrated 
the nutritional qualities of V. cyprinoides and P. malabarica and suggested their utilities 
as functional food components.  
 Anti-inflammatory, anti-hypertensive, antioxidant and anti-diabetic potentials 
of EtOAc:MeOH (ethyl acetate:methanol) solvent extract of V. cyprinoides and P. 
malabarica were assessed by different in vitro models. The EtOAc:MeOH extract of P. 
malabarica was demonstrated greater 1,1-diphenyl-2-picryl-hydrazil and 2,2’-azinobis-
3-ethylbenzothiozoline-6-sulfonic acid radical scavenging abilities (IC50 0.76 and 1.27 
mg/mL, respectively). A higher angiotensin converting enzyme-1 (ACE-1) inhibitory 
activity coupled with anti-cyclooxygenase-2 and anti-5-lipoxygenase (IC50 1.11, 0.92 
and 1.51 mg/mL, respectively) properties along with DPP-4 and α-glucosidase (IC50 
1.00 and 1.47 mg/mL, respectively) inhibitory activities registered for EtOAc:MeOH 
extract of P. malabarica than V. cyprinoides. This study revealed that the EtOAc:MeOH 
extract of P. malabarica registered greater antioxidative properties, and the activities 
were showed significant positive correlation with antihypertensive, anti-inflammatory, 
and anti-diabetic activities. The utilities of spectroscopic tools for analyzing the 
signature peaks and relative abundance of the vital functional groups present in the 
solvent extracts, and to furnish with essential rules regarding the presence of 
electronegative functional groups responsible for the bioactivities were illustrated. A 
significant co-linearity was found to exist between the electronegative groups present in 
the downfield position of the NMR spectra and the bioactivities of the EtOAc:MeOH 
extracts derived from the bivalve clam species.  
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The bioassay guided chemical prospecting of EtOAc:MeOH extract of 
bivalve clam V. cyprinoides led to isolation of bio-potent metabolites, which were 
grouped into spirocyclic ether derivatives (1-2), irregular meroterpenoids (3-5), 
hexahydro isochromenyl analogues (6-7) and cholestenol derivatives (8-10). The 
structures of isolated compounds were unambiguously assigned by 1D (1H, 13C, 
135DEPT), 2D (1H-1H COSY, HSQC, HMBC, NOESY) nuclear magnetic resonances 
(NMR) spectroscopy, fourier transform infrared (FTIR) and mass experiments.  
The bioactivity-guided purification of EtOAc:MeOH extract of V. cyprinoides 
resulted in the identification of two spirocyclic ether derivatives namely 16-
hydroxyhexyl-(2-ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-propanoate (1) and 
(E)-18-ethyl-17,19-dihydroxyhept-14-enyl-(2-ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-
dien)-10-acetate (2). These two compounds enclosed a rearranged monocyclofarnesyl 
framework with a dihydrofuran ring spiro fused to substituted cyclohexene framework, 
and found to possess an oxaspiro[4.5]deca-dienyl skeleton. The extensive one and two 
dimensional NMR experimentations (1H-1H COSY, HSQC and HMBC) ascertained that 
the basic O-spirocyclic structural attributions of 1 and 2 were found to be similar, but 
differed in their side chain attachments. The compound 1 enclosed 16-hydroxyhexyl-10-
propanoate at C-10 whereas, 2 enclosed distinctive 18-ethyl-17,19-dihydroxyhept-14-
enyl-10-acetate unit at C-10 position. The compounds with O-heterocyclic-spiro 
functionalities were found to be significant bioactive agents among various classes of 
organic compounds. The spiro compounds were found to enclose two rings shared with 
one atom (the quaternary spiroatom) and the conformation of the ligands (compounds) 
has been rigidified by the introduction of ring framework. In this manner, the cyclic 
derivatives were appeared to experience a reduced conformational stress during the 
binding to a target site (enzymes or proteins). 
The present study demonstrated the identification of three irregular 
meroterpenoid derivatives bearing oxygen heterocycles (3-5) from V. cyprinoides. The 
chromatographic purification of EtOAc:MeOH extract of black clam resulted in the 
identification of O-heterocyclic fused irregular meroterpenoid derivative named as 8-
(1,3,3a,4,5,7a-hexahydro-1-(hydroxymethyl)-3-oxoisobenzofuran-4-yl)-ethyl-pentanoate 
(3) along with one each of O-heterocyclic pyranone characterized as tetrahydro-3-
methoxy-5-((E)-8,12-dimethyloct-8-enyl)-pyran-2-one (4) and O-heterocyclic dihydro 
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furanone-dihydropyran ring enclosed dihydro-5-(8-(9,12-dihydro-8-methyl-11-propyl-
2H-pyran-8-yl)-ethyl)-furan-2(3H)-one (5). The compound 3 was composed with a basic 
C11 skeleton including the hexahydro oxoisobenzofuran and pentanoate side chain, 
which were linked through an ethyl linkage. The compound 4 was found to be α-pyrone 
enclosed sesquiterpene-based C16 prenylated bisabolene type of meroterpenoid, 
whereas the compound 5 was enclosed an irregular C15 furano meroterpenoid as its 
basic structural framework. Extensive two dimensional NMR experiments with 
compound 5 has explained that it was composed of two parts, which were dihydro-
furan-2(3H)-one part and {8-(9,12-dihydro-8-methyl-11-propyl)-2H-pyran-8-yl part 
linked through an ethyl moiety. The O-heterocyclic skeletons with varying substitutions 
of electronegative functionalities might play significant functional roles towards the 
potential biological activities of the irregular meroterpenoid derivatives bearing oxygen 
heterocycles (3-5) from V. cyprinoides. 
The identification and characterization of two hexahydro isochromenyl 
meroterpenoids, (10E)-butyl-9-(6-ethyl-hexahydro-1H-isochromen-3-yl)-pent-10-enoate 
(6) and (12E)-(hexahydro-1H-isochromen-3-yl)-methyl-hept-12-enoate (7) from V. 
cyprinoides were described in the present study. The compound, 6 was an irregularly 
arranged C20 hexahydro isochromenyl meroterpenoid, whereas the compound 7 was 
found to be an irregularly arranged C17 isochromenyl meroterpenoid. The extensive 
NMR experiments proposed that the basic hexahydro isochromenyl frameworks of 6 and 
7 were similar, but found to be varied in their side chain attachments. The compound 6 
enclosed ethyl moiety at C-6 and butyl-pent-10-enoate side chain at C-3 whereas, in 7, 
the ethyl moiety at C-6 was absent and C-3 position was linked to methyl hept-12-
enoate. The presence of O-heterocyclic tetrahydro chromenyl derivatives with lipophilic 
side chains might play a noteworthy role towards their potential bioactivities. 
The present study also described the characterization of a new abeo-pregnane-
type sterol derivative as 19 (10→5) abeo-20-methyl-pregn-1-en-3-yl-3β-methoxy-hex-
25-enoate (8) along with two cholestenol derivatives, which were characterized as 
(22E)-241-homocholesta-5,22-dien-(3β,241β)-diol (9) and (22E),(241E)-241,242-dihomo 
cholesta-5,22,241-trien-3β-ol (10). The methyl group (-CH3-19) at C-10 position of the 
pregnane steroid derivative, 8 was shifted to C-5, and therefore, it was named as 19 
(10→5) abeo pregnane. Also, the characteristic hydroxyl group at C-3 of sterols was 
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substituted by the highly electronegative groups like carboxylates, which was apparent 
from the deshielded proton signal at δ ~4.5 (corresponded to ester linkages) in the 1H 
NMR spectrum. The two cholestenol derivatives were found to be similar, except the 
side chain moieties. The cholesta-dienol derivative, 9 was deduced to enclose the 
olefinic and hydroxyl groups in the side chain framework attached at C-17, whereas the 
dihomocholesta-trien-ol derivative, 10 was found to possess two isolated alkenes at C-
22 and C-241 positions in the side chain (attached at C-17). 
The spirocyclic ether derivatives, (E)-18-ethyl-17,19-dihydroxyhept-14-enyl-
(2-ethyl-2,6-dimethyl-1-oxaspiro[4.5]dec-3,8-dien)-10-acetate (2) and 16-hydroxy 
hexyl-(2-ethyl-2,6-dimethyl-1-oxaspiro [4.5]dec-3,8-dien)-10-propanoate (1) isolated 
from V. cyprinoides were displayed significantly greater (p < 0.05) antioxidant activities 
against DPPH radical (IC50 0.54 and 0.59 mg/mL, correspondingly) when equated to α-
tocopherol and other compounds in series (IC50 > 0.60 mg/mL). The antioxidant activity 
against DPPH radical for the irregular meroterpenoid derivatives bearing oxygen 
heterocycles (3-5) were found to be lesser compared to spirocyclics, even though no 
significant difference (p > 0.05) was apparent for the DPPH radical scavenging 
potentials of 3-5 (IC50 0.63-0.71 mg/mL) along with α-tocopherol (IC50 0.65 mg/mL). 
The prenylated spirocyclic ether derivatives, 1 and 2 (IC50 0.62-0.67 mg/mL) along with 
furano meroterpenoid derivative, 5 (IC50 0.64 mg/mL) not displayed (p > 0.05) any 
significant difference in ABTS+ radical scavenging properties, and their antioxidative 
activities against ABTS+ radical were found to be significantly greater (p < 0.05) than 
those exhibited by other compounds in this series and α-tocopherol (IC50 0.76 mg/mL). 
No significant difference was apparent in ABTS+ radical inhibition for the α-pyrone 
derivative, 4 (IC50 0.76 mg/mL) and hexahydrobenzo furanone, 3 (IC50 0.72 mg/mL) 
with the reference, α-tocopherol (IC50 0.76 mg/mL). 
The spirocyclic ether derivative, 2 exhibited significantly greater (p < 0.05) 
inhibitory activity against constitutive pro-inflammatory COX-1 and inducible isoform 
COX-2 (IC50 0.86 and 0.65 mg/mL, respectively) when related to other compounds 
(IC50 > 0.90 and > 0.70 mg/mL, respectively) isolated from V. cyprinoides. The 
compound 2 exhibited greater COX-2 inhibitory potential followed by spirocyclic ether 
derivative 1 (IC50 0.70 mg/mL), hexahydrobenzo furanone, 3 (IC50 0.74 mg/mL) and 
furano meroterpenoid derivative, 5 (IC50 0.76 mg/mL), in descending order. The 
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spirocyclic ether derivative, 1 and irregular meroterpenoids 3 and 5 did not record any 
significant difference among each other with regard to their COX-2 inhibitory potentials 
(p > 0.05). Notably, the greater selectivity index {SI > 1.02, IC50 (anti-COX-1/anti-
COX-2)} of the compounds isolated from V. cyprinoides (1-10) were appropriately 
suggested their selective inhibition of the inducible pro-inflammatory COX-2 than the 
constitutive COX-1. Similarly, the spirocyclic ether derivatives, 1-2 (IC50 0.75-0.77 
mg/mL), hexahydrobenzo furanone, 3 (IC50 0.76 mg/mL) along with furano 
meroterpenoid, 5 (IC50 0.80 mg/mL) were exhibited significantly greater inhibitory 
potentials (p < 0.05) against pro-inflammatory 5-LOX as compared to other compounds 
and ibuprofen (IC50 > 0.90 mg/mL). No noteworthy variance (p > 0.05) in the inhibitory 
potencies towards 5-LOX was apparent for the irregular meroterpenoid, 4 (IC50 0.92 
mg/mL) and hexahydro isochromenyl meroterpenoids, 6-7 (IC50 ~0.97 mg/mL), whereas 
the bioactivities were appeared to be akin to ibuprofen (IC50 > 0.90 mg/mL). 
 Structure-activity relationship analysis of the isolated compounds were carried 
out using hydrophobic parameter (logarithmic scale of the octanol-water partition 
coefﬁcient, log Pow), electronic descriptor variables (polarizability, Pl) together with 
steric factors {molar refractivity (MR), molar volume (MV), parachor (Pr)}. The 
spirocyclic ether derivatives, 1 (log Pow 3.79) and 2 (log Pow 3.32) along with 
hexahydrobenzo furanone, 3 (log Pow 1.81) were exhibited acceptable hydrophilic-
lipophilic balance (log Pow 2-5) and found to be lesser than that of reference, α-
tocopherol showing significantly greater hydrophobilicity (log Pow 9.98). Moreover, the 
α-pyrone derivative, 4 (log Pow 3.59), furano meroterpenoid, 5 (log Pow 2.25) and 
hexahydro isochromenyl analogues, 6-7 (log Pow 3.1-4.0) were registered optimum 
hydrophobic-lipophilic balance (log Pow 2-5). The lesser bulk (steric) parameters of 
compounds 1-3 (MR 75-120 cm3/mol; MV < 375 cm3; Pr < 960 cm3) might contribute 
towards their greater radical scavenging potentials compared to α-tocopherol (MV 462.7 
cm3; Pr 1123 cm3; MR 135.06 cm3). Also, the compounds 4-7 recorded lesser bulk 
(steric) parameters (MR < 100 cm3/mol; MV < 350 cm3; Pr < 800 cm3), which might 
contribute towards their greater antioxidative potential over α-tocopherol. The 
electronic property as determined by tPSA factor was greater for compounds, 1-3 
(tPSA1 55.76; tPSA2 75.99; tPSA3 72.83) as compared to the standards, ibuprofen 
(tPSA 37.30) and α-tocopherol (tPSA 29.46), which might be correlated with the greater 
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bioactive potentials of the two irregular spirocyclic ether derivatives (1-2) and the 
irregular meroterpenoid 3. The bioactivities of the compounds 4-7 were not influenced 
by their electronic parameters and therefore, found to be insignificant in predicting their 
bioactive potentials. The lower hydrophobicity (log Pow 2.25) and lesser steric bulkiness 
along with greater electronic properties of the compounds, particularly spirocyclic ether 
derivatives, 1-2, hexahydrobenzo furanone, 3 and furano meroterpenoid derivative (5) 
imparted towards their greater bioactive potentials and bioavailability as compared to 
other compounds isolated from the bivalve clam V. cyprinoides.  
 The number of active reaction centers or the number of acidic protons available 
to neutralize the DPPH radical were predicted by the proposed mechanism of DPPH 
radical inhibition for the tilted compounds isolated from V. cyprinoides. The spirocyclic 
ether derivatives, 1-2, hexahydrobenzo furanone, 3 and furano meroterpenoid derivative, 
5 were found to enclose greater number of electron-rich active sites that can effectively 
participate in the resonance stabilization and appeared to exhibit primary role to stabilize 
the DPPH radical.  
 Molecular docking studies were determined the relations between the 
compounds (ligands) and the active sites of target inducible pro-inflammatory enzymes 
(COX-2 and 5-LOX). The greater numbers of hydrogen bonds in both the active regions 
of 5-LOX and COX-2 along with the lower values of docking parameters (binding 
energy, docking energy and inhibition constant) were recorded for compounds 1-5. In 
particular, the spirocyclic ether derivative, 2 (COX-2 number of hydrogen bonds-4; 5-
LOX number of hydrogen bonds-3) and hexahydrobenzo furanone, 3 (COX-2 number 
of hydrogen bonds-4; 5-LOX number of hydrogen bonds-3) were found to enclose 
greater number of enzyme inhibition sites for COX-2 and 5-LOX as determined by the 
hydrogen bonds. The anti-inflammatory bioactive potentials were evaluated by the in 
vitro 5-LOX and COX-2 inhibition assays for the compounds from V. cyprinoides 
deduced to be coherent with the in silico molecular docking calculations. 
The chemical investigations of EtOAc:MeOH extract of P. malabarica led to 
the isolation of different metabolites belonging to aryl polyketide derivatives (1-3), 
tetrahydro chromenyl analogues (4-5), isopimarane norditerpenoid (6), meroterpeno 2H-
pyranoids (7-8) and cholestenol derivatives (9-10). The chemical structures of these 
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previously undescribed metabolites were resolved by detailed spectroscopic analysis 
along with mass spectrometric experiments. 
 The chemical investigation of EtOAc:MeOH extract of P. malabarica 
directed to the isolation of three unprecedented aryl polyketide analogues, such as (13-
(methoxycarbonyl)-11-((E)-18-ethylhexa-16,19-dienyl)-12-propyl-cyclohex-10-enyl)-
methyl-3-hydroxy benzoate (1), isobutyl-13-(6-(benzoyloxy)-10-methylpentyl)-tetra 
hydro-13-methyl-2H-pyran-17-carboxylate (2) and (E)-12-(17-ethyl-tetrahydro-16-
hydroxy-15-(methylpentanoate)-14-oxo-2H-pyran-13-yl)-9-methyl-but-11-enyl benzoa- 
te (3). The 1H aromatic signals (δ 6.5-8.5) of the compounds 2 and 3 exhibited proton 
integral of five each, which established their monosubstituted benzyl framework, 
whereas, the compound 1 exhibited four aromatic resonances in which one was found to 
be singlet proton that designated the presence of meta disubstituted aryl ring of 1. The 
putative PKS enzyme cascade-assisted biosynthetic pathways of these previously 
unreported aryl polyketide compounds (1-3) appropriately substantiated their structural 
attributions.  
 Previously undescribed tetrahydro chromenyl derivatives, characterized as 61-
(3-((E)-31b-(furan-2’-yl)-prop-31b-en-31-yl)-4a,5,6,8a-tetrahydro-8-methyl-2H-chromen-
6-yl)-ethyl-5’’-methyl-hexanoate (4) and 7-(2’-ethyl-1’-hydroxynonan-2’-yl)-6,7,8,8a-
tetrahydro-3H-isochromen-1-(5H)-one (5) were isolated from P. malabarica. These 
were composed of furanyl-2H-tetrahydro chromenyl (4) and tetrahydro isochromen-
(5H)-one (5) moieties, which were reported for the first time in marine organism. The 
1H NMR spectrum of compound 4 was exhibited a highly deshielded singlet at δ 6.92 
showing intense HSQC interaction with the carbon at δ 124.76 (-CH-), which confirmed 
the presence of an alkenic proton attached to the highly electronegative centre of furan 
ring system. The presence of furanyl ring in compound 4 was confirmed by three 
aromatic 1H NMR resonances. The chromenyl derivatives were valuable 
pharmacophores which exhibiting important structural and functional peculiarities in 
natural product research, and receiving more prominent considerations as cardinal 
bioactive pharmacophores in present-day drug discovery. Although these groups of 
compounds constitute an important share of natural products, variation in substitution 
patterns might lead to pharmacophore templates with greater bioactivity and selectivity. 
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The present study demonstrated the isolation of 18 (4→14),19 (4→8) bis-
abeo-nor-isopimarane-1,5-diene-3-yl-3β-methoxy-propyl pentanoate (6), which 
represented the first description of C19 isopimarane norditerpenoid possessing the bis-
abeo C19 norditerpenoid framework from a natural bivalve source. Generally, the ent-
pimarane diterpenoid skeletons have 20 carbons including a methyl (-CH3) group at C-
10 whereas, the methyl at C-10 was not apparent in the titled compound, thus 
confirming the presence of norditerpenoid functionality. The usual gem-dimethyl groups 
(C-18 and C-19) found at C-4 position in isopimarane and 20-nor-isopimarane 
diterpenoids were absent at C-4 in 6. However, the -CH3 (C-18 and C-19) groups at C-4 
was shifted to C-14 and C-8 positions, respectively, and therefore, it named as 18 
(4→14),19 (4→8) bis-abeo nor-isopimarane. This unprecedented isopimarane 
derivative isolated from P. malabrica would be a potential natural alternative to the 
commercially available synthetic antioxidants and anti-inflammatory agents. 
The present study also reported the identification of two undescribed 
meroterpeno 2H-pyranoids from P. malabarica. This is the first report of biogenic 
allyloxy-(isopentanyl)-cyclohexene (7) and 2H-pyrans bearing decadienyl (8) 
frameworks from marine organisms. The C18 sesquiterpenoid with irregularly 
prenylated farnesene skeleton characterized as 2-((E)-deca-1,8-dien-10-yl)-11,12-
dihydro-13-propyl-2H-pyran (8). Another compound, 1’-((10E)-10-(10-(pentan-4-yl)-
cyclohex-4-enyl)-allyloxy)-tetrahydro-2’,2’-dimethyl-2H-pyran (7) was signified the 
first occurrence of C21 prenylated bisabolene-type meroterpenoid from a natural 
resource, while tetrahydro-2’,2’-dimethyl-2H-pyran bonded to cyclohex-4-enyl moiety 
through the allyloxy bond. The titled compounds were previously undescribed marine 
natural components possessing the pyranyl regiochemistries and found to be the first 
depiction of bioactive meroterpeno 2H-pyranoids from P. malabrica. 
 The present study was envisaged the isolation of two new sterol derivatives 
as (22E)-241,242-methyldihomocholesta-5,22-dien-3β-ol (9) and 23-gem-dimethyl 
cholesta-5-en-3β-ol (10) from P. malabarica. The C-30 dihomosterol and 23-gem-
dimethyl-3β-hydroxy-Δ5-cholestane skeleton (9-10) represent the first examples of 
steroids possessing the C-30 dihomosterol system (9) and 23-gem-dimethyl-3β-
hydroxy-Δ5-cholestane (10) framework from a natural source with bioactive pluralities. 
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The (E)-12-(17-ethyl-tetrahydro-16-hydroxy-15-(methylpentanoate)-14-oxo-
2H-pyran-13-yl)-9-methyl-but-11-enyl benzoate (3) and 61-(3-((E)-31b-(furan-2’-yl)-
prop-31b-en-31-yl)-4a,5,6,8a-tetrahydro-8-methyl-2H-chromen-6-yl)-ethyl-5’’-methyl-
hexanoate (4) were exhibited significantly greater DPPH (IC50 ~0.57 mg/mL) and 
ABTS+ (IC50 ~0.68 mg/mL) scavenging activities (p < 0.05)  as compared to other 
compounds in the series and α-tocopherol (IC50 > 0.65 mg/mL). The titled C19 
isopimarane norditerpenoid from P. malabarica not exhibited any significant difference 
(p > 0.05) in scavenging DPPH and ABTS+ free radicals (IC50 0.65 and 0.78 mg/mL, 
correspondingly) equated to α-tocopherol (IC50 0.65 and 0.76 mg/mL, respectively). No 
significant difference was apparent (p > 0.05) in ABTS+ scavenging potentials among 
compound 5 (IC50 0.79 mg/mL) and α-tocopherol (IC50 0.76 mg/mL, respectively). 
The hydroxy benzoate derivative, 3 (IC50 0.68 mg/mL) was registered greater 
inhibitory potential against pro-inflammatory COX-2 isoform followed by those of 
hydroxy benzoate, 1 (IC50 0.74 mg/mL) and furanyl-2H-tetrahydro-chromenyl, 4 (IC50 
0.72 mg/mL), in descending order. The compounds 1, 3 and 4 were registered greater 
COX-2 inhibitory potentials as compared to other compounds in this series. The potent 
5-LOX inhibitory effects were recorded for the compounds 3, 6 and 4 (IC50 ~0.76 
mg/mL) when related to other compounds and ibuprofen (IC50 > 0.80 mg/mL). The 
compounds 1 and 3 were demonstrated significantly greater inhibition towards pro-
inflammatory 5-LOX (IC50 0.81 and 0.76 mg/mL, correspondingly) than that revealed 
by ibuprofen (IC50 0.96 mg/mL) along with significantly greater selectivity (anti-COX-
1IC50/anti-COX-2IC50 > 1.05) indices compared to ibuprofen (SI < 1). Significantly 
greater 5-LOX inhibitory activities of tetrahydro chromenyl analogues (4-5) (IC50 0.76-
0.82 mg/mL) along with isopimarane norditerpenoid (6) (IC50 0.75 mg/mL) compared to 
ibuprofen (IC50 0.96 mg/mL) specified their potent anti-inflammatory effects. The 
greater selectivity (SI > 1.05) of the titled compounds, 1-10 isolated from P. malabarica 
than ibuprofen (SI 0.63) was appropriately demonstrated their selective inhibitory 
properties towards inflammatory COX-2 over COX-1.   
 Structure-activity relationship analysis of the compounds isolated from P. 
malabarica revealed the optimum hydrophilic-lipophilic balance of the aryl polyketide, 3 
(log Pow 4.81) and tetrahydro chromenyl derivatives (compounds 4-5) (log Pow 4.44-4.82). 
The hydrophobic-lipophilic properties of other compounds in the series were found to be 
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lesser (log Pow < 9) as compared to commercially used antioxidant α-tocopherol (log Pow 
9.98). The hydrophobicity of the compounds was found to be inversely proportional to 
their intermembrane permeability and bioavailability, and a greater log Pow value (> 6) 
negatively affect their bioactive properties.  Notably, the lesser electronic property of α-
tocopherol (tPSA 29.46) compared to aryl polyketides, 1-3 (tPSA > 60) and tetrahydro 
chromenyl analogues 4-5 (tPSA 44-46) appropriately signified the greater electronic 
interaction of the latter resulting in potentially greater free radical scavenging activities. 
Likewise, greater steric bulk of α-tocopherol (MR 135.06 cm3, Pr 1123 cm3) than those 
recorded with regard to aryl polyketides (MR 113-126 cm3; Pr ~1000 cm3) and tetrahydro 
chromenyl analogues, 4-5 (MR 94-122 cm3; Pr 790-970 cm3) explained their greater 
bioactivities. 
 The numbers of bioactive reaction centers in the isolated compounds from P. 
malabarica were correlated with their antioxidant potentials in the DPPH radical 
scavenging model. The aryl polyketide derivatives, particularly 3 was found to possess 
greater number of conjugated systems that could easily transfer H atom to DPPH radical 
by hydrogen atom transfer (HAT) mechanism to attain resonance stabilization, thus 
corroborating its potential DPPH radical scavenging activity (IC50 0.59 mg/mL). The 
furanyl-2H-tetrahydro chromenyl, 4 and other aryl polyketide derivatives, 1-2 were 
found to enclose antioxidative centers in their vicinities, and their antioxidant activities 
were correlated with the proposed DPPH mechanism. 
 Moreover, the in silico molecular docking studies of compounds from P. 
malabarica were carried out to determine their interactions with the active sites of pro-
inflammatory inducible COX-2 and 5-LOX enzymes. The greater number of hydrogen 
bonds (in active regions of 5-LOX and COX-2) and lesser docking parameter values 
were recorded for compounds 1-4 and 6. In specific, the aryl polyketide derivatives, 1-3 
and C19 isopimarane norditerpenoid, 6 were found to register greater number of 
enzyme inhibition sites for COX-2 and 5-LOX based on the numbers of H-bonds in 
their active sites. The in vitro 5-LOX and COX-2 anti-inflammatory analysis of the 
compounds from P. malabarica were found to exhibit linearity with the in silico 
molecular docking simulations. 
 Comprehensive analyses demonstrated that during the last decade, the typical 
percentages of bioactive compounds amongst the newer compounds are diminishing, 
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though there are a countless numbers of marine natural compounds yet to be 
investigated. This may indicated that the research level of bio-potencies is not keeping 
up with the identification of newer compounds. With innumerable bivalve clams from 
coastal ecosystem representing a large community of marine fauna, the coastal waters of 
India are acknowledged for their particular richness. The present study explored these 
two prominent bivalve clam species as a source for potentially useful bioactive 
properties, and a library of previously undescribed molecules with prospective bioactive 
properties against inflammatory mediators and reactive oxygen species. This study is 
the first of its kind to demonstrate that the low value bivalve clams V. cyprinoides and 
P. malabarica are endowed with potential bioactive properties. Furthermore, the newer 
bioactive compounds from V. cyprinoides and P. malabarica described in the present 
study will form copious resources for upcoming bioactivity guided investigations and 
development of biomedically important new pharmacological leads.  
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